OG_ID,loading,group_id,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00843,1.3522797677946397,OG_00843,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_09247,1.3140416090986515,OG_09247,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03779,1.2897255409671529,OG_03779,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_09806,1.288459860515022,OG_09806,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_05874,1.2525985941223765,OG_05874,FUN_026023-T1,Peve_00026728,Pocillopora_meandrina_HIv1___RNAseq.g10495.t1,three_way,61.43916666666667,FUN_026023-T1,Q91717,,,,,31.0,277.0,2.3e-26,123.6,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_04560,1.2443547944439286,OG_04560,FUN_022199-T1,Peve_00041449,Pocillopora_meandrina_HIv1___RNAseq.g4798.t1,three_way,67.538,,,,,,,,,,,,,,,,,
OG_04454,1.224441658833893,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,1.224441658833893,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_08859,1.207837319249153,OG_08859,FUN_038245-T1,Peve_00007985,Pocillopora_meandrina_HIv1___TS.g5460.t2,three_way,84.75483333333334,FUN_038245-T1,P24733,,,,,61.2,841.0,5e-306,1052.7,"sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",,,,,,
OG_01489,1.206119131834557,OG_01489,FUN_006165-T1,Peve_00023607,Pocillopora_meandrina_HIv1___RNAseq.g20426.t1,three_way,60.60533333333333,FUN_006165-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),33.7,5014.0,0.0,2299.2,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_08721,1.2022272050914065,OG_08721,FUN_037974-T1,Peve_00013894,Pocillopora_meandrina_HIv1___RNAseq.g26183.t1,three_way,56.88933333333333,FUN_037974-T1,Q3UHR0,,,,,27.2,746.0,2.1e-45,187.6,sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2,,,,,,
OG_09596,1.2002655762576842,OG_09596,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_09963,1.1985706409418937,OG_09963,FUN_043144-T1,Peve_00034957,Pocillopora_meandrina_HIv1___RNAseq.g6886.t1,three_way,84.25150000000001,FUN_043144-T1,Q26481,,,,,73.1,279.0,2e-116,420.2,sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3,,,,,,
OG_01200,1.1913562745198223,OG_01200,FUN_004864-T1,Peve_00043710,Pocillopora_meandrina_HIv1___RNAseq.g8629.t1,three_way,43.367666666666665,,,,,,,,,,,,,,,,,
OG_01123,1.1907719645198922,OG_01123,FUN_004691-T1,Peve_00019711,Pocillopora_meandrina_HIv1___TS.g20478.t1,three_way,79.91966666666667,FUN_004691-T1,Q9Y2I6,NINL_HUMAN,,Ninein-like protein,Homo sapiens (Human),30.6,517.0,7.2999999999999975e-47,191.8,sp|Q9Y2I6|NINL_HUMAN Ninein-like protein OS=Homo sapiens OX=9606 GN=NINL PE=1 SV=2,GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0034454,microtubule anchoring at centrosome [GO:0034454],centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874],calcium ion binding [GO:0005509],GO:0005815; GO:0005829; GO:0007010,microtubule organizing center; cytosol; cytoskeleton organization
OG_08599,1.1866390004550098,OG_08599,FUN_037741-T1,Peve_00037358,Pocillopora_meandrina_HIv1___RNAseq.g1334.t1,three_way,67.00733333333334,,,,,,,,,,,,,,,,,
OG_08709,1.1690558372333717,OG_08709,FUN_037961-T1,Peve_00009703,Pocillopora_meandrina_HIv1___RNAseq.g26230.t1,three_way,75.68066666666667,FUN_037961-T1,A7RKS5,RSSA_NEMVE,,Small ribosomal subunit protein uS2 (40S ribosomal protein SA),Nematostella vectensis (Starlet sea anemone),75.9,257.0,1e-107,391.3,sp|A7RKS5|RSSA_NEMVE Small ribosomal subunit protein uS2 OS=Nematostella vectensis OX=45351 GN=v1g198553 PE=3 SV=1,GO:0000028; GO:0002181; GO:0003735; GO:0022627,cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028],cytosolic small ribosomal subunit [GO:0022627],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0065003,cytoplasmic translation; structural molecule activity; protein-containing complex assembly
OG_09075,1.16860045823547,OG_09075,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_02158,1.1685226276089646,OG_02158,FUN_008490-T1,Peve_00028832,Pocillopora_meandrina_HIv1___RNAseq.g30381.t1,three_way,71.13933333333334,FUN_008490-T1,Q6A070,TGRM1_MOUSE,,TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B),Mus musculus (Mouse),27.4,2074.0,5.2e-149,531.2,sp|Q6A070|TGRM1_MOUSE TOG array regulator of axonemal microtubules protein 1 OS=Mus musculus OX=10090 GN=Togaram1 PE=1 SV=3,GO:0005737; GO:0005929; GO:0031116; GO:0035082; GO:0036064; GO:1905515,axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005815; GO:0005929; GO:0007010; GO:0043226; GO:0044782,microtubule organizing center; cilium; cytoskeleton organization; organelle; cilium organization
OG_02930,1.167870739178792,OG_02930,FUN_012029-T1,Peve_00044958,Pocillopora_meandrina_HIv1___RNAseq.g24045.t1,three_way,82.663,FUN_012029-T1,P11533,,,,,29.7,3968.0,0.0,1575.5,sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1,,,,,,
OG_08878,1.1626853098755416,OG_08878,FUN_038277-T1,Peve_00041700,Pocillopora_meandrina_HIv1___TS.g8098.t1,three_way,74.06316666666667,FUN_038277-T1,Q0V8S9,,,,,34.8,135.0,1.4e-13,84.7,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_04737,1.1592098487453668,OG_04737,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_05268,1.1540234842679198,OG_05268,FUN_023921-T1,Peve_00026572,Pocillopora_meandrina_HIv1___TS.g27910.t1,three_way,65.93933333333332,,,,,,,,,,,,,,,,,
OG_08830,1.1511667023393148,OG_08830,FUN_038167-T1,Peve_00025790,Pocillopora_meandrina_HIv1___RNAseq.g1070.t1,three_way,91.073,FUN_038167-T1,P23098,,,,,73.8,4465.0,0.0,6623.9,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_01161,1.1500137726805848,OG_01161,FUN_004780-T1,Peve_00037744,Pocillopora_meandrina_HIv1___RNAseq.g6689.t1,three_way,84.39833333333334,FUN_004780-T1,Q6P3J5,EF2_DANRE,,Elongation factor 2b (EF-2) (EC 3.6.5.-),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,858.0,0.0,1342.8,sp|Q6P3J5|EF2_DANRE Elongation factor 2b OS=Danio rerio OX=7955 GN=eef2b PE=1 SV=1,GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0006414; GO:0043009; GO:0043022; GO:0071466; GO:1990904,cellular response to xenobiotic stimulus [GO:0071466]; chordate embryonic development [GO:0043009]; translational elongation [GO:0006414],cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development
OG_03941,1.1490541312321314,OG_03941,FUN_016076-T1,Peve_00021921,Pocillopora_meandrina_HIv1___RNAseq.g21616.t1,three_way,70.497,FUN_016076-T1,Q9C9C6,,,,,49.4,180.0,1.2e-34,147.9,sp|Q9C9C6|RL62_ARATH Large ribosomal subunit protein eL6y OS=Arabidopsis thaliana OX=3702 GN=RPL6B PE=2 SV=1,,,,,,
OG_04999,1.14623213243913,OG_04999,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_04571,1.14502409953521,OG_04571,FUN_022218-T1,Peve_00028321,Pocillopora_meandrina_HIv1___RNAseq.g4733.t1c,three_way,83.12133333333334,FUN_022218-T1,Q6QN10,,,,,66.3,181.0,2.999999999999999e-47,189.9,sp|Q6QN10|NACA_CHILA Nascent polypeptide-associated complex subunit alpha OS=Chinchilla lanigera OX=34839 PE=2 SV=1,,,,,,
OG_07669,1.1441486569710548,OG_07669,FUN_034724-T1,Peve_00033264,Pocillopora_meandrina_HIv1___RNAseq.g28719.t1,three_way,89.57333333333334,FUN_034724-T1,P39023,RL3_HUMAN,,Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (HIV-1 TAR RNA-binding protein B) (TARBP-B),Homo sapiens (Human),72.8,397.0,2.4e-170,599.7,sp|P39023|RL3_HUMAN Large ribosomal subunit protein uL3 OS=Homo sapiens OX=9606 GN=RPL3 PE=1 SV=2,GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0022625; GO:0022626; GO:0032991; GO:0070062; GO:0071353,cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198; GO:0005634; GO:0005730; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; RNA binding; structural molecule activity; nucleus; nucleolus; cytosol; ribosome; organelle
OG_06809,1.1375200810324595,OG_06809,FUN_031708-T1,Peve_00002669,Pocillopora_meandrina_HIv1___RNAseq.g5756.t1,three_way,77.23333333333333,FUN_031708-T1,P26642,,,,,62.6,436.0,1.7000000000000001e-134,480.7,sp|P26642|EF1GA_XENLA Elongation factor 1-gamma-A OS=Xenopus laevis OX=8355 GN=eef1g-a PE=1 SV=1,,,,,,
OG_02564,1.136507609515168,OG_02564,FUN_010663-T1,Peve_00031442,Pocillopora_meandrina_HIv1___RNAseq.g21359.t1,three_way,44.581500000000005,FUN_010663-T1,Q99MV1,TDRD1_MOUSE,,Tudor domain-containing protein 1,Mus musculus (Mouse),28.6,814.0,2.1e-72,277.7,sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005829; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,cytosol; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_02795,1.135012873321995,OG_02795,FUN_011758-T1,Peve_00037784,Pocillopora_meandrina_HIv1___RNAseq.g23896.t1,three_way,91.42466666666668,FUN_011758-T1,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),63.4,4613.0,0.0,5645.5,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_08639,1.1342392147950695,OG_08639,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_06103,1.133360735763455,OG_06103,FUN_027804-T1,Peve_00036486,Pocillopora_meandrina_HIv1___RNAseq.g13899.t1,three_way,84.46000000000001,FUN_027804-T1,Q9U9L2,,,,,82.8,250.0,9.3e-123,441.0,sp|Q9U9L2|RL8_ANOGA Large ribosomal subunit protein uL2 OS=Anopheles gambiae OX=7165 GN=RpL8 PE=2 SV=2,,,,,,
OG_01330,1.129598041584303,OG_01330,FUN_005220-T1,Peve_00035492,Pocillopora_meandrina_HIv1___TS.g19865.t1,three_way,97.09066666666666,FUN_005220-T1,Q9TTR8,,,,,73.7,266.0,5e-111,402.1,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_01390,1.1274573406015622,OG_01390,FUN_005365-T1,Peve_00016036,Pocillopora_meandrina_HIv1___RNAseq.g8222.t1,three_way,83.86883333333333,FUN_005365-T1,O01727,,,,,80.4,189.0,2.900000000000001e-86,319.7,sp|O01727|RS6_BRAFL Small ribosomal subunit protein eS6 OS=Branchiostoma floridae OX=7739 GN=RPS6 PE=3 SV=1,,,,,,
OG_02088,1.1271637947754425,OG_02088,FUN_008314-T1,Peve_00026747,Pocillopora_meandrina_HIv1___RNAseq.g5785.t1,three_way,57.846,,,,,,,,,,,,,,,,,
OG_02599,1.124561320356317,OG_02599,FUN_010720-T1,Peve_00029905,Pocillopora_meandrina_HIv1___RNAseq.g20949.t2,three_way,83.7885,FUN_010720-T1,P58197,AP2A_RAT,,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),Rattus norvegicus (Rat),63.4,227.0,3.3e-68,260.8,sp|P58197|AP2A_RAT Transcription factor AP-2-alpha OS=Rattus norvegicus OX=10116 GN=Tfap2a PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001501; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:1990837; GO:2000378,anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559],clathrin-coated pit [GO:0005905]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0012501; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; extracellular matrix organization; organelle; anatomical structure development; cell motility; nervous system process; molecular adaptor activity; transcription regulator activity
OG_10090,1.121435647166466,OG_10090,FUN_043420-T1,Peve_00005576,Pocillopora_meandrina_HIv1___TS.g1600.t1,three_way,92.59866666666667,FUN_043420-T1,Q13813,,,,,59.0,2468.0,0.0,2752.6,"sp|Q13813|SPTN1_HUMAN Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTAN1 PE=1 SV=3",,,,,,
OG_05875,1.118370164128111,OG_05875,FUN_026024-T1,Peve_00026729,Pocillopora_meandrina_HIv1___RNAseq.g10496.t1,three_way,59.858,FUN_026024-T1,O46392,,,,,37.0,216.0,5.4e-35,152.1,sp|O46392|CO1A2_CANLF Collagen alpha-2(I) chain OS=Canis lupus familiaris OX=9615 GN=COL1A2 PE=2 SV=2,,,,,,
OG_00936,1.1173954409934326,OG_00936,FUN_004285-T1,Peve_00018587,Pocillopora_meandrina_HIv1___TS.g7877.t1,three_way,51.23383333333334,FUN_004285-T1,Q15811,,,,,38.4,86.0,2.3e-07,60.1,sp|Q15811|ITSN1_HUMAN Intersectin-1 OS=Homo sapiens OX=9606 GN=ITSN1 PE=1 SV=3,,,,,,
OG_05401,1.1147944631196751,OG_05401,FUN_024332-T1,Peve_00016315,Pocillopora_meandrina_HIv1___RNAseq.g18928.t1,three_way,91.02566666666668,FUN_024332-T1,A7S3J7,,,,,82.1,263.0,2.4e-123,443.0,sp|A7S3J7|RS3A_NEMVE Small ribosomal subunit protein eS1 OS=Nematostella vectensis OX=45351 GN=v1g242621 PE=3 SV=1,,,,,,
OG_02331,1.1113683368498306,OG_02331,FUN_008924-T1,Peve_00028630,Pocillopora_meandrina_HIv1___RNAseq.g14267.t1,three_way,80.87533333333333,FUN_008924-T1,O76756,,,,,75.1,209.0,9.500000000000001e-86,317.8,sp|O76756|RS8_APIME Small ribosomal subunit protein eS8 OS=Apis mellifera OX=7460 GN=RpS8 PE=2 SV=2,,,,,,
OG_02734,1.1110409991083896,OG_02734,FUN_011264-T1,Peve_00030536,Pocillopora_meandrina_HIv1___RNAseq.g22310.t1,three_way,79.29683333333332,FUN_011264-T1,P02401,,,,,70.6,68.0,7.3e-19,94.7,sp|P02401|RLA2_RAT Large ribosomal subunit protein P2 OS=Rattus norvegicus OX=10116 GN=Rplp2 PE=1 SV=2,,,,,,
OG_01437,1.108745337673702,OG_01437,FUN_005873-T1,Peve_00015756,Pocillopora_meandrina_HIv1___RNAseq.g19664.t1,three_way,58.21833333333333,,,,,,,,,,,,,,,,,
OG_05445,1.1078536646048098,OG_05445,FUN_024401-T1,Peve_00033232,Pocillopora_meandrina_HIv1___RNAseq.g18633.t1,three_way,75.52233333333334,FUN_024401-T1,P20595,GCYB1_RAT,,Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit),Rattus norvegicus (Rat),46.0,620.0,2.1e-138,494.6,sp|P20595|GCYB1_RAT Guanylate cyclase soluble subunit beta-1 OS=Rattus norvegicus OX=10116 GN=Gucy1b1 PE=1 SV=2,GO:0004383; GO:0005525; GO:0005829; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0032991; GO:0038060; GO:0044877; GO:0046872; GO:0051879; GO:0070026; GO:0070482; GO:0071732; GO:0098831; GO:0098978,cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482],"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone cytoplasmic component [GO:0098831]; protein-containing complex [GO:0032991]",GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005829; GO:0009975; GO:0016829; GO:0055086; GO:1901135,catalytic activity; cytosol; cyclase activity; lyase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02112,1.1058042187818544,OG_02112,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_02305,1.1004094771673114,OG_02305,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,42.3,137.0,2.1e-31,140.2,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_02305,1.1004094771673114,OG_02305,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,46.9,128.0,2.5e-29,133.3,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_00071,1.0985945839405722,OG_00071,FUN_000393-T1,Peve_00033591,Pocillopora_meandrina_HIv1___RNAseq.g2528.t1,three_way,82.34016666666666,FUN_000393-T1,P08429,,,,,65.9,349.0,9.9e-131,468.0,sp|P08429|RL4A_XENLA Large ribosomal subunit protein uL4A OS=Xenopus laevis OX=8355 GN=rpl4-a PE=2 SV=2,,,,,,
OG_06574,1.0970811633209745,OG_06574,FUN_029519-T1,Peve_00022876,Pocillopora_meandrina_HIv1___TS.g2888.t1,three_way,93.70616666666666,FUN_029519-T1,Q9JHU4,DYHC1_MOUSE,,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",Mus musculus (Mouse),73.3,4665.0,0.0,6825.7,sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2,GO:0003341; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0008569; GO:0016887; GO:0030175; GO:0030286; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1905832,cell division [GO:0051301]; cilium movement [GO:0003341]; establishment of spindle localization [GO:0051293]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; filopodium [GO:0030175]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0016787; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; hydrolase activity; isomerase activity; ATP-dependent activity
OG_09436,1.0935951928059804,OG_09436,FUN_041408-T1,Peve_00017539,Pocillopora_meandrina_HIv1___RNAseq.g15729.t1,three_way,62.90833333333333,,,,,,,,,,,,,,,,,
OG_04359,1.0933643172352283,OG_04359,FUN_018010-T1,Peve_00000404,Pocillopora_meandrina_HIv1___RNAseq.g25255.t4,three_way,81.14033333333334,FUN_018010-T1,A2CG49,,,,,35.3,3036.0,0.0,1707.6,sp|A2CG49|KALRN_MOUSE Kalirin OS=Mus musculus OX=10090 GN=Kalrn PE=1 SV=1,,,,,,
OG_08594,1.093341414987747,OG_08594,FUN_037709-T1,Peve_00027437,Pocillopora_meandrina_HIv1___RNAseq.g1402.t1,three_way,58.09033333333333,FUN_037709-T1,E7F1U2,DNMBP_DANRE,,Dynamin-binding protein (Scaffold protein Tuba),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,728.0,7.8e-103,377.5,sp|E7F1U2|DNMBP_DANRE Dynamin-binding protein OS=Danio rerio OX=7955 GN=dnmbp PE=2 SV=1,GO:0001822; GO:0005085; GO:0005737; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793,cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005794; GO:0005856; GO:0043226; GO:0044782; GO:0048856; GO:0098772,Golgi apparatus; cytoskeleton; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_00314,1.0930460050225763,OG_00314,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_01493,1.0925779160389062,OG_01493,FUN_006169-T1,Peve_00021028,Pocillopora_meandrina_HIv1___RNAseq.g20427.t1,three_way,83.96716666666667,FUN_006169-T1,Q80UV9,TAF1_MOUSE,,Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250),Mus musculus (Mouse),45.8,1844.0,0.0,1349.7,sp|Q80UV9|TAF1_MOUSE Transcription initiation factor TFIID subunit 1 OS=Mus musculus OX=10090 GN=Taf1 PE=1 SV=2,GO:0003677; GO:0004402; GO:0004674; GO:0005524; GO:0005634; GO:0005669; GO:0016251; GO:0017025; GO:0042789; GO:0045120; GO:0051123; GO:0060261; GO:0071339; GO:0106310; GO:1990841,mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123],MLL1 complex [GO:0071339]; nucleus [GO:0005634]; pronucleus [GO:0045120]; transcription factor TFIID complex [GO:0005669],ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025],GO:0003677; GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0043226; GO:0065003; GO:0140096; GO:0140223,"DNA binding; catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; general transcription initiation factor activity"
OG_02762,1.0909381966443472,OG_02762,FUN_011699-T1,Peve_00018060,Pocillopora_meandrina_HIv1___RNAseq.g23827.t1,three_way,86.615,FUN_011699-T1,P47836,,,,,73.9,241.0,3.3e-106,386.0,sp|P47836|RS4_CHICK Small ribosomal subunit protein eS4 OS=Gallus gallus OX=9031 GN=RPS4 PE=1 SV=2,,,,,,
OG_01955,1.0906408264762115,OG_01955,FUN_008021-T1,Peve_00031303,Pocillopora_meandrina_HIv1___RNAseq.g30342.t1,three_way,69.569,,,,,,,,,,,,,,,,,
OG_07128,1.089371813999579,OG_07128,FUN_032428-T1,Peve_00007849,Pocillopora_meandrina_HIv1___RNAseq.g24119.t1,three_way,84.269,FUN_032428-T1,P14148,RL7_MOUSE,,Large ribosomal subunit protein uL30 (60S ribosomal protein L7),Mus musculus (Mouse),78.3,180.0,4.8e-79,295.8,sp|P14148|RL7_MOUSE Large ribosomal subunit protein uL30 OS=Mus musculus OX=10090 GN=Rpl7 PE=1 SV=2,GO:0000463; GO:0002181; GO:0003677; GO:0003729; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0022625; GO:0042802; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242; GO:1990904,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202],DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003677; GO:0003723; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; DNA binding; RNA binding; structural molecule activity; cytosol; ribosome; organelle
OG_04711,1.0880742163898158,OG_04711,FUN_022518-T1,Peve_00030465,Pocillopora_meandrina_HIv1___TS.g21661.t1,three_way,66.89816666666665,FUN_022518-T1,Q99996,AKAP9_HUMAN,,A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao),Homo sapiens (Human),36.4,291.0,1.9e-34,152.1,sp|Q99996|AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens OX=9606 GN=AKAP9 PE=1 SV=4,GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007268; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0034237; GO:0034705; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0098909; GO:0098978; GO:0099104; GO:0099147; GO:1903358,cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165],centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076],DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325],GO:0003677; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0023052; GO:0043226; GO:0060090; GO:0098772,DNA binding; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; signaling; organelle; molecular adaptor activity; molecular function regulator activity
OG_01728,1.0873411860657318,OG_01728,FUN_007020-T1,Peve_00037180,Pocillopora_meandrina_HIv1___RNAseq.g20542.t1,three_way,63.67233333333333,FUN_007020-T1,Q6ZZY0,,,,,46.9,497.0,1.3e-139,499.6,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_02420,1.0842688963888083,OG_02420,FUN_009308-T1,Peve_00021835,Pocillopora_meandrina_HIv1___RNAseq.g14442.t1,three_way,91.04433333333331,FUN_009308-T1,Q0MQI6,,,,,83.0,442.0,4.8e-226,785.0,"sp|Q0MQI6|NDUV1_PANTR NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial OS=Pan troglodytes OX=9598 GN=NDUFV1 PE=2 SV=1",,,,,,
OG_02355,1.0799074319301176,OG_02355,FUN_008958-T1,Peve_00021624,Pocillopora_meandrina_HIv1___RNAseq.g4045.t1,three_way,88.27633333333334,FUN_008958-T1,P36241,,,,,80.5,77.0,5.2e-27,121.7,sp|P36241|RL19_DROME Large ribosomal subunit protein eL19 OS=Drosophila melanogaster OX=7227 GN=RpL19 PE=1 SV=2,,,,,,
OG_05572,1.0781159215591574,OG_05572,FUN_024815-T1,Peve_00026076,Pocillopora_meandrina_HIv1___RNAseq.g18772.t1,three_way,69.34433333333334,FUN_024815-T1,Q96PE2,ARHGH_HUMAN,,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),Homo sapiens (Human),40.1,1066.0,9.2e-179,630.2,sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056,actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0007010; GO:0098772,cytosol; cytoskeleton organization; molecular function regulator activity
OG_03690,1.0770702984398044,OG_03690,FUN_014952-T1,Peve_00006246,Pocillopora_meandrina_HIv1___RNAseq.g21119.t1,three_way,65.61866666666666,,,,,,,,,,,,,,,,,
OG_08284,1.076894586151008,OG_08284,FUN_036208-T1,Peve_00038733,Pocillopora_meandrina_HIv1___RNAseq.g27354.t1,three_way,51.08383333333333,FUN_036208-T1,Q5F363,,,,,36.3,658.0,8.7e-114,414.1,sp|Q5F363|JARD2_CHICK Protein Jumonji OS=Gallus gallus OX=9031 GN=JARID2 PE=2 SV=1,,,,,,
OG_03230,1.076820882229611,OG_03230,FUN_012772-T1,Peve_00007600,Pocillopora_meandrina_HIv1___RNAseq.g13653.t1,three_way,86.02266666666667,FUN_012772-T1,Q9DFQ7,,,,,76.6,111.0,5.199999999999999e-43,175.6,sp|Q9DFQ7|RL24_GILMI Large ribosomal subunit protein eL24 OS=Gillichthys mirabilis OX=8222 GN=rpl24 PE=2 SV=2,,,,,,
OG_04647,1.0739714042779978,OG_04647,FUN_022379-T1,Peve_00013225,Pocillopora_meandrina_HIv1___RNAseq.g9304.t1,three_way,65.24716666666666,FUN_022379-T1,Q13439,,,,,31.5,124.0,1.8e-06,57.0,sp|Q13439|GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens OX=9606 GN=GOLGA4 PE=1 SV=1,,,,,,
OG_03139,1.0738600755819934,OG_03139,FUN_012521-T1,Peve_00029780,Pocillopora_meandrina_HIv1___RNAseq.g23961.t1,three_way,79.82916666666667,FUN_012521-T1,Q3SZ90,RL13A_BOVIN,,Large ribosomal subunit protein uL13 (60S ribosomal protein L13a),Bos taurus (Bovine),63.1,195.0,5.899999999999999e-68,259.6,sp|Q3SZ90|RL13A_BOVIN Large ribosomal subunit protein uL13 OS=Bos taurus OX=9913 GN=RPL13A PE=2 SV=3,GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0032496; GO:0042592; GO:0045202; GO:0048246; GO:0060425; GO:0071346; GO:0097452; GO:1901194,cellular response to type II interferon [GO:0071346]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; synapse [GO:0045202],mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002376; GO:0003723; GO:0005198; GO:0005840; GO:0043226; GO:0048870,immune system process; RNA binding; structural molecule activity; ribosome; organelle; cell motility
OG_08491,1.0737501562892453,OG_08491,FUN_037330-T1,Peve_00006234,Pocillopora_meandrina_HIv1___RNAseq.g10692.t1,three_way,60.120000000000005,FUN_037330-T1,Q8IVV2,,,,,39.6,273.0,5.8e-47,192.2,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_07978,1.0733055983938935,OG_07978,FUN_035600-T1,Peve_00027480,Pocillopora_meandrina_HIv1___RNAseq.g28038.t1,three_way,84.73833333333333,FUN_035600-T1,Q9T043,,,,,54.9,133.0,1.4e-32,140.6,sp|Q9T043|RL142_ARATH Large ribosomal subunit protein eL14y OS=Arabidopsis thaliana OX=3702 GN=RPL14B PE=1 SV=1,,,,,,
OG_02351,1.072438155298387,OG_02351,FUN_008952-T1,Peve_00037679,Pocillopora_meandrina_HIv1___RNAseq.g4051.t1,three_way,70.46833333333333,FUN_008952-T1,Q8TDM6,,,,,31.0,1363.0,9.8e-134,480.3,sp|Q8TDM6|DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4,,,,,,
OG_08856,1.0712151215587284,OG_08856,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_06310,1.070981677535755,OG_06310,FUN_028549-T1,Peve_00000746,Pocillopora_meandrina_HIv1___RNAseq.g6218.t1,three_way,56.03633333333333,FUN_028549-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),30.5,285.0,4.8e-29,131.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_10002,1.0687461230774695,OG_10002,FUN_043236-T1,Peve_00001435,Pocillopora_meandrina_HIv1___RNAseq.g6748.t1,three_way,69.04316666666666,FUN_043236-T1,Q30D77,COOA1_MOUSE,,Collagen alpha-1(XXIV) chain,Mus musculus (Mouse),41.1,107.0,1.5e-17,94.0,sp|Q30D77|COOA1_MOUSE Collagen alpha-1(XXIV) chain OS=Mus musculus OX=10090 GN=Col24a1 PE=2 SV=2,GO:0002244; GO:0005201; GO:0005576; GO:0005581; GO:0062023,hematopoietic progenitor cell differentiation [GO:0002244],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030154,structural molecule activity; extracellular region; cell differentiation
OG_01906,1.067818909195849,OG_01906,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),61.6,620.0,3.3e-199,697.6,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01906,1.067818909195849,OG_01906,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),40.4,146.0,3.1999999999999997e-29,132.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_02358,1.067810519488679,OG_02358,FUN_008961-T1,Peve_00006948,Pocillopora_meandrina_HIv1___RNAseq.g4042.t1,three_way,60.446,,,,,,,,,,,,,,,,,
OG_08852,1.0677756121617663,OG_08852,FUN_038217-T1,Peve_00038841,Pocillopora_meandrina_HIv1___RNAseq.g901.t2,three_way,66.15016666666666,FUN_038217-T1,Q9UKN7,,,,,32.5,2688.0,0.0,1096.6,sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2,,,,,,
OG_00295,1.0673117224533768,OG_00295,FUN_001086-T1,Peve_00003185,Pocillopora_meandrina_HIv1___RNAseq.g29387.t1,three_way,66.87883333333333,FUN_001086-T1,Q6DRG7,MYPT1_DANRE,,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),Danio rerio (Zebrafish) (Brachydanio rerio),65.8,225.0,9.999999999999999e-33,143.7,sp|Q6DRG7|MYPT1_DANRE Protein phosphatase 1 regulatory subunit 12A OS=Danio rerio OX=7955 GN=ppp1r12a PE=2 SV=2,GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0017020; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0030510; GO:0031017; GO:0031672; GO:0046982; GO:0048812; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357,actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; neuron projection morphogenesis [GO:0048812]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165],A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018],14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0048856; GO:0098772,anatomical structure development; molecular function regulator activity
OG_00295,1.0673117224533768,OG_00295,FUN_001086-T1,Peve_00003185,Pocillopora_meandrina_HIv1___RNAseq.g29387.t1,three_way,66.87883333333333,FUN_001086-T1,Q6DRG7,MYPT1_DANRE,,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),Danio rerio (Zebrafish) (Brachydanio rerio),81.6,38.0,1.9e-07,59.7,sp|Q6DRG7|MYPT1_DANRE Protein phosphatase 1 regulatory subunit 12A OS=Danio rerio OX=7955 GN=ppp1r12a PE=2 SV=2,GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0017020; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0030510; GO:0031017; GO:0031672; GO:0046982; GO:0048812; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357,actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; neuron projection morphogenesis [GO:0048812]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165],A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018],14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0048856; GO:0098772,anatomical structure development; molecular function regulator activity
OG_01391,1.066486373457166,OG_01391,FUN_005366-T1,Peve_00041492,Pocillopora_meandrina_HIv1___RNAseq.g6638.t1,three_way,90.41666666666669,FUN_005366-T1,Q9CR47,,,,,71.3,174.0,1.5999999999999999e-62,240.7,sp|Q9CR47|NSA2_MOUSE Ribosome biogenesis protein NSA2 homolog OS=Mus musculus OX=10090 GN=Nsa2 PE=2 SV=1,,,,,,
OG_09598,1.0653310618631755,OG_09598,FUN_041745-T1,Peve_00000338,Pocillopora_meandrina_HIv1___RNAseq.g15790.t1,three_way,56.4945,,,,,,,,,,,,,,,,,
OG_02309,1.0652166605950586,OG_02309,FUN_008889-T1,Peve_00020945,Pocillopora_meandrina_HIv1___RNAseq.g4003.t1,three_way,51.47683333333334,FUN_008889-T1,D3Z8E6,CAMP1_RAT,,Calmodulin-regulated spectrin-associated protein 1,Rattus norvegicus (Rat),43.7,142.0,7.000000000000001e-32,142.1,sp|D3Z8E6|CAMP1_RAT Calmodulin-regulated spectrin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Camsap1 PE=1 SV=2,GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0036449; GO:0051011,cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule minus-end [GO:0036449],calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507],GO:0007010; GO:0008092,cytoskeleton organization; cytoskeletal protein binding
OG_08647,1.0642762081897368,OG_08647,FUN_037838-T1,Peve_00000575,Pocillopora_meandrina_HIv1___TS.g22869.t1,three_way,95.46833333333332,FUN_037838-T1,P62265,,,,,88.2,152.0,1.3e-68,260.4,sp|P62265|RS14_CRIGR Small ribosomal subunit protein uS11 OS=Cricetulus griseus OX=10029 GN=RPS14 PE=2 SV=3,,,,,,
OG_02855,1.062097411079642,OG_02855,FUN_011893-T1,Peve_00008033,Pocillopora_meandrina_HIv1___TS.g16684.t2,three_way,72.4585,FUN_011893-T1,Q9WVE9,ITSN1_RAT,,Intersectin-1 (EH domain and SH3 domain regulator of endocytosis 1),Rattus norvegicus (Rat),40.1,1088.0,5.1e-58,228.0,sp|Q9WVE9|ITSN1_RAT Intersectin-1 OS=Rattus norvegicus OX=10116 GN=Itsn1 PE=1 SV=2,GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007267; GO:0008104; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0042734; GO:0043025; GO:0043195; GO:0043197; GO:0043524; GO:0044305; GO:0048488; GO:0051402; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098843; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288,cell-cell signaling [GO:0007267]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase-mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488],apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone [GO:0098833]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; terminal bouton [GO:0043195],calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064],GO:0005635; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0060090; GO:0098772,nuclear envelope; endosome; cytosol; cytoskeleton; plasma membrane; programmed cell death; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular function regulator activity
OG_02220,1.0617754911391768,OG_02220,FUN_008615-T1,Peve_00015389,Pocillopora_meandrina_HIv1___RNAseq.g12744.t1,three_way,73.05916666666667,FUN_008615-T1,O35161,CELR1_MOUSE,,Cadherin EGF LAG seven-pass G-type receptor 1,Mus musculus (Mouse),33.5,2618.0,0.0,1375.5,sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3,GO:0001736; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007166; GO:0007266; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475,anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell surface receptor signaling pathway [GO:0007166]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060],membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005886; GO:0007155; GO:0042060; GO:0048856; GO:0048870; GO:0060089,nucleoplasm; plasma membrane; cell adhesion; wound healing; anatomical structure development; cell motility; molecular transducer activity
OG_05387,1.0616229556977788,OG_05387,FUN_024208-T1,Peve_00031873,Pocillopora_meandrina_HIv1___RNAseq.g18905.t1b,three_way,71.887,FUN_024208-T1,O09167,RL21_MOUSE,,Large ribosomal subunit protein eL21 (60S ribosomal protein L21),Mus musculus (Mouse),65.0,160.0,4.7e-52,206.1,sp|O09167|RL21_MOUSE Large ribosomal subunit protein eL21 OS=Mus musculus OX=10090 GN=Rpl21 PE=1 SV=4,GO:0002181; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098794,cytoplasmic translation [GO:0002181],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; postsynapse [GO:0098794]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005783; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; endoplasmic reticulum; cytosol; ribosome; organelle
OG_06270,1.0614558871839752,OG_06270,FUN_028301-T1,Peve_00000714,Pocillopora_meandrina_HIv1___TS.g10572.t1,three_way,51.42816666666666,FUN_028301-T1,D3ZSP7,TTC3_RAT,,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D),Rattus norvegicus (Rat),27.5,741.0,7.4e-62,241.5,sp|D3ZSP7|TTC3_RAT E3 ubiquitin-protein ligase TTC3 OS=Rattus norvegicus OX=10116 GN=Ttc3 PE=3 SV=3,GO:0004842; GO:0005634; GO:0005773; GO:0005794; GO:0006511; GO:0008270; GO:0030517; GO:0045665; GO:0070936,negative regulation of axon extension [GO:0030517]; negative regulation of neuron differentiation [GO:0045665]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; vacuole [GO:0005773],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005773; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vacuole; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05958,1.061384064565981,OG_05958,FUN_026305-T1,Peve_00025709,Pocillopora_meandrina_HIv1___RNAseq.g3058.t1,three_way,89.43866666666666,FUN_026305-T1,P21613,,,,,58.8,972.0,2.4e-239,830.5,sp|P21613|KINH_DORPE Kinesin heavy chain OS=Doryteuthis pealeii OX=1051067 PE=1 SV=1,,,,,,
OG_00827,1.0601961279855798,OG_00827,FUN_004056-T1,Peve_00007130,Pocillopora_meandrina_HIv1___TS.g18499.t1,three_way,72.9045,FUN_004056-T1,Q6P0Q8,MAST2_HUMAN,,Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1),Homo sapiens (Human),43.5,1429.0,1.8999999999999995e-236,821.2,sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2,GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310,cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_06612,1.0581260293821286,OG_06612,FUN_029763-T1,Peve_00019504,Pocillopora_meandrina_HIv1___RNAseq.g17323.t1,three_way,61.1925,FUN_029763-T1,Q6PCS4,,,,,36.2,716.0,2.9e-92,342.0,sp|Q6PCS4|RHG29_DANRE Rho GTPase-activating protein 29 OS=Danio rerio OX=7955 GN=arhgap29 PE=2 SV=1,,,,,,
OG_07251,1.0580423106099466,OG_07251,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,9.999999999999999e-116,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_09390,1.056355226610384,OG_09390,FUN_040686-T1,Peve_00007674,Pocillopora_meandrina_HIv1___RNAseq.g6452.t1,three_way,90.56466666666668,FUN_040686-T1,G1U0Q2,,,,,80.8,146.0,1.8e-62,240.0,sp|G1U0Q2|RS15_RABIT Small ribosomal subunit protein uS19 OS=Oryctolagus cuniculus OX=9986 GN=RPS15 PE=1 SV=1,,,,,,
OG_08994,1.0563003118753758,OG_08994,FUN_038524-T1,Peve_00041750,Pocillopora_meandrina_HIv1___RNAseq.g28186.t1,three_way,79.337,FUN_038524-T1,Q8BKX6,SMG1_MOUSE,,Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1),Mus musculus (Mouse),37.7,3713.0,0.0,2274.6,sp|Q8BKX6|SMG1_MOUSE Serine/threonine-protein kinase SMG1 OS=Mus musculus OX=10090 GN=Smg1 PE=1 SV=3,GO:0000184; GO:0004674; GO:0005524; GO:0005654; GO:0006281; GO:0032204; GO:0033391; GO:0042162; GO:0046854; GO:0046872; GO:0106310,"DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of telomere maintenance [GO:0032204]",chromatoid body [GO:0033391]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005654; GO:0006281; GO:0006629; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleoplasm; DNA repair; lipid metabolic process; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08289,1.0549078901346962,OG_08289,FUN_036224-T1,Peve_00025944,Pocillopora_meandrina_HIv1___RNAseq.g27547.t1,three_way,76.61933333333333,FUN_036224-T1,P41123,,,,,62.6,211.0,9e-68,258.1,sp|P41123|RL13_RAT Large ribosomal subunit protein eL13 OS=Rattus norvegicus OX=10116 GN=Rpl13 PE=1 SV=2,,,,,,
OG_05252,1.054778548439622,OG_05252,FUN_023700-T1,Peve_00017416,Pocillopora_meandrina_HIv1___RNAseq.g17595.t2b,three_way,81.831,FUN_023700-T1,O14776,TCRG1_HUMAN,,Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150),Homo sapiens (Human),60.9,274.0,1.7000000000000001e-65,251.1,sp|O14776|TCRG1_HUMAN Transcription elongation regulator 1 OS=Homo sapiens OX=9606 GN=TCERG1 PE=1 SV=2,GO:0000122; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0061629; GO:0070063,mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation factor activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390],GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0140110,RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_00060,1.053745579612649,OG_00060,FUN_000352-T1,Peve_00033531,Pocillopora_meandrina_HIv1___RNAseq.g29116.t1,three_way,77.85483333333333,FUN_000352-T1,P18395,,,,,46.0,817.0,5.600000000000001e-180,632.9,sp|P18395|CSDE1_RAT Cold shock domain-containing protein E1 OS=Rattus norvegicus OX=10116 GN=Csde1 PE=2 SV=1,,,,,,
OG_03839,1.0526683290150065,OG_03839,FUN_015298-T1,Peve_00004801,Pocillopora_meandrina_HIv1___RNAseq.g22106.t1,three_way,63.3705,FUN_015298-T1,Q8QFX1,,,,,28.4,1242.0,2.3999999999999997e-83,313.2,sp|Q8QFX1|RIMB2_CHICK RIMS-binding protein 2 OS=Gallus gallus OX=9031 GN=RIMBP2 PE=1 SV=1,,,,,,
OG_05430,1.0517716100051964,OG_05430,FUN_024376-T1,Peve_00020239,Pocillopora_meandrina_HIv1___RNAseq.g18601.t1,three_way,98.059,FUN_024376-T1,Q3T169,RS3_BOVIN,,Small ribosomal subunit protein uS3 (EC 4.2.99.18) (40S ribosomal protein S3),Bos taurus (Bovine),90.4,239.0,1.4e-120,433.7,sp|Q3T169|RS3_BOVIN Small ribosomal subunit protein uS3 OS=Bos taurus OX=9913 GN=RPS3 PE=2 SV=1,GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235,apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003677; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005730; GO:0006281; GO:0012501; GO:0016829; GO:0043226; GO:0140097,"DNA binding; RNA binding; catalytic activity; structural molecule activity; nucleus; nucleolus; DNA repair; programmed cell death; lyase activity; organelle; catalytic activity, acting on DNA"
OG_09850,1.051201058782192,OG_09850,FUN_042841-T1,Peve_00007267,Pocillopora_meandrina_HIv1___RNAseq.g7258.t1,three_way,84.73333333333333,FUN_042841-T1,Q2TBQ5,RL7A_BOVIN,,Large ribosomal subunit protein eL8 (60S ribosomal protein L7a),Bos taurus (Bovine),63.1,263.0,3.5e-85,316.2,sp|Q2TBQ5|RL7A_BOVIN Large ribosomal subunit protein eL8 OS=Bos taurus OX=9913 GN=RPL7A PE=2 SV=3,GO:0000470; GO:0003723; GO:0003735; GO:0005730; GO:0016020; GO:0022625; GO:0045202,maturation of LSU-rRNA [GO:0000470],cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; synapse [GO:0045202],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_06174,1.0503562645210645,OG_06174,FUN_028030-T1,Peve_00044201,Pocillopora_meandrina_HIv1___RNAseq.g13933.t1,three_way,44.60566666666666,,,,,,,,,,,,,,,,,
OG_09597,1.0497905570738562,OG_09597,FUN_041744-T1,Peve_00000340,Pocillopora_meandrina_HIv1___RNAseq.g15789.t1,three_way,72.12516666666667,,,,,,,,,,,,,,,,,
OG_00708,1.0443467469982328,OG_00708,FUN_002469-T1,Peve_00034012,Pocillopora_meandrina_HIv1___TS.g4051.t1,three_way,74.81733333333334,FUN_002469-T1,Q7TMY8,HUWE1_MOUSE,,"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (E3Histone) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",Mus musculus (Mouse),41.0,4757.0,0.0,2664.4,sp|Q7TMY8|HUWE1_MOUSE E3 ubiquitin-protein ligase HUWE1 OS=Mus musculus OX=10090 GN=Huwe1 PE=1 SV=5,GO:0000209; GO:0003677; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006284; GO:0006513; GO:0030154; GO:0031398; GO:0032922; GO:0035359; GO:0043123; GO:0043161; GO:0061630; GO:0070936; GO:0140852; GO:0141198,base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; transferase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_05274,1.0438946537034994,OG_05274,FUN_023928-T1,Peve_00026565,Pocillopora_meandrina_HIv1___TS.g27906.t1a,three_way,36.54933333333333,FUN_023928-T1,Q3V2Q8,N42L1_MOUSE,,NEDD4-binding protein 2-like 1,Mus musculus (Mouse),51.4,175.0,3.6999999999999997e-41,172.2,sp|Q3V2Q8|N42L1_MOUSE NEDD4-binding protein 2-like 1 OS=Mus musculus OX=10090 GN=N4bp2l1 PE=1 SV=1,,,,,,
OG_07364,1.0430391869947089,OG_07364,FUN_033776-T1,Peve_00005287,Pocillopora_meandrina_HIv1___RNAseq.g26654.t1,three_way,88.918,FUN_033776-T1,P47830,,,,,77.0,148.0,7.8e-42,171.4,sp|P47830|RL27A_XENLA Large ribosomal subunit protein uL15 OS=Xenopus laevis OX=8355 GN=rpl27a PE=2 SV=2,,,,,,
OG_09562,1.0428787549767449,OG_09562,FUN_041672-T1,Peve_00007760,Pocillopora_meandrina_HIv1___RNAseq.g14001.t1,three_way,59.1795,,,,,,,,,,,,,,,,,
OG_02321,1.042183653383125,OG_02321,FUN_008913-T1,Peve_00033015,Pocillopora_meandrina_HIv1___RNAseq.g3978.t1,three_way,86.956,FUN_008913-T1,Q56K14,RLA1_BOVIN,,Large ribosomal subunit protein P1 (60S acidic ribosomal protein P1),Bos taurus (Bovine),67.7,65.0,1.8e-17,90.1,sp|Q56K14|RLA1_BOVIN Large ribosomal subunit protein P1 OS=Bos taurus OX=9913 GN=RPLP1 PE=3 SV=1,GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0030295; GO:0043021,cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414],cytosolic large ribosomal subunit [GO:0022625],protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0098772,cytoplasmic translation; structural molecule activity; molecular function regulator activity
OG_08449,1.0420119760057531,OG_08449,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),43.2,586.0,1.7999999999999998e-127,459.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08449,1.0420119760057531,OG_08449,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),49.5,105.0,7.2e-15,85.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_04652,1.0419078207669192,OG_04652,FUN_022389-T1,Peve_00037602,Pocillopora_meandrina_HIv1___TS.g19607.t1,three_way,66.46,FUN_022389-T1,D3Z2X2,DNHD1_MOUSE,,Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein),Mus musculus (Mouse),22.8,4456.0,4.4999999999999995e-257,891.3,sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3,GO:0005524; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0045505; GO:0051959; GO:0120316,flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316],dynein complex [GO:0030286]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; isomerase activity; reproductive process; organelle; cilium organization; cell motility; ATP-dependent activity
OG_03145,1.0413363538067446,OG_03145,FUN_012531-T1,Peve_00013910,Pocillopora_meandrina_HIv1___RNAseq.g23956.t1c,three_way,73.822,FUN_012531-T1,Q32LP2,RADI_BOVIN,,Radixin,Bos taurus (Bovine),71.5,583.0,2.8e-132,473.8,sp|Q32LP2|RADI_BOVIN Radixin OS=Bos taurus OX=9913 GN=RDX PE=2 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0008360; GO:0030175; GO:0032154; GO:0045177; GO:0050839; GO:0051693; GO:0120044; GO:1902115; GO:1902966; GO:2000643,actin filament capping [GO:0051693]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839],GO:0005856; GO:0005886; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_01630,1.039531454099584,OG_01630,FUN_006744-T1,Peve_00039581,Pocillopora_meandrina_HIv1___RNAseq.g20530.t1,three_way,63.90916666666666,FUN_006744-T1,Q8BNA6,FAT3_MOUSE,,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Mus musculus (Mouse),33.8,4122.0,0.0,2094.3,sp|Q8BNA6|FAT3_MOUSE Protocadherin Fat 3 OS=Mus musculus OX=10090 GN=Fat3 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:1904936; GO:2000171,cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],dendrite [GO:0030425]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0048856; GO:0048870,plasma membrane; cell adhesion; anatomical structure development; cell motility
OG_06717,1.038666976757134,OG_06717,FUN_031467-T1,Peve_00026558,Pocillopora_meandrina_HIv1___RNAseq.g5084.t2,three_way,78.09566666666667,FUN_031467-T1,Q5RDQ2,PALS1_PONAB,,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),46.4,576.0,2.3e-140,501.5,sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1,GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204,central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204],ATP binding [GO:0005524],GO:0005794; GO:0043226; GO:0048856,Golgi apparatus; organelle; anatomical structure development
OG_07951,1.0382741799775612,OG_07951,FUN_035476-T1,Peve_00033971,Pocillopora_meandrina_HIv1___TS.g14334.t1b,three_way,75.7615,FUN_035476-T1,Q58EX7,PKHG4_HUMAN,,Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1),Homo sapiens (Human),31.9,906.0,1.4e-119,433.0,sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056,axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0098772,cytosol; plasma membrane; molecular function regulator activity
OG_09471,1.037873912302246,OG_09471,FUN_041497-T1,Peve_00017073,Pocillopora_meandrina_HIv1___RNAseq.g15661.t1,three_way,80.51666666666667,FUN_041497-T1,P62046,,,,,32.5,711.0,2.7e-36,155.2,sp|P62046|LRCH1_MOUSE Leucine-rich repeat and calponin homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrch1 PE=1 SV=2,,,,,,
OG_01295,1.0378307331604215,OG_01295,FUN_005120-T1,Peve_00026681,Pocillopora_meandrina_HIv1___TS.g20003.t1,three_way,92.25233333333334,FUN_005120-T1,P37380,,,,,81.6,185.0,9.3e-77,287.7,sp|P37380|RL17_PODCA Large ribosomal subunit protein uL22 OS=Podocoryna carnea OX=6096 GN=RPL17 PE=2 SV=1,,,,,,
OG_00154,1.0376182705177437,OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),47.8,912.0,6.499999999999998e-229,796.2,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_00154,1.0376182705177437,OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),37.4,286.0,1.3e-27,127.5,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_03546,1.03761353372641,OG_03546,FUN_014673-T1,Peve_00013033,Pocillopora_meandrina_HIv1___RNAseq.g22680.t1,three_way,77.56683333333334,FUN_014673-T1,Q96AY4,TTC28_HUMAN,,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),Homo sapiens (Human),44.3,828.0,5.7e-171,604.4,sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4,GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301,cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922],kinase binding [GO:0019900],GO:0005815,microtubule organizing center
OG_00570,1.036738790981992,OG_00570,FUN_001628-T1,Peve_00009929,Pocillopora_meandrina_HIv1___RNAseq.g2165.t1,three_way,85.88366666666667,FUN_001628-T1,P49706,,,,,57.9,290.0,2.8e-88,326.6,sp|P49706|CCND2_CHICK G1/S-specific cyclin-D2 OS=Gallus gallus OX=9031 GN=CCND2 PE=3 SV=1,,,,,,
OG_08049,1.0365455456971462,OG_08049,FUN_035737-T1,Peve_00044088,Pocillopora_meandrina_HIv1___RNAseq.g11864.t1,three_way,77.52216666666666,FUN_035737-T1,Q8BYH8,CHD9_MOUSE,,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.-) (ATP-dependent helicase CHD9) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),Mus musculus (Mouse),43.2,2161.0,0.0,1496.1,sp|Q8BYH8|CHD9_MOUSE Chromodomain-helicase-DNA-binding protein 9 OS=Mus musculus OX=10090 GN=Chd9 PE=1 SV=2,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005829; GO:0006325; GO:0016887,chromatin organization [GO:0006325],cytosol [GO:0005829]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0140657,DNA binding; catalytic activity; nucleoplasm; cytosol; chromatin organization; hydrolase activity; isomerase activity; ATP-dependent activity
OG_02560,1.0364596300547757,OG_02560,FUN_010659-T1,Peve_00031472,Pocillopora_meandrina_HIv1___RNAseq.g21313.t1,three_way,90.361,FUN_010659-T1,Q76I81,,,,,81.8,121.0,1.5999999999999996e-53,209.9,sp|Q76I81|RS12_BOVIN Small ribosomal subunit protein eS12 OS=Bos taurus OX=9913 GN=RPS12 PE=2 SV=1,,,,,,
OG_08990,1.036306035855636,OG_08990,FUN_038512-T1,Peve_00041679,Pocillopora_meandrina_HIv1___RNAseq.20620_t,three_way,87.99716666666667,FUN_038512-T1,Q6P1M3,L2GL2_HUMAN,,LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2),Homo sapiens (Human),41.5,959.0,1.6e-203,711.4,sp|Q6P1M3|L2GL2_HUMAN LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0008593; GO:0009791; GO:0015820; GO:0016332; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0035264; GO:0043231; GO:0045159; GO:0045197; GO:0051294; GO:0051301; GO:0060670; GO:0060716,branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; labyrinthine layer blood vessel development [GO:0060716]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0043226; GO:0048856; GO:0098772,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_00533,1.036261114065636,OG_00533,FUN_001547-T1,Peve_00020470,Pocillopora_meandrina_HIv1___RNAseq.g2064.t1,three_way,91.406,FUN_001547-T1,E9Q8T7,DYH1_MOUSE,,Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7),Mus musculus (Mouse),64.2,4208.0,0.0,5480.6,sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1,GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0007288; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288],extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; cytoskeleton organization; microtubule-based movement; isomerase activity; reproductive process; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_03764,1.0361683828172112,OG_03764,FUN_015089-T1,Peve_00010705,Pocillopora_meandrina_HIv1___RNAseq.g21187.t1,three_way,72.56533333333334,FUN_015089-T1,Q71F56,MD13L_HUMAN,,Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like),Homo sapiens (Human),29.0,2382.0,7.899999999999999e-204,713.4,sp|Q71F56|MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens OX=9606 GN=MED13L PE=1 SV=1,GO:0003713; GO:0005654; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592]; nucleoplasm [GO:0005654],transcription coactivator activity [GO:0003713],GO:0005654; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_03925,1.0361668228626228,OG_03925,FUN_016037-T1,Peve_00011810,Pocillopora_meandrina_HIv1___RNAseq.g21651.t1,three_way,74.29166666666667,FUN_016037-T1,F6ZDS4,TPR_MOUSE,,Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein),Mus musculus (Mouse),40.7,1012.0,4.0000000000000014e-74,282.7,sp|F6ZDS4|TPR_MOUSE Nucleoprotein TPR OS=Mus musculus OX=10090 GN=Tpr PE=1 SV=1,GO:0000122; GO:0000775; GO:0003682; GO:0003729; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006913; GO:0007094; GO:0010965; GO:0015031; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein transport [GO:0015031]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056],GO:0003723; GO:0005198; GO:0005635; GO:0006355; GO:0006913; GO:0043226,RNA binding; structural molecule activity; nuclear envelope; regulation of DNA-templated transcription; nucleocytoplasmic transport; organelle
OG_03925,1.0361668228626228,OG_03925,FUN_016037-T1,Peve_00011810,Pocillopora_meandrina_HIv1___RNAseq.g21651.t1,three_way,74.29166666666667,FUN_016037-T1,F6ZDS4,TPR_MOUSE,,Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein),Mus musculus (Mouse),34.5,145.0,1.9e-07,61.2,sp|F6ZDS4|TPR_MOUSE Nucleoprotein TPR OS=Mus musculus OX=10090 GN=Tpr PE=1 SV=1,GO:0000122; GO:0000775; GO:0003682; GO:0003729; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006913; GO:0007094; GO:0010965; GO:0015031; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein transport [GO:0015031]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056],GO:0003723; GO:0005198; GO:0005635; GO:0006355; GO:0006913; GO:0043226,RNA binding; structural molecule activity; nuclear envelope; regulation of DNA-templated transcription; nucleocytoplasmic transport; organelle
OG_08400,1.033554413399797,OG_08400,FUN_037048-T1,Peve_00032330,Pocillopora_meandrina_HIv1___RNAseq.g26794.t1,three_way,85.69433333333333,FUN_037048-T1,Q56JU9,,,,,76.4,127.0,1e-40,167.5,sp|Q56JU9|RS24_BOVIN Small ribosomal subunit protein eS24 OS=Bos taurus OX=9913 GN=RPS24 PE=2 SV=2,,,,,,
OG_03369,1.0321353149376793,OG_03369,FUN_013615-T1,Peve_00002656,Pocillopora_meandrina_HIv1___RNAseq.g13534.t1,three_way,66.598,FUN_013615-T1,Q6Y7W8,,,,,35.4,621.0,1.4999999999999999e-40,170.2,sp|Q6Y7W8|GGYF2_MOUSE GRB10-interacting GYF protein 2 OS=Mus musculus OX=10090 GN=Gigyf2 PE=1 SV=2,,,,,,
OG_09892,1.031225543127002,OG_09892,FUN_042971-T1,Peve_00039041,Pocillopora_meandrina_HIv1___RNAseq.g7105.t1,three_way,58.312333333333335,FUN_042971-T1,Q9NRR4,,,,,54.2,879.0,1.8999999999999998e-283,977.6,sp|Q9NRR4|RNC_HUMAN Ribonuclease 3 OS=Homo sapiens OX=9606 GN=DROSHA PE=1 SV=2,,,,,,
OG_00581,1.0310263556248769,OG_00581,FUN_001654-T1,Peve_00038365,Pocillopora_meandrina_HIv1___RNAseq.g29407.t1,three_way,87.83066666666666,FUN_001654-T1,Q4R7Y4,GBLP_MACFA,,"Small ribosomal subunit protein RACK1 (Guanine nucleotide-binding protein subunit beta-2-like 1) [Cleaved into: Small ribosomal subunit protein RACK1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),83.1,313.0,2.1e-132,473.4,sp|Q4R7Y4|GBLP_MACFA Small ribosomal subunit protein RACK1 OS=Macaca fascicularis OX=9541 GN=GNB2L1 PE=2 SV=3,GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005840; GO:0006915; GO:0007369; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032436; GO:0032880; GO:0042169; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0045182; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:1990904; GO:2000114; GO:2000543,apoptotic process [GO:0006915]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840],protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; translation regulator activity [GO:0045182],GO:0005634; GO:0005840; GO:0012501; GO:0043226; GO:0045182; GO:0098772,nucleus; ribosome; programmed cell death; organelle; translation regulator activity; molecular function regulator activity
OG_01884,1.030900993210622,OG_01884,FUN_007860-T1,Peve_00044448,Pocillopora_meandrina_HIv1___TS.g21287.t1,three_way,81.536,FUN_007860-T1,Q6ZPV2,,,,,48.0,1450.0,1.3e-305,1051.2,sp|Q6ZPV2|INO80_MOUSE Chromatin-remodeling ATPase INO80 OS=Mus musculus OX=10090 GN=Ino80 PE=1 SV=2,,,,,,
OG_01456,1.030692285234049,OG_01456,FUN_005914-T1,Peve_00008476,Pocillopora_meandrina_HIv1___RNAseq.g19568.t1,three_way,83.68299999999999,FUN_005914-T1,Q3T199,,,,,93.0,143.0,3.500000000000001e-71,268.9,sp|Q3T199|RS23_BOVIN Small ribosomal subunit protein uS12 OS=Bos taurus OX=9913 GN=RPS23 PE=1 SV=1,,,,,,
OG_02232,1.0304570118114436,OG_02232,FUN_008642-T1,Peve_00031673,Pocillopora_meandrina_HIv1___RNAseq.g9.t1,three_way,77.27466666666666,FUN_008642-T1,Q3ZC89,MAP2_BOVIN,,Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M),Bos taurus (Bovine),79.0,367.0,2.6e-176,619.8,sp|Q3ZC89|MAP2_BOVIN Methionine aminopeptidase 2 OS=Bos taurus OX=9913 GN=METAP2 PE=2 SV=1,GO:0004177; GO:0004239; GO:0005737; GO:0006508; GO:0008235; GO:0046872; GO:0070006,proteolysis [GO:0006508],cytoplasm [GO:0005737],aminopeptidase activity [GO:0004177]; initiator methionyl aminopeptidase activity [GO:0004239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_09706,1.030214030129302,OG_09706,FUN_041940-T1,Peve_00023590,Pocillopora_meandrina_HIv1___RNAseq.g15638.t2,three_way,64.672,FUN_041940-T1,Q9UPV0,CE164_HUMAN,,Centrosomal protein of 164 kDa (Cep164),Homo sapiens (Human),68.5,89.0,1.8e-32,143.7,sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3,GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539,cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],,GO:0005615; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0043226; GO:0044782,extracellular space; nucleoplasm; microtubule organizing center; cytosol; DNA repair; organelle; cilium organization
OG_09706,1.030214030129302,OG_09706,FUN_041940-T1,Peve_00023590,Pocillopora_meandrina_HIv1___RNAseq.g15638.t2,three_way,64.672,FUN_041940-T1,Q9UPV0,CE164_HUMAN,,Centrosomal protein of 164 kDa (Cep164),Homo sapiens (Human),29.7,138.0,2.2e-06,57.0,sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3,GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539,cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],,GO:0005615; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0043226; GO:0044782,extracellular space; nucleoplasm; microtubule organizing center; cytosol; DNA repair; organelle; cilium organization
OG_06522,1.0287610699966272,OG_06522,FUN_029339-T1,Peve_00023361,Pocillopora_meandrina_HIv1___RNAseq.g17301.t1,three_way,61.434333333333335,FUN_029339-T1,Q01973,ROR1_HUMAN,,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",Homo sapiens (Human),31.6,773.0,1.1000000000000001e-118,429.1,sp|Q01973|ROR1_HUMAN Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens OX=9606 GN=ROR1 PE=1 SV=2,GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0015026; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092,astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0006355; GO:0016740; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_03321,1.0286061782286853,OG_03321,FUN_013400-T1,Peve_00028081,Pocillopora_meandrina_HIv1___RNAseq.g22939.t1,three_way,70.60533333333333,FUN_013400-T1,B5DE31,YBOX1_DANRE,,Y-box-binding protein 1 (YB-1) (ZfY1) (Y-box transcription factor),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,107.0,1e-40,168.7,sp|B5DE31|YBOX1_DANRE Y-box-binding protein 1 OS=Danio rerio OX=7955 GN=ybx1 PE=1 SV=1,GO:0000932; GO:0001556; GO:0003676; GO:0003723; GO:0005634; GO:0006397; GO:0007343; GO:0008190; GO:0008327; GO:0008380; GO:0008544; GO:0010468; GO:0017148; GO:0035198; GO:0043009; GO:0045947; GO:0048025; GO:0048255; GO:0048598; GO:0050658; GO:0050686; GO:0051031; GO:0051236; GO:0062153; GO:0070062; GO:1990428; GO:2000773,"chordate embryonic development [GO:0043009]; egg activation [GO:0007343]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; establishment of RNA localization [GO:0051236]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of mRNA processing [GO:0050686]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; oocyte maturation [GO:0001556]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]",extracellular exosome [GO:0070062]; nucleus [GO:0005634]; P-body [GO:0000932],C5-methylcytidine-containing RNA reader activity [GO:0062153]; eukaryotic initiation factor 4E binding [GO:0008190]; methyl-CpG binding [GO:0008327]; miRNA binding [GO:0035198]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0060090,DNA binding; RNA binding; nucleus; mRNA metabolic process; reproductive process; organelle; anatomical structure development; molecular adaptor activity
OG_08898,1.0285710816005402,OG_08898,FUN_038311-T1,Peve_00020693,Pocillopora_meandrina_HIv1___RNAseq.g1142.t1,three_way,76.04366666666667,FUN_038311-T1,Q8R5K6,,,,,43.3,217.0,3.7999999999999996e-39,163.3,sp|Q8R5K6|TOB1_RAT Protein Tob1 OS=Rattus norvegicus OX=10116 GN=Tob1 PE=1 SV=1,,,,,,
OG_07645,1.0285446639552922,OG_07645,FUN_034460-T1,Peve_00025955,Pocillopora_meandrina_HIv1___RNAseq.g25842.t2,three_way,66.28216666666667,FUN_034460-T1,Q8QGX4,PRKDC_CHICK,,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1),Gallus gallus (Chicken),40.0,1500.0,3.2e-308,1059.7,sp|Q8QGX4|PRKDC_CHICK DNA-dependent protein kinase catalytic subunit OS=Gallus gallus OX=9031 GN=PRKDC PE=2 SV=1,GO:0000723; GO:0000724; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0008630; GO:0031571; GO:0033152; GO:0035979; GO:0042254; GO:0070419; GO:0106310,double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; ribosome biogenesis [GO:0042254]; telomere maintenance [GO:0000723],nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016740; GO:0032200; GO:0042254; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; transferase activity; telomere organization; ribosome biogenesis; organelle; catalytic activity, acting on a protein"
OG_09636,1.0279702105880917,OG_09636,FUN_041827-T1,Peve_00039124,Pocillopora_meandrina_HIv1___RNAseq.g15809.t1,three_way,78.95666666666666,FUN_041827-T1,Q9UL03,,,,,53.7,536.0,5.9e-156,552.4,sp|Q9UL03|INT6_HUMAN Integrator complex subunit 6 OS=Homo sapiens OX=9606 GN=INTS6 PE=1 SV=1,,,,,,
OG_01656,1.02783681420992,OG_01656,FUN_006826-T1,Peve_00023770,Pocillopora_meandrina_HIv1___RNAseq.g20475.t1,three_way,76.18166666666667,,,,,,,,,,,,,,,,,
OG_07375,1.0277202618756858,OG_07375,FUN_033797-T1,Peve_00029703,Pocillopora_meandrina_HIv1___RNAseq.g26319.t1,three_way,67.2325,FUN_033797-T1,O95071,,,,,39.0,318.0,1.5e-52,211.1,sp|O95071|UBR5_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2,,,,,,
OG_04723,1.0272041226959985,OG_04723,FUN_022586-T1,Peve_00020593,Pocillopora_meandrina_HIv1___RNAseq.g4434.t2,three_way,67.00133333333333,FUN_022586-T1,Q9BE31,,,,,29.9,632.0,8e-77,289.7,sp|Q9BE31|RHG12_MACFA Rho GTPase-activating protein 12 OS=Macaca fascicularis OX=9541 GN=ARHGAP12 PE=2 SV=1,,,,,,
OG_06259,1.0255069470674352,OG_06259,FUN_028277-T1,Peve_00018996,Pocillopora_meandrina_HIv1___RNAseq.g15500.t2,three_way,61.196,,,,,,,,,,,,,,,,,
OG_03252,1.025402807904746,OG_03252,FUN_012983-T1,Peve_00028830,Pocillopora_meandrina_HIv1___RNAseq.g30380.t2,three_way,73.10633333333334,,,,,,,,,,,,,,,,,
OG_02833,1.0248861746559326,OG_02833,FUN_011848-T1,Peve_00034362,Pocillopora_meandrina_HIv1___TS.g16261.t2,three_way,56.089333333333336,,,,,,,,,,,,,,,,,
OG_08474,1.0241921150913442,OG_08474,FUN_037291-T1,Peve_00032666,Pocillopora_meandrina_HIv1___RNAseq.22530_t,three_way,88.56233333333334,FUN_037291-T1,Q5EAD6,RL15_BOVIN,,Large ribosomal subunit protein eL15 (60S ribosomal protein L15),Bos taurus (Bovine),76.0,204.0,2.1e-90,333.2,sp|Q5EAD6|RL15_BOVIN Large ribosomal subunit protein eL15 OS=Bos taurus OX=9913 GN=RPL15 PE=2 SV=3,GO:0002181; GO:0003723; GO:0003735; GO:0022625,cytoplasmic translation [GO:0002181],cytosolic large ribosomal subunit [GO:0022625],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198,cytoplasmic translation; RNA binding; structural molecule activity
OG_05672,1.0235779661942728,OG_05672,FUN_025466-T1,Peve_00043837,Pocillopora_meandrina_HIv1___RNAseq.g13240.t1,three_way,86.86633333333333,FUN_025466-T1,Q8VDJ3,,,,,52.2,1291.0,0.0,1320.8,sp|Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus OX=10090 GN=Hdlbp PE=1 SV=1,,,,,,
OG_06768,1.0233840008633188,OG_06768,FUN_031608-T1,Peve_00012512,Pocillopora_meandrina_HIv1___RNAseq.g5967.t1,three_way,78.76383333333334,FUN_031608-T1,Q92541,RTF1_HUMAN,,RNA polymerase-associated protein RTF1 homolog,Homo sapiens (Human),48.1,349.0,1e-80,302.4,sp|Q92541|RTF1_HUMAN RNA polymerase-associated protein RTF1 homolog OS=Homo sapiens OX=9606 GN=RTF1 PE=1 SV=4,GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0006368; GO:0016055; GO:0016593; GO:0019827,blastocyst growth [GO:0001832]; chromatin organization [GO:0006325]; endodermal cell fate commitment [GO:0001711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0043226,DNA binding; RNA binding; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; organelle
OG_07349,1.0233804561046986,OG_07349,FUN_033756-T1,Peve_00004915,Pocillopora_meandrina_HIv1___RNAseq.g28747.t1,three_way,85.5945,FUN_033756-T1,Q13136,LIPA1_HUMAN,,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),Homo sapiens (Human),45.4,1218.0,1.3e-187,658.7,sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1,GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077,cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444],,GO:0005829; GO:0007010; GO:0007155; GO:0034330; GO:0043226,cytosol; cytoskeleton organization; cell adhesion; cell junction organization; organelle
OG_01608,1.022973927819775,OG_01608,FUN_006652-T1,Peve_00029039,Pocillopora_meandrina_HIv1___RNAseq.g19955.t1,three_way,64.58433333333333,FUN_006652-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),32.4,1666.0,2.3000000000000004e-224,781.6,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_01081,1.022744098590018,OG_01081,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),27.6,757.0,3.299999999999999e-41,172.6,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01081,1.022744098590018,OG_01081,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),34.8,224.0,3.6e-27,125.9,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_03909,1.0226073635157176,OG_03909,FUN_015985-T1,Peve_00024008,Pocillopora_meandrina_HIv1___RNAseq.g21401.t1,three_way,57.967666666666666,,,,,,,,,,,,,,,,,
OG_04464,1.0221610387564417,OG_04464,FUN_019346-T1,Peve_00032914,Pocillopora_meandrina_HIv1___RNAseq.g20864.t1,three_way,58.6805,FUN_019346-T1,Q80XP9,WNK3_MOUSE,,Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3),Mus musculus (Mouse),68.5,378.0,6e-143,510.8,sp|Q80XP9|WNK3_MOUSE Serine/threonine-protein kinase WNK3 OS=Mus musculus OX=10090 GN=Wnk3 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005912; GO:0005923; GO:0006884; GO:0007231; GO:0010765; GO:0010800; GO:0035633; GO:0043066; GO:0044325; GO:0050801; GO:0051928; GO:0070294; GO:0071474; GO:0072659; GO:0090188; GO:0090279; GO:0106310; GO:0140693; GO:0140694; GO:0141109; GO:1903077; GO:1903078; GO:1904062; GO:2000651,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; maintenance of blood-brain barrier [GO:0035633]; membraneless organelle assembly [GO:0140694]; monoatomic ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; osmosensory signaling pathway [GO:0007231]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of calcium ion import [GO:0090279]; regulation of monoatomic cation transmembrane transport [GO:1904062]; renal sodium ion absorption [GO:0070294],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transmembrane transporter binding [GO:0044325]; transporter activator activity [GO:0141109],GO:0003014; GO:0003824; GO:0016740; GO:0060090; GO:0072659; GO:0098772; GO:0140096,"renal system process; catalytic activity; transferase activity; molecular adaptor activity; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08405,1.0217525278328734,OG_08405,FUN_037056-T1,Peve_00018389,Pocillopora_meandrina_HIv1___RNAseq.g26785.t1,three_way,92.43566666666666,FUN_037056-T1,P23358,,,,,79.1,163.0,2.6e-70,266.2,sp|P23358|RL12_RAT Large ribosomal subunit protein uL11 OS=Rattus norvegicus OX=10116 GN=Rpl12 PE=2 SV=1,,,,,,
OG_01425,1.0194766237075286,OG_01425,FUN_005812-T1,Peve_00039600,Pocillopora_meandrina_HIv1___RNAseq.g19558.t1,three_way,91.84433333333334,FUN_005812-T1,Q8WXX0,DYH7_HUMAN,,Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2),Homo sapiens (Human),54.7,4000.0,0.0,4338.5,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0016887; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729,cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_02571,1.0180003517041805,OG_02571,FUN_010674-T1,Peve_00044786,Pocillopora_meandrina_HIv1___RNAseq.g21350.t1,three_way,81.68766666666667,FUN_010674-T1,O75116,ROCK2_HUMAN,,"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)",Homo sapiens (Human),50.3,445.0,8.199999999999999e-109,396.7,sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=4,GO:0000281; GO:0001837; GO:0001934; GO:0002020; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007266; GO:0008270; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0036464; GO:0042752; GO:0043410; GO:0044788; GO:0045019; GO:0045616; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061133; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; mitotic cytokinesis [GO:0000281]; modulation by host of viral process [GO:0044788]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; zinc ion binding [GO:0008270],GO:0000910; GO:0003012; GO:0003013; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0030154; GO:0043226; GO:0072659; GO:0098772; GO:0140096,"cytokinesis; muscle system process; circulatory system process; RNA binding; catalytic activity; structural molecule activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; cell differentiation; organelle; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01002,1.0176058686788043,OG_01002,FUN_004421-T1,Peve_00026932,Pocillopora_meandrina_HIv1___RNAseq.g16665.t1,three_way,58.136,FUN_004421-T1,F1NWE3,,,,,29.1,1542.0,2.5e-170,601.7,sp|F1NWE3|PTPRS_CHICK Receptor-type tyrosine-protein phosphatase S OS=Gallus gallus OX=9031 GN=PTPRS PE=1 SV=3,,,,,,
OG_07956,1.0170385061599738,OG_07956,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999993e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_04633,1.0160426326651713,OG_04633,FUN_022346-T1,Peve_00018538,Pocillopora_meandrina_HIv1___RNAseq.g4661.t1,three_way,98.06033333333332,FUN_022346-T1,Q3T057,RL23_BOVIN,,Large ribosomal subunit protein uL14 (60S ribosomal protein L23),Bos taurus (Bovine),92.1,139.0,2.0999999999999997e-68,259.6,sp|Q3T057|RL23_BOVIN Large ribosomal subunit protein uL14 OS=Bos taurus OX=9913 GN=RPL23 PE=2 SV=2,GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0045202; GO:0050821; GO:0070180; GO:0070314; GO:0072717; GO:1901798; GO:1903450; GO:1990948; GO:2000059,cellular response to actinomycin D [GO:0072717]; G1 to G0 transition [GO:0070314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; regulation of G1 to G0 transition [GO:1903450]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202],large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005198; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0098772,RNA binding; structural molecule activity; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_01876,1.0155923492133976,OG_01876,FUN_007849-T1,Peve_00039898,Pocillopora_meandrina_HIv1___RNAseq.g18286.t1,three_way,90.37933333333334,FUN_007849-T1,O00470,MEIS1_HUMAN,,Homeobox protein Meis1,Homo sapiens (Human),58.7,349.0,4.1e-94,347.1,sp|O00470|MEIS1_HUMAN Homeobox protein Meis1 OS=Homo sapiens OX=9606 GN=MEIS1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001654; GO:0002089; GO:0003677; GO:0003682; GO:0005634; GO:0005667; GO:0007420; GO:0007626; GO:0008284; GO:0009880; GO:0009887; GO:0030097; GO:0035855; GO:0045638; GO:0045665; GO:0045944; GO:0060216; GO:0061049,angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell growth involved in cardiac muscle cell development [GO:0061049]; definitive hemopoiesis [GO:0060216]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; lens morphogenesis in camera-type eye [GO:0002089]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944],chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_07318,1.014258581091546,OG_07318,FUN_033711-T1,Peve_00014636,Pocillopora_meandrina_HIv1___RNAseq.g28838.t1,three_way,71.58500000000001,FUN_033711-T1,O00418,EF2K_HUMAN,,Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase),Homo sapiens (Human),45.3,695.0,2.2e-155,550.8,sp|O00418|EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens OX=9606 GN=EEF2K PE=1 SV=2,GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637,cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]",GO:0003824; GO:0005829; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02978,1.0132188173571657,OG_02978,FUN_012145-T1,Peve_00033299,Pocillopora_meandrina_HIv1___RNAseq.g23871.t1,three_way,72.78233333333333,FUN_012145-T1,Q9Y6R4,M3K4_HUMAN,,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),Homo sapiens (Human),35.0,1732.0,4.6e-247,856.7,sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2,GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745,chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_04024,1.0128882347648167,OG_04024,FUN_016330-T1,Peve_00032370,Pocillopora_meandrina_HIv1___RNAseq.g9857.t2,three_way,82.74833333333333,FUN_016330-T1,Q9NRC6,SPTN5_HUMAN,,"Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)",Homo sapiens (Human),28.1,3578.0,0.0,1392.1,"sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2",GO:0002046; GO:0003779; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007030; GO:0007041; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030054; GO:0030507; GO:0030864; GO:0032029; GO:0032391; GO:0034452; GO:0042802; GO:0042995; GO:0045179; GO:0045505; GO:0051015; GO:0051693; GO:0097381,actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041],apical cortex [GO:0045179]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; spectrin [GO:0008091],actin binding [GO:0003779]; actin filament binding [GO:0051015]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; opsin binding [GO:0002046]; spectrin binding [GO:0030507],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_09902,1.012573440025001,OG_09902,FUN_042998-T1,Peve_00015176,Pocillopora_meandrina_HIv1___RNAseq.g7022.t1,three_way,83.66866666666667,FUN_042998-T1,Q6ZWV7,RL35_MOUSE,,Large ribosomal subunit protein uL29 (60S ribosomal protein L35),Mus musculus (Mouse),78.7,122.0,6.5e-42,171.4,sp|Q6ZWV7|RL35_MOUSE Large ribosomal subunit protein uL29 OS=Mus musculus OX=10090 GN=Rpl35 PE=1 SV=1,GO:0000463; GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; cytosol; ribosome; organelle
OG_01846,1.0122164000451497,OG_01846,FUN_007795-T1,Peve_00022050,Pocillopora_meandrina_HIv1___TS.g21334.t1,three_way,60.86366666666667,FUN_007795-T1,Q9NR09,BIRC6_HUMAN,,Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),Homo sapiens (Human),29.0,4083.0,0.0,1173.3,sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3,GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237,apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802],cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; nucleus; endosome; microtubule organizing center; cytosol; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06846,1.0119458231020728,OG_06846,FUN_031787-T1,Peve_00019324,Pocillopora_meandrina_HIv1___RNAseq.g5568.t1,three_way,65.77866666666667,FUN_031787-T1,A7Z026,,,,,44.6,294.0,6.300000000000001e-65,250.4,sp|A7Z026|PPR37_BOVIN Protein phosphatase 1 regulatory subunit 37 OS=Bos taurus OX=9913 GN=PPP1R37 PE=2 SV=1,,,,,,
OG_08930,1.0114774384228833,OG_08930,FUN_038392-T1,Peve_00000048,Pocillopora_meandrina_HIv1___RNAseq.g28264.t1,three_way,76.04899999999999,FUN_038392-T1,P16065,,,,,36.6,998.0,4.3999999999999996e-160,567.0,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_05005,1.0114467166099057,OG_05005,FUN_023153-T1,Peve_00014158,Pocillopora_meandrina_HIv1___RNAseq.g17694.t1,three_way,72.7995,FUN_023153-T1,Q9Y2H2,SAC2_HUMAN,,Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2),Homo sapiens (Human),48.1,774.0,2e-204,714.5,sp|Q9Y2H2|SAC2_HUMAN Phosphatidylinositide phosphatase SAC2 OS=Homo sapiens OX=9606 GN=INPP5F PE=1 SV=3,GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0043231; GO:0043491; GO:0043812; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135,adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135],axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037],inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803],GO:0003012; GO:0003824; GO:0005768; GO:0006629; GO:0016192; GO:0016787; GO:0031410; GO:0043226,muscle system process; catalytic activity; endosome; lipid metabolic process; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_03999,1.011439068932437,OG_03999,FUN_016288-T1,Peve_00010631,Pocillopora_meandrina_HIv1___RNAseq.g397.t1,three_way,75.145,FUN_016288-T1,Q9Z315,,,,,40.3,769.0,9.7e-115,416.0,sp|Q9Z315|SNUT1_MOUSE U4/U6.U5 tri-snRNP-associated protein 1 OS=Mus musculus OX=10090 GN=Sart1 PE=1 SV=1,,,,,,
OG_06014,1.0113483468177764,OG_06014,FUN_026541-T1,Peve_00020321,Pocillopora_meandrina_HIv1___RNAseq.g4240.t1,three_way,62.72516666666667,FUN_026541-T1,P55197,AF10_HUMAN,,Protein AF-10 (ALL1-fused gene from chromosome 10 protein),Homo sapiens (Human),78.8,184.0,1.1999999999999999e-90,336.3,sp|P55197|AF10_HUMAN Protein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0031491; GO:0032991; GO:0042393; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; histone binding; organelle
OG_06014,1.0113483468177764,OG_06014,FUN_026541-T1,Peve_00020321,Pocillopora_meandrina_HIv1___RNAseq.g4240.t1,three_way,62.72516666666667,FUN_026541-T1,P55197,AF10_HUMAN,,Protein AF-10 (ALL1-fused gene from chromosome 10 protein),Homo sapiens (Human),46.3,67.0,7.8e-10,67.8,sp|P55197|AF10_HUMAN Protein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0031491; GO:0032991; GO:0042393; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; histone binding; organelle
OG_08722,1.011330545296629,OG_08722,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),36.1,280.0,6.1e-42,174.9,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08722,1.011330545296629,OG_08722,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),43.2,148.0,5.4e-22,108.6,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_01550,1.0099225155601497,OG_01550,FUN_006425-T1,Peve_00043546,Pocillopora_meandrina_HIv1___TS.g29666.t1,three_way,69.39816666666667,FUN_006425-T1,Q96P50,,,,,30.0,253.0,1.1e-26,124.4,"sp|Q96P50|ACAP3_HUMAN Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ACAP3 PE=1 SV=2",,,,,,
OG_01418,1.0099038625979695,OG_01418,FUN_005725-T1,Peve_00039545,Pocillopora_meandrina_HIv1___RNAseq.g19424.t1,three_way,40.257666666666665,,,,,,,,,,,,,,,,,
OG_10055,1.0092379064436374,OG_10055,FUN_043349-T1,Peve_00043040,Pocillopora_meandrina_HIv1___TS.g20680.t2,three_way,60.5675,FUN_043349-T1,P20909,,,,,33.1,236.0,3.2e-34,149.4,sp|P20909|COBA1_RAT Collagen alpha-1(XI) chain OS=Rattus norvegicus OX=10116 GN=Col11a1 PE=1 SV=2,,,,,,
OG_06098,1.0089901638460543,OG_06098,FUN_027734-T1,Peve_00036493,Pocillopora_meandrina_HIv1___RNAseq.g13905.t1,three_way,66.03566666666666,FUN_027734-T1,Q86YF9,DZIP1_HUMAN,,Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1),Homo sapiens (Human),28.4,334.0,1.3e-27,127.1,sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0043231; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140706; GO:1903566,ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0060090,nucleus; nucleoplasm; microtubule organizing center; cytosol; reproductive process; organelle; cilium organization; anatomical structure development; molecular adaptor activity
OG_06676,1.0083550616998254,OG_06676,FUN_031079-T1,Peve_00028146,Pocillopora_meandrina_HIv1___RNAseq.27627_t,three_way,61.867666666666665,,,,,,,,,,,,,,,,,
OG_02497,1.0080296450387554,OG_02497,FUN_009835-T1,Peve_00000517,Pocillopora_meandrina_HIv1___RNAseq.g24530.t2,three_way,68.508,FUN_009835-T1,Q6PDN3,MYLK_MOUSE,,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",Mus musculus (Mouse),46.4,371.0,2.3e-87,327.0,"sp|Q6PDN3|MYLK_MOUSE Myosin light chain kinase, smooth muscle OS=Mus musculus OX=10090 GN=Mylk PE=1 SV=3",GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005911; GO:0006939; GO:0014820; GO:0019899; GO:0030027; GO:0032154; GO:0035865; GO:0046872; GO:0071277; GO:0071466; GO:0098969,cellular response to calcium ion [GO:0071277]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820],cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725],actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687],GO:0003012; GO:0003824; GO:0008092; GO:0016192; GO:0016740; GO:0140096,"muscle system process; catalytic activity; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_07883,1.0079767402672204,OG_07883,FUN_035260-T1,Peve_00032643,Pocillopora_meandrina_HIv1___RNAseq.g27881.t1,three_way,64.38783333333333,FUN_035260-T1,O88738,BIRC6_MOUSE,,Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),Mus musculus (Mouse),43.8,267.0,4.8e-62,241.9,sp|O88738|BIRC6_MOUSE Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Mus musculus OX=10090 GN=Birc6 PE=1 SV=2,GO:0000922; GO:0001890; GO:0004869; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237,apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; placenta development [GO:0001890]; positive regulation of cell population proliferation [GO:0008284]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712],centrosome [GO:0005813]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802],cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005768; GO:0005815; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; endosome; microtubule organizing center; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01532,1.0072514091014655,OG_01532,FUN_006331-T1,Peve_00012580,Pocillopora_meandrina_HIv1___RNAseq.g20347.t1,three_way,69.86616666666667,FUN_006331-T1,Q92545,TM131_HUMAN,,Transmembrane protein 131 (Protein RW1),Homo sapiens (Human),41.2,1098.0,1.3000000000000002e-218,762.3,sp|Q92545|TM131_HUMAN Transmembrane protein 131 OS=Homo sapiens OX=9606 GN=TMEM131 PE=1 SV=3,GO:0005518; GO:0016020; GO:0032964,collagen biosynthetic process [GO:0032964],membrane [GO:0016020],collagen binding [GO:0005518],,
OG_07673,1.007041743868469,OG_07673,FUN_034780-T1,Peve_00029729,Pocillopora_meandrina_HIv1___RNAseq.g12275.t1,three_way,82.57533333333333,FUN_034780-T1,Q9Y4W6,AFG32_HUMAN,,Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein),Homo sapiens (Human),68.9,637.0,6.099999999999999e-247,855.1,sp|Q9Y4W6|AFG32_HUMAN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Homo sapiens OX=9606 GN=AFG3L2 PE=1 SV=2,GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0030163; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0051604; GO:0055001; GO:0060013; GO:0072753; GO:0110097; GO:0141164,axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0055085; GO:0061024; GO:0140096; GO:0140657,"catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; cell junction organization; organelle; anatomical structure development; protein maturation; transmembrane transport; membrane organization; catalytic activity, acting on a protein; ATP-dependent activity"
OG_01080,1.0069831325301688,OG_01080,FUN_004568-T1,Peve_00041493,Pocillopora_meandrina_HIv1___RNAseq.g6639.t1,three_way,81.07966666666665,FUN_004568-T1,Q9JHS4,CLPX_MOUSE,,"ATP-dependent clpX-like chaperone, mitochondrial (EC 3.6.4.10) (ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial) (Caseinolytic mitochondrial matrix peptidase chaperone subunit)",Mus musculus (Mouse),56.7,527.0,5.9e-152,539.3,"sp|Q9JHS4|CLPX_MOUSE ATP-dependent clpX-like chaperone, mitochondrial OS=Mus musculus OX=10090 GN=Clpx PE=1 SV=2",GO:0004176; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662,ATP metabolic process [GO:0046034]; proteolysis involved in protein catabolic process [GO:0051603],cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; ATP-dependent protein folding chaperone [GO:0140662]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0044183; GO:0055086; GO:0098772; GO:0140096; GO:0140657; GO:1901135,"catalytic activity; nucleoplasm; mitochondrion; cytosol; hydrolase activity; organelle; protein folding chaperone; nucleobase-containing small molecule metabolic process; molecular function regulator activity; catalytic activity, acting on a protein; ATP-dependent activity; carbohydrate derivative metabolic process"
OG_05679,1.006525056599968,OG_05679,FUN_025516-T1,Peve_00002247,Pocillopora_meandrina_HIv1___RNAseq.g13210.t1,three_way,89.46916666666667,,,,,,,,,,,,,,,,,
OG_06669,1.0062865268595031,OG_06669,FUN_031068-T1,Peve_00028133,Pocillopora_meandrina_HIv1___RNAseq.g30321.t1,three_way,84.0175,FUN_031068-T1,P05094,,,,,65.8,876.0,0.0,1176.4,sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3,,,,,,
OG_02872,1.0058645412557137,OG_02872,FUN_011922-T1,Peve_00002208,Pocillopora_meandrina_HIv1___TS.g16203.t1,three_way,84.6935,FUN_011922-T1,Q9C102,GLT1_SCHPO,,Glutamate synthase [NADH] (EC 1.4.1.14) (Glutamine-oxoglutarate aminotransferase) (GOGAT),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),51.7,2161.0,0.0,2202.6,sp|Q9C102|GLT1_SCHPO Glutamate synthase [NADH] OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=glt1 PE=1 SV=1,GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0016040; GO:0016639; GO:0019676; GO:0050660; GO:0051538; GO:0097054,ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054],cytosol [GO:0005829]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO:0016639]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; oxidoreductase activity; organelle
OG_00655,1.0056872257456502,OG_00655,FUN_001941-T1,Peve_00024483,Pocillopora_meandrina_HIv1___TS.g6439.t1,three_way,68.33433333333333,FUN_001941-T1,Q6IPM2,IQCE_HUMAN,,IQ domain-containing protein E,Homo sapiens (Human),30.0,433.0,1.4e-21,107.1,sp|Q6IPM2|IQCE_HUMAN IQ domain-containing protein E OS=Homo sapiens OX=9606 GN=IQCE PE=1 SV=2,GO:0005929; GO:0035108; GO:0060170,limb morphogenesis [GO:0035108],ciliary membrane [GO:0060170]; cilium [GO:0005929],,GO:0005929; GO:0043226,cilium; organelle
OG_08347,1.0055088079839185,OG_08347,FUN_036881-T1,Peve_00006965,Pocillopora_meandrina_HIv1___TS.g13145.t5a,three_way,67.16199999999999,FUN_036881-T1,O94988,,,,,26.8,1111.0,2.2000000000000008e-59,232.6,sp|O94988|FA13A_HUMAN Protein FAM13A OS=Homo sapiens OX=9606 GN=FAM13A PE=1 SV=2,,,,,,
OG_09567,1.0043533576321413,OG_09567,FUN_041691-T1,Peve_00041081,Pocillopora_meandrina_HIv1___TS.g11766.t1a,three_way,79.19200000000001,FUN_041691-T1,Q9Y0H3,,,,,62.6,139.0,2e-47,189.9,sp|Q9Y0H3|RS19_MYXGL Small ribosomal subunit protein eS19 OS=Myxine glutinosa OX=7769 GN=rps19 PE=2 SV=1,,,,,,
OG_07177,1.004235294398331,OG_07177,FUN_032628-T1,Peve_00033703,Pocillopora_meandrina_HIv1___RNAseq.g29789.t1,three_way,82.41583333333334,FUN_032628-T1,Q9EQW7,KI13A_MOUSE,,Kinesin-like protein KIF13A,Mus musculus (Mouse),47.9,1454.0,0.0,1170.6,sp|Q9EQW7|KI13A_MOUSE Kinesin-like protein KIF13A OS=Mus musculus OX=10090 GN=Kif13a PE=1 SV=1,GO:0000139; GO:0003777; GO:0005524; GO:0005813; GO:0005874; GO:0006886; GO:0008017; GO:0008333; GO:0010008; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383,cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459],centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0006886; GO:0007018; GO:0008092; GO:0016192; GO:0016853; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; protein localization to plasma membrane; ATP-dependent activity
OG_02620,1.0039291047161092,OG_02620,FUN_010763-T1,Peve_00008038,Pocillopora_meandrina_HIv1___RNAseq.g20924.t1,three_way,83.1185,FUN_010763-T1,O46382,,,,,58.7,1985.0,0.0,2090.5,sp|O46382|BIG1_BOVIN Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Bos taurus OX=9913 GN=ARFGEF1 PE=1 SV=1,,,,,,
OG_05453,1.0037641990101556,OG_05453,FUN_024411-T1,Peve_00011775,Pocillopora_meandrina_HIv1___RNAseq.g18636.t1,three_way,77.30883333333334,FUN_024411-T1,Q7T163,KDISB_DANRE,,Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B),Danio rerio (Zebrafish) (Brachydanio rerio),35.3,893.0,4.3999999999999996e-141,504.6,sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3,GO:0005770; GO:0007399; GO:0019887; GO:0030165; GO:0031902; GO:0038180,nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399],late endosome [GO:0005770]; late endosome membrane [GO:0031902],PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887],GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0098772,endosome; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_05522,1.00317271510358,OG_05522,FUN_024625-T1,Peve_00012720,Pocillopora_meandrina_HIv1___TS.g28341.t1,three_way,37.063,,,,,,,,,,,,,,,,,
OG_05161,1.002966992920959,OG_05161,FUN_023459-T1,Peve_00037224,Pocillopora_meandrina_HIv1___RNAseq.g17544.t1,three_way,95.354,FUN_023459-T1,O75643,U520_HUMAN,,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),Homo sapiens (Human),74.1,2143.0,0.0,3215.6,sp|O75643|U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens OX=9606 GN=SNRNP200 PE=1 SV=2,GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005886; GO:0005929; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013,"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]",catalytic step 2 spliceosome [GO:0071013]; cilium [GO:0005929]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005886; GO:0005929; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0065003; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; plasma membrane; cilium; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; protein-containing complex assembly; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05470,1.001844387135879,OG_05470,FUN_024453-T1,Peve_00010317,Pocillopora_meandrina_HIv1___RNAseq.g18578.t1,three_way,82.89666666666666,FUN_024453-T1,Q3SYR7,,,,,65.0,177.0,1.7e-59,230.3,sp|Q3SYR7|RL9_BOVIN Large ribosomal subunit protein uL6 OS=Bos taurus OX=9913 GN=RPL9 PE=2 SV=1,,,,,,
OG_06115,1.0011715052388266,OG_06115,FUN_027832-T1,Peve_00020550,Pocillopora_meandrina_HIv1___TS.g11651.t1a,three_way,84.66816666666666,FUN_027832-T1,Q6NRH1,,,,,58.3,408.0,3.2e-139,496.5,sp|Q6NRH1|DCAF8_XENLA DDB1- and CUL4-associated factor 8 OS=Xenopus laevis OX=8355 GN=dcaf8 PE=2 SV=1,,,,,,
OG_01740,1.000304562498203,OG_01740,FUN_007062-T1,Peve_00025326,Pocillopora_meandrina_HIv1___RNAseq.g20109.t1,three_way,70.79983333333334,FUN_007062-T1,Q8IX03,KIBRA_HUMAN,,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),Homo sapiens (Human),29.0,1136.0,8.3e-51,204.1,sp|Q8IX03|KIBRA_HUMAN Protein KIBRA OS=Homo sapiens OX=9606 GN=WWC1 PE=1 SV=1,GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0035329; GO:0035330; GO:0035331; GO:0035591; GO:0043410; GO:0046621; GO:0048471; GO:0060090,cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587],kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0007163; GO:0043226; GO:0048870; GO:0060090; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_02260,0.99882805089537,OG_02260,FUN_008707-T1,Peve_00034989,Pocillopora_meandrina_HIv1___TS.g9102.t1,three_way,77.2585,FUN_008707-T1,Q99246,,,,,52.7,1458.0,0.0,1323.9,sp|Q99246|CAC1D_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1D OS=Mus musculus OX=10090 GN=Cacna1d PE=1 SV=3,,,,,,
OG_04029,0.9982738690512428,OG_04029,FUN_016337-T1,Peve_00044566,Pocillopora_meandrina_HIv1___RNAseq.g9732.t1,three_way,81.75833333333334,,,,,,,,,,,,,,,,,
OG_09093,0.9980144679750476,OG_09093,FUN_038891-T1,Peve_00028706,Pocillopora_meandrina_HIv1___RNAseq.g28660.t1,three_way,59.693333333333335,FUN_038891-T1,Q8CBY3,,,,,44.1,488.0,6.699999999999999e-90,333.6,sp|Q8CBY3|LENG8_MOUSE Leukocyte receptor cluster member 8 homolog OS=Mus musculus OX=10090 GN=Leng8 PE=1 SV=1,,,,,,
OG_10099,0.9977135343139898,OG_10099,FUN_043435-T1,Peve_00028842,Pocillopora_meandrina_HIv1___RNAseq.g7834.t1,three_way,66.19233333333334,FUN_043435-T1,Q9WU63,,,,,37.7,151.0,4.9e-23,110.5,sp|Q9WU63|HEBP2_MOUSE Heme-binding protein 2 OS=Mus musculus OX=10090 GN=Hebp2 PE=1 SV=1,,,,,,
OG_10119,0.9973423003493234,OG_10119,FUN_043495-T1,Peve_00024915,Pocillopora_meandrina_HIv1___TS.g1707.t3,three_way,64.6395,FUN_043495-T1,Q7Z7A1,CNTRL_HUMAN,,Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110),Homo sapiens (Human),33.3,916.0,5.599999999999997e-29,132.9,sp|Q7Z7A1|CNTRL_HUMAN Centriolin OS=Homo sapiens OX=9606 GN=CNTRL PE=1 SV=2,GO:0001822; GO:0003281; GO:0005794; GO:0005813; GO:0005815; GO:0005829; GO:0005886; GO:0016020; GO:0034451; GO:0035904; GO:0036064; GO:0048471; GO:0051301; GO:0060976; GO:0090543; GO:0090619; GO:0097431; GO:0120103,aorta development [GO:0035904]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; ventricular septum development [GO:0003281],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],,GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0048856,Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; organelle; anatomical structure development
OG_01757,0.9971599173764824,OG_01757,FUN_007100-T1,Peve_00033790,Pocillopora_meandrina_HIv1___RNAseq.g19049.t1b,three_way,84.0445,FUN_007100-T1,O95714,HERC2_HUMAN,,E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2),Homo sapiens (Human),53.6,4960.0,0.0,4944.0,sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; plasma membrane; DNA repair; intracellular protein transport; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09814,0.99694694637009,OG_09814,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),49.4,1473.0,0.0,1337.0,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09814,0.99694694637009,OG_09814,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),30.0,247.0,2.5e-08,63.9,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_08545,0.9964870227807252,OG_08545,FUN_037499-T1,Peve_00028563,Pocillopora_meandrina_HIv1___RNAseq.g1314.t1,three_way,52.762,FUN_037499-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),26.9,750.0,3.7e-53,211.8,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_09888,0.99604624213796,OG_09888,FUN_042963-T1,Peve_00039045,Pocillopora_meandrina_HIv1___RNAseq.4783_t,three_way,65.88283333333334,FUN_042963-T1,Q4VGL6,RC3H1_MOUSE,,Roquin-1 (Roquin) (EC 2.3.2.27) (Protein Sanroque) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1),Mus musculus (Mouse),60.2,523.0,1.3e-165,585.5,sp|Q4VGL6|RC3H1_MOUSE Roquin-1 OS=Mus musculus OX=10090 GN=Rc3h1 PE=1 SV=1,GO:0000184; GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0001782; GO:0002634; GO:0002635; GO:0003725; GO:0003729; GO:0003730; GO:0004842; GO:0005737; GO:0008270; GO:0010468; GO:0010494; GO:0010608; GO:0030889; GO:0033962; GO:0035198; GO:0035613; GO:0042098; GO:0043029; GO:0043488; GO:0045623; GO:0046007; GO:0048535; GO:0048536; GO:0050852; GO:0050856; GO:0061014; GO:0061158; GO:0061470; GO:0071347; GO:1900151; GO:1901224; GO:1905762; GO:2000320; GO:2000628,"3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932],CCR4-NOT complex binding [GO:1905762]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; RNA binding; catalytic activity; mRNA metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02317,0.9957870562158552,OG_02317,FUN_008908-T1,Peve_00017912,Pocillopora_meandrina_HIv1___TS.g30016.t1,three_way,61.309333333333335,FUN_008908-T1,G8HTB6,,,,,95.7,349.0,1.3e-187,657.1,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_00887,0.9954034325564172,OG_00887,FUN_004202-T1,Peve_00008456,Pocillopora_meandrina_HIv1___RNAseq.g16814.t1,three_way,83.68566666666666,FUN_004202-T1,Q91W43,GCSP_MOUSE,,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))",Mus musculus (Mouse),66.0,968.0,0.0,1327.0,"sp|Q91W43|GCSP_MOUSE Glycine dehydrogenase (decarboxylating), mitochondrial OS=Mus musculus OX=10090 GN=Gldc PE=1 SV=1",GO:0004375; GO:0005654; GO:0005739; GO:0005886; GO:0005960; GO:0006546; GO:0016594; GO:0016829; GO:0019464; GO:0019899; GO:0030170; GO:0036255; GO:0042803; GO:0065003; GO:0070280; GO:1903442; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein-containing complex assembly [GO:0065003]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005886; GO:0006520; GO:0016491; GO:0016829; GO:0043226; GO:0065003,catalytic activity; nucleoplasm; mitochondrion; plasma membrane; amino acid metabolic process; oxidoreductase activity; lyase activity; organelle; protein-containing complex assembly
OG_06943,0.9948576020509856,OG_06943,FUN_032053-T1,Peve_00012451,Pocillopora_meandrina_HIv1___RNAseq.g6027.t1,three_way,65.46633333333334,FUN_032053-T1,Q68DK2,ZFY26_HUMAN,,Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein) (FYVE-CENT) (Spastizin),Homo sapiens (Human),31.7,1223.0,2.8e-168,595.9,sp|Q68DK2|ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ZFYVE26 PE=1 SV=4,GO:0000281; GO:0000724; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0008270; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:1905037,autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496],phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270],GO:0000910; GO:0005764; GO:0005768; GO:0005773; GO:0005815; GO:0006281; GO:0006310; GO:0007040; GO:0008289; GO:0031410; GO:0043226,cytokinesis; lysosome; endosome; vacuole; microtubule organizing center; DNA repair; DNA recombination; lysosome organization; lipid binding; cytoplasmic vesicle; organelle
OG_06606,0.9935754093445408,OG_06606,FUN_029754-T1,Peve_00019513,Pocillopora_meandrina_HIv1___RNAseq.g17315.t1,three_way,73.25083333333333,FUN_029754-T1,D3ZYR1,FCHO2_RAT,,F-BAR domain only protein 2,Rattus norvegicus (Rat),35.2,1026.0,1.2e-117,426.0,sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1,GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793,clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]",GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0065003; GO:0072659,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; protein-containing complex assembly; protein localization to plasma membrane
OG_05733,0.9928943375093846,OG_05733,FUN_025659-T1,Peve_00042174,Pocillopora_meandrina_HIv1___RNAseq.g23073.t1,three_way,72.82333333333334,,,,,,,,,,,,,,,,,
OG_04092,0.992100749088654,OG_04092,FUN_016432-T1,Peve_00004351,Pocillopora_meandrina_HIv1___RNAseq.g9813.t3,three_way,72.73966666666666,FUN_016432-T1,P10894,PLCB1_BOVIN,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1)",Bos taurus (Bovine),58.2,490.0,5.7e-156,553.1,"sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1",GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498,G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607],"calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]",GO:0003824; GO:0005829; GO:0006629; GO:0008289; GO:0016787; GO:0043226; GO:0050877; GO:0055085; GO:0098772,catalytic activity; cytosol; lipid metabolic process; lipid binding; hydrolase activity; organelle; nervous system process; transmembrane transport; molecular function regulator activity
OG_09840,0.9920623633712764,OG_09840,FUN_042821-T1,Peve_00019575,Pocillopora_meandrina_HIv1___RNAseq.g7439.t2,three_way,61.8725,FUN_042821-T1,A2RV61,,,,,30.5,1466.0,5.5e-152,540.4,sp|A2RV61|GAPD1_XENLA GTPase-activating protein and VPS9 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=gapvd1 PE=2 SV=1,,,,,,
OG_05498,0.99140948534204,OG_05498,FUN_024557-T1,Peve_00039513,Pocillopora_meandrina_HIv1___RNAseq.g18656.t1,three_way,51.671,,,,,,,,,,,,,,,,,
OG_01183,0.9913154658937718,OG_01183,FUN_004833-T1,Peve_00041797,Pocillopora_meandrina_HIv1___RNAseq.g8607.t1,three_way,66.8355,FUN_004833-T1,Q6JAN0,AGRV1_DANRE,,Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,6348.0,0.0,2524.2,sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1,GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007194; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264,cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171],adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787],GO:0003824; GO:0016787; GO:0048856; GO:0050877; GO:0060089; GO:0098772,catalytic activity; hydrolase activity; anatomical structure development; nervous system process; molecular transducer activity; molecular function regulator activity
OG_01487,0.9909641843507512,OG_01487,FUN_006163-T1,Peve_00023605,Pocillopora_meandrina_HIv1___RNAseq.g20424.t1,three_way,83.34083333333334,FUN_006163-T1,Q8NI27,,,,,59.9,1202.0,0.0,1382.1,sp|Q8NI27|THOC2_HUMAN THO complex subunit 2 OS=Homo sapiens OX=9606 GN=THOC2 PE=1 SV=2,,,,,,
OG_07552,0.9903061836945442,OG_07552,FUN_034143-T1,Peve_00018766,Pocillopora_meandrina_HIv1___RNAseq.g26306.t1,three_way,76.9615,FUN_034143-T1,Q03168,,,,,61.2,335.0,1.4e-113,411.0,sp|Q03168|ASPP_AEDAE Lysosomal aspartic protease OS=Aedes aegypti OX=7159 GN=AAEL006169 PE=1 SV=2,,,,,,
OG_03772,0.9899971637618517,OG_03772,FUN_015101-T1,Peve_00027022,Pocillopora_meandrina_HIv1___RNAseq.g22124.t1,three_way,62.69583333333333,FUN_015101-T1,P47708,RP3A_MOUSE,,Rabphilin-3A (Exophilin-1),Mus musculus (Mouse),37.0,683.0,1.8e-109,398.3,sp|P47708|RP3A_MOUSE Rabphilin-3A OS=Mus musculus OX=10090 GN=Rph3a PE=1 SV=2,GO:0005509; GO:0005544; GO:0005546; GO:0006886; GO:0008270; GO:0008430; GO:0016082; GO:0019898; GO:0030141; GO:0030672; GO:0031267; GO:0032991; GO:0042301; GO:0043005; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0061669; GO:0070679,intracellular protein transport [GO:0006886]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle priming [GO:0016082],dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0006886; GO:0008289; GO:0031410; GO:0043226; GO:0065003,intracellular protein transport; lipid binding; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_00055,0.9891075423757224,OG_00055,FUN_000330-T1,Peve_00033547,Pocillopora_meandrina_HIv1___RNAseq.g29083.t1,three_way,89.4465,FUN_000330-T1,A0A3G2LGI8,,,,,54.5,2571.0,0.0,2154.8,sp|A0A3G2LGI8|TLN_OSCPE Talin OS=Oscarella pearsei OX=1940113 GN=TLN PE=1 SV=1,,,,,,
OG_06246,0.988726602636076,OG_06246,FUN_028241-T1,Peve_00019542,Pocillopora_meandrina_HIv1___RNAseq.g15522.t1,three_way,71.78316666666666,FUN_028241-T1,Q155Q3,DIXC1_HUMAN,,Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1),Homo sapiens (Human),41.1,725.0,4.900000000000001e-71,270.8,sp|Q155Q3|DIXC1_HUMAN Dixin OS=Homo sapiens OX=9606 GN=DIXDC1 PE=1 SV=2,GO:0001725; GO:0003779; GO:0005829; GO:0005925; GO:0019904; GO:0021799; GO:0021869; GO:0030177; GO:0032956; GO:0043015; GO:0045665; GO:0060070; GO:0070507; GO:0098794; GO:0098885; GO:0098978,canonical Wnt signaling pathway [GO:0060070]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; stress fiber [GO:0001725],actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904],GO:0005829; GO:0008092; GO:0034330; GO:0048870,cytosol; cytoskeletal protein binding; cell junction organization; cell motility
OG_01221,0.9885533843674316,OG_01221,FUN_004903-T1,Peve_00028646,Pocillopora_meandrina_HIv1___RNAseq.g8331.t1,three_way,93.306,FUN_004903-T1,A5PK63,,,,,79.9,134.0,9.9e-55,214.2,sp|A5PK63|RS17_BOVIN Small ribosomal subunit protein eS17 OS=Bos taurus OX=9913 GN=RPS17 PE=2 SV=1,,,,,,
OG_07643,0.988198041437664,OG_07643,FUN_034422-T1,Peve_00038700,Pocillopora_meandrina_HIv1___RNAseq.g28563.t1,three_way,91.19266666666668,FUN_034422-T1,Q6DEU9,CTR9_XENTR,,RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),77.7,896.0,0.0,1350.1,sp|Q6DEU9|CTR9_XENTR RNA polymerase-associated protein CTR9 homolog OS=Xenopus tropicalis OX=8364 GN=ctr9 PE=2 SV=1,GO:0000122; GO:0000791; GO:0001711; GO:0006368; GO:0016593; GO:0016607; GO:0019827; GO:0045638,endodermal cell fate commitment [GO:0001711]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368],Cdc73/Paf1 complex [GO:0016593]; euchromatin [GO:0000791]; nuclear speck [GO:0016607],,GO:0006355; GO:0043226,regulation of DNA-templated transcription; organelle
OG_09837,0.987201447966493,OG_09837,FUN_042817-T1,Peve_00019562,Pocillopora_meandrina_HIv1___RNAseq.g7434.t3,three_way,67.52316666666667,FUN_042817-T1,Q8N1W1,ARG28_HUMAN,,Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor) (p190-RhoGEF) (p190RhoGEF) (Rho guanine nucleotide exchange factor),Homo sapiens (Human),26.8,1282.0,1.1e-79,300.4,sp|Q8N1W1|ARG28_HUMAN Rho guanine nucleotide exchange factor 28 OS=Homo sapiens OX=9606 GN=ARHGEF28 PE=1 SV=3,GO:0000902; GO:0003723; GO:0005085; GO:0005829; GO:0005886; GO:0008270; GO:0021955; GO:0035023; GO:0048013; GO:0051056; GO:0060052,cell morphogenesis [GO:0000902]; central nervous system neuron axonogenesis [GO:0021955]; ephrin receptor signaling pathway [GO:0048013]; neurofilament cytoskeleton organization [GO:0060052]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],cytosol [GO:0005829]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005829; GO:0005886; GO:0007010; GO:0098772,RNA binding; cytosol; plasma membrane; cytoskeleton organization; molecular function regulator activity
OG_09336,0.9870300271113016,OG_09336,FUN_040299-T1,Peve_00038649,Pocillopora_meandrina_HIv1___TS.g20792.t1,three_way,42.627833333333335,FUN_040299-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),24.5,4769.0,0.0,1096.6,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_00528,0.9869102596630774,OG_00528,FUN_001532-T1,Peve_00000627,Pocillopora_meandrina_HIv1___RNAseq.g2048.t1,three_way,76.9355,FUN_001532-T1,Q80W14,,,,,53.5,593.0,3.1e-96,354.8,sp|Q80W14|PR40B_MOUSE Pre-mRNA-processing factor 40 homolog B OS=Mus musculus OX=10090 GN=Prpf40b PE=1 SV=2,,,,,,
OG_04968,0.9866285111748124,OG_04968,FUN_023073-T1,Peve_00014063,Pocillopora_meandrina_HIv1___RNAseq.g1646.t2,three_way,77.28333333333333,FUN_023073-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),42.4,2171.0,0.0,1587.8,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_01504,0.9861083074191996,OG_01504,FUN_006236-T1,Peve_00011453,Pocillopora_meandrina_HIv1___RNAseq.g20448.t1,three_way,65.54733333333333,,,,,,,,,,,,,,,,,
OG_07832,0.9858292765998348,OG_07832,FUN_035154-T1,Peve_00006880,Pocillopora_meandrina_HIv1___RNAseq.g27634.t1,three_way,56.06466666666667,FUN_035154-T1,Q9UKV3,,,,,30.4,280.0,5e-24,114.8,sp|Q9UKV3|ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens OX=9606 GN=ACIN1 PE=1 SV=2,,,,,,
OG_03918,0.9857602137462996,OG_03918,FUN_016014-T1,Peve_00004540,Pocillopora_meandrina_HIv1___RNAseq.g21369.t1,three_way,67.8095,FUN_016014-T1,B2RX88,CSPP1_MOUSE,,Centrosome and spindle pole associated protein 1,Mus musculus (Mouse),29.2,1240.0,2.1e-09,66.6,sp|B2RX88|CSPP1_MOUSE Centrosome and spindle pole associated protein 1 OS=Mus musculus OX=10090 GN=Cspp1 PE=1 SV=2,GO:0000922; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0005929; GO:0032467; GO:0034451; GO:0036064; GO:0051781,positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922],,GO:0005654; GO:0005815; GO:0005929; GO:0043226,nucleoplasm; microtubule organizing center; cilium; organelle
OG_04857,0.9855373171080004,OG_04857,FUN_022871-T1,Peve_00012299,Pocillopora_meandrina_HIv1___RNAseq.g3616.t1,three_way,89.286,FUN_022871-T1,Q90788,NKX25_CHICK,,Homeobox protein Nkx-2.5 (cNKx-2.5) (Homeobox protein NK-2 homolog E),Gallus gallus (Chicken),52.2,159.0,1.2e-33,145.2,sp|Q90788|NKX25_CHICK Homeobox protein Nkx-2.5 OS=Gallus gallus OX=9031 GN=NKX-2.5 PE=2 SV=1,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001947; GO:0003148; GO:0003166; GO:0003168; GO:0003211; GO:0003221; GO:0003222; GO:0003228; GO:0003278; GO:0003285; GO:0003342; GO:0003350; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007512; GO:0010628; GO:0010667; GO:0010765; GO:0010832; GO:0030097; GO:0030154; GO:0030855; GO:0030878; GO:0032991; GO:0032993; GO:0042803; GO:0045666; GO:0045823; GO:0048536; GO:0050673; GO:0050679; GO:0051891; GO:0055005; GO:0055117; GO:0060037; GO:0060038; GO:0060043; GO:0060048; GO:0060261; GO:0060347; GO:0060412; GO:0060413; GO:0060928; GO:0060929; GO:0060971; GO:0061629; GO:0071772; GO:0090090; GO:1903779; GO:1904019; GO:1904036; GO:1990664,adult heart development [GO:0007512]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial cardiac muscle tissue development [GO:0003228]; atrial septum morphogenesis [GO:0060413]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; bundle of His development [GO:0003166]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle contraction [GO:0060048]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; embryonic heart tube left/right pattern formation [GO:0060971]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of heart contraction [GO:0045823]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; proepicardium development [GO:0003342]; pulmonary myocardium development [GO:0003350]; Purkinje myocyte differentiation [GO:0003168]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cardiac muscle contraction [GO:0055117]; regulation of transcription by RNA polymerase II [GO:0006357]; response to BMP [GO:0071772]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; septum secundum development [GO:0003285]; spleen development [GO:0048536]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],cytosol [GO:0005829]; Nkx-2.5 complex [GO:1990664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0007010; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_03826,0.984348596146456,OG_03826,FUN_015256-T1,Peve_00014304,Pocillopora_meandrina_HIv1___RNAseq.g22207.t1,three_way,71.4415,FUN_015256-T1,G1SE76,,,,,76.7,146.0,2.9999999999999995e-54,213.0,sp|G1SE76|RL23A_RABIT Large ribosomal subunit protein uL23 OS=Oryctolagus cuniculus OX=9986 GN=RPL23A PE=1 SV=1,,,,,,
OG_05492,0.9837959141047328,OG_05492,FUN_024524-T1,Peve_00034558,Pocillopora_meandrina_HIv1___RNAseq.g18542.t1,three_way,74.3655,FUN_024524-T1,Q96PY6,NEK1_HUMAN,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55),Homo sapiens (Human),32.6,1424.0,3.4000000000000003e-128,461.5,sp|Q96PY6|NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens OX=9606 GN=NEK1 PE=1 SV=2,GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310,cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_09573,0.983622271950352,OG_09573,FUN_041705-T1,Peve_00001480,Pocillopora_meandrina_HIv1___RNAseq.g13973.t1,three_way,45.37833333333334,FUN_041705-T1,Q95VY2,,,,,43.7,174.0,1.7000000000000002e-32,140.6,sp|Q95VY2|TCTP_BRABE Translationally-controlled tumor protein homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1,,,,,,
OG_04075,0.983470436681538,OG_04075,FUN_016400-T1,Peve_00006411,Pocillopora_meandrina_HIv1___RNAseq.g9752.t1,three_way,83.30466666666666,FUN_016400-T1,Q6NUP7,PP4R4_HUMAN,,Serine/threonine-protein phosphatase 4 regulatory subunit 4,Homo sapiens (Human),46.8,667.0,3.4e-166,587.0,sp|Q6NUP7|PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PPP4R4 PE=1 SV=1,GO:0001835; GO:0004864; GO:0004865; GO:0005737; GO:0005829; GO:0005929; GO:0008287; GO:0019888; GO:0036064; GO:0043231,blastocyst hatching [GO:0001835],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase complex [GO:0008287],protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],GO:0005815; GO:0005829; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; cilium; organelle; molecular function regulator activity
OG_07521,0.983171083769318,OG_07521,FUN_034091-T1,Peve_00037069,Pocillopora_meandrina_HIv1___RNAseq.g26062.t1,three_way,83.5495,FUN_034091-T1,Q9VWG3,,,,,62.3,154.0,1.1e-44,181.0,sp|Q9VWG3|RS10B_DROME Small ribosomal subunit protein eS10B OS=Drosophila melanogaster OX=7227 GN=RpS10b PE=1 SV=2,,,,,,
OG_00087,0.983164660033186,OG_00087,FUN_000440-T1,Peve_00003439,Pocillopora_meandrina_HIv1___RNAseq.g2328.t2,three_way,87.82716666666667,FUN_000440-T1,P11029,,,,,63.2,2251.0,0.0,2921.0,sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1,,,,,,
OG_08517,0.982845954434052,OG_08517,FUN_037447-T1,Peve_00027251,Pocillopora_meandrina_HIv1___RNAseq.g10986.t1,three_way,85.654,FUN_037447-T1,Q3T0V4,,,,,75.0,156.0,5.1999999999999995e-61,235.3,sp|Q3T0V4|RS11_BOVIN Small ribosomal subunit protein uS17 OS=Bos taurus OX=9913 GN=RPS11 PE=2 SV=3,,,,,,
OG_07952,0.9826391163860408,OG_07952,FUN_035478-T1,Peve_00033970,Pocillopora_meandrina_HIv1___TS.g14339.t1,three_way,81.2215,FUN_035478-T1,P08487,,,,,46.2,825.0,3.7e-203,709.9,"sp|P08487|PLCG1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Bos taurus OX=9913 GN=PLCG1 PE=1 SV=1",,,,,,
OG_06313,0.9826068827369222,OG_06313,FUN_028553-T1,Peve_00000750,Pocillopora_meandrina_HIv1___TS.g15553.t2,three_way,74.64583333333333,FUN_028553-T1,A2AT37,RENT2_MOUSE,,Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog) (Upf2),Mus musculus (Mouse),48.4,1041.0,5e-267,922.5,sp|A2AT37|RENT2_MOUSE Regulator of nonsense transcripts 2 OS=Mus musculus OX=10090 GN=Upf2 PE=1 SV=1,GO:0000184; GO:0001889; GO:0003723; GO:0005737; GO:0005829; GO:0006986; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471,"animal organ regeneration [GO:0031100]; liver development [GO:0001889]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to unfolded protein [GO:0006986]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; perinuclear region of cytoplasm [GO:0048471],RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0005829; GO:0016071; GO:0043226; GO:0048856,DNA binding; RNA binding; cytosol; mRNA metabolic process; organelle; anatomical structure development
OG_03496,0.9825150523048204,OG_03496,FUN_014605-T1,Peve_00001902,Pocillopora_meandrina_HIv1___RNAseq.g22752.t1,three_way,91.59133333333334,FUN_014605-T1,Q14254,FLOT2_HUMAN,,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1),Homo sapiens (Human),58.5,417.0,1.6999999999999998e-105,384.4,sp|Q14254|FLOT2_HUMAN Flotillin-2 OS=Homo sapiens OX=9606 GN=FLOT2 PE=1 SV=2,GO:0001931; GO:0002020; GO:0002080; GO:0005768; GO:0005886; GO:0005901; GO:0005912; GO:0005925; GO:0007155; GO:0008544; GO:0010629; GO:0016020; GO:0016323; GO:0016600; GO:0030027; GO:0030139; GO:0031410; GO:0031982; GO:0032839; GO:0043123; GO:0043231; GO:0044291; GO:0044860; GO:0045661; GO:0048471; GO:0050821; GO:0070062; GO:0072659; GO:0098937; GO:0098978; GO:0099072; GO:1902992; GO:1903905,anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of establishment of T cell polarity [GO:1903905]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982],protease binding [GO:0002020],GO:0005768; GO:0005886; GO:0007018; GO:0007155; GO:0031410; GO:0043226; GO:0048856; GO:0072659,endosome; plasma membrane; microtubule-based movement; cell adhesion; cytoplasmic vesicle; organelle; anatomical structure development; protein localization to plasma membrane
OG_07580,0.9817395918648588,OG_07580,FUN_034263-T1,Peve_00039351,Pocillopora_meandrina_HIv1___TS.g19376.t1,three_way,59.382,FUN_034263-T1,Q6INA9,,,,,36.2,318.0,1.2999999999999998e-47,193.4,sp|Q6INA9|SETB1_XENLA Histone-lysine N-methyltransferase SETDB1 OS=Xenopus laevis OX=8355 GN=setdb1 PE=2 SV=1,,,,,,
OG_05731,0.9816361164026915,OG_05731,FUN_025657-T1,Peve_00042176,Pocillopora_meandrina_HIv1___RNAseq.g23075.t1,three_way,71.07683333333333,FUN_025657-T1,P17863,,,,,33.1,341.0,1.1e-45,186.4,sp|P17863|SKI_AVIES Transforming protein Ski OS=Avian erythroblastosis virus (strain Sloan-Kettering) OX=11862 GN=V-SKI PE=1 SV=1,,,,,,
OG_06268,0.9813616199408668,OG_06268,FUN_028299-T1,Peve_00000718,Pocillopora_meandrina_HIv1___RNAseq.g15542.t2,three_way,70.94366666666667,,,,,,,,,,,,,,,,,
OG_05337,0.9811810868274384,OG_05337,FUN_024053-T1,Peve_00000160,Pocillopora_meandrina_HIv1___RNAseq.g19257.t2,three_way,68.68216666666666,FUN_024053-T1,Q8CIQ7,DOCK3_MOUSE,,Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP),Mus musculus (Mouse),42.0,1682.0,0.0,1276.5,sp|Q8CIQ7|DOCK3_MOUSE Dedicator of cytokinesis protein 3 OS=Mus musculus OX=10090 GN=Dock3 PE=1 SV=1,GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007264; GO:0017124,small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; cytosol [GO:0005829],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_09214,0.9811714478100044,OG_09214,FUN_039931-T1,Peve_00036243,Pocillopora_meandrina_HIv1___RNAseq.g7332.t1,three_way,58.890166666666666,FUN_039931-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),40.3,578.0,1.5999999999999999e-96,355.9,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_00414,0.9811160549947698,OG_00414,FUN_001316-T1,Peve_00036964,Pocillopora_meandrina_HIv1___RNAseq.g2261.t1,three_way,53.97383333333333,FUN_001316-T1,Q8IVL1,,,,,36.1,388.0,7.2e-66,255.0,sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3,,,,,,
OG_01618,0.9803867612141356,OG_01618,FUN_006727-T1,Peve_00039555,Pocillopora_meandrina_HIv1___RNAseq.g20013.t1,three_way,71.43566666666666,FUN_006727-T1,Q3UTQ8,CDKL5_MOUSE,,Cyclin-dependent kinase-like 5 (EC 2.7.11.22),Mus musculus (Mouse),44.0,616.0,8.800000000000001e-125,449.5,sp|Q3UTQ8|CDKL5_MOUSE Cyclin-dependent kinase-like 5 OS=Mus musculus OX=10090 GN=Cdkl5 PE=1 SV=1,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0016301; GO:0034504; GO:0036064; GO:0097542; GO:0106310; GO:1902017,protein localization to nucleus [GO:0034504]; regulation of cilium assembly [GO:1902017],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05639,0.9802135983782768,OG_05639,FUN_025343-T1,Peve_00027051,Pocillopora_meandrina_HIv1___RNAseq.g13379.t1,three_way,83.50133333333333,FUN_025343-T1,P13732,,,,,66.7,93.0,9.900000000000001e-30,130.6,sp|P13732|RL22_TRIGR Large ribosomal subunit protein eL22 OS=Tripneustes gratilla OX=7673 GN=RPL22 PE=2 SV=1,,,,,,
OG_04407,0.9798002749862038,OG_04407,FUN_018425-T1,Peve_00031687,Pocillopora_meandrina_HIv1___RNAseq.g10172.t1,three_way,90.69833333333332,FUN_018425-T1,Q9GT45,,,,,81.4,113.0,5.400000000000001e-44,178.3,sp|Q9GT45|RS26_ANOGA Small ribosomal subunit protein eS26 OS=Anopheles gambiae OX=7165 GN=RpS26 PE=3 SV=2,,,,,,
OG_06993,0.979555276818973,OG_06993,FUN_032139-T1,Peve_00007913,Pocillopora_meandrina_HIv1___TS.g24062.t1,three_way,49.26766666666666,,,,,,,,,,,,,,,,,
OG_09683,0.9794881896029222,OG_09683,FUN_041908-T1,Peve_00007888,Pocillopora_meandrina_HIv1___RNAseq.g15648.t1,three_way,83.73049999999999,FUN_041908-T1,Q17QZ4,,,,,57.2,383.0,2e-95,351.3,sp|Q17QZ4|TFDP1_BOVIN Transcription factor Dp-1 OS=Bos taurus OX=9913 GN=TFDP1 PE=2 SV=1,,,,,,
OG_05025,0.9790643074313108,OG_05025,FUN_023188-T1,Peve_00009990,Pocillopora_meandrina_HIv1___RNAseq.g670.t1,three_way,70.7675,,,,,,,,,,,,,,,,,
OG_09619,0.9785590487446548,OG_09619,FUN_041779-T1,Peve_00042838,Pocillopora_meandrina_HIv1___RNAseq.g15878.t1,three_way,82.13516666666666,FUN_041779-T1,P23098,,,,,25.2,3572.0,0.0,1097.8,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_04227,0.9782231480722744,OG_04227,FUN_017022-T1,Peve_00018298,Pocillopora_meandrina_HIv1___RNAseq.g20360.t1,three_way,58.69716666666667,FUN_017022-T1,Q8BV79,,,,,28.2,2731.0,2.9e-254,881.7,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_01121,0.978083416178248,OG_01121,FUN_004684-T1,Peve_00035122,Pocillopora_meandrina_HIv1___RNAseq.g8765.t1,three_way,65.35983333333333,FUN_004684-T1,Q07008,NOTC1_RAT,,Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Rattus norvegicus (Rat),42.2,628.0,7.7e-77,291.2,sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3,GO:0000122; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006915; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008283; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685],"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003677; GO:0005634; GO:0005783; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006954; GO:0012501; GO:0016192; GO:0022414; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; nucleus; endoplasmic reticulum; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; inflammatory response; programmed cell death; vesicle-mediated transport; reproductive process; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular transducer activity; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_09455,0.9778562419643986,OG_09455,FUN_041463-T1,Peve_00013687,Pocillopora_meandrina_HIv1___RNAseq.g15689.t1,three_way,54.7395,FUN_041463-T1,Q95209,SORL_RABIT,,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),Oryctolagus cuniculus (Rabbit),36.6,2110.0,7.4e-199,697.2,sp|Q95209|SORL_RABIT Sortilin-related receptor OS=Oryctolagus cuniculus OX=9986 GN=SORL1 PE=1 SV=1,GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845,adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],,GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226,extracellular space; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_05892,0.9761529101427978,OG_05892,FUN_026058-T1,Peve_00022194,Pocillopora_meandrina_HIv1___RNAseq.g10568.t1,three_way,87.0575,FUN_026058-T1,Q9BUQ8,,,,,74.4,575.0,3.3e-256,885.9,sp|Q9BUQ8|DDX23_HUMAN Probable ATP-dependent RNA helicase DDX23 OS=Homo sapiens OX=9606 GN=DDX23 PE=1 SV=3,,,,,,
OG_00487,0.9758921557481308,OG_00487,FUN_001453-T1,Peve_00018442,Pocillopora_meandrina_HIv1___RNAseq.g1954.t1,three_way,80.51,FUN_001453-T1,Q9UBR2,CATZ_HUMAN,,Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X),Homo sapiens (Human),61.6,297.0,1.4000000000000005e-111,404.1,sp|Q9UBR2|CATZ_HUMAN Cathepsin Z OS=Homo sapiens OX=9606 GN=CTSZ PE=1 SV=1,GO:0002003; GO:0004180; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0005886; GO:0005938; GO:0006508; GO:0008234; GO:0009986; GO:0010757; GO:0016807; GO:0030134; GO:0030426; GO:0031410; GO:0033116; GO:0035580; GO:0043231; GO:0051603; GO:0060441; GO:0062023; GO:0070062; GO:1904813,angiotensin maturation [GO:0002003]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580],carboxypeptidase activity [GO:0004180]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234],GO:0003824; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; lysosome; vacuole; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_08415,0.9756640599595108,OG_08415,FUN_037071-T1,Peve_00004736,Pocillopora_meandrina_HIv1___RNAseq.g26783.t1,three_way,86.73233333333333,FUN_037071-T1,Q99973,TEP1_HUMAN,,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),Homo sapiens (Human),26.9,577.0,1.6999999999999998e-43,179.9,sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2,GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904,telomere maintenance via recombination [GO:0000722],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0006310; GO:0016740; GO:0032200; GO:0140097,"RNA binding; catalytic activity; DNA recombination; transferase activity; telomere organization; catalytic activity, acting on DNA"
OG_00644,0.9754768303942298,OG_00644,FUN_001889-T1,Peve_00030492,Pocillopora_meandrina_HIv1___RNAseq.g2578.t2,three_way,70.65033333333334,,,,,,,,,,,,,,,,,
OG_05505,0.974600727550346,OG_05505,FUN_024577-T1,Peve_00007643,Pocillopora_meandrina_HIv1___TS.g28491.t1,three_way,74.36816666666667,FUN_024577-T1,Q2LD37,BLTP1_HUMAN,,Bridge-like lipid transfer protein family member 1 (Fragile site-associated protein),Homo sapiens (Human),29.4,5271.0,0.0,1751.9,sp|Q2LD37|BLTP1_HUMAN Bridge-like lipid transfer protein family member 1 OS=Homo sapiens OX=9606 GN=BLTP1 PE=1 SV=2,GO:0001558; GO:0005634; GO:0005789; GO:0005886; GO:0006909; GO:0016020; GO:0016197; GO:0030856; GO:0031966; GO:0032456; GO:0048488; GO:0098793; GO:0120009; GO:0140268; GO:1904121,endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intermembrane lipid transfer [GO:0120009]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793],phosphatidylethanolamine transfer activity [GO:1904121],GO:0005215; GO:0005634; GO:0005886; GO:0016192; GO:0043226; GO:0061024,transporter activity; nucleus; plasma membrane; vesicle-mediated transport; organelle; membrane organization
OG_05208,0.9741255158175112,OG_05208,FUN_023592-T1,Peve_00023919,Pocillopora_meandrina_HIv1___RNAseq.g3311.t1,three_way,44.60383333333333,FUN_023592-T1,E9PVX6,KI67_MOUSE,,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog),Mus musculus (Mouse),42.2,135.0,5.7e-18,95.9,sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1,GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072089; GO:0072574; GO:0140693; GO:1902275; GO:1990705,cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088]; stem cell proliferation [GO:0072089],"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0007059; GO:0022414; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; chromosome; nucleolus; chromosome segregation; reproductive process; organelle; molecular adaptor activity
OG_05454,0.97350076271482,OG_05454,FUN_024412-T1,Peve_00007146,Pocillopora_meandrina_HIv1___RNAseq.g18635.t1,three_way,68.411,FUN_024412-T1,Q6ZQ58,,,,,38.2,878.0,1.9e-105,385.6,sp|Q6ZQ58|LARP1_MOUSE La-related protein 1 OS=Mus musculus OX=10090 GN=Larp1 PE=1 SV=3,,,,,,
OG_09237,0.9717624613355474,OG_09237,FUN_039990-T1,Peve_00004422,Pocillopora_meandrina_HIv1___RNAseq.g7562.t1,three_way,81.36533333333333,FUN_039990-T1,Q96CN4,EVI5L_HUMAN,,EVI5-like protein (Ecotropic viral integration site 5-like protein),Homo sapiens (Human),45.3,516.0,1.2e-114,415.2,sp|Q96CN4|EVI5L_HUMAN EVI5-like protein OS=Homo sapiens OX=9606 GN=EVI5L PE=1 SV=1,GO:0005096; GO:0031267; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],,GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0098772,molecular function regulator activity
OG_03024,0.971495841822903,OG_03024,FUN_012250-T1,Peve_00020519,Pocillopora_meandrina_HIv1___RNAseq.g23517.t1,three_way,75.335,FUN_012250-T1,Q5T5C0,STXB5_HUMAN,,Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1),Homo sapiens (Human),38.5,1156.0,1.5999999999999999e-208,728.0,sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807],acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075],GO:0005829; GO:0005886; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_07233,0.9711560707548718,OG_07233,FUN_032906-T1,Peve_00014529,Pocillopora_meandrina_HIv1___RNAseq.g24991.t1,three_way,83.96633333333334,FUN_032906-T1,Q14671,,,,,46.1,1272.0,9e-53,210.7,sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3,,,,,,
OG_05204,0.9710381594648884,OG_05204,FUN_023588-T1,Peve_00028963,Pocillopora_meandrina_HIv1___TS.g17411.t1,three_way,68.98,FUN_023588-T1,Q5ZK33,LETM1_CHICK,,Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1),Gallus gallus (Chicken),40.7,644.0,2.9999999999999993e-105,384.4,sp|Q5ZK33|LETM1_CHICK Mitochondrial proton/calcium exchanger protein OS=Gallus gallus OX=9031 GN=LETM1 PE=2 SV=1,GO:0005509; GO:0005739; GO:0005743; GO:0006813; GO:0006816; GO:0006851; GO:0007005; GO:0007007; GO:0015369; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093,calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; potassium ion transport [GO:0006813]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022],GO:0005215; GO:0005739; GO:0007005; GO:0043226; GO:0055085; GO:0061024; GO:0065003,transporter activity; mitochondrion; mitochondrion organization; organelle; transmembrane transport; membrane organization; protein-containing complex assembly
OG_05094,0.9709608088674164,OG_05094,FUN_023341-T1,Peve_00023294,Pocillopora_meandrina_HIv1___RNAseq.g17422.t2,three_way,63.56933333333334,FUN_023341-T1,O15066,KIF3B_HUMAN,,"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]",Homo sapiens (Human),28.9,557.0,1.3000000000000002e-44,183.7,sp|O15066|KIF3B_HUMAN Kinesin-like protein KIF3B OS=Homo sapiens OX=9606 GN=KIF3B PE=1 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016192; GO:0016887; GO:0016939; GO:0030425; GO:0030496; GO:0031267; GO:0032467; GO:0032839; GO:0036372; GO:0042073; GO:0043197; GO:0060271; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0098971; GO:0098978; GO:0120170; GO:1904115,anterograde axonal transport [GO:0008089]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; opsin transport [GO:0036372]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; vesicle-mediated transport [GO:0016192],axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_06499,0.97020733429762,OG_06499,FUN_029290-T1,Peve_00036558,Pocillopora_meandrina_HIv1___RNAseq.g11162.t1,three_way,72.6425,FUN_029290-T1,O95602,RPA1_HUMAN,,DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194),Homo sapiens (Human),50.1,1092.0,2e-264,913.7,sp|O95602|RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens OX=9606 GN=POLR1A PE=1 SV=2,GO:0000287; GO:0000785; GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005739; GO:0006360; GO:0008270; GO:0071667; GO:1904750,negative regulation of protein localization to nucleolus [GO:1904750]; transcription by RNA polymerase I [GO:0006360],chromatin [GO:0000785]; chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005694; GO:0005739; GO:0006351; GO:0016740; GO:0043226; GO:0140098,"DNA binding; catalytic activity; nucleoplasm; chromosome; mitochondrion; DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on RNA"
OG_05823,0.969750754761688,OG_05823,FUN_025840-T1,Peve_00028313,Pocillopora_meandrina_HIv1___RNAseq.g10336.t1,three_way,94.462,FUN_025840-T1,Q5ZLC5,ATPB_CHICK,,"ATP synthase F(1) complex catalytic subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)",Gallus gallus (Chicken),91.4,466.0,4.6e-241,835.1,"sp|Q5ZLC5|ATPB_CHICK ATP synthase F(1) complex catalytic subunit beta, mitochondrial OS=Gallus gallus OX=9031 GN=ATP5F1B PE=1 SV=1",GO:0001525; GO:0005524; GO:0005739; GO:0005743; GO:0015986; GO:0016887; GO:0042776; GO:0045259; GO:0046933,angiogenesis [GO:0001525]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]",GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; transporter activity; mitochondrion; hydrolase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03793,0.969418280047376,OG_03793,FUN_015164-T1,Peve_00001860,Pocillopora_meandrina_HIv1___TS.g25730.t1,three_way,68.88416666666667,FUN_015164-T1,Q14667,,,,,30.3,2363.0,1.9999999999999998e-285,984.6,sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3,,,,,,
OG_09501,0.9686959438810988,OG_09501,FUN_041545-T1,Peve_00000890,Pocillopora_meandrina_HIv1___RNAseq.g15994.t2,three_way,60.269666666666666,FUN_041545-T1,Q80TI0,ASTRB_MOUSE,,Protein Aster-B (GRAM domain-containing protein 1B),Mus musculus (Mouse),34.0,679.0,3.2e-86,321.2,sp|Q80TI0|ASTRB_MOUSE Protein Aster-B OS=Mus musculus OX=10090 GN=Gramd1b PE=1 SV=2,GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268,cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786],GO:0005215; GO:0005886; GO:0008289,transporter activity; plasma membrane; lipid binding
OG_00102,0.9685835967705267,OG_00102,FUN_000488-T1,Peve_00038241,Pocillopora_meandrina_HIv1___RNAseq.g2338.t1,three_way,92.94666666666666,FUN_000488-T1,Q5E9E6,,,,,80.0,215.0,6.099999999999999e-96,351.7,sp|Q5E9E6|RL10A_BOVIN Large ribosomal subunit protein uL1 OS=Bos taurus OX=9913 GN=RPL10A PE=2 SV=3,,,,,,
OG_05395,0.968523361314306,OG_05395,FUN_024222-T1,Peve_00031895,Pocillopora_meandrina_HIv1___RNAseq.g18914.t1,three_way,77.07900000000001,FUN_024222-T1,Q13887,KLF5_HUMAN,,Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2),Homo sapiens (Human),38.6,166.0,5.3e-19,96.7,sp|Q13887|KLF5_HUMAN Krueppel-like factor 5 OS=Homo sapiens OX=9606 GN=KLF5 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0008270; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0060576; GO:0061586; GO:1901653; GO:1990830; GO:1990837,angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816],chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005654; GO:0005794; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleoplasm; Golgi apparatus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00053,0.968346229291136,OG_00053,FUN_000323-T1,Peve_00012596,Pocillopora_meandrina_HIv1___RNAseq.g29002.t2,three_way,82.90066666666667,FUN_000323-T1,Q9QYF3,MYO5A_RAT,,"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle)",Rattus norvegicus (Rat),51.1,1879.0,0.0,1338.6,sp|Q9QYF3|MYO5A_RAT Unconventional myosin-Va OS=Rattus norvegicus OX=10116 GN=Myo5a PE=1 SV=1,GO:0000146; GO:0000149; GO:0001726; GO:0001750; GO:0003774; GO:0003779; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005777; GO:0005783; GO:0005790; GO:0005794; GO:0005829; GO:0005882; GO:0005884; GO:0006582; GO:0006887; GO:0006892; GO:0007015; GO:0007268; GO:0007601; GO:0008021; GO:0015629; GO:0016020; GO:0016192; GO:0016236; GO:0016459; GO:0016461; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0030048; GO:0030050; GO:0030073; GO:0030141; GO:0030318; GO:0030424; GO:0030425; GO:0031267; GO:0031982; GO:0031987; GO:0032252; GO:0032400; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0033602; GO:0042417; GO:0042438; GO:0042470; GO:0042476; GO:0042552; GO:0042641; GO:0042642; GO:0042759; GO:0042802; GO:0043008; GO:0043025; GO:0043473; GO:0044877; GO:0048066; GO:0048306; GO:0048820; GO:0050808; GO:0050885; GO:0051015; GO:0051643; GO:0051967; GO:0055037; GO:0065003; GO:0072659; GO:0097718; GO:0098685; GO:0098794; GO:0098871; GO:0098978; GO:0099089; GO:0099566; GO:0099640; GO:0150103; GO:1900078; GO:1903078; GO:1904754; GO:1990904,"actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; axo-dendritic protein transport [GO:0099640]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; developmental pigmentation [GO:0048066]; dopamine metabolic process [GO:0042417]; endoplasmic reticulum localization [GO:0051643]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; macroautophagy [GO:0016236]; melanin biosynthetic process [GO:0042438]; melanin metabolic process [GO:0006582]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; myelination [GO:0042552]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuromuscular process controlling balance [GO:0050885]; odontogenesis [GO:0042476]; pigmentation [GO:0043473]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; reactive gliosis [GO:0150103]; regulation of exocytosis [GO:0017157]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin, myosin complex part [GO:0042642]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; recycling endosome [GO:0055037]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]",actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075],GO:0003774; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0023052; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0050877; GO:0065003; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; lysosome; endosome; vacuole; peroxisome; endoplasmic reticulum; Golgi apparatus; cytosol; cytoskeleton; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; signaling; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; nervous system process; protein-containing complex assembly; protein localization to plasma membrane; ATP-dependent activity
OG_02607,0.968309573037582,OG_02607,FUN_010736-T1,Peve_00038978,Pocillopora_meandrina_HIv1___RNAseq.g20940.t1,three_way,50.23233333333334,FUN_010736-T1,Q95209,SORL_RABIT,,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),Oryctolagus cuniculus (Rabbit),28.3,762.0,9.3e-88,327.4,sp|Q95209|SORL_RABIT Sortilin-related receptor OS=Oryctolagus cuniculus OX=9986 GN=SORL1 PE=1 SV=1,GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845,adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],,GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226,extracellular space; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_02516,0.9678110356665124,OG_02516,FUN_010575-T1,Peve_00032734,Pocillopora_meandrina_HIv1___RNAseq.g21523.t1,three_way,73.19066666666667,FUN_010575-T1,Q9C091,GRB1L_HUMAN,,GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein),Homo sapiens (Human),33.4,1940.0,6.8e-250,866.3,sp|Q9C091|GRB1L_HUMAN GREB1-like protein OS=Homo sapiens OX=9606 GN=GREB1L PE=1 SV=2,GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0061205; GO:0072177,branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065],membrane [GO:0016020],,GO:0022414; GO:0030154; GO:0042254; GO:0048856,reproductive process; cell differentiation; ribosome biogenesis; anatomical structure development
OG_03767,0.9674263955773418,OG_03767,FUN_015095-T1,Peve_00043821,Pocillopora_meandrina_HIv1___RNAseq.g22283.t1,three_way,81.09083333333334,FUN_015095-T1,Q8IZ69,TRM2A_HUMAN,,tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.35) (mRNA (uracil-5-)-methyltransferase TRMT2A) (EC 2.1.1.-),Homo sapiens (Human),40.3,618.0,9.4e-120,432.6,sp|Q8IZ69|TRM2A_HUMAN tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens OX=9606 GN=TRMT2A PE=1 SV=2,GO:0003723; GO:0005829; GO:0006397; GO:0008033; GO:0008169; GO:0030697; GO:0032259,methylation [GO:0032259]; mRNA processing [GO:0006397]; tRNA processing [GO:0008033],cytosol [GO:0005829],"C-methyltransferase activity [GO:0008169]; RNA binding [GO:0003723]; tRNA (uracil(54)-C5)-methyltransferase activity, S-adenosyl methionine-dependent [GO:0030697]",GO:0003723; GO:0003824; GO:0005829; GO:0006399; GO:0016071; GO:0016740; GO:0140098,"RNA binding; catalytic activity; cytosol; tRNA metabolic process; mRNA metabolic process; transferase activity; catalytic activity, acting on RNA"
OG_09110,0.967378095453572,OG_09110,FUN_039036-T1,Peve_00028756,Pocillopora_meandrina_HIv1___RNAseq.g28692.t1,three_way,82.128,FUN_039036-T1,Q8N8E3,,,,,40.0,442.0,1.5e-65,251.9,sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2,,,,,,
OG_01216,0.9672880880610352,OG_01216,FUN_004897-T1,Peve_00015867,Pocillopora_meandrina_HIv1___RNAseq.g8671.t1,three_way,80.57000000000001,FUN_004897-T1,Q9Y3U8,,,,,63.4,93.0,7.6e-25,114.4,sp|Q9Y3U8|RL36_HUMAN Large ribosomal subunit protein eL36 OS=Homo sapiens OX=9606 GN=RPL36 PE=1 SV=3,,,,,,
OG_04006,0.9672627749323452,OG_04006,FUN_016305-T1,Peve_00032293,Pocillopora_meandrina_HIv1___RNAseq.g10040.t1,three_way,94.53566666666669,FUN_016305-T1,Q6NZ04,SIX1B_DANRE,,Homeobox protein six1b (Homeobox protein six1a) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,285.0,6.9e-92,338.6,sp|Q6NZ04|SIX1B_DANRE Homeobox protein six1b OS=Danio rerio OX=7955 GN=six1b PE=1 SV=1,GO:0000978; GO:0000981; GO:0002074; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0014857; GO:0021984; GO:0043282; GO:0048741; GO:0048839; GO:0048935; GO:0051146,adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; chordate pharyngeal muscle development [GO:0043282]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; peripheral nervous system neuron development [GO:0048935]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146],cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_10113,0.9667081620826944,OG_10113,FUN_043483-T1,Peve_00021710,Pocillopora_meandrina_HIv1___RNAseq.g7933.t1,three_way,81.26899999999999,FUN_043483-T1,Q96E35,,,,,48.1,241.0,4.4e-58,226.1,sp|Q96E35|ZMY19_HUMAN Zinc finger MYND domain-containing protein 19 OS=Homo sapiens OX=9606 GN=ZMYND19 PE=1 SV=1,,,,,,
OG_06181,0.9661932388455168,OG_06181,FUN_028088-T1,Peve_00031660,Pocillopora_meandrina_HIv1___TS.g11574.t1,three_way,88.21483333333333,FUN_028088-T1,P18907,,,,,76.6,988.0,0.0,1502.3,sp|P18907|AT1A1_HORSE Sodium/potassium-transporting ATPase subunit alpha-1 OS=Equus caballus OX=9796 GN=ATP1A1 PE=3 SV=1,,,,,,
OG_01324,0.9660476250073152,OG_01324,FUN_005194-T1,Peve_00001277,Pocillopora_meandrina_HIv1___RNAseq.g15136.t1,three_way,66.81283333333333,,,,,,,,,,,,,,,,,
OG_00361,0.9660066876199164,OG_00361,FUN_001195-T1,Peve_00006935,Pocillopora_meandrina_HIv1___RNAseq.g29525.t1,three_way,41.97683333333333,,,,,,,,,,,,,,,,,
OG_05462,0.9657043847141212,OG_05462,FUN_024445-T1,Peve_00025478,Pocillopora_meandrina_HIv1___RNAseq.g18708.t1,three_way,87.55799999999999,FUN_024445-T1,Q14643,,,,,59.9,2841.0,0.0,3137.1,"sp|Q14643|ITPR1_HUMAN Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1 OS=Homo sapiens OX=9606 GN=ITPR1 PE=1 SV=3",,,,,,
OG_00619,0.9655165696935928,OG_00619,FUN_001787-T1,Peve_00008715,Pocillopora_meandrina_HIv1___RNAseq.g2639.t1,three_way,71.26766666666667,FUN_001787-T1,Q9HCE0,EPG5_HUMAN,,Ectopic P granules protein 5 homolog,Homo sapiens (Human),30.6,2484.0,0.0,1120.1,sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2,GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786,autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],,GO:0002376; GO:0005764; GO:0005773; GO:0006954; GO:0012501; GO:0016192; GO:0030154; GO:0043226,immune system process; lysosome; vacuole; inflammatory response; programmed cell death; vesicle-mediated transport; cell differentiation; organelle
OG_06700,0.9652729579394148,OG_06700,FUN_031267-T1,Peve_00036736,Pocillopora_meandrina_HIv1___RNAseq.11406_t,three_way,69.776,FUN_031267-T1,P20072,,,,,40.6,313.0,1.1000000000000001e-60,237.3,sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2,,,,,,
OG_01636,0.9652299281795268,OG_01636,FUN_006769-T1,Peve_00027411,Pocillopora_meandrina_HIv1___RNAseq.g20028.t1,three_way,57.7305,FUN_006769-T1,Q9Y2U8,MAN1_HUMAN,,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),Homo sapiens (Human),42.9,317.0,7.4e-55,216.9,sp|Q9Y2U8|MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2,GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446,negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446],GO:0003677,DNA binding
OG_03447,0.9641119998917672,OG_03447,FUN_014512-T1,Peve_00032000,Pocillopora_meandrina_HIv1___TS.g27391.t1,three_way,41.315000000000005,,,,,,,,,,,,,,,,,
OG_00214,0.9639811130057472,OG_00214,FUN_000933-T1,Peve_00009727,Pocillopora_meandrina_HIv1___RNAseq.g29459.t1,three_way,43.35483333333333,,,,,,,,,,,,,,,,,
OG_00953,0.9639181717416504,OG_00953,FUN_004313-T1,Peve_00033929,Pocillopora_meandrina_HIv1___RNAseq.g16987.t1,three_way,67.48483333333334,FUN_004313-T1,Q90693,,,,,37.8,1339.0,2e-235,817.8,sp|Q90693|PTC1_CHICK Protein patched homolog 1 OS=Gallus gallus OX=9031 GN=PTCH1 PE=1 SV=1,,,,,,
OG_07469,0.9638754691274208,OG_07469,FUN_033979-T1,Peve_00004846,Pocillopora_meandrina_HIv1___RNAseq.g26111.t1,three_way,80.1855,FUN_033979-T1,O70247,,,,,40.7,570.0,5.3000000000000004e-111,403.3,sp|O70247|SC5A6_RAT Sodium-dependent multivitamin transporter OS=Rattus norvegicus OX=10116 GN=Slc5a6 PE=1 SV=1,,,,,,
OG_08617,0.9638566801605573,OG_08617,FUN_037768-T1,Peve_00014328,Pocillopora_meandrina_HIv1___RNAseq.g1480.t1,three_way,79.92966666666668,FUN_037768-T1,O35552,F263_RAT,,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain-type isozyme) (RB2K) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",Rattus norvegicus (Rat),53.4,440.0,1.1000000000000001e-130,468.4,"sp|O35552|F263_RAT 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 OS=Rattus norvegicus OX=10116 GN=Pfkfb3 PE=2 SV=1",GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0006096; GO:0006110; GO:0006915; GO:0010001; GO:0061744,"apoptotic process [GO:0006915]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; motor behavior [GO:0061744]; regulation of glycolytic process [GO:0006110]",cytosol [GO:0005829]; nucleoplasm [GO:0005654],"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]",GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; programmed cell death; transferase activity; hydrolase activity; cell differentiation; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00679,0.963414002321033,OG_00679,FUN_002102-T1,Peve_00004294,Pocillopora_meandrina_HIv1___RNAseq.g1737.t1,three_way,59.12716666666666,FUN_002102-T1,P18461,,,,,37.9,833.0,3.8e-141,503.8,sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus OX=9031 GN=FGFR2 PE=2 SV=1,,,,,,
OG_02207,0.9633349745258704,OG_02207,FUN_008583-T1,Peve_00028408,Pocillopora_meandrina_HIv1___RNAseq.g12778.t1,three_way,81.406,FUN_008583-T1,Q5RB35,MKLN1_PONAB,,Muskelin,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),61.2,738.0,2.1e-273,943.0,sp|Q5RB35|MKLN1_PONAB Muskelin OS=Pongo abelii OX=9601 GN=MKLN1 PE=2 SV=1,GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030036; GO:0042803; GO:0098895; GO:0098968; GO:0098982; GO:0099003; GO:0099164,actin cytoskeleton organization [GO:0030036]; cell-matrix adhesion [GO:0007160]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport in synapse [GO:0099003],cell cortex [GO:0005938]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; nucleoplasm [GO:0005654]; postsynaptic endosome membrane [GO:0098895]; postsynaptic specialization membrane of symmetric synapse [GO:0099164]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151],protein homodimerization activity [GO:0042803],GO:0005654; GO:0005829; GO:0007010; GO:0007155; GO:0016192,nucleoplasm; cytosol; cytoskeleton organization; cell adhesion; vesicle-mediated transport
OG_08673,0.963126417990712,OG_08673,FUN_037909-T1,Peve_00020691,Pocillopora_meandrina_HIv1___RNAseq.g1145.t1,three_way,93.333,FUN_037909-T1,P48149,,,,,84.6,130.0,6.6e-61,234.6,sp|P48149|RS15A_DROME Small ribosomal subunit protein uS8A OS=Drosophila melanogaster OX=7227 GN=RpS15Aa PE=1 SV=2,,,,,,
OG_00092,0.962330466876291,OG_00092,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),34.1,695.0,4.9e-100,368.2,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00092,0.962330466876291,OG_00092,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),47.9,71.0,4.6e-13,79.3,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_02248,0.9621895882529116,OG_02248,FUN_008665-T1,Peve_00044711,Pocillopora_meandrina_HIv1___RNAseq.g64.t1,three_way,73.61466666666666,FUN_008665-T1,Q6RHR9,,,,,33.7,1372.0,3.9e-185,650.6,"sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1",,,,,,
OG_03886,0.96181470656588,OG_03886,FUN_015434-T1,Peve_00033645,Pocillopora_meandrina_HIv1___RNAseq.g22219.t1,three_way,88.301,FUN_015434-T1,P53448,,,,,75.0,356.0,4.3999999999999996e-147,522.3,sp|P53448|ALDOC_CARAU Fructose-bisphosphate aldolase C OS=Carassius auratus OX=7957 GN=aldoc PE=2 SV=2,,,,,,
OG_00033,0.9613125875755616,OG_00033,FUN_000239-T1,Peve_00033353,Pocillopora_meandrina_HIv1___RNAseq.g28955.t1,three_way,97.61933333333332,FUN_000239-T1,Q2KHT7,,,,,89.3,84.0,1.7e-38,159.5,sp|Q2KHT7|RS27_BOVIN Small ribosomal subunit protein eS27 OS=Bos taurus OX=9913 GN=RPS27 PE=1 SV=3,,,,,,
OG_06119,0.9611739344580522,OG_06119,FUN_027850-T1,Peve_00024333,Pocillopora_meandrina_HIv1___TS.g11653.t1,three_way,77.86916666666667,,,,,,,,,,,,,,,,,
OG_03865,0.961072337609121,OG_03865,FUN_015373-T1,Peve_00000221,Pocillopora_meandrina_HIv1___RNAseq.g10184.t1,three_way,76.64383333333333,FUN_015373-T1,Q01320,TOP2A_MOUSE,,"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)",Mus musculus (Mouse),67.5,1208.0,0.0,1654.4,sp|Q01320|TOP2A_MOUSE DNA topoisomerase 2-alpha OS=Mus musculus OX=10090 GN=Top2a PE=1 SV=2,GO:0000228; GO:0000287; GO:0000775; GO:0000793; GO:0001673; GO:0002244; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006265; GO:0006325; GO:0006974; GO:0007059; GO:0007143; GO:0008301; GO:0009330; GO:0030261; GO:0030263; GO:0040016; GO:0042752; GO:0042803; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:0051309; GO:1990904,apoptotic chromosome condensation [GO:0030263]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511],"centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; male germ cell nucleus [GO:0001673]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]","ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; ubiquitin binding [GO:0043130]",GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006355; GO:0007059; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140097; GO:0140657,"nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; isomerase activity; reproductive process; cell differentiation; organelle; meiotic nuclear division; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02369,0.9607552683405196,OG_02369,FUN_008978-T1,Peve_00017852,Pocillopora_meandrina_HIv1___RNAseq.g14265.t1,three_way,33.91433333333333,,,,,,,,,,,,,,,,,
OG_02298,0.9607162677132496,OG_02298,FUN_008877-T1,Peve_00043352,Pocillopora_meandrina_HIv1___TS.g30031.t1,three_way,72.87216666666667,FUN_008877-T1,Q8IZQ1,WDFY3_HUMAN,,WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy),Homo sapiens (Human),36.1,2785.0,0.0,1567.7,sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2,GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204,aggrephagy [GO:0035973],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605],1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270],GO:0005635; GO:0005654; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006914; GO:0008289; GO:0043226,nuclear envelope; nucleoplasm; nucleolus; vacuole; cytosol; plasma membrane; autophagy; lipid binding; organelle
OG_06683,0.9603300662009832,OG_06683,FUN_031186-T1,Peve_00041875,Pocillopora_meandrina_HIv1___RNAseq.g5214.t1,three_way,69.12466666666667,FUN_031186-T1,P25500,,,,,64.8,491.0,5.8e-181,636.0,sp|P25500|PAPOA_BOVIN Poly(A) polymerase alpha OS=Bos taurus OX=9913 GN=PAPOLA PE=1 SV=3,,,,,,
OG_09495,0.9602182751265972,OG_09495,FUN_041535-T1,Peve_00039113,Pocillopora_meandrina_HIv1___RNAseq.g15374.t1,three_way,78.69216666666667,FUN_041535-T1,Q5R7X2,,,,,44.6,655.0,4.1e-134,480.7,sp|Q5R7X2|SR140_PONAB U2 snRNP-associated SURP motif-containing protein OS=Pongo abelii OX=9601 GN=U2SURP PE=2 SV=1,,,,,,
OG_10221,0.9597329217221472,OG_10221,FUN_043835-T1,Peve_00041794,Pocillopora_meandrina_HIv1___TS.g12323.t1,three_way,54.1065,,,,,,,,,,,,,,,,,
OG_05766,0.9594109069300129,OG_05766,FUN_025724-T1,Peve_00001160,Pocillopora_meandrina_HIv1___RNAseq.g10456.t1,three_way,61.71366666666667,FUN_025724-T1,Q5NUA6,NF2L2_BOVIN,,"Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2)",Bos taurus (Bovine),43.4,122.0,1e-17,93.2,sp|Q5NUA6|NF2L2_BOVIN Nuclear factor erythroid 2-related factor 2 OS=Bos taurus OX=9913 GN=NFE2L2 PE=2 SV=2,GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0010499; GO:0016567; GO:0034599; GO:0043161; GO:0043565; GO:0045088; GO:0045454; GO:0045944; GO:0071498; GO:0110076,cell redox homeostasis [GO:0045454]; cellular response to fluid shear stress [GO:0071498]; cellular response to oxidative stress [GO:0034599]; negative regulation of ferroptosis [GO:0110076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of innate immune response [GO:0045088]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; transcription regulator activity
OG_06372,0.959362158906191,OG_06372,FUN_028977-T1,Peve_00014804,Pocillopora_meandrina_HIv1___RNAseq.g25607.t1,three_way,64.57616666666667,FUN_028977-T1,Q3UG20,KMT2E_MOUSE,,Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog),Mus musculus (Mouse),30.4,460.0,1e-47,194.1,sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2,GO:0000791; GO:0002446; GO:0003713; GO:0005737; GO:0005813; GO:0008270; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0035064; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:1900087,epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; retinoic acid receptor signaling pathway [GO:0048384],centrosome [GO:0005813]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005815; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"immune system process; catalytic activity; microtubule organizing center; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_04335,0.9585386771254608,OG_04335,FUN_017947-T1,Peve_00000380,Pocillopora_meandrina_HIv1___RNAseq.g25233.t1,three_way,66.458,FUN_017947-T1,F1M0Z1,TRIO_RAT,,Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein),Rattus norvegicus (Rat),44.3,314.0,2.1999999999999998e-69,265.8,sp|F1M0Z1|TRIO_RAT Triple functional domain protein OS=Rattus norvegicus OX=10116 GN=Trio PE=1 SV=4,GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310,axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170],cell projection [GO:0042995]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05146,0.958430217812514,OG_05146,FUN_023423-T1,Peve_00019215,Pocillopora_meandrina_HIv1___RNAseq.g583.t1,three_way,90.14433333333334,FUN_023423-T1,Q5R416,CTNA2_PONAB,,Catenin alpha-2 (Alpha N-catenin),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),41.2,1200.0,2.9000000000000003e-214,747.3,sp|Q5R416|CTNA2_PONAB Catenin alpha-2 OS=Pongo abelii OX=9601 GN=CTNNA2 PE=2 SV=3,GO:0005198; GO:0005634; GO:0005737; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222,axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; nucleus [GO:0005634],actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198],GO:0005198; GO:0005634; GO:0005856; GO:0007155; GO:0008092; GO:0043226; GO:0048870,structural molecule activity; nucleus; cytoskeleton; cell adhesion; cytoskeletal protein binding; organelle; cell motility
OG_04880,0.9584042945050608,OG_04880,FUN_022914-T1,Peve_00001826,Pocillopora_meandrina_HIv1___RNAseq.g3710.t1,three_way,80.40933333333334,FUN_022914-T1,Q63028,ADDA_RAT,,Alpha-adducin (Erythrocyte adducin subunit alpha),Rattus norvegicus (Rat),47.2,375.0,3.7e-87,323.9,sp|Q63028|ADDA_RAT Alpha-adducin OS=Rattus norvegicus OX=10116 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0005200; GO:0005516; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006811; GO:0006884; GO:0007010; GO:0008290; GO:0014069; GO:0016020; GO:0020027; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0046983; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:0071300; GO:1903142; GO:1903393,actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cytoskeleton organization [GO:0007010]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; monoatomic ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608],GO:0005198; GO:0005634; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; nucleus; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_10175,0.95819795209833,OG_10175,FUN_043584-T1,Peve_00045195,Pocillopora_meandrina_HIv1___RNAseq.g6988.t1,three_way,66.09083333333334,FUN_043584-T1,P21180,CO2_MOUSE,,Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)],Mus musculus (Mouse),25.1,491.0,5.4e-29,131.0,sp|P21180|CO2_MOUSE Complement C2 OS=Mus musculus OX=10090 GN=C2 PE=1 SV=2,GO:0004252; GO:0005615; GO:0006508; GO:0006958; GO:0007584; GO:0032496; GO:0045087; GO:0046872; GO:0097066; GO:2000427,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; proteolysis [GO:0006508]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to thyroid hormone [GO:0097066]",extracellular space [GO:0005615],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003824; GO:0005615; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_09635,0.958174043877104,OG_09635,FUN_041824-T1,Peve_00039128,Pocillopora_meandrina_HIv1___RNAseq.g15806.t1,three_way,95.95933333333332,FUN_041824-T1,P0C6F1,DYH2_MOUSE,,Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2),Mus musculus (Mouse),72.9,2852.0,0.0,4229.9,sp|P0C6F1|DYH2_MOUSE Dynein axonemal heavy chain 2 OS=Mus musculus OX=10090 GN=Dnah2 PE=1 SV=1,GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0008569; GO:0016887; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285,cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_05069,0.958085064926242,OG_05069,FUN_023272-T1,Peve_00031864,Pocillopora_meandrina_HIv1___RNAseq.g17803.t1,three_way,64.60916666666667,FUN_023272-T1,Q9Z1Z1,E2AK3_RAT,,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2),Rattus norvegicus (Rat),35.6,1035.0,9.7e-144,512.7,sp|Q9Z1Z1|E2AK3_RAT Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Rattus norvegicus OX=10116 GN=Eif2ak3 PE=1 SV=1,GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006412; GO:0006446; GO:0006983; GO:0007029; GO:0007595; GO:0009967; GO:0010575; GO:0010628; GO:0010629; GO:0017148; GO:0019217; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031016; GO:0031018; GO:0031642; GO:0032055; GO:0032933; GO:0034198; GO:0034976; GO:0036499; GO:0036503; GO:0042149; GO:0042802; GO:0043066; GO:0044233; GO:0044322; GO:0045444; GO:0045943; GO:0048009; GO:0048471; GO:0051787; GO:0051879; GO:0060734; GO:0070059; GO:0070417; GO:0106310; GO:1900182; GO:1902010; GO:1902235; GO:1902237; GO:1903788; GO:1990737,angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation [GO:0006446]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005783; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07698,0.9579048060950373,OG_07698,FUN_034832-T1,Peve_00006740,Pocillopora_meandrina_HIv1___TS.g14528.t1,three_way,88.521,FUN_034832-T1,O35242,,,,,46.1,921.0,1.3e-227,791.2,sp|O35242|FAN_MOUSE Protein FAN OS=Mus musculus OX=10090 GN=Nsmaf PE=1 SV=2,,,,,,
OG_08676,0.9574393871296912,OG_08676,FUN_037915-T1,Peve_00006148,Pocillopora_meandrina_HIv1___RNAseq.g1174.t1,three_way,75.068,FUN_037915-T1,O43149,,,,,34.5,3025.0,0.0,1415.6,sp|O43149|ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZZEF1 PE=1 SV=6,,,,,,
OG_01995,0.9569397856888274,OG_01995,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_02454,0.9568429421823724,OG_02454,FUN_009532-T1,Peve_00009560,Pocillopora_meandrina_HIv1___RNAseq.g24493.t1,three_way,88.02533333333334,FUN_009532-T1,Q148N0,,,,,64.9,976.0,0.0,1304.7,sp|Q148N0|ODO1_BOVIN 2-oxoglutarate dehydrogenase complex component E1 OS=Bos taurus OX=9913 GN=OGDH PE=1 SV=1,,,,,,
OG_05050,0.9567901955442673,OG_05050,FUN_023240-T1,Peve_00029849,Pocillopora_meandrina_HIv1___RNAseq.g17391.t1,three_way,69.214,FUN_023240-T1,Q6Y685,TACC1_MOUSE,,Transforming acidic coiled-coil-containing protein 1,Mus musculus (Mouse),43.0,193.0,1.1e-29,133.3,sp|Q6Y685|TACC1_MOUSE Transforming acidic coiled-coil-containing protein 1 OS=Mus musculus OX=10090 GN=Tacc1 PE=1 SV=1,GO:0000226; GO:0003713; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0008283; GO:0019904; GO:0021987; GO:0022008; GO:0022027; GO:0030331; GO:0030496; GO:0032886; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301,cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; regulation of microtubule-based process [GO:0032886],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634],nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005815; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; microtubule organizing center; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06478,0.9563210641246797,OG_06478,FUN_029246-T1,Peve_00013747,Pocillopora_meandrina_HIv1___RNAseq.g25404.t1,three_way,78.42166666666667,FUN_029246-T1,Q9Y2I9,TBC30_HUMAN,,TBC1 domain family member 30,Homo sapiens (Human),49.0,569.0,8.899999999999999e-139,496.1,sp|Q9Y2I9|TBC30_HUMAN TBC1 domain family member 30 OS=Homo sapiens OX=9606 GN=TBC1D30 PE=1 SV=2,GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0016604; GO:0031267; GO:0036064; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; nuclear body [GO:0016604]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; plasma membrane; cilium; organelle; molecular function regulator activity
OG_01126,0.9562013021259808,OG_01126,FUN_004695-T1,Peve_00044672,Pocillopora_meandrina_HIv1___RNAseq.g8771.t1,three_way,71.41250000000001,,,,,,,,,,,,,,,,,
OG_01501,0.956184115267628,OG_01501,FUN_006227-T1,Peve_00002943,Pocillopora_meandrina_HIv1___TS.g29772.t1,three_way,66.25183333333334,FUN_006227-T1,P49793,,,,,37.4,1753.0,1.3e-226,788.9,sp|P49793|NUP98_RAT Nuclear pore complex protein Nup98-Nup96 OS=Rattus norvegicus OX=10116 GN=Nup98 PE=1 SV=2,,,,,,
OG_08091,0.9556010197049306,OG_08091,FUN_035824-T1,Peve_00037802,Pocillopora_meandrina_HIv1___RNAseq.g11933.t1,three_way,90.67833333333334,FUN_035824-T1,P08239,,,,,72.6,354.0,3e-148,526.2,sp|P08239|GNAO_BOVIN Guanine nucleotide-binding protein G(o) subunit alpha OS=Bos taurus OX=9913 GN=GNAO1 PE=1 SV=4,,,,,,
OG_08277,0.9555947658785324,OG_08277,FUN_036195-T1,Peve_00011109,Pocillopora_meandrina_HIv1___RNAseq.g27367.t1,three_way,72.57383333333334,FUN_036195-T1,Q3UMR0,ANR27_MOUSE,,Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein),Mus musculus (Mouse),42.3,787.0,1.5999999999999999e-96,355.9,sp|Q3UMR0|ANR27_MOUSE Ankyrin repeat domain-containing protein 27 OS=Mus musculus OX=10090 GN=Ankrd27 PE=1 SV=2,GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0045022; GO:0048812; GO:0050775; GO:0097422,early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031],cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149],GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,lysosome; endosome; vacuole; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_04072,0.9555565020005942,OG_04072,FUN_016393-T1,Peve_00006406,Pocillopora_meandrina_HIv1___RNAseq.g9756.t1,three_way,90.81433333333334,FUN_016393-T1,Q3T087,,,,,81.8,176.0,2.5e-82,306.2,sp|Q3T087|RL11_BOVIN Large ribosomal subunit protein uL5 OS=Bos taurus OX=9913 GN=RPL11 PE=2 SV=3,,,,,,
OG_03094,0.9555021096346228,OG_03094,FUN_012379-T1,Peve_00042533,Pocillopora_meandrina_HIv1___TS.g16234.t1b,three_way,77.48716666666667,FUN_012379-T1,P91620,SIF2_DROME,,"Protein still life, isoforms C/SIF type 2",Drosophila melanogaster (Fruit fly),32.8,1044.0,4.7e-133,477.6,"sp|P91620|SIF2_DROME Protein still life, isoforms C/SIF type 2 OS=Drosophila melanogaster OX=7227 GN=sif PE=2 SV=2",GO:0005085; GO:0007264; GO:0016020; GO:0030036; GO:0045202; GO:0050770; GO:0050772; GO:0050803; GO:0051491,actin cytoskeleton organization [GO:0030036]; positive regulation of axonogenesis [GO:0050772]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; small GTPase-mediated signal transduction [GO:0007264],membrane [GO:0016020]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0007010; GO:0098772,cytoskeleton organization; molecular function regulator activity
OG_01511,0.9554665006068568,OG_01511,FUN_006248-T1,Peve_00033332,Pocillopora_meandrina_HIv1___RNAseq.g20387.t1,three_way,74.98666666666666,FUN_006248-T1,O95831,AIFM1_HUMAN,,"Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8)",Homo sapiens (Human),55.4,509.0,4.2e-169,596.3,"sp|O95831|AIFM1_HUMAN Apoptosis-inducing factor 1, mitochondrial OS=Homo sapiens OX=9606 GN=AIFM1 PE=1 SV=1",GO:0002931; GO:0003677; GO:0003954; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0009636; GO:0016174; GO:0016651; GO:0030182; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0060545; GO:0070059; GO:0070301; GO:0071392; GO:0071456; GO:0071732; GO:0071949; GO:0072572; GO:0160203; GO:1902065; GO:1904045,apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nitric oxide [GO:0071732]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial disulfide relay system [GO:0160203]; mitochondrial respiratory chain complex assembly [GO:0033108]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; protein import into mitochondrial intermembrane space [GO:0045041]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],"DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; poly-ADP-D-ribose binding [GO:0072572]; protein dimerization activity [GO:0046983]",GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0012501; GO:0016491; GO:0030154; GO:0043226; GO:0055085; GO:0065003,DNA binding; catalytic activity; nucleus; mitochondrion; cytosol; protein folding; programmed cell death; oxidoreductase activity; cell differentiation; organelle; transmembrane transport; protein-containing complex assembly
OG_05916,0.9554115072582992,OG_05916,FUN_026108-T1,Peve_00014996,Pocillopora_meandrina_HIv1___RNAseq.g10317.t1,three_way,87.78083333333333,FUN_026108-T1,Q9HD67,MYO10_HUMAN,,Unconventional myosin-X (Unconventional myosin-10),Homo sapiens (Human),45.4,2065.0,0.0,1582.8,sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3,GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002,cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165],cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]",GO:0003774; GO:0003824; GO:0005730; GO:0005829; GO:0005886; GO:0008092; GO:0008289; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleolus; cytosol; plasma membrane; cytoskeletal protein binding; lipid binding; isomerase activity; organelle; ATP-dependent activity
OG_09257,0.9546974462558246,OG_09257,FUN_040059-T1,Peve_00014920,Pocillopora_meandrina_HIv1___RNAseq.g7726.t1,three_way,86.54366666666667,FUN_040059-T1,Q99LC5,,,,,71.0,328.0,1.4000000000000001e-123,444.1,"sp|Q99LC5|ETFA_MOUSE Electron transfer flavoprotein subunit alpha, mitochondrial OS=Mus musculus OX=10090 GN=Etfa PE=1 SV=2",,,,,,
OG_05732,0.9544734483621476,OG_05732,FUN_025658-T1,Peve_00042175,Pocillopora_meandrina_HIv1___RNAseq.g23074.t1,three_way,65.081,FUN_025658-T1,Q8C033,ARHGA_MOUSE,,Rho guanine nucleotide exchange factor 10,Mus musculus (Mouse),34.0,920.0,1.1e-133,479.9,sp|Q8C033|ARHGA_MOUSE Rho guanine nucleotide exchange factor 10 OS=Mus musculus OX=10090 GN=Arhgef10 PE=1 SV=2,GO:0005085; GO:0005813; GO:0019894; GO:0022011; GO:0035025; GO:0051298; GO:0051496; GO:0090307,centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496],centrosome [GO:0005813],guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894],GO:0005815; GO:0007010; GO:0008092; GO:0098772,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; molecular function regulator activity
OG_02323,0.9542925876597086,OG_02323,FUN_008915-T1,Peve_00033002,Pocillopora_meandrina_HIv1___RNAseq.g3980.t1,three_way,93.944,FUN_008915-T1,P58375,,,,,80.4,112.0,2.2e-45,183.0,sp|P58375|RL30_SPOFR Large ribosomal subunit protein eL30 OS=Spodoptera frugiperda OX=7108 GN=RpL30 PE=3 SV=1,,,,,,
OG_06489,0.9542713123554968,OG_06489,FUN_029264-T1,Peve_00030745,Pocillopora_meandrina_HIv1___RNAseq.g15034.t1,three_way,71.40766666666667,,,,,,,,,,,,,,,,,
OG_07132,0.954018868788777,OG_07132,FUN_032433-T1,Peve_00038721,Pocillopora_meandrina_HIv1___RNAseq.g20796.t1b,three_way,50.24216666666667,FUN_032433-T1,Q12789,TF3C1_HUMAN,,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),Homo sapiens (Human),25.0,1605.0,2.7e-101,372.9,sp|Q12789|TF3C1_HUMAN General transcription factor 3C polypeptide 1 OS=Homo sapiens OX=9606 GN=GTF3C1 PE=1 SV=4,GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904,5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797],membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127],DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995],GO:0003677; GO:0005654; GO:0005730; GO:0006351; GO:0006399; GO:0043226; GO:0140223,DNA binding; nucleoplasm; nucleolus; DNA-templated transcription; tRNA metabolic process; organelle; general transcription initiation factor activity
OG_07594,0.9538711500394716,OG_07594,FUN_034300-T1,Peve_00013958,Pocillopora_meandrina_HIv1___RNAseq.g28501.t1,three_way,80.99333333333334,FUN_034300-T1,Q86WG5,MTMRD_HUMAN,,Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2),Homo sapiens (Human),39.3,2002.0,0.0,1303.1,sp|Q86WG5|MTMRD_HUMAN Myotubularin-related protein 13 OS=Homo sapiens OX=9606 GN=SBF2 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005774; GO:0005829; GO:0006914; GO:0010008; GO:0016020; GO:0019208; GO:0019902; GO:0030424; GO:0035091; GO:0042552; GO:0042802; GO:0048471,autophagy [GO:0006914]; myelination [GO:0042552],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774],guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006914; GO:0008289; GO:0098772,cytosol; autophagy; lipid binding; molecular function regulator activity
OG_07238,0.9538090525254748,OG_07238,FUN_032958-T1,Peve_00014537,Pocillopora_meandrina_HIv1___RNAseq.g24985.t1,three_way,92.142,FUN_032958-T1,Q16204,CCDC6_HUMAN,,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),Homo sapiens (Human),66.4,369.0,7.5e-39,162.9,sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2,GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802,,cytoskeleton [GO:0005856]; cytosol [GO:0005829],identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005829; GO:0005856; GO:0043226,structural molecule activity; cytosol; cytoskeleton; organelle
OG_06440,0.9537925892978432,OG_06440,FUN_029144-T1,Peve_00000512,Pocillopora_meandrina_HIv1___RNAseq.g25729.t1,three_way,75.978,FUN_029144-T1,Q14BN4,,,,,59.9,289.0,1.6e-89,332.4,sp|Q14BN4|SLMAP_HUMAN Sarcolemmal membrane-associated protein OS=Homo sapiens OX=9606 GN=SLMAP PE=1 SV=1,,,,,,
OG_02903,0.9537396018764872,OG_02903,FUN_011973-T1,Peve_00001000,Pocillopora_meandrina_HIv1___RNAseq.g23724.t1,three_way,61.82216666666667,FUN_011973-T1,Q54G43,SHKE_DICDI,,Dual specificity protein kinase shkE (EC 2.7.11.1) (SH2 domain-containing protein 5) (SH2 domain-containing protein E),Dictyostelium discoideum (Social amoeba),31.5,251.0,1.8e-23,113.2,sp|Q54G43|SHKE_DICDI Dual specificity protein kinase shkE OS=Dictyostelium discoideum OX=44689 GN=shkE PE=3 SV=1,GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0106310,signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_00808,0.9526588807727808,OG_00808,FUN_004007-T1,Peve_00044893,Pocillopora_meandrina_HIv1___RNAseq.g11703.t1b,three_way,74.065,FUN_004007-T1,O95405,,,,,43.3,743.0,2.8000000000000003e-161,571.2,sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2,,,,,,
OG_01107,0.9525674835233432,OG_01107,FUN_004626-T1,Peve_00039247,Pocillopora_meandrina_HIv1___TS.g19833.t1,three_way,41.262166666666666,,,,,,,,,,,,,,,,,
OG_01343,0.952517286769292,OG_01343,FUN_005244-T1,Peve_00003366,Pocillopora_meandrina_HIv1___RNAseq.g8140.t2,three_way,77.56250000000001,FUN_005244-T1,Q8TDJ6,,,,,34.9,3319.0,0.0,1533.5,sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2,,,,,,
OG_05903,0.9521967423305172,OG_05903,FUN_026088-T1,Peve_00004126,Pocillopora_meandrina_HIv1___RNAseq.g10571.t1,three_way,73.563,FUN_026088-T1,Q5FVG2,E41L5_RAT,,Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5),Rattus norvegicus (Rat),47.5,358.0,2.8e-86,321.6,sp|Q5FVG2|E41L5_RAT Band 4.1-like protein 5 OS=Rattus norvegicus OX=10116 GN=Epb41l5 PE=1 SV=2,GO:0000902; GO:0001701; GO:0001756; GO:0001837; GO:0001839; GO:0001917; GO:0001954; GO:0003382; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007498; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0030036; GO:0031032; GO:0031252; GO:0032525; GO:0032587; GO:0048318; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560,"actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis [GO:0000902]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]",adherens junction [GO:0005912]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904],GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0048870,nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; cell motility
OG_01570,0.9513958307801028,OG_01570,FUN_006568-T1,Peve_00038422,Pocillopora_meandrina_HIv1___RNAseq.g20309.t1,three_way,78.6515,FUN_006568-T1,Q08DP6,,,,,49.5,588.0,1.7e-150,534.6,sp|Q08DP6|RHG10_BOVIN Rho GTPase-activating protein 10 OS=Bos taurus OX=9913 GN=ARHGAP10 PE=2 SV=1,,,,,,
OG_03143,0.9513846537504708,OG_03143,FUN_012528-T1,Peve_00013908,Pocillopora_meandrina_HIv1___RNAseq.g23974.t1,three_way,64.574,FUN_012528-T1,Q14149,MORC3_HUMAN,,MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3),Homo sapiens (Human),59.4,483.0,9.3e-152,539.3,sp|Q14149|MORC3_HUMAN MORC family CW-type zinc finger protein 3 OS=Homo sapiens OX=9606 GN=MORC3 PE=1 SV=3,GO:0000122; GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006468; GO:0008270; GO:0009791; GO:0016363; GO:0016605; GO:0016887; GO:0018105; GO:0030674; GO:0032688; GO:0035064; GO:0048147; GO:0050821; GO:0051457; GO:0140002; GO:0140374; GO:2000774,antiviral innate immune response [GO:0140374]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular senescence [GO:2000774]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821],chromatin [GO:0000785]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; histone H3K4me3 reader activity [GO:0140002]; methylated histone binding [GO:0035064]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016787; GO:0043226; GO:0060090; GO:0098542,immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; hydrolase activity; organelle; molecular adaptor activity; defense response to other organism
OG_06532,0.951272543616136,OG_06532,FUN_029392-T1,Peve_00044524,Pocillopora_meandrina_HIv1___TS.g2905.t4c,three_way,42.15233333333333,,,,,,,,,,,,,,,,,
OG_03225,0.9512198006220736,OG_03225,FUN_012766-T1,Peve_00026363,Pocillopora_meandrina_HIv1___RNAseq.g23151.t1c,three_way,53.47366666666667,,,,,,,,,,,,,,,,,
OG_06001,0.9509152118534652,OG_06001,FUN_026490-T1,Peve_00002095,Pocillopora_meandrina_HIv1___RNAseq.g4192.t1,three_way,88.14433333333334,FUN_026490-T1,O57683,,,,,77.7,1266.0,0.0,1677.9,sp|O57683|SF3B1_XENLA Splicing factor 3B subunit 1 OS=Xenopus laevis OX=8355 GN=sf3b1 PE=2 SV=1,,,,,,
OG_08795,0.9508627911115138,OG_08795,FUN_038091-T1,Peve_00007109,Pocillopora_meandrina_HIv1___RNAseq.g818.t1,three_way,94.97433333333332,FUN_038091-T1,A6QLG5,RS9_BOVIN,,Small ribosomal subunit protein uS4 (40S ribosomal protein S9),Bos taurus (Bovine),90.0,170.0,6.9e-83,308.1,sp|A6QLG5|RS9_BOVIN Small ribosomal subunit protein uS4 OS=Bos taurus OX=9913 GN=RPS9 PE=2 SV=1,GO:0003735; GO:0005730; GO:0006412; GO:0019843; GO:0022627; GO:0032040; GO:0042274; GO:1990904,ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small-subunit processome [GO:0032040],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_03163,0.950766996585582,OG_03163,FUN_012561-T1,Peve_00016373,Pocillopora_meandrina_HIv1___RNAseq.g23582.t1,three_way,69.20983333333334,FUN_012561-T1,Q92834,RPGR_HUMAN,,X-linked retinitis pigmentosa GTPase regulator,Homo sapiens (Human),44.0,448.0,1.1e-68,263.1,sp|Q92834|RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens OX=9606 GN=RPGR PE=1 SV=2,GO:0001750; GO:0003723; GO:0005085; GO:0005737; GO:0005794; GO:0005813; GO:0006511; GO:0006886; GO:0007601; GO:0010508; GO:0016567; GO:0032391; GO:0036064; GO:0036126; GO:0042073; GO:0042462; GO:0060271; GO:0061630; GO:0097499,cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; positive regulation of autophagy [GO:0010508]; protein localization to non-motile cilium [GO:0097499]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126],guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630],GO:0003723; GO:0003824; GO:0005794; GO:0005815; GO:0005929; GO:0006886; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0098772; GO:0140096,"RNA binding; catalytic activity; Golgi apparatus; microtubule organizing center; cilium; intracellular protein transport; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; nervous system process; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06114,0.9503610097389356,OG_06114,FUN_027831-T1,Peve_00020551,Pocillopora_meandrina_HIv1___RNAseq.g13868.t1,three_way,74.62966666666667,FUN_027831-T1,Q9H892,,,,,27.8,753.0,8.2e-63,243.4,sp|Q9H892|TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens OX=9606 GN=TTC12 PE=1 SV=2,,,,,,
OG_01712,0.9503044731735244,OG_01712,FUN_006986-T1,Peve_00009622,Pocillopora_meandrina_HIv1___RNAseq.g20224.t1,three_way,77.79516666666666,FUN_006986-T1,O60841,IF2P_HUMAN,,Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2),Homo sapiens (Human),72.7,593.0,6e-261,902.5,sp|O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=4,GO:0000049; GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0042255; GO:0045202; GO:0046872,regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0016787,RNA binding; catalytic activity; GTPase activity; cytosol; hydrolase activity
OG_03514,0.949511377205225,OG_03514,FUN_014625-T1,Peve_00002412,Pocillopora_meandrina_HIv1___TS.g27550.t1,three_way,56.03566666666666,,,,,,,,,,,,,,,,,
OG_07988,0.9489536233107948,OG_07988,FUN_035618-T1,Peve_00029653,Pocillopora_meandrina_HIv1___TS.g15425.t1,three_way,87.45883333333333,FUN_035618-T1,Q9Y5B9,,,,,59.7,937.0,0.0,1174.5,sp|Q9Y5B9|SP16H_HUMAN FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1,,,,,,
OG_01411,0.9480200209630432,OG_01411,FUN_005697-T1,Peve_00008482,Pocillopora_meandrina_HIv1___RNAseq.g19565.t1,three_way,83.81866666666667,FUN_005697-T1,O93308,,,,,50.9,1241.0,1.7e-278,960.7,sp|O93308|SMC1A_XENLA Structural maintenance of chromosomes protein 1A OS=Xenopus laevis OX=8355 GN=smc1a PE=1 SV=1,,,,,,
OG_05616,0.9474304214444202,OG_05616,FUN_025304-T1,Peve_00040949,Pocillopora_meandrina_HIv1___RNAseq.g13460.t1,three_way,85.93833333333333,FUN_025304-T1,Q9I7S6,,,,,53.0,372.0,3.1e-112,407.1,"sp|Q9I7S6|PDE9A_DROME High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A OS=Drosophila melanogaster OX=7227 GN=Pde9 PE=2 SV=2",,,,,,
OG_02173,0.947115825637849,OG_02173,FUN_008522-T1,Peve_00012217,Pocillopora_meandrina_HIv1___RNAseq.g14762.t2,three_way,80.53666666666668,FUN_008522-T1,Q9UPE1,,,,,59.4,547.0,7.599999999999999e-136,485.7,sp|Q9UPE1|SRPK3_HUMAN SRSF protein kinase 3 OS=Homo sapiens OX=9606 GN=SRPK3 PE=1 SV=2,,,,,,
OG_01951,0.9469375041529898,OG_01951,FUN_008016-T1,Peve_00031315,Pocillopora_meandrina_HIv1___RNAseq.g30338.t1,three_way,69.895,FUN_008016-T1,Q6GYQ0,RGPA1_HUMAN,,Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240),Homo sapiens (Human),36.5,2122.0,0.0,1175.6,sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1,GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630,activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; nucleus [GO:0005634],GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982],GO:0005634; GO:0043226; GO:0098772,nucleus; organelle; molecular function regulator activity
OG_01160,0.9465995817662298,OG_01160,FUN_004779-T1,Peve_00037747,Pocillopora_meandrina_HIv1___RNAseq.g6693.t1,three_way,80.62566666666666,FUN_004779-T1,A2A2Y4,FRMD3_HUMAN,,FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O),Homo sapiens (Human),49.3,341.0,6.399999999999999e-96,352.8,sp|A2A2Y4|FRMD3_HUMAN FERM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FRMD3 PE=1 SV=1,GO:0005856; GO:0008092; GO:0016020; GO:0031032,actomyosin structure organization [GO:0031032],cytoskeleton [GO:0005856]; membrane [GO:0016020],cytoskeletal protein binding [GO:0008092],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_06777,0.946329836580016,OG_06777,FUN_031643-T1,Peve_00043580,Pocillopora_meandrina_HIv1___RNAseq.g5686.t1,three_way,83.8815,FUN_031643-T1,Q14738,2A5D_HUMAN,,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta),Homo sapiens (Human),65.9,548.0,3.3e-205,716.1,sp|Q14738|2A5D_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform OS=Homo sapiens OX=9606 GN=PPP2R5D PE=1 SV=1,GO:0000159; GO:0005634; GO:0005654; GO:0005829; GO:0007165; GO:0007399; GO:0019888; GO:0051177; GO:0072542,meiotic sister chromatid cohesion [GO:0051177]; nervous system development [GO:0007399]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159],protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888],GO:0005634; GO:0005654; GO:0005829; GO:0043226; GO:0048856; GO:0098772,nucleus; nucleoplasm; cytosol; organelle; anatomical structure development; molecular function regulator activity
OG_09809,0.9461492525839192,OG_09809,FUN_042631-T1,Peve_00030043,Pocillopora_meandrina_HIv1___RNAseq.g11506.t1,three_way,73.376,FUN_042631-T1,Q5VTB9,RN220_HUMAN,,E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220),Homo sapiens (Human),33.0,657.0,3.9999999999999997e-63,244.2,sp|Q5VTB9|RN220_HUMAN E3 ubiquitin-protein ligase RNF220 OS=Homo sapiens OX=9606 GN=RNF220 PE=1 SV=1,GO:0003358; GO:0004842; GO:0005634; GO:0005652; GO:0005654; GO:0005737; GO:0006513; GO:0008013; GO:0008270; GO:0016567; GO:0021904; GO:0032991; GO:0051091; GO:0051865; GO:0061630; GO:0090263; GO:0098794; GO:0098978; GO:0099149; GO:2000677,dorsal/ventral neural tube patterning [GO:0021904]; noradrenergic neuron development [GO:0003358]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of transcription regulatory region DNA binding [GO:2000677],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],beta-catenin binding [GO:0008013]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09299,0.9461359207524292,OG_09299,FUN_040152-T1,Peve_00038144,Pocillopora_meandrina_HIv1___RNAseq.g8496.t1,three_way,65.6315,FUN_040152-T1,P17702,,,,,49.2,122.0,2.2999999999999997e-24,113.2,sp|P17702|RL28_RAT Large ribosomal subunit protein eL28 OS=Rattus norvegicus OX=10116 GN=Rpl28 PE=1 SV=4,,,,,,
OG_07670,0.9448525735192702,OG_07670,FUN_034727-T1,Peve_00033249,Pocillopora_meandrina_HIv1___RNAseq.g28714.t1,three_way,89.599,FUN_034727-T1,Q93009,UBP7_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7),Homo sapiens (Human),59.7,1090.0,0.0,1328.5,sp|Q93009|UBP7_HUMAN Ubiquitin carboxyl-terminal hydrolase 7 OS=Homo sapiens OX=9606 GN=USP7 PE=1 SV=2,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006283; GO:0006307; GO:0006508; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0042752; GO:0044027; GO:0045721; GO:0048511; GO:0050821; GO:0051090; GO:0070203; GO:0075342; GO:0101005; GO:1901796; GO:1904262; GO:1904353; GO:1905279; GO:1990380,"DNA alkylation repair [GO:0006307]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of TORC1 signaling [GO:1904262]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of establishment of protein localization to telomere [GO:0070203]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; symbiont-mediated disruption of host cell PML body [GO:0075342]; transcription-coupled nucleotide-excision repair [GO:0006283]",chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06781,0.9445336633984124,OG_06781,FUN_031648-T1,Peve_00043574,Pocillopora_meandrina_HIv1___RNAseq.g5681.t1,three_way,93.75783333333334,FUN_031648-T1,Q6PD03,2A5A_MOUSE,,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha),Mus musculus (Mouse),75.4,443.0,6.199999999999999e-189,661.8,sp|Q6PD03|2A5A_MOUSE Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform OS=Mus musculus OX=10090 GN=Ppp2r5a PE=1 SV=1,GO:0000159; GO:0000775; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0007165; GO:0019210; GO:0019900; GO:0030018; GO:0031430; GO:0072542; GO:1903077,negative regulation of protein localization to plasma membrane [GO:1903077]; signal transduction [GO:0007165],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]",kinase binding [GO:0019900]; kinase inhibitor activity [GO:0019210]; protein phosphatase activator activity [GO:0072542],GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; plasma membrane; organelle; molecular function regulator activity
OG_09179,0.9444596642755226,OG_09179,FUN_039859-T1,Peve_00014928,Pocillopora_meandrina_HIv1___TS.g1031.t1,three_way,39.94166666666667,,,,,,,,,,,,,,,,,
OG_04625,0.944309412861654,OG_04625,FUN_022333-T1,Peve_00028601,Pocillopora_meandrina_HIv1___RNAseq.g4652.t1,three_way,61.93866666666667,FUN_022333-T1,Q92609,TBCD5_HUMAN,,TBC1 domain family member 5,Homo sapiens (Human),37.5,610.0,3.2e-104,381.3,sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1,GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:1905394,"autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]",autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904],AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394],GO:0005773; GO:0005794; GO:0005829; GO:0006914; GO:0016192; GO:0043226; GO:0098772,vacuole; Golgi apparatus; cytosol; autophagy; vesicle-mediated transport; organelle; molecular function regulator activity
OG_00243,0.943817824046893,OG_00243,FUN_001006-T1,Peve_00015278,Pocillopora_meandrina_HIv1___RNAseq.g29174.t1,three_way,60.991,FUN_001006-T1,Q498G2,,,,,27.4,727.0,1.3e-40,171.0,sp|Q498G2|CE152_XENLA Centrosomal protein of 152 kDa OS=Xenopus laevis OX=8355 GN=cep152 PE=2 SV=1,,,,,,
OG_09823,0.943782791785708,OG_09823,FUN_042656-T1,Peve_00031588,Pocillopora_meandrina_HIv1___RNAseq.g4910.t1a,three_way,75.37983333333334,FUN_042656-T1,Q5VYK3,ECM29_HUMAN,,Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog),Homo sapiens (Human),44.3,1886.0,0.0,1510.7,sp|Q5VYK3|ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 OS=Homo sapiens OX=9606 GN=ECPAS PE=1 SV=2,GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0031410; GO:0036503; GO:0043248; GO:0060090; GO:0070628,ERAD pathway [GO:0036503]; proteasome assembly [GO:0043248],centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502],molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628],GO:0005634; GO:0005654; GO:0005768; GO:0005783; GO:0005815; GO:0030163; GO:0031410; GO:0043226; GO:0060090; GO:0065003,nucleus; nucleoplasm; endosome; endoplasmic reticulum; microtubule organizing center; protein catabolic process; cytoplasmic vesicle; organelle; molecular adaptor activity; protein-containing complex assembly
OG_03310,0.9437546000251908,OG_03310,FUN_013387-T1,Peve_00034571,Pocillopora_meandrina_HIv1___RNAseq.g22979.t1,three_way,82.8835,FUN_013387-T1,Q3UY96,,,,,33.7,1633.0,7.6e-245,849.4,sp|Q3UY96|CFA74_MOUSE Cilia- and flagella-associated protein 74 OS=Mus musculus OX=10090 GN=Cfap74 PE=2 SV=3,,,,,,
OG_04041,0.9432100330635969,OG_04041,FUN_016350-T1,Peve_00004331,Pocillopora_meandrina_HIv1___RNAseq.16312_t,three_way,70.639,FUN_016350-T1,Q90WR8,SP3_CHICK,,Transcription factor Sp3,Gallus gallus (Chicken),48.7,117.0,7.9e-20,100.1,sp|Q90WR8|SP3_CHICK Transcription factor Sp3 OS=Gallus gallus OX=9031 GN=SP3 PE=1 SV=1,GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001779; GO:0001889; GO:0002318; GO:0003682; GO:0005829; GO:0006357; GO:0008270; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0043353; GO:0045944; GO:0048596; GO:0048706; GO:0060216; GO:0061629,B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; myeloid progenitor cell differentiation [GO:0002318]; natural killer cell differentiation [GO:0001779]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217],cytosol [GO:0005829]; PML body [GO:0016605]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09670,0.9430696321859164,OG_09670,FUN_041888-T1,Peve_00033407,Pocillopora_meandrina_HIv1___RNAseq.g15416.t1,three_way,83.91333333333334,FUN_041888-T1,Q3SZ65,,,,,83.1,397.0,6.8999999999999995e-189,661.4,sp|Q3SZ65|IF4A2_BOVIN Eukaryotic initiation factor 4A-II OS=Bos taurus OX=9913 GN=EIF4A2 PE=2 SV=1,,,,,,
OG_05473,0.943044811431332,OG_05473,FUN_024456-T1,Peve_00010312,Pocillopora_meandrina_HIv1___RNAseq.g18574.t1,three_way,77.98883333333333,FUN_024456-T1,A7S6A1,,,,,59.2,903.0,2.2000000000000002e-272,939.9,sp|A7S6A1|U518_NEMVE FHIP family protein v1g243165 OS=Nematostella vectensis OX=45351 GN=v1g243165 PE=3 SV=1,,,,,,
OG_04064,0.9430044136977368,OG_04064,FUN_016385-T1,Peve_00022914,Pocillopora_meandrina_HIv1___RNAseq.g9738.t1,three_way,70.09116666666667,FUN_016385-T1,Q15061,WDR43_HUMAN,,WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog),Homo sapiens (Human),40.4,599.0,7.9e-112,406.0,sp|Q15061|WDR43_HUMAN WD repeat-containing protein 43 OS=Homo sapiens OX=9606 GN=WDR43 PE=1 SV=3,GO:0000462; GO:0000785; GO:0000993; GO:0001650; GO:0003711; GO:0003723; GO:0005654; GO:0005730; GO:0032040; GO:0034243; GO:0042274; GO:0045943; GO:2000036; GO:2000234,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; ribosomal small subunit biogenesis [GO:0042274]",chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040],RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation factor activity [GO:0003711],GO:0003723; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0140110,RNA binding; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_01259,0.9429606332367916,OG_01259,FUN_005018-T1,Peve_00015875,Pocillopora_meandrina_HIv1___RNAseq.g8677.t1,three_way,82.69383333333333,FUN_005018-T1,Q6GPM1,,,,,45.6,799.0,4e-132,474.2,sp|Q6GPM1|ZFR_XENLA Zinc finger RNA-binding protein OS=Xenopus laevis OX=8355 GN=zfr PE=2 SV=1,,,,,,
OG_02918,0.942516282524842,OG_02918,FUN_012001-T1,Peve_00000536,Pocillopora_meandrina_HIv1___RNAseq.g24024.t1,three_way,59.24283333333334,FUN_012001-T1,Q60902,EP15R_MOUSE,,Epidermal growth factor receptor substrate 15-like 1 (Epidermal growth factor receptor pathway substrate 15-related sequence) (Eps15-rs) (Eps15-related protein) (Eps15R),Mus musculus (Mouse),34.3,137.0,4.6e-13,78.6,sp|Q60902|EP15R_MOUSE Epidermal growth factor receptor substrate 15-like 1 OS=Mus musculus OX=10090 GN=Eps15l1 PE=1 SV=3,GO:0005509; GO:0005634; GO:0030132; GO:0048488; GO:0098793,synaptic vesicle endocytosis [GO:0048488],clathrin coat of coated pit [GO:0030132]; nucleus [GO:0005634]; presynapse [GO:0098793],calcium ion binding [GO:0005509],GO:0005634; GO:0016192; GO:0043226,nucleus; vesicle-mediated transport; organelle
OG_09591,0.9423984781545688,OG_09591,FUN_041734-T1,Peve_00024444,Pocillopora_meandrina_HIv1___RNAseq.6485_t,three_way,58.46866666666666,FUN_041734-T1,Q7Z7M0,MEGF8_HUMAN,,Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4),Homo sapiens (Human),33.1,2861.0,0.0,1367.4,sp|Q7Z7M0|MEGF8_HUMAN Multiple epidermal growth factor-like domains protein 8 OS=Homo sapiens OX=9606 GN=MEGF8 PE=1 SV=2,GO:0000151; GO:0003143; GO:0005509; GO:0005634; GO:0007224; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0070062; GO:0071907; GO:0097094; GO:0097155; GO:1990403,aorta development [GO:0035904]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224],extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],calcium ion binding [GO:0005509],GO:0005634; GO:0043226; GO:0048856; GO:0048870; GO:0065003,nucleus; organelle; anatomical structure development; cell motility; protein-containing complex assembly
OG_07904,0.9421727774174464,OG_07904,FUN_035341-T1,Peve_00029661,Pocillopora_meandrina_HIv1___TS.g3597.t1,three_way,81.158,FUN_035341-T1,Q3URV1,BROMI_MOUSE,,Protein broad-minded (TBC1 domain family member 32),Mus musculus (Mouse),41.3,269.0,9.2e-49,195.3,sp|Q3URV1|BROMI_MOUSE Protein broad-minded OS=Mus musculus OX=10090 GN=Tbc1d32 PE=1 SV=2,GO:0001822; GO:0002088; GO:0003406; GO:0005737; GO:0005929; GO:0007224; GO:0007368; GO:0007507; GO:0021532; GO:0021915; GO:0035082; GO:0042733; GO:0043010; GO:0060021; GO:0060041; GO:0060271; GO:0060831; GO:0061512; GO:1905515,axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; neural tube development [GO:0021915]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retina development in camera-type eye [GO:0060041]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005929; GO:0007010; GO:0043226; GO:0044782; GO:0048856,cilium; cytoskeleton organization; organelle; cilium organization; anatomical structure development
OG_03893,0.9420812520950264,OG_03893,FUN_015448-T1,Peve_00013022,Pocillopora_meandrina_HIv1___RNAseq.g22266.t1,three_way,60.5595,FUN_015448-T1,Q08E13,RNF10_BOVIN,,E3 ubiquitin-protein ligase RNF10 (EC 2.3.2.27) (RING finger protein 10),Bos taurus (Bovine),39.1,791.0,5.5e-107,390.2,sp|Q08E13|RNF10_BOVIN E3 ubiquitin-protein ligase RNF10 OS=Bos taurus OX=9913 GN=RNF10 PE=2 SV=1,GO:0000976; GO:0005634; GO:0005737; GO:0006513; GO:0008270; GO:0031643; GO:0045944; GO:0061630; GO:1990116,positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein monoubiquitination [GO:0006513]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytoplasm [GO:0005737]; nucleus [GO:0005634],transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_00540,0.941980956419178,OG_00540,FUN_001562-T1,Peve_00013899,Pocillopora_meandrina_HIv1___RNAseq.g2018.t1,three_way,83.21833333333333,FUN_001562-T1,Q8IWZ3,,,,,58.1,812.0,4.4e-82,308.9,sp|Q8IWZ3|ANKH1_HUMAN Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKHD1 PE=1 SV=1,,,,,,
OG_06384,0.941098518499007,OG_06384,FUN_029014-T1,Peve_00003118,Pocillopora_meandrina_HIv1___TS.g9087.t1,three_way,52.617,FUN_029014-T1,B8VIW9,,,,,40.2,1040.0,3.2999999999999996e-188,660.6,sp|B8VIW9|FP_ACRMI Fibronectin type III domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_07066,0.9407987652176496,OG_07066,FUN_032299-T1,Peve_00020128,Pocillopora_meandrina_HIv1___RNAseq.g24900.t1,three_way,50.632333333333335,FUN_032299-T1,Q3ZT31,SNX25_MOUSE,,Sorting nexin-25,Mus musculus (Mouse),27.2,125.0,1.3e-07,60.8,sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3,GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091,negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801],endosome [GO:0005768]; endosome membrane [GO:0010008],phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005768; GO:0008289; GO:0031410; GO:0043226,endosome; lipid binding; cytoplasmic vesicle; organelle
OG_00685,0.9404075828511124,OG_00685,FUN_002352-T1,Peve_00022332,Pocillopora_meandrina_HIv1___RNAseq.g33.t1,three_way,56.47666666666667,FUN_002352-T1,Q69ZL1,,,,,41.2,658.0,7.2e-121,437.6,"sp|Q69ZL1|FGD6_MOUSE FYVE, RhoGEF and PH domain-containing protein 6 OS=Mus musculus OX=10090 GN=Fgd6 PE=1 SV=2",,,,,,
OG_00703,0.9402691318271008,OG_00703,FUN_002453-T1,Peve_00023668,Pocillopora_meandrina_HIv1___RNAseq.g14891.t1,three_way,78.35433333333334,,,,,,,,,,,,,,,,,
OG_01730,0.9400388087784824,OG_01730,FUN_007024-T1,Peve_00032896,Pocillopora_meandrina_HIv1___RNAseq.g20020.t1,three_way,90.27,FUN_007024-T1,O49447,ADT3_ARATH,,"ADP,ATP carrier protein 3, mitochondrial (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3)",Arabidopsis thaliana (Mouse-ear cress),66.6,308.0,3.2e-110,399.8,"sp|O49447|ADT3_ARATH ADP,ATP carrier protein 3, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=AAC3 PE=1 SV=1",GO:0005471; GO:0005739; GO:0005743; GO:0005886; GO:0009941; GO:0015865; GO:0016020; GO:0140021; GO:1990544,mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; purine nucleotide transport [GO:0015865],chloroplast envelope [GO:0009941]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP:ADP antiporter activity [GO:0005471],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_08895,0.9397220098095852,OG_08895,FUN_038302-T1,Peve_00000035,Pocillopora_meandrina_HIv1___RNAseq.g28304.t1,three_way,90.22033333333331,FUN_038302-T1,F8WK50,,,,,59.3,1273.0,2.6e-295,1016.5,sp|F8WK50|FLII_DANRE Protein flightless-1 homolog OS=Danio rerio OX=7955 GN=flii PE=1 SV=1,,,,,,
OG_03414,0.93955312892629,OG_03414,FUN_014462-T1,Peve_00023416,Pocillopora_meandrina_HIv1___RNAseq.g22646.t2,three_way,80.2825,FUN_014462-T1,Q9C086,IN80B_HUMAN,,INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog) (hIes2) (PAP-1-associated protein 1) (PAPA-1) (Zinc finger HIT domain-containing protein 4),Homo sapiens (Human),52.8,195.0,3.8e-12,73.9,sp|Q9C086|IN80B_HUMAN INO80 complex subunit B OS=Homo sapiens OX=9606 GN=INO80B PE=1 SV=2,GO:0000723; GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0008270; GO:0016604; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],zinc ion binding [GO:0008270],GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226,nucleoplasm; nucleolus; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle
OG_08080,0.9391984628976224,OG_08080,FUN_035804-T1,Peve_00017708,Pocillopora_meandrina_HIv1___RNAseq.g11921.t1,three_way,69.93833333333333,FUN_035804-T1,Q8NCN5,,,,,39.3,819.0,1e-170,602.1,"sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2",,,,,,
OG_05535,0.9391456111592732,OG_05535,FUN_024724-T1,Peve_00012714,Pocillopora_meandrina_HIv1___RNAseq.g18835.t1,three_way,82.242,FUN_024724-T1,Q9EPW0,INP4A_MOUSE,,"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Inositol polyphosphate 4-phosphatase-1) (4-Ptase-1) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)",Mus musculus (Mouse),37.1,911.0,3.5e-154,547.4,sp|Q9EPW0|INP4A_MOUSE Inositol polyphosphate-4-phosphatase type I A OS=Mus musculus OX=10090 GN=Inpp4a PE=1 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0006798; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0052828; GO:0055038; GO:0098978; GO:0099072,polyphosphate catabolic process [GO:0006798]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038],"inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]",GO:0003824; GO:0005634; GO:0005886; GO:0016787; GO:0043226,catalytic activity; nucleus; plasma membrane; hydrolase activity; organelle
OG_06491,0.938855755417334,OG_06491,FUN_029269-T1,Peve_00002504,Pocillopora_meandrina_HIv1___RNAseq.g25417.t1,three_way,91.27916666666668,FUN_029269-T1,P08110,,,,,69.4,779.0,1.7e-282,973.4,sp|P08110|ENPL_CHICK Endoplasmin OS=Gallus gallus OX=9031 GN=HSP90B1 PE=1 SV=1,,,,,,
OG_04109,0.9386238935845987,OG_04109,FUN_016475-T1,Peve_00040144,Pocillopora_meandrina_HIv1___RNAseq.g10194.t1,three_way,66.4755,FUN_016475-T1,P0C5Y8,ALS2_RAT,,Alsin (Amyotrophic lateral sclerosis 2 protein homolog),Rattus norvegicus (Rat),30.6,1765.0,3.8e-188,661.0,sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1,GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072,"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267],GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0016192; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,nucleus; endosome; microtubule organizing center; cytosol; vesicle-mediated transport; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_00166,0.9386010460102804,OG_00166,FUN_000641-T1,Peve_00012249,Pocillopora_meandrina_HIv1___TS.g17921.t4,three_way,55.0825,FUN_000641-T1,A6QLA0,,,,,45.6,780.0,1.1e-188,662.1,sp|A6QLA0|NFX1_BOVIN Transcriptional repressor NF-X1 OS=Bos taurus OX=9913 GN=NFX1 PE=2 SV=1,,,,,,
OG_06738,0.9385901958981376,OG_06738,FUN_031525-T1,Peve_00022761,Pocillopora_meandrina_HIv1___TS.g23851.t1,three_way,69.21566666666666,FUN_031525-T1,O75445,USH2A_HUMAN,,Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein),Homo sapiens (Human),31.2,5403.0,0.0,2352.8,sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3,GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696,establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696],collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022],GO:0005576; GO:0005815; GO:0008092; GO:0030154; GO:0030312; GO:0031012; GO:0050877,extracellular region; microtubule organizing center; cytoskeletal protein binding; cell differentiation; external encapsulating structure; extracellular matrix; nervous system process
OG_04500,0.9385462133305558,OG_04500,FUN_021938-T1,Peve_00023930,Pocillopora_meandrina_HIv1___RNAseq.g2960.t2,three_way,73.7475,FUN_021938-T1,Q4W5Z4,DNM3A_CHICK,,DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (Cysteine methyltransferase DNMT3A) (EC 2.1.1.-),Gallus gallus (Chicken),47.0,651.0,6.4e-174,612.5,sp|Q4W5Z4|DNM3A_CHICK DNA (cytosine-5)-methyltransferase 3A OS=Gallus gallus OX=9031 GN=DNMT3A PE=2 SV=1,GO:0000791; GO:0001046; GO:0003886; GO:0005634; GO:0005737; GO:0008270; GO:0009408; GO:0016363; GO:0032259; GO:0044027; GO:0045892; GO:0071774; GO:0106363,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; response to fibroblast growth factor [GO:0071774]; response to heat [GO:0009408],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],core promoter sequence-specific DNA binding [GO:0001046]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; protein-cysteine methyltransferase activity [GO:0106363]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0140096; GO:0140097,"DNA binding; catalytic activity; nucleus; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_02036,0.9383253935475874,OG_02036,FUN_008238-T1,Peve_00003880,Pocillopora_meandrina_HIv1___RNAseq.g17929.t1,three_way,69.81566666666667,FUN_008238-T1,Q8R2K4,TAF6L_MOUSE,,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha),Mus musculus (Mouse),43.2,472.0,5.600000000000001e-89,330.1,sp|Q8R2K4|TAF6L_MOUSE TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L OS=Mus musculus OX=10090 GN=Taf6l PE=1 SV=1,GO:0000124; GO:0005634; GO:0005669; GO:0006282; GO:0006355; GO:0006367; GO:0016251; GO:0043484; GO:0045893; GO:0046695; GO:0046982; GO:1904672,positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; transcription initiation at RNA polymerase II promoter [GO:0006367],nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669],protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0005634; GO:0006355; GO:0043226; GO:0140223,nucleus; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_02132,0.9382789930826382,OG_02132,FUN_008436-T1,Peve_00003898,Pocillopora_meandrina_HIv1___RNAseq.g18055.t1,three_way,83.60333333333334,FUN_008436-T1,Q07889,SOS1_HUMAN,,Son of sevenless homolog 1 (SOS-1),Homo sapiens (Human),56.7,1047.0,0.0,1162.9,sp|Q07889|SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens OX=9606 GN=SOS1 PE=1 SV=1,GO:0001782; GO:0001942; GO:0002931; GO:0003209; GO:0003344; GO:0005085; GO:0005096; GO:0005154; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0008286; GO:0008543; GO:0014044; GO:0014069; GO:0017124; GO:0019221; GO:0019901; GO:0033081; GO:0035264; GO:0038095; GO:0042110; GO:0042127; GO:0042129; GO:0042552; GO:0043025; GO:0045742; GO:0046982; GO:0048009; GO:0048011; GO:0048514; GO:0050853; GO:0050900; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:0098978; GO:0140693; GO:1904693; GO:1905360; GO:2000973,axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vitellogenesis [GO:0007296],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular condensate scaffold activity [GO:0140693]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124],GO:0002376; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0098772,immune system process; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; anatomical structure development; cell motility; molecular adaptor activity; molecular function regulator activity
OG_02721,0.9382161809103275,OG_02721,FUN_011049-T1,Peve_00013424,Pocillopora_meandrina_HIv1___TS.g26228.t1,three_way,60.9865,,,,,,,,,,,,,,,,,
OG_07665,0.9374776698493628,OG_07665,FUN_034720-T1,Peve_00033269,Pocillopora_meandrina_HIv1___RNAseq.g28723.t1,three_way,62.28366666666667,FUN_034720-T1,P82094,TMF1_HUMAN,,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),Homo sapiens (Human),40.1,685.0,2.8999999999999997e-43,179.1,sp|P82094|TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens OX=9606 GN=TMF1 PE=1 SV=2,GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845,acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006355; GO:0007018; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; regulation of DNA-templated transcription; microtubule-based movement; programmed cell death; reproductive process; cell differentiation; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_01445,0.937374198542152,OG_01445,FUN_005893-T1,Peve_00015773,Pocillopora_meandrina_HIv1___RNAseq.g19681.t1,three_way,81.42,FUN_005893-T1,G5EBX9,PPE_CAEEL,,Serine/threonine-protein phosphatase with EF-hands pef-1 (CePPEF) (EC 3.1.3.16) (Phosphatase with EF hands 1),Caenorhabditis elegans,49.7,580.0,1.8000000000000001e-162,574.3,sp|G5EBX9|PPE_CAEEL Serine/threonine-protein phosphatase with EF-hands pef-1 OS=Caenorhabditis elegans OX=6239 GN=pef-1 PE=1 SV=1,GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0030145; GO:0030424; GO:0030425; GO:0043025; GO:0043204; GO:0050906,detection of stimulus involved in sensory perception [GO:0050906],axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; cilium; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09642,0.9372350770205904,OG_09642,FUN_041837-T1,Peve_00009647,Pocillopora_meandrina_HIv1___RNAseq.g15083.t1,three_way,77.079,FUN_041837-T1,Q676U5,A16L1_HUMAN,,Autophagy-related protein 16-1 (APG16-like 1),Homo sapiens (Human),34.9,601.0,7.8e-79,296.2,sp|Q676U5|A16L1_HUMAN Autophagy-related protein 16-1 OS=Homo sapiens OX=9606 GN=ATG16L1 PE=1 SV=2,GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0006501; GO:0010508; GO:0015031; GO:0016236; GO:0016237; GO:0019787; GO:0021766; GO:0022038; GO:0030424; GO:0034045; GO:0034274; GO:0034497; GO:0036020; GO:0039689; GO:0042802; GO:0043495; GO:0051020; GO:0051607; GO:0097225; GO:0098792; GO:0098930; GO:0098978; GO:0120095; GO:0140059; GO:1903860,autophagosome assembly [GO:0000045]; axonal transport [GO:0098930]; C-terminal protein lipidation [GO:0006501]; corpus callosum development [GO:0022038]; defense response to virus [GO:0051607]; dendrite arborization [GO:0140059]; hippocampus development [GO:0021766]; macroautophagy [GO:0016236]; microautophagy [GO:0016237]; negative regulation of dendrite extension [GO:1903860]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095],GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like protein transferase activity [GO:0019787],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0007018; GO:0016740; GO:0043226; GO:0048856; GO:0060090; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; microtubule-based movement; transferase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein"
OG_09358,0.9371636282061844,OG_09358,FUN_040444-T1,Peve_00004018,Pocillopora_meandrina_HIv1___RNAseq.g6519.t1,three_way,96.19533333333334,FUN_040444-T1,P80021,,,,,82.6,552.0,6.3e-254,877.9,"sp|P80021|ATPA_PIG ATP synthase F(1) complex subunit alpha, mitochondrial OS=Sus scrofa OX=9823 GN=ATP5F1A PE=1 SV=2",,,,,,
OG_07069,0.9369613637923482,OG_07069,FUN_032304-T1,Peve_00029762,Pocillopora_meandrina_HIv1___RNAseq.g24893.t1,three_way,84.42699999999999,FUN_032304-T1,Q99470,,,,,60.9,115.0,4.5e-38,158.7,sp|Q99470|SDF2_HUMAN Stromal cell-derived factor 2 OS=Homo sapiens OX=9606 GN=SDF2 PE=1 SV=2,,,,,,
OG_01033,0.936845864234742,OG_01033,FUN_004468-T1,Peve_00007166,Pocillopora_meandrina_HIv1___RNAseq.g4953.t1,three_way,63.32233333333333,FUN_004468-T1,P23727,P85A_BOVIN,,Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha),Bos taurus (Bovine),32.1,636.0,1.2e-79,299.7,sp|P23727|P85A_BOVIN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Bos taurus OX=9913 GN=PIK3R1 PE=1 SV=1,GO:0001678; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005942; GO:0005943; GO:0008286; GO:0015031; GO:0032869; GO:0033120; GO:0034446; GO:0034976; GO:0035014; GO:0042307; GO:0042802; GO:0043066; GO:0043125; GO:0043491; GO:0043548; GO:0043560; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0140767; GO:0141038; GO:1900103; GO:1903078,cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular glucose homeostasis [GO:0001678]; negative regulation of apoptotic process [GO:0043066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446],"nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]",1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; enzyme-substrate adaptor activity [GO:0140767]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0005634; GO:0006355; GO:0006629; GO:0007155; GO:0043226; GO:0060090; GO:0098772,nucleus; regulation of DNA-templated transcription; lipid metabolic process; cell adhesion; organelle; molecular adaptor activity; molecular function regulator activity
OG_05177,0.9368195442739834,OG_05177,FUN_023507-T1,Peve_00005822,Pocillopora_meandrina_HIv1___RNAseq.g568.t1,three_way,58.58383333333333,,,,,,,,,,,,,,,,,
OG_06004,0.936287009150543,OG_06004,FUN_026494-T1,Peve_00004180,Pocillopora_meandrina_HIv1___RNAseq.g4199.t1,three_way,63.488,FUN_026494-T1,Q71M21,,,,,28.2,1343.0,2.3000000000000001e-88,329.7,sp|Q71M21|RH21B_XENLA Rho GTPase-activating protein 21-B OS=Xenopus laevis OX=8355 GN=arhgap21-b PE=2 SV=1,,,,,,
OG_03332,0.9360884885910058,OG_03332,FUN_013545-T1,Peve_00038572,Pocillopora_meandrina_HIv1___RNAseq.g22955.t1a,three_way,83.74533333333333,FUN_013545-T1,Q99570,PI3R4_HUMAN,,Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein),Homo sapiens (Human),51.6,1405.0,0.0,1382.1,sp|Q99570|PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PIK3R4 PE=1 SV=3,GO:0000425; GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005929; GO:0005930; GO:0006468; GO:0006622; GO:0006623; GO:0010506; GO:0015630; GO:0016020; GO:0016241; GO:0030670; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0036064; GO:0036092; GO:0042149; GO:0043231; GO:0043491; GO:0045022; GO:0045171; GO:0045324; GO:0071561; GO:0097352; GO:0106310,autophagosome maturation [GO:0097352]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; pexophagy [GO:0000425]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241],"autophagosome [GO:0005776]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]",ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005768; GO:0005773; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; vacuole; microtubule organizing center; cytosol; cytoskeleton; cilium; lipid metabolic process; intracellular protein transport; autophagy; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_08667,0.93595597360502,OG_08667,FUN_037903-T1,Peve_00028717,Pocillopora_meandrina_HIv1___RNAseq.g28653.t1,three_way,61.3495,FUN_037903-T1,Q5XK85,,,,,25.0,1134.0,1.4e-34,150.2,sp|Q5XK85|KATIP_XENLA Protein KATNIP homolog OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_01507,0.9352675920998532,OG_01507,FUN_006242-T1,Peve_00011455,Pocillopora_meandrina_HIv1___RNAseq.g20444.t1,three_way,65.56483333333334,FUN_006242-T1,Q6GQJ2,JADE1_XENLA,,Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17),Xenopus laevis (African clawed frog),44.8,511.0,5.6e-120,433.7,sp|Q6GQJ2|JADE1_XENLA Protein Jade-1 OS=Xenopus laevis OX=8355 GN=jade1 PE=2 SV=1,GO:0000123; GO:0005634; GO:0005737; GO:0005856; GO:0006357; GO:0006915; GO:0008270; GO:0042995,apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0005856; GO:0006355; GO:0012501; GO:0043226,nucleus; cytoskeleton; regulation of DNA-templated transcription; programmed cell death; organelle
OG_04315,0.935265703667882,OG_04315,FUN_017915-T1,Peve_00017903,Pocillopora_meandrina_HIv1___RNAseq.g332.t1,three_way,82.63666666666667,FUN_017915-T1,P07814,SYEP_HUMAN,,Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)],Homo sapiens (Human),58.0,1343.0,0.0,1438.3,sp|P07814|SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens OX=9606 GN=EPRS1 PE=1 SV=5,GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006418; GO:0006424; GO:0006433; GO:0008270; GO:0016020; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042802; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904,cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005829; GO:0005886; GO:0006399; GO:0006520; GO:0016874; GO:0140098,"RNA binding; catalytic activity; cytosol; plasma membrane; tRNA metabolic process; amino acid metabolic process; ligase activity; catalytic activity, acting on RNA"
OG_02904,0.9351723773149304,OG_02904,FUN_011974-T1,Peve_00000999,Pocillopora_meandrina_HIv1___RNAseq.g23723.t1,three_way,49.84633333333333,FUN_011974-T1,Q9BQF6,SENP7_HUMAN,,Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7),Homo sapiens (Human),48.3,321.0,1.3e-68,263.1,sp|Q9BQF6|SENP7_HUMAN Sentrin-specific protease 7 OS=Homo sapiens OX=9606 GN=SENP7 PE=1 SV=4,GO:0005634; GO:0005737; GO:0006508; GO:0016926; GO:0070139; GO:0099523; GO:0099524; GO:0140374,antiviral innate immune response [GO:0140374]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523],SUMO-specific endopeptidase activity [GO:0070139],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; hydrolase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_03635,0.9350553453284908,OG_03635,FUN_014855-T1,Peve_00038800,Pocillopora_meandrina_HIv1___RNAseq.g22371.t1,three_way,96.05733333333332,FUN_014855-T1,Q6P2Q9,PRP8_HUMAN,,Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220),Homo sapiens (Human),92.1,2321.0,0.0,4492.2,sp|Q6P2Q9|PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens OX=9606 GN=PRPF8 PE=1 SV=2,GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157,"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_01851,0.9344348901686184,OG_01851,FUN_007801-T1,Peve_00022055,Pocillopora_meandrina_HIv1___RNAseq.g18338.t1,three_way,56.8715,,,,,,,,,,,,,,,,,
OG_09610,0.9343981323057946,OG_09610,FUN_041768-T1,Peve_00041573,Pocillopora_meandrina_HIv1___RNAseq.g15245.t1,three_way,58.71716666666667,FUN_041768-T1,Q641Q2,WAC2A_HUMAN,,WASH complex subunit 2A,Homo sapiens (Human),43.1,202.0,2.6000000000000002e-37,159.8,sp|Q641Q2|WAC2A_HUMAN WASH complex subunit 2A OS=Homo sapiens OX=9606 GN=WASHC2A PE=1 SV=3,GO:0005730; GO:0005769; GO:0005829; GO:0005886; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0036010; GO:0042147; GO:0043231; GO:0071203; GO:1901981; GO:1905394,"endosomal transport [GO:0016197]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203],phosphatidylinositol phosphate binding [GO:1901981]; retromer complex binding [GO:1905394],GO:0005730; GO:0005768; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleolus; endosome; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_05241,0.9342540507533444,OG_05241,FUN_023682-T1,Peve_00014139,Pocillopora_meandrina_HIv1___RNAseq.g17753.t1,three_way,78.52883333333334,FUN_023682-T1,A7SK48,EIF3A_NEMVE,,Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10),Nematostella vectensis (Starlet sea anemone),73.3,786.0,8.7e-296,1018.1,sp|A7SK48|EIF3A_NEMVE Eukaryotic translation initiation factor 3 subunit A OS=Nematostella vectensis OX=45351 GN=v1g190699 PE=3 SV=2,GO:0001732; GO:0002188; GO:0003729; GO:0003743; GO:0016282; GO:0033290; GO:0043614; GO:0071540; GO:0071541,formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188],"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]",mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_01366,0.9341893784291888,OG_01366,FUN_005313-T1,Peve_00003312,Pocillopora_meandrina_HIv1___RNAseq.g8174.t1,three_way,94.14516666666668,FUN_005313-T1,Q04727,TLE4_HUMAN,,Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4),Homo sapiens (Human),84.8,356.0,3.9e-180,632.1,sp|Q04727|TLE4_HUMAN Transducin-like enhancer protein 4 OS=Homo sapiens OX=9606 GN=TLE4 PE=1 SV=3,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0090090; GO:0140297; GO:1990830; GO:1990907,cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055],beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_04662,0.9341780512505592,OG_04662,FUN_022408-T1,Peve_00037583,Pocillopora_meandrina_HIv1___RNAseq.g4541.t1,three_way,68.21366666666667,FUN_022408-T1,F1QJX5,UBR3_DANRE,,E3 ubiquitin-protein ligase ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase ubr3),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,844.0,4.4000000000000004e-125,451.1,sp|F1QJX5|UBR3_DANRE E3 ubiquitin-protein ligase ubr3 OS=Danio rerio OX=7955 GN=ubr3 PE=2 SV=2,GO:0000151; GO:0005737; GO:0008270; GO:0016567; GO:0048592; GO:0061630; GO:0071596,eye morphogenesis [GO:0048592]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00252,0.9340668158208602,OG_00252,FUN_001016-T1,Peve_00041043,Pocillopora_meandrina_HIv1___RNAseq.g29160.t1,three_way,48.55133333333333,FUN_001016-T1,Q0IHU9,,,,,42.9,203.0,7.6e-44,180.6,sp|Q0IHU9|PRUN2_XENTR Protein prune homolog 2 OS=Xenopus tropicalis OX=8364 GN=Prune2 PE=2 SV=1,,,,,,
OG_04102,0.9339505879275202,OG_04102,FUN_016453-T1,Peve_00040136,Pocillopora_meandrina_HIv1___RNAseq.g97.t1,three_way,59.23416666666667,FUN_016453-T1,Q0VF49,,,,,25.1,355.0,6.7e-07,58.5,sp|Q0VF49|K2012_HUMAN Uncharacterized protein KIAA2012 OS=Homo sapiens OX=9606 GN=KIAA2012 PE=1 SV=2,,,,,,
OG_06284,0.9334802924344752,OG_06284,FUN_028470-T1,Peve_00036788,Pocillopora_meandrina_HIv1___RNAseq.g16126.t1,three_way,85.66233333333334,FUN_028470-T1,Q17LW0,,,,,59.3,1107.0,1.4e-292,1007.3,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_06533,0.9334544168693132,OG_06533,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,55.2,87.0,8.5e-18,94.4,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06533,0.9334544168693132,OG_06533,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,56.2,48.0,2e-06,56.6,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_08783,0.9333023623128472,OG_08783,FUN_038072-T1,Peve_00000952,Pocillopora_meandrina_HIv1___TS.g5330.t1,three_way,63.88366666666666,FUN_038072-T1,A2A870,,,,,41.9,74.0,6.3e-06,55.5,sp|A2A870|FBF1_MOUSE Fas-binding factor 1 OS=Mus musculus OX=10090 GN=Fbf1 PE=1 SV=1,,,,,,
OG_04615,0.9331937563842636,OG_04615,FUN_022314-T1,Peve_00021691,Pocillopora_meandrina_HIv1___TS.g22047.t1,three_way,61.79866666666667,,,,,,,,,,,,,,,,,
OG_02184,0.9329305186879396,OG_02184,FUN_008537-T1,Peve_00044625,Pocillopora_meandrina_HIv1___RNAseq.g14737.t1,three_way,73.81949999999999,FUN_008537-T1,Q7Z6B7,SRGP1_HUMAN,,SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13),Homo sapiens (Human),33.9,834.0,3.3e-120,434.5,sp|Q7Z6B7|SRGP1_HUMAN SLIT-ROBO Rho GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=SRGAP1 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0007266; GO:0016477; GO:0030336; GO:0031267,cell migration [GO:0016477]; negative regulation of cell migration [GO:0030336]; Rho protein signal transduction [GO:0007266],cytoplasm [GO:0005737]; cytosol [GO:0005829],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0048870; GO:0098772,cytosol; cell motility; molecular function regulator activity
OG_06232,0.9328719065194556,OG_06232,FUN_028185-T1,Peve_00001293,Pocillopora_meandrina_HIv1___TS.g11524.t1,three_way,76.6565,FUN_028185-T1,Q86YW9,MD12L_HUMAN,,Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like),Homo sapiens (Human),39.9,1865.0,0.0,1122.5,sp|Q86YW9|MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens OX=9606 GN=MED12L PE=1 SV=2,GO:0003713; GO:0008013; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592],beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713],GO:0006355; GO:0060090; GO:0140110,regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_01475,0.9325109906585748,OG_01475,FUN_006038-T1,Peve_00023433,Pocillopora_meandrina_HIv1___RNAseq.g20251.t1,three_way,65.71133333333333,FUN_006038-T1,Q7T2C4,S26A5_DANRE,,Prestin (Solute carrier family 26 member 5),Danio rerio (Zebrafish) (Brachydanio rerio),37.0,686.0,1.8e-115,418.3,sp|Q7T2C4|S26A5_DANRE Prestin OS=Danio rerio OX=7955 GN=slc26a5 PE=2 SV=1,GO:0005737; GO:0005886; GO:0006821; GO:0008271; GO:0015075; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0016020; GO:0019531; GO:0019532; GO:0042391; GO:0160044; GO:0160046; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; oxalate transport [GO:0019532]; regulation of membrane potential [GO:0042391]; sulfate transmembrane transport [GO:1902358],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; formate transmembrane transporter activity [GO:0015499]; monoatomic ion transmembrane transporter activity [GO:0015075]; oxalate transmembrane transporter activity [GO:0019531]; oxalate:chloride antiporter activity [GO:0160046]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06754,0.9319947737605756,OG_06754,FUN_031565-T1,Peve_00021513,Pocillopora_meandrina_HIv1___RNAseq.g5072.t1,three_way,87.24600000000001,FUN_031565-T1,Q01728,,,,,54.5,932.0,1.8e-266,920.2,sp|Q01728|NAC1_RAT Sodium/calcium exchanger 1 OS=Rattus norvegicus OX=10116 GN=Slc8a1 PE=1 SV=3,,,,,,
OG_09015,0.9312433510701448,OG_09015,FUN_038577-T1,Peve_00012107,Pocillopora_meandrina_HIv1___RNAseq.g1011.t1,three_way,67.471,FUN_038577-T1,Q0QWG9,GRD2I_MOUSE,,"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)",Mus musculus (Mouse),28.8,420.0,9.800000000000001e-34,147.1,sp|Q0QWG9|GRD2I_MOUSE Delphilin OS=Mus musculus OX=10090 GN=Grid2ip PE=1 SV=1,GO:0007216; GO:0030036; GO:0043197; GO:0045202; GO:0045211; GO:0060292; GO:0098688; GO:0098978; GO:0099072; GO:0099092; GO:0099566; GO:0150048,actin cytoskeleton organization [GO:0030036]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],"cerebellar granule cell to Purkinje cell synapse [GO:0150048]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]",,GO:0007010; GO:0043226,cytoskeleton organization; organelle
OG_05138,0.9310676041231216,OG_05138,FUN_023410-T1,Peve_00017394,Pocillopora_meandrina_HIv1___RNAseq.g17575.t1,three_way,54.03783333333333,FUN_023410-T1,Q1LYG0,,,,,34.5,313.0,3.9e-50,201.8,sp|Q1LYG0|SPD2A_DANRE SH3 and PX domain-containing protein 2A OS=Danio rerio OX=7955 GN=sh3pxd2a PE=3 SV=2,,,,,,
OG_00007,0.9310010534402228,OG_00007,FUN_000194-T1,Peve_00038470,Pocillopora_meandrina_HIv1___RNAseq.g28898.t1,three_way,77.11833333333334,FUN_000194-T1,P70182,,,,,60.2,447.0,3.4e-147,523.5,sp|P70182|PI51A_MOUSE Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2,,,,,,
OG_08674,0.9307704408187796,OG_08674,FUN_037910-T1,Peve_00004651,Pocillopora_meandrina_HIv1___TS.g5680.t1,three_way,79.7845,FUN_037910-T1,Q8IV35,,,,,30.2,865.0,1.6e-100,369.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_03452,0.9307642578975034,OG_03452,FUN_014527-T1,Peve_00044379,Pocillopora_meandrina_HIv1___RNAseq.g22617.t1,three_way,81.44616666666667,FUN_014527-T1,O15297,PPM1D_HUMAN,,Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1),Homo sapiens (Human),51.3,277.0,1.2e-79,298.5,sp|O15297|PPM1D_HUMAN Protein phosphatase 1D OS=Homo sapiens OX=9606 GN=PPM1D PE=1 SV=1,GO:0000086; GO:0004674; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006346; GO:0006470; GO:0008285; GO:0009267; GO:0009314; GO:0009617; GO:0030330; GO:0035970; GO:0045814; GO:0046872; GO:0051019; GO:0060260; GO:1902531,"cellular response to starvation [GO:0009267]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; regulation of intracellular signal transduction [GO:1902531]; regulation of transcription initiation by RNA polymerase II [GO:0060260]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]",cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06910,0.9307414971613608,OG_06910,FUN_031970-T1,Peve_00043666,Pocillopora_meandrina_HIv1___RNAseq.g30204.t1,three_way,57.15116666666666,FUN_031970-T1,Q96J02,,,,,37.4,270.0,1.6e-43,180.3,sp|Q96J02|ITCH_HUMAN E3 ubiquitin-protein ligase Itchy homolog OS=Homo sapiens OX=9606 GN=ITCH PE=1 SV=2,,,,,,
OG_07438,0.930740516165512,OG_07438,FUN_033928-T1,Peve_00022640,Pocillopora_meandrina_HIv1___RNAseq.g26589.t1,three_way,76.85166666666666,FUN_033928-T1,A6H8T2,,,,,34.0,712.0,1.4e-110,402.1,sp|A6H8T2|DNAI7_DANRE Dynein axonemal intermediate chain 7 OS=Danio rerio OX=7955 GN=dnai7 PE=2 SV=2,,,,,,
OG_10035,0.93058105960965,OG_10035,FUN_043299-T1,Peve_00026362,Pocillopora_meandrina_HIv1___RNAseq.g8894.t1,three_way,72.17666666666666,FUN_043299-T1,Q6P9Q6,FKB15_MOUSE,,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),Mus musculus (Mouse),36.7,619.0,1.2000000000000001e-80,303.5,sp|Q6P9Q6|FKB15_MOUSE FK506-binding protein 15 OS=Mus musculus OX=10090 GN=Fkbp15 PE=1 SV=2,GO:0003779; GO:0005768; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030424; GO:0030426,endocytosis [GO:0006897],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; early endosome [GO:0005769]; endosome [GO:0005768]; growth cone [GO:0030426]; membrane [GO:0016020],actin binding [GO:0003779],GO:0005768; GO:0005856; GO:0008092; GO:0016192; GO:0031410; GO:0043226,endosome; cytoskeleton; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_03654,0.9304929688925628,OG_03654,FUN_014890-T1,Peve_00003524,Pocillopora_meandrina_HIv1___RNAseq.g21063.t1,three_way,80.91116666666667,FUN_014890-T1,Q9BT92,TCHP_HUMAN,,Trichoplein keratin filament-binding protein (Protein TCHP) (Mitochondrial protein with oncostatic activity) (Mitostatin) (Tumor suppressor protein),Homo sapiens (Human),54.1,135.0,7.5e-30,132.5,sp|Q9BT92|TCHP_HUMAN Trichoplein keratin filament-binding protein OS=Homo sapiens OX=9606 GN=TCHP PE=1 SV=1,GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0006915; GO:0030030; GO:0030057; GO:0030308; GO:0031965; GO:0036064; GO:0045095; GO:0045179; GO:1902018,apoptotic process [GO:0006915]; cell projection organization [GO:0030030]; negative regulation of cell growth [GO:0030308]; negative regulation of cilium assembly [GO:1902018],apical cortex [GO:0045179]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],,GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0012501; GO:0043226,mitochondrion; microtubule organizing center; cytosol; plasma membrane; cilium; programmed cell death; organelle
OG_09486,0.9303548994085816,OG_09486,FUN_041519-T1,Peve_00024151,Pocillopora_meandrina_HIv1___RNAseq.g15592.t1,three_way,58.06766666666667,FUN_041519-T1,P27393,,,,,62.9,224.0,9e-84,314.3,sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1,,,,,,
OG_05014,0.9303069353316464,OG_05014,FUN_023173-T1,Peve_00009976,Pocillopora_meandrina_HIv1___TS.g25350.t1,three_way,83.18433333333333,FUN_023173-T1,O93309,SMC3_XENLA,,Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3),Xenopus laevis (African clawed frog),50.2,630.0,2.6e-150,533.9,sp|O93309|SMC3_XENLA Structural maintenance of chromosomes protein 3 OS=Xenopus laevis OX=8355 GN=smc3 PE=1 SV=2,GO:0000775; GO:0000785; GO:0003690; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0007064; GO:0016887; GO:0030892; GO:0030893; GO:0051301; GO:0051321,cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; regulation of DNA replication [GO:0006275],"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0022414; GO:0043226,DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; reproductive process; organelle
OG_09387,0.9301726628734904,OG_09387,FUN_040680-T1,Peve_00009589,Pocillopora_meandrina_HIv1___RNAseq.g6447.t1,three_way,74.92949999999999,FUN_040680-T1,Q13972,RGRF1_HUMAN,,Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25),Homo sapiens (Human),40.1,1471.0,1.8e-260,901.0,sp|Q13972|RGRF1_HUMAN Ras-specific guanine nucleotide-releasing factor 1 OS=Homo sapiens OX=9606 GN=RASGRF1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0030426; GO:0031175; GO:0034976; GO:0035022; GO:0035254; GO:0043005; GO:0043409; GO:0043410; GO:0044342; GO:0046578; GO:0046579; GO:0048167; GO:0048168,long-term memory [GO:0007616]; negative regulation of MAPK cascade [GO:0043409]; neuron projection development [GO:0031175]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of Ras protein signal transduction [GO:0046578]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0050877; GO:0098772,cytosol; plasma membrane; nervous system process; molecular function regulator activity
OG_05803,0.9293590879958284,OG_05803,FUN_025793-T1,Peve_00021012,Pocillopora_meandrina_HIv1___RNAseq.g10402.t1,three_way,55.269666666666666,FUN_025793-T1,Q6R3M4,POLI_MOUSE,,DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B),Mus musculus (Mouse),40.9,541.0,1.2e-94,349.0,sp|Q6R3M4|POLI_MOUSE DNA polymerase iota OS=Mus musculus OX=10090 GN=Poli PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0019985; GO:0046872; GO:0071494,cellular response to UV-C [GO:0071494]; DNA replication [GO:0006260]; translesion synthesis [GO:0019985],nucleus [GO:0005634],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_04243,0.9290507083423664,OG_04243,FUN_017765-T1,Peve_00003282,Pocillopora_meandrina_HIv1___RNAseq.g446.t1,three_way,79.75516666666667,FUN_017765-T1,Q5RD44,B3A2_PONAB,,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Solute carrier family 4 member 2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),43.1,1043.0,1.9e-207,724.5,sp|Q5RD44|B3A2_PONAB Anion exchange protein 2 OS=Pongo abelii OX=9601 GN=SLC4A2 PE=2 SV=2,GO:0016323; GO:0016324; GO:0030316; GO:0032956; GO:0043377; GO:0045124; GO:0051453; GO:0140900; GO:2000565,"negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]",apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323],chloride:bicarbonate antiporter activity [GO:0140900],GO:0005215; GO:0030154,transporter activity; cell differentiation
OG_05075,0.9290091786697378,OG_05075,FUN_023301-T1,Peve_00041311,Pocillopora_meandrina_HIv1___RNAseq.g17777.t1,three_way,77.84916666666666,FUN_023301-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),31.5,371.0,1.6000000000000001e-38,162.5,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_01982,0.9289851124210068,OG_01982,FUN_008090-T1,Peve_00033656,Pocillopora_meandrina_HIv1___RNAseq.g30101.t1,three_way,80.22983333333333,FUN_008090-T1,P58405,STRN3_RAT,,Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen),Rattus norvegicus (Rat),44.9,824.0,2.0999999999999996e-171,604.4,sp|P58405|STRN3_RAT Striatin-3 OS=Rattus norvegicus OX=10116 GN=Strn3 PE=1 SV=2,GO:0005516; GO:0005654; GO:0005794; GO:0005886; GO:0019901; GO:0030425; GO:0030674; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0035331; GO:0043025; GO:0044877; GO:0045892; GO:0051721; GO:0070016; GO:0090443; GO:0098794,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; response to estradiol [GO:0032355],dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0043226; GO:0060090,nucleoplasm; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_00982,0.9284067248056368,OG_00982,FUN_004365-T1,Peve_00008937,Pocillopora_meandrina_HIv1___TS.g7532.t1,three_way,75.77499999999999,FUN_004365-T1,Q6PC91,,,,,64.1,156.0,5.7e-44,178.7,sp|Q6PC91|BT3L4_DANRE Transcription factor BTF3 homolog 4 OS=Danio rerio OX=7955 GN=btf3l4 PE=2 SV=1,,,,,,
OG_00028,0.9282982922097006,OG_00028,FUN_000231-T1,Peve_00012025,Pocillopora_meandrina_HIv1___RNAseq.g28946.t1,three_way,54.33083333333334,FUN_000231-T1,Q1ZXH8,GXCDD_DICDI,,Guanine exchange factor for Rac 30,Dictyostelium discoideum (Social amoeba),36.5,203.0,4.3e-26,122.5,sp|Q1ZXH8|GXCDD_DICDI Guanine exchange factor for Rac 30 OS=Dictyostelium discoideum OX=44689 GN=gxcDD PE=4 SV=3,GO:0005085; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005938; GO:0008270; GO:0016020; GO:0030587; GO:0030670; GO:0031152; GO:0031267; GO:0032009; GO:0035556,aggregation involved in sorocarp development [GO:0031152]; intracellular signal transduction [GO:0035556]; sorocarp development [GO:0030587],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early phagosome [GO:0032009]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670],"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0005856; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,cytoskeleton; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_00237,0.9281108539475952,OG_00237,FUN_000992-T1,Peve_00004455,Pocillopora_meandrina_HIv1___RNAseq.g29194.t1,three_way,92.068,FUN_000992-T1,P82471,GNAQ_RAT,,Guanine nucleotide-binding protein G(q) subunit alpha (EC 3.6.5.-) (Guanine nucleotide-binding protein alpha-q),Rattus norvegicus (Rat),82.2,353.0,8.9e-169,594.3,sp|P82471|GNAQ_RAT Guanine nucleotide-binding protein G(q) subunit alpha OS=Rattus norvegicus OX=10116 GN=Gnaq PE=2 SV=2,GO:0001501; GO:0001508; GO:0001664; GO:0003924; GO:0003925; GO:0005096; GO:0005525; GO:0005737; GO:0005794; GO:0005834; GO:0005886; GO:0005901; GO:0007186; GO:0007189; GO:0007200; GO:0007206; GO:0007207; GO:0007208; GO:0007215; GO:0007218; GO:0007507; GO:0008217; GO:0009791; GO:0010543; GO:0016020; GO:0016322; GO:0021884; GO:0030234; GO:0030425; GO:0031683; GO:0031965; GO:0032024; GO:0034695; GO:0042711; GO:0042733; GO:0043066; GO:0043267; GO:0044297; GO:0044877; GO:0045634; GO:0046872; GO:0047391; GO:0048066; GO:0050821; GO:0060158; GO:0060828; GO:0086100; GO:0098793; GO:0099524; GO:1904888; GO:1990806,action potential [GO:0001508]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; endothelin receptor signaling pathway [GO:0086100]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; ligand-gated ion channel signaling pathway [GO:1990806]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; neuron remodeling [GO:0016322]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of insulin secretion [GO:0032024]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of blood pressure [GO:0008217]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; regulation of platelet activation [GO:0010543]; response to prostaglandin E [GO:0034695]; skeletal system development [GO:0001501],caveola [GO:0005901]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynapse [GO:0098793],alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; enzyme regulator activity [GO:0030234]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0003924; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; GTPase activity; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_00196,0.9279976642260002,OG_00196,FUN_000908-T1,Peve_00010044,Pocillopora_meandrina_HIv1___RNAseq.g29495.t1,three_way,77.85966666666667,FUN_000908-T1,Q8QG61,,,,,64.7,499.0,3.3e-210,732.6,sp|Q8QG61|CRY1_CHICK Cryptochrome-1 OS=Gallus gallus OX=9031 GN=CRY1 PE=2 SV=1,,,,,,
OG_00418,0.9279931318608148,OG_00418,FUN_001323-T1,Peve_00036961,Pocillopora_meandrina_HIv1___RNAseq.g2265.t1,three_way,51.98283333333333,,,,,,,,,,,,,,,,,
OG_07077,0.9277973805336868,OG_07077,FUN_032314-T1,Peve_00031926,Pocillopora_meandrina_HIv1___RNAseq.g24787.t1,three_way,73.028,FUN_032314-T1,P83205,CATB_SHEEP,,Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain],Ovis aries (Sheep),56.0,336.0,2.5e-107,390.2,sp|P83205|CATB_SHEEP Cathepsin B OS=Ovis aries OX=9940 GN=CTSB PE=1 SV=2,GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090,cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471],collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0006575; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; modified amino acid metabolic process; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01828,0.9276607269290786,OG_01828,FUN_007708-T1,Peve_00013719,Pocillopora_meandrina_HIv1___RNAseq.g5861.t1,three_way,82.725,FUN_007708-T1,Q70CQ2,UBP34_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34),Homo sapiens (Human),42.6,3491.0,0.0,2497.2,sp|Q70CQ2|UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2,GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0031647; GO:0071108; GO:0090263,positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07641,0.9273047950878216,OG_07641,FUN_034420-T1,Peve_00021291,Pocillopora_meandrina_HIv1___RNAseq.g28575.t1,three_way,76.00066666666666,FUN_034420-T1,Q32LP4,S4A10_BOVIN,,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Bos taurus (Bovine),48.4,1093.0,1.6000000000000002e-273,944.1,sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1,GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982,bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_00878,0.927200761403091,OG_00878,FUN_004171-T1,Peve_00031567,Pocillopora_meandrina_HIv1___TS.g17567.t1,three_way,78.7845,FUN_004171-T1,Q865S1,,,,,55.2,1283.0,0.0,1110.1,sp|Q865S1|AP3D1_BOVIN AP-3 complex subunit delta-1 OS=Bos taurus OX=9913 GN=AP3D1 PE=1 SV=2,,,,,,
OG_09798,0.9265654849743176,OG_09798,FUN_042606-T1,Peve_00034915,Pocillopora_meandrina_HIv1___RNAseq.g16848.t1,three_way,70.83866666666667,FUN_042606-T1,O77627,,,,,34.6,318.0,4.900000000000003e-22,107.5,sp|O77627|JUN_BOVIN Transcription factor Jun OS=Bos taurus OX=9913 GN=JUN PE=2 SV=2,,,,,,
OG_03047,0.9264321955615072,OG_03047,FUN_012293-T1,Peve_00036366,Pocillopora_meandrina_HIv1___RNAseq.g23562.t1,three_way,84.339,FUN_012293-T1,Q96JB1,,,,,26.2,4649.0,0.0,1572.4,sp|Q96JB1|DYH8_HUMAN Dynein axonemal heavy chain 8 OS=Homo sapiens OX=9606 GN=DNAH8 PE=1 SV=2,,,,,,
OG_01839,0.9263892537062974,OG_01839,FUN_007785-T1,Peve_00032269,Pocillopora_meandrina_HIv1___RNAseq.g5904.t3,three_way,77.73566666666667,FUN_007785-T1,Q7ZZC8,NEK9_XENLA,,Serine/threonine-protein kinase Nek9 (xNek9) (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9),Xenopus laevis (African clawed frog),45.7,637.0,6e-157,556.2,sp|Q7ZZC8|NEK9_XENLA Serine/threonine-protein kinase Nek9 OS=Xenopus laevis OX=8355 GN=nek9 PE=2 SV=1,GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0019901; GO:0030295; GO:0046872; GO:0051301; GO:0106310,cell division [GO:0051301]; mitotic cell cycle [GO:0000278],centrosome [GO:0005813]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000278; GO:0003824; GO:0005815; GO:0016740; GO:0098772; GO:0140096,"mitotic cell cycle; catalytic activity; microtubule organizing center; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05256,0.9263871428864892,OG_05256,FUN_023759-T1,Peve_00044461,Pocillopora_meandrina_HIv1___RNAseq.g3497.t1,three_way,51.79566666666666,FUN_023759-T1,E7FBY6,AGRA2_DANRE,,Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124),Danio rerio (Zebrafish) (Brachydanio rerio),26.0,889.0,4.7e-66,255.4,sp|E7FBY6|AGRA2_DANRE Adhesion G protein-coupled receptor A2 OS=Danio rerio OX=7955 GN=adgra2 PE=1 SV=2,GO:0001525; GO:0004930; GO:0005886; GO:0007399; GO:0060070; GO:1990909,angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; nervous system development [GO:0007399],plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0048856; GO:0060089,plasma membrane; anatomical structure development; molecular transducer activity
OG_08169,0.9259973190597772,OG_08169,FUN_035973-T1,Peve_00006612,Pocillopora_meandrina_HIv1___RNAseq.g12337.t2,three_way,84.21,FUN_035973-T1,Q11136,PEPD_MOUSE,,Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase 4) (Peptidase D) (Proline dipeptidase) (Prolidase),Mus musculus (Mouse),65.2,492.0,1.2999999999999999e-197,690.6,sp|Q11136|PEPD_MOUSE Xaa-Pro dipeptidase OS=Mus musculus OX=10090 GN=Pepd PE=1 SV=3,GO:0006508; GO:0008233; GO:0030145; GO:0030574; GO:0043069; GO:0070006; GO:0102009,collagen catabolic process [GO:0030574]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],,manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_09463,0.925831457902002,OG_09463,FUN_041486-T1,Peve_00004078,Pocillopora_meandrina_HIv1___RNAseq.g15672.t2,three_way,56.60683333333333,FUN_041486-T1,D3ZZL9,,,,,35.3,388.0,1.7e-30,137.9,sp|D3ZZL9|GCC2_RAT GRIP and coiled-coil domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Gcc2 PE=1 SV=1,,,,,,
OG_05291,0.9256862194698852,OG_05291,FUN_023958-T1,Peve_00017996,Pocillopora_meandrina_HIv1___RNAseq.g18521.t1,three_way,58.741,,,,,,,,,,,,,,,,,
OG_08513,0.9253748198177444,OG_08513,FUN_037439-T1,Peve_00014239,Pocillopora_meandrina_HIv1___RNAseq.g10962.t1,three_way,78.76766666666666,FUN_037439-T1,P97393,RHG05_MOUSE,,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),Mus musculus (Mouse),30.1,1790.0,6.2e-194,680.2,sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3,GO:0002053; GO:0005096; GO:0005783; GO:0005829; GO:0005886; GO:0007165; GO:0008361; GO:0010631; GO:0010634; GO:0016477; GO:0030879; GO:0042169,cell migration [GO:0016477]; epithelial cell migration [GO:0010631]; mammary gland development [GO:0030879]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; signal transduction [GO:0007165],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; SH2 domain binding [GO:0042169],GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0048856; GO:0048870; GO:0098772,endoplasmic reticulum; cytosol; plasma membrane; organelle; anatomical structure development; cell motility; molecular function regulator activity
OG_02284,0.9253675015606216,OG_02284,FUN_008781-T1,Peve_00042606,Pocillopora_meandrina_HIv1___RNAseq.g12693.t1,three_way,80.42633333333333,,,,,,,,,,,,,,,,,
OG_03409,0.9253507267379396,OG_03409,FUN_014456-T1,Peve_00009600,Pocillopora_meandrina_HIv1___RNAseq.g22824.t1,three_way,65.45816666666667,FUN_014456-T1,O35551,RABE1_MOUSE,,Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha),Mus musculus (Mouse),33.5,367.0,7.700000000000001e-38,160.6,sp|O35551|RABE1_MOUSE Rab GTPase-binding effector protein 1 OS=Mus musculus OX=10090 GN=Rabep1 PE=1 SV=2,GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0055037; GO:0098978; GO:0099149; GO:1903441,apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037],growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803],GO:0005768; GO:0005829; GO:0012501; GO:0016192; GO:0031410; GO:0043226; GO:0048018; GO:0098772,endosome; cytosol; programmed cell death; vesicle-mediated transport; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_08977,0.925124018828262,OG_08977,FUN_038488-T1,Peve_00013519,Pocillopora_meandrina_HIv1___TS.g8002.t1a,three_way,57.826,FUN_038488-T1,Q8JHF2,,,,,52.1,263.0,1.5e-77,291.6,"sp|Q8JHF2|LFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe OS=Danio rerio OX=7955 GN=lfng PE=2 SV=2",,,,,,
OG_05761,0.9249564019348236,OG_05761,FUN_025702-T1,Peve_00004694,Pocillopora_meandrina_HIv1___RNAseq.g13827.t1,three_way,44.88766666666667,FUN_025702-T1,Q08D19,,,,,43.6,110.0,8.7e-14,80.1,sp|Q08D19|GOLI4_XENTR Golgi integral membrane protein 4 OS=Xenopus tropicalis OX=8364 GN=golim4 PE=2 SV=2,,,,,,
OG_09653,0.9248857790439818,OG_09653,FUN_041854-T1,Peve_00025833,Pocillopora_meandrina_HIv1___RNAseq.g15067.t2,three_way,60.3945,FUN_041854-T1,Q8N137,CNTRB_HUMAN,,Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8),Homo sapiens (Human),35.5,242.0,1.8e-21,106.7,sp|Q8N137|CNTRB_HUMAN Centrobin OS=Homo sapiens OX=9606 GN=CNTROB PE=1 SV=1,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0036064; GO:0051299; GO:1902017; GO:1902410,centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829],protein domain specific binding [GO:0019904],GO:0005815; GO:0005829; GO:0043226,microtubule organizing center; cytosol; organelle
OG_10158,0.9248405252255476,OG_10158,FUN_043553-T1,Peve_00009529,Pocillopora_meandrina_HIv1___RNAseq.g8042.t1,three_way,85.187,FUN_043553-T1,Q8NE28,,,,,26.2,443.0,8.100000000000001e-38,160.2,sp|Q8NE28|STKL1_HUMAN Serine/threonine kinase-like domain-containing protein STKLD1 OS=Homo sapiens OX=9606 GN=STKLD1 PE=1 SV=5,,,,,,
OG_06573,0.9247939903364364,OG_06573,FUN_029518-T1,Peve_00008555,Pocillopora_meandrina_HIv1___RNAseq.g17117.t1,three_way,79.40516666666666,FUN_029518-T1,Q00438,,,,,47.7,558.0,2.7e-132,473.8,sp|Q00438|PTBP1_RAT Polypyrimidine tract-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Ptbp1 PE=1 SV=2,,,,,,
OG_09377,0.924568827815341,OG_09377,FUN_040610-T1,Peve_00015406,Pocillopora_meandrina_HIv1___TS.g215.t1,three_way,55.4595,,,,,,,,,,,,,,,,,
OG_03191,0.9243055907512828,OG_03191,FUN_012664-T1,Peve_00025332,Pocillopora_meandrina_HIv1___RNAseq.g22887.t1,three_way,83.10666666666667,,,,,,,,,,,,,,,,,
OG_09216,0.9238538532663964,OG_09216,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_09084,0.923757319851652,OG_09084,FUN_038831-T1,Peve_00028780,Pocillopora_meandrina_HIv1___RNAseq.g28634.t1,three_way,67.26416666666667,FUN_038831-T1,F8VPZ5,ERCC6_MOUSE,,DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB),Mus musculus (Mouse),51.2,1068.0,1.6000000000000004e-277,957.6,sp|F8VPZ5|ERCC6_MOUSE DNA excision repair protein ERCC-6 OS=Mus musculus OX=10090 GN=Ercc6 PE=1 SV=1,GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006338; GO:0006362; GO:0006974; GO:0006979; GO:0007254; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0016887; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032786; GO:0034243; GO:0035264; GO:0042262; GO:0045494; GO:0045943; GO:0045944; GO:0045945; GO:0060261; GO:0090734; GO:0097680; GO:0110016; GO:0140463; GO:0140658; GO:0140664; GO:1905168; GO:2001033,"base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription elongation by RNA polymerase I [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]",B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein tyrosine kinase activator activity [GO:0030296]",GO:0003677; GO:0003824; GO:0005634; GO:0005730; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0060090; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleolus; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; cell differentiation; organelle; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_05560,0.9237002774136576,OG_05560,FUN_024778-T1,Peve_00016140,Pocillopora_meandrina_HIv1___RNAseq.g18804.t1,three_way,93.01066666666668,FUN_024778-T1,Q91ZW3,,,,,72.6,999.0,0.0,1404.0,sp|Q91ZW3|SMCA5_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 OS=Mus musculus OX=10090 GN=Smarca5 PE=1 SV=1,,,,,,
OG_03678,0.92363398985123,OG_03678,FUN_014932-T1,Peve_00037144,Pocillopora_meandrina_HIv1___RNAseq.g21090.t2,three_way,93.364,FUN_014932-T1,P26818,,,,,66.9,680.0,9.099999999999999e-271,934.1,sp|P26818|ARBK2_BOVIN G protein-coupled receptor kinase 3 OS=Bos taurus OX=9913 GN=GRK3 PE=2 SV=1,,,,,,
OG_07350,0.9235833093739614,OG_07350,FUN_033757-T1,Peve_00004916,Pocillopora_meandrina_HIv1___RNAseq.g28746.t2,three_way,69.06666666666666,FUN_033757-T1,Q8IYG6,LRC56_HUMAN,,Leucine-rich repeat-containing protein 56,Homo sapiens (Human),35.6,413.0,1.5000000000000001e-30,136.0,sp|Q8IYG6|LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens OX=9606 GN=LRRC56 PE=1 SV=1,GO:0005929; GO:0030030,cell projection organization [GO:0030030],cilium [GO:0005929],,GO:0005929; GO:0043226,cilium; organelle
OG_02982,0.9234455977760152,OG_02982,FUN_012152-T1,Peve_00035458,Pocillopora_meandrina_HIv1___TS.g16648.t1,three_way,75.35416666666667,FUN_012152-T1,Q8NEN0,,,,,32.3,885.0,5.2000000000000004e-117,423.7,sp|Q8NEN0|ARMC2_HUMAN Armadillo repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=ARMC2 PE=1 SV=4,,,,,,
OG_04042,0.9231242677855436,OG_04042,FUN_016351-T1,Peve_00004332,Pocillopora_meandrina_HIv1___RNAseq.g9676.t1,three_way,80.54966666666667,FUN_016351-T1,Q6ZMI0,PPR21_HUMAN,,Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (Ferry endosomal RAB5 effector complex subunit 2) (Fy-2) (KLRAQ motif-containing protein 1),Homo sapiens (Human),40.8,787.0,5.8e-136,486.5,sp|Q6ZMI0|PPR21_HUMAN Protein phosphatase 1 regulatory subunit 21 OS=Homo sapiens OX=9606 GN=PPP1R21 PE=1 SV=1,GO:0003723; GO:0005769; GO:0016020,,early endosome [GO:0005769]; membrane [GO:0016020],RNA binding [GO:0003723],GO:0003723; GO:0005768; GO:0031410; GO:0043226,RNA binding; endosome; cytoplasmic vesicle; organelle
OG_01994,0.922826565729891,OG_01994,FUN_008103-T1,Peve_00017193,Pocillopora_meandrina_HIv1___RNAseq.g17899.t1,three_way,61.52516666666666,FUN_008103-T1,Q3T1I9,,,,,33.8,1354.0,5.6000000000000005e-182,640.2,sp|Q3T1I9|RPAP1_RAT RNA polymerase II-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Rpap1 PE=1 SV=1,,,,,,
OG_03955,0.9227941984360624,OG_03955,FUN_016100-T1,Peve_00010771,Pocillopora_meandrina_HIv1___RNAseq.g21590.t1,three_way,83.7185,FUN_016100-T1,Q13948,,,,,48.2,676.0,4.2e-151,536.6,sp|Q13948|CASP_HUMAN Protein CASP OS=Homo sapiens OX=9606 GN=CUX1 PE=1 SV=2,,,,,,
OG_05413,0.9227663733703266,OG_05413,FUN_024350-T1,Peve_00021948,Pocillopora_meandrina_HIv1___RNAseq.g18672.t1,three_way,54.338166666666666,FUN_024350-T1,Q01804,OTUD4_HUMAN,,OTU domain-containing protein 4 (EC 3.4.19.12) (HIV-1-induced protein HIN-1),Homo sapiens (Human),46.7,285.0,7.4e-66,254.2,sp|Q01804|OTUD4_HUMAN OTU domain-containing protein 4 OS=Homo sapiens OX=9606 GN=OTUD4 PE=1 SV=4,GO:0003723; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006307; GO:0006508; GO:0034122; GO:0035871; GO:0060090; GO:0061578; GO:0070536; GO:0071108; GO:0140374; GO:1903093; GO:2000660,antiviral innate immune response [GO:0140374]; DNA alkylation repair [GO:0006307]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of protein K48-linked deubiquitination [GO:1903093],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0016787; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; RNA binding; catalytic activity; nucleus; cytosol; DNA repair; hydrolase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_00678,0.9222489024684254,OG_00678,FUN_002093-T1,Peve_00004291,Pocillopora_meandrina_HIv1___RNAseq.g1731.t2,three_way,44.53733333333333,,,,,,,,,,,,,,,,,
OG_07597,0.9217716840258036,OG_07597,FUN_034305-T1,Peve_00011309,Pocillopora_meandrina_HIv1___RNAseq.g28496.t1,three_way,63.1735,FUN_034305-T1,Q96CN9,GCC1_HUMAN,,GRIP and coiled-coil domain-containing protein 1 (Golgi coiled-coil protein 1),Homo sapiens (Human),28.7,791.0,3.6e-50,201.4,sp|Q96CN9|GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GCC1 PE=1 SV=1,GO:0000138; GO:0000139; GO:0005794; GO:0005829; GO:0031267,,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138],small GTPase binding [GO:0031267],GO:0005794; GO:0005829; GO:0043226,Golgi apparatus; cytosol; organelle
OG_00315,0.9217331701385576,OG_00315,FUN_001122-T1,Peve_00029372,Pocillopora_meandrina_HIv1___TS.g6543.t1,three_way,62.12316666666666,FUN_001122-T1,O75691,UTP20_HUMAN,,Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6),Homo sapiens (Human),32.2,1710.0,8.1e-220,766.1,sp|O75691|UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens OX=9606 GN=UTP20 PE=1 SV=3,GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040; GO:0042274,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]",RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0005730; GO:0005886; GO:0043226,RNA binding; nucleoplasm; nucleolus; plasma membrane; organelle
OG_00421,0.9216946123509444,OG_00421,FUN_001328-T1,Peve_00036956,Pocillopora_meandrina_HIv1___RNAseq.g2270.t1b,three_way,79.90283333333333,FUN_001328-T1,Q5F471,,,,,41.4,903.0,8.500000000000001e-174,612.5,sp|Q5F471|PP6R3_CHICK Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Gallus gallus OX=9031 GN=PPP6R3 PE=2 SV=1,,,,,,
OG_08936,0.921675909768173,OG_08936,FUN_038400-T1,Peve_00000036,Pocillopora_meandrina_HIv1___RNAseq.g28274.t1,three_way,75.47866666666667,FUN_038400-T1,Q6P5D8,SMHD1_MOUSE,,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-),Mus musculus (Mouse),23.5,2075.0,6.200000000000001e-86,321.6,sp|Q6P5D8|SMHD1_MOUSE Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Mus musculus OX=10090 GN=Smchd1 PE=1 SV=2,GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0016604; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060818; GO:2000042; GO:2001034,chromosome organization [GO:0051276]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],"Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006325; GO:0016787; GO:0043226; GO:0048856,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; chromatin organization; hydrolase activity; organelle; anatomical structure development
OG_10167,0.9216097773551762,OG_10167,FUN_043567-T1,Peve_00030048,Pocillopora_meandrina_HIv1___RNAseq.g8054.t1,three_way,49.1965,,,,,,,,,,,,,,,,,
OG_00103,0.9215339869501542,OG_00103,FUN_000489-T1,Peve_00043825,Pocillopora_meandrina_HIv1___TS.g4918.t1,three_way,64.97083333333333,FUN_000489-T1,Q12923,,,,,26.7,2887.0,7.2e-210,733.8,sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2,,,,,,
OG_06207,0.9214968943541568,OG_06207,FUN_028143-T1,Peve_00037720,Pocillopora_meandrina_HIv1___TS.g11444.t1,three_way,74.73266666666667,FUN_028143-T1,Q5SZT7,NKAPL_MOUSE,,NKAP-like protein,Mus musculus (Mouse),72.4,123.0,4.9e-41,169.9,sp|Q5SZT7|NKAPL_MOUSE NKAP-like protein OS=Mus musculus OX=10090 GN=Nkapl PE=1 SV=1,GO:0003682; GO:0005634; GO:0007283; GO:0030154,cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0022414; GO:0030154; GO:0043226,nucleus; reproductive process; cell differentiation; organelle
OG_06442,0.9213917788613724,OG_06442,FUN_029149-T1,Peve_00000508,Pocillopora_meandrina_HIv1___RNAseq.g25732.t1,three_way,83.18866666666666,FUN_029149-T1,Q62717,,,,,54.3,1182.0,0.0,1248.0,sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1,,,,,,
OG_07700,0.9212004395549488,OG_07700,FUN_034834-T1,Peve_00010452,Pocillopora_meandrina_HIv1___RNAseq.g27184.t1,three_way,72.52166666666666,FUN_034834-T1,Q7TT47,,,,,53.2,637.0,7.000000000000001e-182,639.0,sp|Q7TT47|SPG7_RAT Mitochondrial inner membrane m-AAA protease component paraplegin OS=Rattus norvegicus OX=10116 GN=Spg7 PE=2 SV=2,,,,,,
OG_05913,0.9210413577156934,OG_05913,FUN_026104-T1,Peve_00044188,Pocillopora_meandrina_HIv1___RNAseq.g10324.t1,three_way,89.33133333333333,FUN_026104-T1,P15690,,,,,68.5,695.0,7.7e-284,977.6,"sp|P15690|NDUS1_BOVIN NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS1 PE=1 SV=1",,,,,,
OG_06527,0.9209605368090192,OG_06527,FUN_029356-T1,Peve_00023383,Pocillopora_meandrina_HIv1___RNAseq.g17292.t1,three_way,73.16533333333334,FUN_029356-T1,Q15397,,,,,44.1,424.0,5.2e-92,339.7,sp|Q15397|PUM3_HUMAN Pumilio homolog 3 OS=Homo sapiens OX=9606 GN=PUM3 PE=1 SV=3,,,,,,
OG_03055,0.920921481984244,OG_03055,FUN_012302-T1,Peve_00038607,Pocillopora_meandrina_HIv1___RNAseq.g23764.t1,three_way,58.20183333333334,FUN_012302-T1,Q640M1,,,,,32.3,764.0,3.5e-72,274.6,sp|Q640M1|UT14A_MOUSE U3 small nucleolar RNA-associated protein 14 homolog A OS=Mus musculus OX=10090 GN=Utp14a PE=1 SV=1,,,,,,
OG_01038,0.9208552093929137,OG_01038,FUN_004473-T1,Peve_00007172,Pocillopora_meandrina_HIv1___RNAseq.g4948.t1,three_way,45.68216666666667,FUN_004473-T1,P98081,DAB_DROME,,Protein disabled,Drosophila melanogaster (Fruit fly),41.4,157.0,2.5e-28,129.4,sp|P98081|DAB_DROME Protein disabled OS=Drosophila melanogaster OX=7227 GN=Dab PE=1 SV=2,GO:0005118; GO:0005829; GO:0006898; GO:0007349; GO:0007391; GO:0008045; GO:0016319; GO:0017124; GO:0030424; GO:0035591; GO:0042051; GO:0045874; GO:0048488; GO:0072583; GO:0098793,cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; positive regulation of sevenless signaling pathway [GO:0045874]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488],axon [GO:0030424]; cytosol [GO:0005829]; presynapse [GO:0098793],sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591],GO:0005829; GO:0016192; GO:0048856; GO:0060090,cytosol; vesicle-mediated transport; anatomical structure development; molecular adaptor activity
OG_02229,0.9208398314582696,OG_02229,FUN_008635-T1,Peve_00024235,Pocillopora_meandrina_HIv1___RNAseq.g14918.t1,three_way,76.26733333333334,FUN_008635-T1,Q6NWJ4,DNJC2_DANRE,,DnaJ homolog subfamily C member 2,Danio rerio (Zebrafish) (Brachydanio rerio),55.8,618.0,1.4000000000000002e-124,448.4,sp|Q6NWJ4|DNJC2_DANRE DnaJ homolog subfamily C member 2 OS=Danio rerio OX=7955 GN=dnajc2 PE=2 SV=1,GO:0003682; GO:0005634; GO:0005829; GO:0006450; GO:0030544; GO:0042393; GO:0043022; GO:0045893; GO:0051083; GO:0061649,'de novo' cotranslational protein folding [GO:0051083]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of translational fidelity [GO:0006450],cytosol [GO:0005829]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; ubiquitin-modified histone reader activity [GO:0061649],GO:0005634; GO:0005829; GO:0006355; GO:0006457; GO:0042393; GO:0043226; GO:0060090,nucleus; cytosol; regulation of DNA-templated transcription; protein folding; histone binding; organelle; molecular adaptor activity
OG_00255,0.9202138193045888,OG_00255,FUN_001019-T1,Peve_00041047,Pocillopora_meandrina_HIv1___RNAseq.g29550.t1,three_way,74.728,FUN_001019-T1,E1C1R4,,,,,44.2,1361.0,1.6999999999999999e-301,1036.9,sp|E1C1R4|UBP47_CHICK Ubiquitin carboxyl-terminal hydrolase 47 OS=Gallus gallus OX=9031 GN=USP47 PE=3 SV=1,,,,,,
OG_07629,0.9196162282642586,OG_07629,FUN_034379-T1,Peve_00027166,Pocillopora_meandrina_HIv1___RNAseq.g26152.t1,three_way,68.00166666666667,FUN_034379-T1,Q86TZ1,,,,,49.0,206.0,4.2e-56,222.6,sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1,,,,,,
OG_05159,0.9194630188877576,OG_05159,FUN_023449-T1,Peve_00037222,Pocillopora_meandrina_HIv1___RNAseq.g17631.t2,three_way,40.68716666666667,,,,,,,,,,,,,,,,,
OG_09906,0.919429018853644,OG_09906,FUN_043003-T1,Peve_00017777,Pocillopora_meandrina_HIv1___RNAseq.g7027.t1,three_way,86.71766666666667,FUN_043003-T1,Q66L49,SCMC1_DANRE,,Mitochondrial adenyl nucleotide antiporter SLC25A24 (Small calcium-binding mitochondrial carrier protein 1) (SCaMC-1) (Solute carrier family 25 member 24),Danio rerio (Zebrafish) (Brachydanio rerio),54.6,467.0,1e-146,521.5,sp|Q66L49|SCMC1_DANRE Mitochondrial adenyl nucleotide antiporter SLC25A24 OS=Danio rerio OX=7955 GN=slc25a24 PE=2 SV=1,GO:0000295; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0015866; GO:0015867; GO:0016020; GO:0051503; GO:0071277; GO:0140987; GO:0140988; GO:1990544,adenine nucleotide transport [GO:0051503]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; mitochondrial ATP transmembrane transport [GO:1990544],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP:phosphate antiporter activity [GO:0140988]; ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_06319,0.91938214364897,OG_06319,FUN_028795-T1,Peve_00000745,Pocillopora_meandrina_HIv1___RNAseq.g20731.t1,three_way,70.815,FUN_028795-T1,P52756,RBM5_HUMAN,,RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9),Homo sapiens (Human),39.6,768.0,1.8e-75,285.8,sp|P52756|RBM5_HUMAN RNA-binding protein 5 OS=Homo sapiens OX=9606 GN=RBM5 PE=1 SV=2,GO:0000245; GO:0000381; GO:0000398; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0006915; GO:0008270; GO:0008285; GO:0043065; GO:0043231,"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]",cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0012501; GO:0016071; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; cytosol; programmed cell death; mRNA metabolic process; organelle; protein-containing complex assembly
OG_09509,0.9191332637772852,OG_09509,FUN_041557-T1,Peve_00033125,Pocillopora_meandrina_HIv1___RNAseq.g16079.t1,three_way,82.36866666666667,FUN_041557-T1,F1LP64,TRIPC_RAT,,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),Rattus norvegicus (Rat),52.2,1669.0,0.0,1587.8,sp|F1LP64|TRIPC_RAT E3 ubiquitin-protein ligase TRIP12 OS=Rattus norvegicus OX=10116 GN=Trip12 PE=1 SV=1,GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0033696; GO:0043161; GO:0045995; GO:0046966; GO:0061630; GO:0140861,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09102,0.9190842524798298,OG_09102,FUN_038919-T1,Peve_00023621,Pocillopora_meandrina_HIv1___RNAseq.g1058.t1,three_way,88.84166666666667,FUN_038919-T1,Q9R1C6,DGKE_MOUSE,,Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon),Mus musculus (Mouse),48.7,487.0,5.8999999999999995e-148,525.8,sp|Q9R1C6|DGKE_MOUSE Diacylglycerol kinase epsilon OS=Mus musculus OX=10090 GN=Dgke PE=1 SV=1,GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006654; GO:0006661; GO:0007200; GO:0008270; GO:0016020; GO:0046339; GO:0046834; GO:0050804; GO:0098978,diacylglycerol metabolic process [GO:0046339]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0006629; GO:0016740,catalytic activity; nucleoplasm; cytosol; lipid metabolic process; transferase activity
OG_07716,0.9187634767321268,OG_07716,FUN_034870-T1,Peve_00005769,Pocillopora_meandrina_HIv1___RNAseq.g27159.t1,three_way,54.551,FUN_034870-T1,Q91Y77,,,,,29.8,423.0,2.3e-49,198.7,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_05287,0.9186584258682216,OG_05287,FUN_023950-T1,Peve_00017994,Pocillopora_meandrina_HIv1___RNAseq.g18524.t1a,three_way,76.55283333333334,FUN_023950-T1,Q92793,CBP_HUMAN,,CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein lactyltransferas CREBBP) (EC 2.3.1.-) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-),Homo sapiens (Human),41.9,2186.0,0.0,1193.7,sp|Q92793|CBP_HUMAN CREB-binding protein OS=Homo sapiens OX=9606 GN=CREBBP PE=1 SV=3,GO:0000122; GO:0000123; GO:0000785; GO:0001223; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006473; GO:0007165; GO:0007249; GO:0008270; GO:0008589; GO:0016407; GO:0016479; GO:0016604; GO:0018076; GO:0030511; GO:0031490; GO:0031648; GO:0031669; GO:0034644; GO:0042592; GO:0042733; GO:0043426; GO:0043993; GO:0044017; GO:0045893; GO:0045944; GO:0048156; GO:0048511; GO:0061629; GO:0061733; GO:0065003; GO:0120300; GO:0140297; GO:1900034; GO:1900182; GO:1905168,canonical NF-kappaB signal transduction [GO:0007249]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of DNA-templated transcription [GO:0006355]; regulation of smoothened signaling pathway [GO:0008589]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008092; GO:0016740; GO:0043226; GO:0051604; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; organelle; protein maturation; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_07070,0.9184631479381642,OG_07070,FUN_032305-T1,Peve_00027302,Pocillopora_meandrina_HIv1___RNAseq.g24891.t1,three_way,48.758833333333335,,,,,,,,,,,,,,,,,
OG_05649,0.9183554979440208,OG_05649,FUN_025372-T1,Peve_00040522,Pocillopora_meandrina_HIv1___RNAseq.g13329.t1,three_way,85.562,FUN_025372-T1,Q92997,DVL3_HUMAN,,Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3),Homo sapiens (Human),61.0,485.0,3.2e-124,447.2,sp|Q92997|DVL3_HUMAN Segment polarity protein dishevelled homolog DVL-3 OS=Homo sapiens OX=9606 GN=DVL3 PE=1 SV=2,GO:0000785; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0009410; GO:0031267; GO:0032880; GO:0032956; GO:0035556; GO:0035567; GO:0043547; GO:0045893; GO:0045944; GO:0046330; GO:0050821; GO:0060070; GO:0060071; GO:0150012,"canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein localization [GO:0032880]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",chromatin [GO:0000785]; cytosol [GO:0005829],beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267],GO:0005829; GO:0006355,cytosol; regulation of DNA-templated transcription
OG_04762,0.9183244794575746,OG_04762,FUN_022662-T1,Peve_00027940,Pocillopora_meandrina_HIv1___RNAseq.g3157.t1b,three_way,84.34933333333333,FUN_022662-T1,Q5ZLC8,,,,,47.4,137.0,1.4e-25,120.2,sp|Q5ZLC8|ANR52_CHICK Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Gallus gallus OX=9031 GN=ANKRD52 PE=2 SV=1,,,,,,
OG_04113,0.9181973555988304,OG_04113,FUN_016489-T1,Peve_00001327,Pocillopora_meandrina_HIv1___RNAseq.g9629.t1,three_way,83.481,FUN_016489-T1,Q8R5L3,,,,,52.2,596.0,7.399999999999999e-171,602.1,sp|Q8R5L3|VPS39_MOUSE Vam6/Vps39-like protein OS=Mus musculus OX=10090 GN=Vps39 PE=1 SV=1,,,,,,
OG_08083,0.9175218984160706,OG_08083,FUN_035810-T1,Peve_00037792,Pocillopora_meandrina_HIv1___RNAseq.g11929.t1,three_way,63.96066666666667,FUN_035810-T1,O15943,CADN_DROME,,Neural-cadherin (Cadherin-N) (dN-cadherin),Drosophila melanogaster (Fruit fly),31.2,2035.0,2.2e-241,838.2,sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2,GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016020; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609,axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803],GO:0005886; GO:0007155; GO:0048856,plasma membrane; cell adhesion; anatomical structure development
OG_06701,0.917344719153662,OG_06701,FUN_031268-T1,Peve_00036751,Pocillopora_meandrina_HIv1___RNAseq.g5181.t2,three_way,67.62816666666666,FUN_031268-T1,Q9UBV2,SE1L1_HUMAN,,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),Homo sapiens (Human),62.3,579.0,1.3e-73,279.6,sp|Q9UBV2|SE1L1_HUMAN Protein sel-1 homolog 1 OS=Homo sapiens OX=9606 GN=SEL1L PE=1 SV=3,GO:0000836; GO:0000839; GO:0005783; GO:0005789; GO:0006641; GO:0007219; GO:0009306; GO:0030970; GO:0036503; GO:0036513; GO:0050821,"ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]",Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839],,GO:0005783; GO:0006629; GO:0006886; GO:0030163; GO:0043226,endoplasmic reticulum; lipid metabolic process; intracellular protein transport; protein catabolic process; organelle
OG_02278,0.9172651760956706,OG_02278,FUN_008769-T1,Peve_00036718,Pocillopora_meandrina_HIv1___RNAseq.g12704.t1,three_way,66.35966666666667,FUN_008769-T1,Q9JHZ4,GRAP1_RAT,,GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)],Rattus norvegicus (Rat),33.5,179.0,7.9e-18,94.4,sp|Q9JHZ4|GRAP1_RAT GRIP1-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Gripap1 PE=1 SV=1,GO:0005085; GO:0005654; GO:0005829; GO:0015031; GO:0030424; GO:0030425; GO:0035255; GO:0042734; GO:0042802; GO:0043025; GO:0055038; GO:0098685; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1903828; GO:1903910,"negative regulation of protein localization [GO:1903828]; negative regulation of receptor clustering [GO:1903910]; protein transport [GO:0015031]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]",axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685],guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255],GO:0005654; GO:0005829; GO:0098772,nucleoplasm; cytosol; molecular function regulator activity
OG_05502,0.9172312649838988,OG_05502,FUN_024566-T1,Peve_00009964,Pocillopora_meandrina_HIv1___RNAseq.g19087.t1,three_way,94.32233333333332,FUN_024566-T1,P81436,OGT1_RABIT,,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT),Oryctolagus cuniculus (Rabbit),77.1,1013.0,5.3000000000000025e-211,736.1,sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2,GO:0000123; GO:0005547; GO:0005634; GO:0005737; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0017122; GO:0031397; GO:0032922; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263,apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122],"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0006355; GO:0008289; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; nucleus; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid binding; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03991,0.9172131020346516,OG_03991,FUN_016163-T1,Peve_00022617,Pocillopora_meandrina_HIv1___RNAseq.g21016.t1,three_way,65.033,FUN_016163-T1,Q9ULI0,ATD2B_HUMAN,,ATPase family AAA domain-containing protein 2B,Homo sapiens (Human),42.8,1254.0,1.0999999999999999e-249,865.1,sp|Q9ULI0|ATD2B_HUMAN ATPase family AAA domain-containing protein 2B OS=Homo sapiens OX=9606 GN=ATAD2B PE=1 SV=4,GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0016887; GO:0042393; GO:0045815; GO:0070577,nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; transcription initiation-coupled chromatin remodeling [GO:0045815],nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577],GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016787; GO:0042393; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; chromatin organization; hydrolase activity; histone binding; organelle; protein-containing complex assembly
OG_01186,0.9172052020165742,OG_01186,FUN_004836-T1,Peve_00019420,Pocillopora_meandrina_HIv1___RNAseq.g8611.t1,three_way,80.11233333333334,FUN_004836-T1,Q8WUQ7,CATIN_HUMAN,,Splicing factor Cactin (Renal carcinoma antigen NY-REN-24),Homo sapiens (Human),60.5,580.0,1.1e-156,555.1,sp|Q8WUQ7|CATIN_HUMAN Splicing factor Cactin OS=Homo sapiens OX=9606 GN=CACTIN PE=1 SV=3,GO:0000398; GO:0001933; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0016607; GO:0031665; GO:0032088; GO:0032688; GO:0032717; GO:0032720; GO:0034122; GO:0043124; GO:0045087; GO:0045292; GO:0045824; GO:0060339; GO:0071013; GO:0071222; GO:0071347; GO:0071356,"cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0016071; GO:0043226; GO:0098542,immune system process; RNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle; defense response to other organism
OG_04868,0.9170212168845904,OG_04868,FUN_022895-T1,Peve_00001718,Pocillopora_meandrina_HIv1___RNAseq.g3694.t1,three_way,68.29366666666667,FUN_022895-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),39.7,715.0,1.4e-142,508.4,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08396,0.9169420345877836,OG_08396,FUN_037010-T1,Peve_00032338,Pocillopora_meandrina_HIv1___RNAseq.g26698.t1,three_way,85.58966666666667,FUN_037010-T1,Q8N2G6,,,,,56.0,234.0,5.3e-63,242.7,sp|Q8N2G6|ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 OS=Homo sapiens OX=9606 GN=ZCCHC24 PE=1 SV=1,,,,,,
OG_02474,0.916864321826664,OG_02474,FUN_009677-T1,Peve_00024097,Pocillopora_meandrina_HIv1___RNAseq.g24567.t1,three_way,78.88666666666667,FUN_009677-T1,Q54LV8,,,,,59.6,94.0,9.6e-25,114.0,sp|Q54LV8|RL34_DICDI Large ribosomal subunit protein eL34 OS=Dictyostelium discoideum OX=44689 GN=rpl34 PE=3 SV=1,,,,,,
OG_04089,0.9167984481992484,OG_04089,FUN_016428-T1,Peve_00004356,Pocillopora_meandrina_HIv1___RNAseq.g9809.t1,three_way,74.45816666666666,FUN_016428-T1,Q15147,,,,,38.6,1257.0,9.2e-231,802.4,"sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3",,,,,,
OG_04605,0.9167402176605836,OG_04605,FUN_022295-T1,Peve_00003689,Pocillopora_meandrina_HIv1___RNAseq.g4689.t1,three_way,77.32466666666667,FUN_022295-T1,Q6P5U8,,,,,35.1,535.0,8e-40,166.8,sp|Q6P5U8|CC148_MOUSE Coiled-coil domain-containing protein 148 OS=Mus musculus OX=10090 GN=Ccdc148 PE=2 SV=1,,,,,,
OG_01105,0.916659862246918,OG_01105,FUN_004624-T1,Peve_00039250,Pocillopora_meandrina_HIv1___RNAseq.g8088.t1,three_way,67.861,FUN_004624-T1,Q3UHC2,LRRK1_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1),Mus musculus (Mouse),29.8,1808.0,4.400000000000001e-211,737.6,sp|Q3UHC2|LRRK1_MOUSE Leucine-rich repeat serine/threonine-protein kinase 1 OS=Mus musculus OX=10090 GN=Lrrk1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533,bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005739; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; plasma membrane; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05852,0.9164984943225136,OG_05852,FUN_025925-T1,Peve_00034317,Pocillopora_meandrina_HIv1___RNAseq.g10524.t1,three_way,79.89450000000001,FUN_025925-T1,A6IPG1,,,,,66.2,225.0,7.6e-65,248.4,sp|A6IPG1|EF1B_RAT Elongation factor 1-beta OS=Rattus norvegicus OX=10116 GN=Eef1b2 PE=1 SV=1,,,,,,
OG_04984,0.9164134749452052,OG_04984,FUN_023111-T1,Peve_00045023,Pocillopora_meandrina_HIv1___RNAseq.g1700.t1,three_way,62.512,FUN_023111-T1,A7MB10,,,,,36.0,1929.0,1.9e-291,1004.2,sp|A7MB10|RRP5_BOVIN Protein RRP5 homolog OS=Bos taurus OX=9913 GN=PDCD11 PE=2 SV=1,,,,,,
OG_09657,0.9161952474020928,OG_09657,FUN_041862-T1,Peve_00030448,Pocillopora_meandrina_HIv1___RNAseq.g15123.t1,three_way,78.17916666666666,FUN_041862-T1,A0A8C0TYJ0,DLG1_CANLF,,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97),Canis lupus familiaris (Dog) (Canis familiaris),54.7,959.0,1.8e-266,920.2,sp|A0A8C0TYJ0|DLG1_CANLF Disks large homolog 1 OS=Canis lupus familiaris OX=9615 GN=DLG1 PE=3 SV=1,GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0005604; GO:0005634; GO:0005789; GO:0005794; GO:0005874; GO:0005923; GO:0007268; GO:0008284; GO:0008360; GO:0009898; GO:0010669; GO:0014069; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019900; GO:0019902; GO:0030041; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031579; GO:0031594; GO:0031641; GO:0033268; GO:0035748; GO:0042098; GO:0042130; GO:0042383; GO:0042982; GO:0043219; GO:0043268; GO:0043491; GO:0043622; GO:0044325; GO:0045121; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0098609; GO:0098911; GO:0098915; GO:0098919; GO:0098978; GO:0099645; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903764; GO:2000134,actin filament polymerization [GO:0030041]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; epithelial structure maintenance [GO:0010669]; establishment of centrosome localization [GO:0051660]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell projection membrane [GO:0031253]; cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060],kinase binding [GO:0019900]; L27 domain binding [GO:0097016]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0003012; GO:0005198; GO:0005634; GO:0005794; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0022414; GO:0023052; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003; GO:0072659; GO:0098772,immune system process; muscle system process; structural molecule activity; nucleus; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; reproductive process; signaling; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly; protein localization to plasma membrane; molecular function regulator activity
OG_02353,0.9161735640285829,OG_02353,FUN_008955-T1,Peve_00037682,Pocillopora_meandrina_HIv1___RNAseq.g4048.t1,three_way,75.81333333333333,FUN_008955-T1,Q149N8,,,,,35.5,1772.0,5.0000000000000005e-278,959.5,sp|Q149N8|SHPRH_HUMAN E3 ubiquitin-protein ligase SHPRH OS=Homo sapiens OX=9606 GN=SHPRH PE=1 SV=2,,,,,,
OG_00769,0.9159679746593148,OG_00769,FUN_003713-T1,Peve_00001357,Pocillopora_meandrina_HIv1___RNAseq.g17373.t2,three_way,74.59033333333333,FUN_003713-T1,A7RX69,TIKI1_NEMVE,,Metalloprotease TIKI homolog (EC 3.4.-.-),Nematostella vectensis (Starlet sea anemone),59.5,373.0,5.4999999999999996e-129,462.6,sp|A7RX69|TIKI1_NEMVE Metalloprotease TIKI homolog OS=Nematostella vectensis OX=45351 GN=v1g27680 PE=2 SV=2,GO:0004222; GO:0006508; GO:0016020; GO:0030178; GO:0046872,negative regulation of Wnt signaling pathway [GO:0030178]; proteolysis [GO:0006508],membrane [GO:0016020],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_00640,0.9159637928377432,OG_00640,FUN_001879-T1,Peve_00030499,Pocillopora_meandrina_HIv1___RNAseq.g2593.t1,three_way,62.20333333333333,FUN_001879-T1,Q6NTR1,,,,,38.1,691.0,1.8e-112,408.3,sp|Q6NTR1|EFNMT_XENLA eEF1A lysine and N-terminal methyltransferase OS=Xenopus laevis OX=8355 GN=mettl13 PE=2 SV=1,,,,,,
OG_08231,0.9153388416453384,OG_08231,FUN_036106-T1,Peve_00003695,Pocillopora_meandrina_HIv1___RNAseq.g27429.t1,three_way,71.5815,FUN_036106-T1,Q68D86,C102B_HUMAN,,Coiled-coil domain-containing protein 102B,Homo sapiens (Human),37.2,390.0,5.6e-42,173.7,sp|Q68D86|C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens OX=9606 GN=CCDC102B PE=1 SV=4,GO:0005737; GO:0005814; GO:0010457; GO:0120283,centriole-centriole cohesion [GO:0010457],centriole [GO:0005814]; cytoplasm [GO:0005737],protein serine/threonine kinase binding [GO:0120283],GO:0043226,organelle
OG_03683,0.9151016813843464,OG_03683,FUN_014942-T1,Peve_00037148,Pocillopora_meandrina_HIv1___RNAseq.g21099.t1,three_way,86.43466666666666,FUN_014942-T1,Q8AX98,TBX1A_XENLA,,T-box transcription factor TBX1-A (T-box protein 1-A),Xenopus laevis (African clawed frog),74.0,196.0,1.3e-84,315.1,sp|Q8AX98|TBX1A_XENLA T-box transcription factor TBX1-A OS=Xenopus laevis OX=8355 GN=tbx1-a PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0003700; GO:0005634; GO:0006357; GO:0045944; GO:0050793; GO:0060788; GO:0071300,cell fate specification [GO:0001708]; cellular response to retinoic acid [GO:0071300]; ectodermal placode formation [GO:0060788]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_08945,0.9149042444635164,OG_08945,FUN_038418-T1,Peve_00000006,Pocillopora_meandrina_HIv1___RNAseq.g1186.t1,three_way,79.584,FUN_038418-T1,P17844,DDX5_HUMAN,,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),Homo sapiens (Human),68.1,470.0,2.1999999999999997e-192,673.7,sp|P17844|DDX5_HUMAN Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens OX=9606 GN=DDX5 PE=1 SV=1,GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003729; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0009299; GO:0016020; GO:0016607; GO:0016887; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0031053; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0046332; GO:0048306; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1990841; GO:1990904; GO:2001014,"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; primary miRNA processing [GO:0031053]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02379,0.914824317256949,OG_02379,FUN_008991-T1,Peve_00023810,Pocillopora_meandrina_HIv1___RNAseq.g3896.t1,three_way,96.42866666666669,FUN_008991-T1,Q2KJI2,STT3A_BOVIN,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18),Bos taurus (Bovine),85.0,695.0,0.0,1212.6,sp|Q2KJI2|STT3A_BOVIN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A OS=Bos taurus OX=9913 GN=STT3A PE=2 SV=1,GO:0004579; GO:0008250; GO:0018279; GO:0043686; GO:0043687; GO:0046872,co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279],oligosaccharyltransferase complex [GO:0008250],dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872],GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_02253,0.9147170302191828,OG_02253,FUN_008699-T1,Peve_00035972,Pocillopora_meandrina_HIv1___RNAseq.g6277.t1,three_way,57.66416666666667,FUN_008699-T1,Q9ESV0,,,,,40.4,639.0,1.6e-122,441.8,sp|Q9ESV0|DDX24_MOUSE ATP-dependent RNA helicase DDX24 OS=Mus musculus OX=10090 GN=Ddx24 PE=1 SV=2,,,,,,
OG_01584,0.9146665037233056,OG_01584,FUN_006621-T1,Peve_00040867,Pocillopora_meandrina_HIv1___RNAseq.g20504.t1,three_way,51.0425,FUN_006621-T1,Q8WWI1,LMO7_HUMAN,,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),Homo sapiens (Human),43.5,131.0,4.7e-23,112.8,sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005635; GO:0005739; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nuclear envelope; mitochondrion; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01018,0.9143849103950912,OG_01018,FUN_004447-T1,Peve_00024327,Pocillopora_meandrina_HIv1___RNAseq.g11246.t1,three_way,84.03683333333333,FUN_004447-T1,Q9UPU5,UBP24_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),Homo sapiens (Human),45.2,2673.0,0.0,2190.2,sp|Q9UPU5|UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens OX=9606 GN=USP24 PE=1 SV=3,GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0016579; GO:0031647,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03035,0.9142635978729812,OG_03035,FUN_012273-T1,Peve_00023570,Pocillopora_meandrina_HIv1___RNAseq.g23877.t1,three_way,69.00583333333333,FUN_012273-T1,Q8WUA2,,,,,69.7,373.0,1.7e-149,530.8,sp|Q8WUA2|PPIL4_HUMAN Peptidyl-prolyl cis-trans isomerase-like 4 OS=Homo sapiens OX=9606 GN=PPIL4 PE=1 SV=1,,,,,,
OG_01076,0.9141499547482892,OG_01076,FUN_004562-T1,Peve_00016040,Pocillopora_meandrina_HIv1___RNAseq.g8226.t1,three_way,71.31733333333334,,,,,,,,,,,,,,,,,
OG_05783,0.9139574586074848,OG_05783,FUN_025757-T1,Peve_00029936,Pocillopora_meandrina_HIv1___RNAseq.g10418.t1,three_way,73.75783333333334,FUN_025757-T1,Q5R4D6,LEO1_PONAB,,RNA polymerase-associated protein LEO1,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),67.6,256.0,2.5000000000000002e-89,330.9,sp|Q5R4D6|LEO1_PONAB RNA polymerase-associated protein LEO1 OS=Pongo abelii OX=9601 GN=LEO1 PE=2 SV=1,GO:0001711; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:0031124; GO:0032968; GO:0045638; GO:1990269,endodermal cell fate commitment [GO:0001711]; mRNA 3'-end processing [GO:0031124]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593],RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269],GO:0006355; GO:0016071,regulation of DNA-templated transcription; mRNA metabolic process
OG_03420,0.9139013318221748,OG_03420,FUN_014474-T1,Peve_00030525,Pocillopora_meandrina_HIv1___TS.g27573.t1,three_way,70.30083333333333,FUN_014474-T1,Q00174,LAMA_DROME,,Laminin subunit alpha (Laminin A chain),Drosophila melanogaster (Fruit fly),35.5,3904.0,3.4e-306,1054.3,sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2,GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711,"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]",axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021],extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048856; GO:0098542,immune system process; structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism
OG_06892,0.9137384083007828,OG_06892,FUN_031931-T1,Peve_00004235,Pocillopora_meandrina_HIv1___RNAseq.g18238.t1,three_way,59.82666666666667,FUN_031931-T1,Q498L0,,,,,51.9,104.0,1.7000000000000002e-22,110.2,sp|Q498L0|C170B_XENLA Centrosomal protein of 170 kDa protein B OS=Xenopus laevis OX=8355 GN=cep170b PE=2 SV=1,,,,,,
OG_09639,0.9135103007231554,OG_09639,FUN_041834-T1,Peve_00029683,Pocillopora_meandrina_HIv1___RNAseq.g15086.t1,three_way,80.92266666666667,FUN_041834-T1,B0R0T1,VWA8_DANRE,,von Willebrand factor A domain-containing protein 8,Danio rerio (Zebrafish) (Brachydanio rerio),55.4,1896.0,0.0,2025.0,sp|B0R0T1|VWA8_DANRE von Willebrand factor A domain-containing protein 8 OS=Danio rerio OX=7955 GN=vwa8 PE=3 SV=1,GO:0005524; GO:0005737; GO:0005739; GO:0016887; GO:0030903,notochord development [GO:0030903],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0048856,catalytic activity; mitochondrion; hydrolase activity; organelle; anatomical structure development
OG_10216,0.913501811534204,OG_10216,FUN_043662-T1,Peve_00001429,Pocillopora_meandrina_HIv1___RNAseq.g7395.t2,three_way,79.739,FUN_043662-T1,P98198,AT8B2_HUMAN,,Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2),Homo sapiens (Human),52.5,1179.0,0.0,1144.4,sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2,GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531,Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
OG_05942,0.9128725450109334,OG_05942,FUN_026179-T1,Peve_00012698,Pocillopora_meandrina_HIv1___RNAseq.g3034.t1,three_way,82.133,FUN_026179-T1,O02695,,,,,58.0,440.0,8.500000000000001e-133,476.1,sp|O02695|PTPR2_MACNE Receptor-type tyrosine-protein phosphatase N2 OS=Macaca nemestrina OX=9545 GN=PTPRN2 PE=2 SV=1,,,,,,
OG_05011,0.9126481105271106,OG_05011,FUN_023163-T1,Peve_00018795,Pocillopora_meandrina_HIv1___TS.g25340.t2c,three_way,74.67866666666667,FUN_023163-T1,Q8K4G5,ABLM1_MOUSE,,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1),Mus musculus (Mouse),48.6,253.0,8.9e-78,292.0,sp|Q8K4G5|ABLM1_MOUSE Actin-binding LIM protein 1 OS=Mus musculus OX=10090 GN=Ablim1 PE=1 SV=1,GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0060271,axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725],actin binding [GO:0003779]; metal ion binding [GO:0046872],GO:0005856; GO:0006351; GO:0006355; GO:0007010; GO:0008092; GO:0043226; GO:0044782,cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_08842,0.9126216391571944,OG_08842,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_09510,0.912515808750852,OG_09510,FUN_041562-T1,Peve_00033130,Pocillopora_meandrina_HIv1___RNAseq.g16036.t1,three_way,88.02866666666667,FUN_041562-T1,Q93008,USP9X_HUMAN,,"Ubiquitin carboxyl-terminal hydrolase 9X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)",Homo sapiens (Human),61.0,2508.0,0.0,2993.4,sp|Q93008|USP9X_HUMAN Ubiquitin carboxyl-terminal hydrolase 9X OS=Homo sapiens OX=9606 GN=USP9X PE=1 SV=4,GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006307; GO:0007059; GO:0007179; GO:0007292; GO:0008104; GO:0008234; GO:0016020; GO:0016477; GO:0016562; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0031647; GO:0032092; GO:0032435; GO:0035520; GO:0042752; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0060271; GO:0061578; GO:0061824; GO:0070410; GO:0070536; GO:0071947; GO:0101005; GO:0140313; GO:0180017; GO:1904515; GO:1990000; GO:1990380,"amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; DNA alkylation repair [GO:0006307]; female gamete generation [GO:0007292]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]",centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634],co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; K11-linked deubiquitinase activity [GO:0180017]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; molecular sequestering activity [GO:0140313],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0006281; GO:0006355; GO:0007059; GO:0016787; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140096; GO:0140313,"catalytic activity; nucleus; microtubule organizing center; cytosol; cilium; DNA repair; regulation of DNA-templated transcription; chromosome segregation; hydrolase activity; reproductive process; organelle; cilium organization; cell motility; catalytic activity, acting on a protein; molecular sequestering activity"
OG_05899,0.91208085382089,OG_05899,FUN_026076-T1,Peve_00002022,Pocillopora_meandrina_HIv1___RNAseq.g10561.t1,three_way,58.79216666666667,FUN_026076-T1,Q9NVE5,,,,,35.0,1254.0,1.6e-196,688.3,sp|Q9NVE5|UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens OX=9606 GN=USP40 PE=1 SV=3,,,,,,
OG_07226,0.9118545108892742,OG_07226,FUN_032832-T1,Peve_00014560,Pocillopora_meandrina_HIv1___RNAseq.g24969.t3,three_way,68.74916666666667,FUN_032832-T1,Q66I22,,,,,48.1,270.0,3.4e-62,241.5,sp|Q66I22|SRRT_DANRE Serrate RNA effector molecule homolog OS=Danio rerio OX=7955 GN=srrt PE=2 SV=1,,,,,,
OG_07226,0.9118545108892742,OG_07226,FUN_032832-T1,Peve_00014560,Pocillopora_meandrina_HIv1___RNAseq.g24969.t3,three_way,68.74916666666667,FUN_032832-T1,Q66I22,,,,,35.9,78.0,3.8e-05,52.0,sp|Q66I22|SRRT_DANRE Serrate RNA effector molecule homolog OS=Danio rerio OX=7955 GN=srrt PE=2 SV=1,,,,,,
OG_09527,0.9116802283512756,OG_09527,FUN_041595-T1,Peve_00036094,Pocillopora_meandrina_HIv1___RNAseq.g15283.t1,three_way,62.94383333333334,FUN_041595-T1,A2AQH4,,,,,38.7,331.0,1.8e-09,67.0,sp|A2AQH4|BCORL_MOUSE BCL-6 corepressor-like protein 1 OS=Mus musculus OX=10090 GN=Bcorl1 PE=2 SV=1,,,,,,
OG_09029,0.9114285280323252,OG_09029,FUN_038622-T1,Peve_00042048,Pocillopora_meandrina_HIv1___RNAseq.g1159.t1,three_way,78.449,FUN_038622-T1,P22448,,,,,31.8,349.0,7.2e-41,169.5,sp|P22448|RARB_CHICK Retinoic acid receptor beta OS=Gallus gallus OX=9031 GN=RARB PE=2 SV=2,,,,,,
OG_03209,0.9113546825876891,OG_03209,FUN_012701-T1,Peve_00016835,Pocillopora_meandrina_HIv1___RNAseq.g12828.t1,three_way,66.00966666666667,,,,,,,,,,,,,,,,,
OG_05562,0.9108831884071016,OG_05562,FUN_024781-T1,Peve_00015076,Pocillopora_meandrina_HIv1___TS.g28189.t2,three_way,75.94966666666666,FUN_024781-T1,Q5F3U9,,,,,42.0,1148.0,3.5999999999999993e-242,840.1,sp|Q5F3U9|PDS5B_CHICK Sister chromatid cohesion protein PDS5 homolog B OS=Gallus gallus OX=9031 GN=PDS5B PE=2 SV=3,,,,,,
OG_01054,0.9108194785007324,OG_01054,FUN_004506-T1,Peve_00044059,Pocillopora_meandrina_HIv1___RNAseq.g11391.t1,three_way,79.72433333333333,FUN_004506-T1,Q96NR8,RDH12_HUMAN,,Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2),Homo sapiens (Human),54.7,298.0,9.599999999999999e-82,305.1,sp|Q96NR8|RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens OX=9606 GN=RDH12 PE=1 SV=3,GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0102354; GO:0110095,cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342],11-cis-retinol dehydrogenase activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0006629; GO:0016491; GO:0050877; GO:0098754,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process; detoxification
OG_10198,0.9104896787629018,OG_10198,FUN_043622-T1,Peve_00008234,Pocillopora_meandrina_HIv1___RNAseq.g6927.t1,three_way,76.94266666666667,FUN_043622-T1,Q9VUX3,NOTUM_DROME,,Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (Protein Notum) (Protein wingful) (dNOTUM),Drosophila melanogaster (Fruit fly),28.2,347.0,8.8e-26,119.8,sp|Q9VUX3|NOTUM_DROME Palmitoleoyl-protein carboxylesterase NOTUM OS=Drosophila melanogaster OX=7227 GN=Notum PE=1 SV=3,GO:0005615; GO:0007419; GO:0009986; GO:0016055; GO:0035220; GO:0035222; GO:0045880; GO:0048076; GO:0048190; GO:0048546; GO:0090090; GO:1990697; GO:1990699,digestive tract morphogenesis [GO:0048546]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of smoothened signaling pathway [GO:0045880]; protein depalmitoleylation [GO:1990697]; regulation of compound eye pigmentation [GO:0048076]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; extracellular space [GO:0005615],palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005615; GO:0016787; GO:0030163; GO:0048856,catalytic activity; extracellular space; hydrolase activity; protein catabolic process; anatomical structure development
OG_04511,0.9104656644331772,OG_04511,FUN_022043-T1,Peve_00004576,Pocillopora_meandrina_HIv1___RNAseq.g9277.t1,three_way,83.28766666666667,FUN_022043-T1,Q9BZE4,GTPB4_HUMAN,,GTP-binding protein 4 (Chronic renal failure gene protein) (GTP-binding protein NGB) (Nucleolar GTP-binding protein 1),Homo sapiens (Human),58.0,638.0,2.2e-202,706.8,sp|Q9BZE4|GTPB4_HUMAN GTP-binding protein 4 OS=Homo sapiens OX=9606 GN=GTPBP4 PE=1 SV=3,GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0010972; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0042273; GO:0048471; GO:0050821; GO:1990275,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA replication [GO:0008156]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; ribosomal large subunit biogenesis [GO:0042273]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; preribosome binding [GO:1990275]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016787; GO:0030154; GO:0043226,RNA binding; catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; cytosol; hydrolase activity; cell differentiation; organelle
OG_01811,0.9101588557653892,OG_01811,FUN_007646-T1,Peve_00034271,Pocillopora_meandrina_HIv1___RNAseq.g5811.t1,three_way,71.30533333333334,FUN_007646-T1,Q92994,,,,,44.1,551.0,3.1e-91,337.4,sp|Q92994|TF3B_HUMAN Transcription factor IIIB 90 kDa subunit OS=Homo sapiens OX=9606 GN=BRF1 PE=1 SV=1,,,,,,
OG_09881,0.9100805302409428,OG_09881,FUN_042949-T1,Peve_00019972,Pocillopora_meandrina_HIv1___TS.g886.t1,three_way,68.23983333333334,FUN_042949-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),34.1,560.0,6.8e-78,293.1,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_01796,0.90997790184936,OG_01796,FUN_007181-T1,Peve_00015050,Pocillopora_meandrina_HIv1___RNAseq.g19781.t1,three_way,79.889,FUN_007181-T1,Q80UM3,NAA15_MOUSE,,"N-alpha-acetyltransferase 15, NatA auxiliary subunit (N-terminal acetyltransferase 1) (NMDA receptor-regulated protein 1) (Protein tubedown-1)",Mus musculus (Mouse),59.2,833.0,7.7e-267,921.4,"sp|Q80UM3|NAA15_MOUSE N-alpha-acetyltransferase 15, NatA auxiliary subunit OS=Mus musculus OX=10090 GN=Naa15 PE=1 SV=1",GO:0001525; GO:0005634; GO:0005737; GO:0008080; GO:0030154; GO:0048471,angiogenesis [GO:0001525]; cell differentiation [GO:0030154],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],N-acetyltransferase activity [GO:0008080],GO:0003824; GO:0005634; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nucleus; transferase activity; cell differentiation; organelle
OG_08751,0.9095587628080692,OG_08751,FUN_038018-T1,Peve_00022791,Pocillopora_meandrina_HIv1___RNAseq.g26531.t1,three_way,70.62033333333333,FUN_038018-T1,A7UA95,RADIL_DANRE,,Ras-associating and dilute domain-containing protein,Danio rerio (Zebrafish) (Brachydanio rerio),28.0,1225.0,3e-109,398.7,sp|A7UA95|RADIL_DANRE Ras-associating and dilute domain-containing protein OS=Danio rerio OX=7955 GN=radil PE=2 SV=1,GO:0001755; GO:0005874; GO:0007165; GO:0034446; GO:0051020,neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],microtubule [GO:0005874],GTPase binding [GO:0051020],GO:0007155; GO:0048870,cell adhesion; cell motility
OG_03825,0.909317127353501,OG_03825,FUN_015245-T1,Peve_00003467,Pocillopora_meandrina_HIv1___RNAseq.g22163.t1,three_way,72.38283333333334,FUN_015245-T1,Q6VAB6,KSR2_HUMAN,,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),Homo sapiens (Human),33.3,953.0,6.5e-104,380.2,sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2,GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162,calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; cytosol; plasma membrane; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_03184,0.9090574876366097,OG_03184,FUN_012639-T1,Peve_00036806,Pocillopora_meandrina_HIv1___RNAseq.g22909.t1,three_way,74.95033333333333,FUN_012639-T1,Q5THJ4,VP13D_HUMAN,,Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D),Homo sapiens (Human),35.7,4659.0,0.0,2452.2,sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2,GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526,lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623],extracellular exosome [GO:0070062]; mitochondrion [GO:0005739],,GO:0005739; GO:0006886; GO:0007005; GO:0043226,mitochondrion; intracellular protein transport; mitochondrion organization; organelle
OG_06188,0.9089320837835014,OG_06188,FUN_028103-T1,Peve_00032588,Pocillopora_meandrina_HIv1___RNAseq.g15573.t1,three_way,47.289,,,,,,,,,,,,,,,,,
OG_06564,0.9089298535410654,OG_06564,FUN_029453-T1,Peve_00021752,Pocillopora_meandrina_HIv1___RNAseq.g17157.t1,three_way,84.16833333333334,FUN_029453-T1,Q9UBC2,EP15R_HUMAN,,Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R),Homo sapiens (Human),53.5,409.0,2.3999999999999998e-105,384.8,sp|Q9UBC2|EP15R_HUMAN Epidermal growth factor receptor substrate 15-like 1 OS=Homo sapiens OX=9606 GN=EPS15L1 PE=1 SV=1,GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0016197; GO:0030132; GO:0045296; GO:0048488; GO:0098793,endocytosis [GO:0006897]; endosomal transport [GO:0016197]; synaptic vesicle endocytosis [GO:0048488],clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509],GO:0005634; GO:0005829; GO:0005886; GO:0016192; GO:0043226,nucleus; cytosol; plasma membrane; vesicle-mediated transport; organelle
OG_08656,0.9086532764678216,OG_08656,FUN_037862-T1,Peve_00022156,Pocillopora_meandrina_HIv1___RNAseq.g1427.t2,three_way,73.77433333333333,FUN_037862-T1,P30839,AL3A2_RAT,,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 4) (Fatty aldehyde dehydrogenase) (Microsomal aldehyde dehydrogenase) (msALDH),Rattus norvegicus (Rat),52.2,454.0,5.5e-140,499.2,sp|P30839|AL3A2_RAT Aldehyde dehydrogenase family 3 member A2 OS=Rattus norvegicus OX=10116 GN=Aldh3a2 PE=1 SV=1,GO:0000302; GO:0004028; GO:0004029; GO:0005737; GO:0005783; GO:0005789; GO:0006081; GO:0006631; GO:0007417; GO:0007422; GO:0008544; GO:0016020; GO:0033306; GO:0042803; GO:0043231; GO:0046292; GO:0046458; GO:0046577; GO:0050061; GO:0052814,aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; formaldehyde metabolic process [GO:0046292]; hexadecanal metabolic process [GO:0046458]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; response to reactive oxygen species [GO:0000302],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; long-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0050061]; long-chain-alcohol oxidase activity [GO:0046577]; medium-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0052814]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226; GO:0048856,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle; anatomical structure development
OG_03845,0.9084450305357212,OG_03845,FUN_015318-T1,Peve_00023982,Pocillopora_meandrina_HIv1___RNAseq.g21728.t1,three_way,82.93366666666667,FUN_015318-T1,Q5QNI2,,,,,31.0,532.0,4.7999999999999997e-54,213.8,sp|Q5QNI2|NCL1_ORYSJ Sodium/calcium exchanger NCL1 OS=Oryza sativa subsp. japonica OX=39947 GN=NCL1 PE=2 SV=1,,,,,,
OG_01413,0.908022189964763,OG_01413,FUN_005700-T1,Peve_00008485,Pocillopora_meandrina_HIv1___RNAseq.g19563.t1,three_way,75.503,FUN_005700-T1,Q9Z2V9,,,,,40.4,213.0,5.4e-36,152.9,sp|Q9Z2V9|CCNI_MOUSE Cyclin-I OS=Mus musculus OX=10090 GN=Ccni PE=2 SV=4,,,,,,
OG_09059,0.9078021934464544,OG_09059,FUN_038742-T1,Peve_00009051,Pocillopora_meandrina_HIv1___RNAseq.g26426.t1,three_way,86.85000000000001,FUN_038742-T1,Q8TB05,,,,,74.4,86.0,2.5e-28,125.9,sp|Q8TB05|UBAD1_HUMAN UBA-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBALD1 PE=1 SV=1,,,,,,
OG_07372,0.9074053763844908,OG_07372,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,43.9,214.0,1.7e-40,169.9,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07372,0.9074053763844908,OG_07372,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,30.4,171.0,0.00058,48.5,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07820,0.9072325923940204,OG_07820,FUN_035088-T1,Peve_00037967,Pocillopora_meandrina_HIv1___TS.g15056.t2,three_way,81.78233333333334,FUN_035088-T1,Q92508,PIEZ1_HUMAN,,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),Homo sapiens (Human),32.0,2582.0,4.8e-312,1072.8,sp|Q92508|PIEZ1_HUMAN Piezo-type mechanosensitive ion channel component 1 OS=Homo sapiens OX=9606 GN=PIEZO1 PE=1 SV=4,GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0031258; GO:0032420; GO:0032437; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260; GO:0140135,cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391],cuticular plate [GO:0032437]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; stereocilium [GO:0032420],mechanosensitive monoatomic cation channel activity [GO:0140135]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005783; GO:0005886; GO:0043226,transporter activity; endoplasmic reticulum; plasma membrane; organelle
OG_09052,0.9069209587070404,OG_09052,FUN_038733-T1,Peve_00013932,Pocillopora_meandrina_HIv1___RNAseq.g26435.t1,three_way,77.6025,FUN_038733-T1,O75175,CNOT3_HUMAN,,CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2),Homo sapiens (Human),43.1,826.0,1.5e-134,481.9,sp|O75175|CNOT3_HUMAN CCR4-NOT transcription complex subunit 3 OS=Homo sapiens OX=9606 GN=CNOT3 PE=1 SV=1,GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006417; GO:0030014; GO:0030015; GO:0031047; GO:0120162; GO:2000036,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829],CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],,GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0030154; GO:0031047; GO:0043226,nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle
OG_07486,0.9062964118178194,OG_07486,FUN_034012-T1,Peve_00007016,Pocillopora_meandrina_HIv1___TS.g18832.t1,three_way,67.49216666666666,FUN_034012-T1,B1AQJ2,UBP36_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 36 (EC 2.3.2.-) (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36),Mus musculus (Mouse),50.0,470.0,3.3e-123,444.5,sp|B1AQJ2|UBP36_MOUSE Ubiquitin carboxyl-terminal hydrolase 36 OS=Mus musculus OX=10090 GN=Usp36 PE=1 SV=1,GO:0003723; GO:0004843; GO:0005730; GO:0005737; GO:0006325; GO:0006508; GO:0007000; GO:0016242; GO:0016579; GO:0016607; GO:0016740; GO:0031647; GO:0050821; GO:0140936; GO:1990380; GO:2000232,chromatin organization [GO:0006325]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730],cysteine-type deubiquitinase activity [GO:0004843]; histone H2B deubiquitinase activity [GO:0140936]; K48-linked deubiquitinase activity [GO:1990380]; RNA binding [GO:0003723]; transferase activity [GO:0016740],GO:0003723; GO:0003824; GO:0005730; GO:0006325; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleolus; chromatin organization; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01171,0.9059641693606624,OG_01171,FUN_004795-T1,Peve_00010263,Pocillopora_meandrina_HIv1___RNAseq.g8536.t1,three_way,53.3395,FUN_004795-T1,Q56A10,ZN608_MOUSE,,Zinc finger protein 608,Mus musculus (Mouse),41.6,219.0,6.9e-29,132.1,sp|Q56A10|ZN608_MOUSE Zinc finger protein 608 OS=Mus musculus OX=10090 GN=Znf608 PE=1 SV=1,GO:0000122; GO:0008270; GO:0033085,negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122],,zinc ion binding [GO:0008270],GO:0006355,regulation of DNA-templated transcription
OG_02049,0.9055377750960392,OG_02049,FUN_008259-T1,Peve_00042075,Pocillopora_meandrina_HIv1___RNAseq.g17963.t1,three_way,74.48566666666667,FUN_008259-T1,O88559,MEN1_MOUSE,,Menin,Mus musculus (Mouse),42.6,599.0,3.6e-116,420.2,sp|O88559|MEN1_MOUSE Menin OS=Mus musculus OX=10090 GN=Men1 PE=1 SV=2,GO:0000122; GO:0000781; GO:0000976; GO:0001216; GO:0001503; GO:0001776; GO:0002051; GO:0002076; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006338; GO:0008283; GO:0008285; GO:0010468; GO:0010628; GO:0017053; GO:0030097; GO:0035097; GO:0035265; GO:0043565; GO:0044342; GO:0044346; GO:0045668; GO:0045669; GO:0045815; GO:0045893; GO:0045944; GO:0046621; GO:0048144; GO:0048147; GO:0048704; GO:0048863; GO:0051301; GO:0051781; GO:0060021; GO:0060135; GO:0072089; GO:1904691; GO:2000045; GO:2000271; GO:2000647; GO:2000738,cell division [GO:0051301]; cell population proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; embryonic skeletal system morphogenesis [GO:0048704]; fibroblast apoptotic process [GO:0044346]; fibroblast proliferation [GO:0048144]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; organ growth [GO:0035265]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of cell division [GO:0051781]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription initiation-coupled chromatin remodeling [GO:0045815]; type B pancreatic cell proliferation [GO:0044342],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976],GO:0002376; GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07968,0.9054911996431771,OG_07968,FUN_035537-T1,Peve_00026592,Pocillopora_meandrina_HIv1___RNAseq.g28000.t1,three_way,95.7,FUN_035537-T1,Q921M3,,,,,79.5,1222.0,0.0,2003.0,sp|Q921M3|SF3B3_MOUSE Splicing factor 3B subunit 3 OS=Mus musculus OX=10090 GN=Sf3b3 PE=1 SV=1,,,,,,
OG_09624,0.9052524774915198,OG_09624,FUN_041788-T1,Peve_00038539,Pocillopora_meandrina_HIv1___RNAseq.g15771.t1,three_way,71.78066666666666,FUN_041788-T1,Q8BX90,FND3A_MOUSE,,Fibronectin type-III domain-containing protein 3A,Mus musculus (Mouse),35.3,996.0,1.6e-163,578.6,sp|Q8BX90|FND3A_MOUSE Fibronectin type-III domain-containing protein 3A OS=Mus musculus OX=10090 GN=Fndc3a PE=1 SV=3,GO:0000139; GO:0001669; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0031410; GO:0060009; GO:0098609,cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; vesicle membrane [GO:0012506],,GO:0005829; GO:0007155; GO:0022414; GO:0031410; GO:0043226; GO:0048856,cytosol; cell adhesion; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development
OG_09711,0.9050111757882058,OG_09711,FUN_041951-T1,Peve_00022248,Pocillopora_meandrina_HIv1___RNAseq.g15252.t1,three_way,67.0045,FUN_041951-T1,Q498F0,,,,,52.2,592.0,2.6e-153,544.3,sp|Q498F0|WDR44_XENLA WD repeat-containing protein 44 OS=Xenopus laevis OX=8355 GN=wdr44 PE=2 SV=1,,,,,,
OG_05003,0.9049598630109984,OG_05003,FUN_023139-T1,Peve_00042477,Pocillopora_meandrina_HIv1___RNAseq.g1749.t1,three_way,49.72316666666666,FUN_023139-T1,P70399,TP53B_MOUSE,,TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),Mus musculus (Mouse),27.4,559.0,4.7999999999999996e-43,179.1,sp|P70399|TP53B_MOUSE TP53-binding protein 1 OS=Mus musculus OX=10090 GN=Tp53bp1 PE=1 SV=3,GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0005634; GO:0005657; GO:0005737; GO:0006281; GO:0006303; GO:0006355; GO:0006974; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0043565; GO:0045830; GO:0045944; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:0097680; GO:0140005; GO:0140941; GO:1990166; GO:1990391; GO:2000042,cellular response to X-ray [GO:0071481]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; protein localization to site of double-strand break [GO:1990166]; regulation of DNA-templated transcription [GO:0006355],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",damaged DNA binding [GO:0003684]; histone H4K20me methyltransferase activity [GO:0140941]; histone H4K20me2 reader activity [GO:0140005]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin-modified histone reader activity [GO:0061649],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; DNA repair; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_05974,0.9046187977884972,OG_05974,FUN_026394-T1,Peve_00032420,Pocillopora_meandrina_HIv1___RNAseq.g2941.t1,three_way,86.70166666666667,FUN_026394-T1,Q01583,DGK1_DROME,,Diacylglycerol kinase 1 (DAG kinase 1) (DGK 1) (Diglyceride kinase 1) (EC 2.7.1.107),Drosophila melanogaster (Fruit fly),39.6,450.0,3.8e-71,270.4,sp|Q01583|DGK1_DROME Diacylglycerol kinase 1 OS=Drosophila melanogaster OX=7227 GN=Dgk PE=2 SV=5,GO:0004143; GO:0005509; GO:0005524; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0035556; GO:0046339,diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0006629; GO:0016740,catalytic activity; plasma membrane; lipid metabolic process; transferase activity
OG_00320,0.9045520546530108,OG_00320,FUN_001139-T1,Peve_00029334,Pocillopora_meandrina_HIv1___RNAseq.g29336.t1,three_way,78.20866666666667,FUN_001139-T1,Q761V0,SC6A5_MOUSE,,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Mus musculus (Mouse),46.3,609.0,5.5e-158,559.3,sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1,GO:0001504; GO:0005886; GO:0015375; GO:0046872; GO:0098690; GO:0098793; GO:0098810,neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504],glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynapse [GO:0098793],glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_02782,0.904180586418894,OG_02782,FUN_011733-T1,Peve_00001121,Pocillopora_meandrina_HIv1___RNAseq.g23840.t2,three_way,53.03233333333333,FUN_011733-T1,Q6ZPR6,,,,,30.4,1491.0,1.3e-160,569.3,sp|Q6ZPR6|IBTK_MOUSE Inhibitor of Bruton tyrosine kinase OS=Mus musculus OX=10090 GN=Ibtk PE=1 SV=3,,,,,,
OG_00308,0.9041567591626728,OG_00308,FUN_001110-T1,Peve_00029335,Pocillopora_meandrina_HIv1___RNAseq.g29363.t1,three_way,71.534,FUN_001110-T1,P15384,,,,,49.9,407.0,2.3e-84,314.7,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_06219,0.9041277642523992,OG_06219,FUN_028162-T1,Peve_00018136,Pocillopora_meandrina_HIv1___RNAseq.g16500.t1,three_way,57.34316666666667,FUN_028162-T1,Q96T23,RSF1_HUMAN,,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),Homo sapiens (Human),42.2,154.0,6.7e-24,114.0,sp|Q96T23|RSF1_HUMAN Remodeling and spacing factor 1 OS=Homo sapiens OX=9606 GN=RSF1 PE=1 SV=2,GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0008270; GO:0031213; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0050434; GO:0140751,chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213],histone binding [GO:0042393]; histone octamer slider activity [GO:0140751]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0065003; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; protein-containing complex assembly; catalytic activity, acting on DNA; ATP-dependent activity"
OG_01177,0.9041107923975352,OG_01177,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_06903,0.9038883543111508,OG_06903,FUN_031949-T1,Peve_00031822,Pocillopora_meandrina_HIv1___RNAseq.g6063.t2,three_way,64.09533333333334,FUN_031949-T1,P81439,,,,,40.1,187.0,5.8e-32,141.7,sp|P81439|EQSTC_ACTEQ Equistatin OS=Actinia equina OX=6106 PE=1 SV=2,,,,,,
OG_02365,0.903739213502841,OG_02365,FUN_008972-T1,Peve_00025074,Pocillopora_meandrina_HIv1___RNAseq.g14268.t1,three_way,56.09883333333333,FUN_008972-T1,Q9BXT4,TDRD1_HUMAN,,Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1),Homo sapiens (Human),22.4,961.0,1.8999999999999998e-35,153.3,sp|Q9BXT4|TDRD1_HUMAN Tudor domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TDRD1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_04211,0.9035869738630874,OG_04211,FUN_016798-T1,Peve_00023973,Pocillopora_meandrina_HIv1___RNAseq.g242.t1,three_way,87.46816666666666,FUN_016798-T1,Q9Y2E4,,,,,56.7,1558.0,0.0,1701.0,sp|Q9Y2E4|DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens OX=9606 GN=DIP2C PE=1 SV=2,,,,,,
OG_05378,0.9035725795429206,OG_05378,FUN_024195-T1,Peve_00018698,Pocillopora_meandrina_HIv1___RNAseq.g18880.t1,three_way,77.08933333333333,FUN_024195-T1,Q96NL6,SCLT1_HUMAN,,Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1),Homo sapiens (Human),27.6,613.0,2.3999999999999998e-54,215.3,sp|Q96NL6|SCLT1_HUMAN Sodium channel and clathrin linker 1 OS=Homo sapiens OX=9606 GN=SCLT1 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005829; GO:0015630; GO:0017080; GO:0030276; GO:0036064; GO:0045162; GO:0060271; GO:0071439; GO:0097539,cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630],clathrin binding [GO:0030276]; sodium channel regulator activity [GO:0017080],GO:0005815; GO:0005829; GO:0005856; GO:0043226; GO:0044782; GO:0061024; GO:0098772,microtubule organizing center; cytosol; cytoskeleton; organelle; cilium organization; membrane organization; molecular function regulator activity
OG_06125,0.903319771405757,OG_06125,FUN_027903-T1,Peve_00020107,Pocillopora_meandrina_HIv1___RNAseq.g13881.t1,three_way,48.315666666666665,FUN_027903-T1,O75487,GPC4_HUMAN,,Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4],Homo sapiens (Human),33.5,507.0,6.5e-73,276.6,sp|O75487|GPC4_HUMAN Glypican-4 OS=Homo sapiens OX=9606 GN=GPC4 PE=1 SV=4,GO:0005634; GO:0005796; GO:0005886; GO:0009897; GO:0009966; GO:0009986; GO:0015026; GO:0016055; GO:0016477; GO:0043202; GO:0045202; GO:0070062; GO:0098696; GO:0098978; GO:0099560; GO:1905606,cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],coreceptor activity [GO:0015026],GO:0005634; GO:0005886; GO:0007155; GO:0043226; GO:0048870; GO:0060089,nucleus; plasma membrane; cell adhesion; organelle; cell motility; molecular transducer activity
OG_08437,0.9032994179766292,OG_08437,FUN_037196-T1,Peve_00004715,Pocillopora_meandrina_HIv1___RNAseq.g11075.t2,three_way,81.52866666666667,FUN_037196-T1,Q15111,PLCL1_HUMAN,,Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein) (PRIP),Homo sapiens (Human),49.5,1043.0,1.4e-302,1040.4,sp|Q15111|PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens OX=9606 GN=PLCL1 PE=1 SV=3,GO:0004435; GO:0004629; GO:0005737; GO:0007214; GO:0032228; GO:0035556; GO:0046488; GO:0048015; GO:0051209; GO:0120163,"gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209]",cytoplasm [GO:0005737],"phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]",GO:0003824; GO:0006629; GO:0016787; GO:0023052; GO:0055085,catalytic activity; lipid metabolic process; hydrolase activity; signaling; transmembrane transport
OG_08153,0.9032569233247542,OG_08153,FUN_035930-T1,Peve_00036624,Pocillopora_meandrina_HIv1___RNAseq.g12067.t1,three_way,73.38733333333333,FUN_035930-T1,Q6EDY6,CARL1_MOUSE,,"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)",Mus musculus (Mouse),37.8,1029.0,9.8e-173,609.8,sp|Q6EDY6|CARL1_MOUSE F-actin-uncapping protein LRRC16A OS=Mus musculus OX=10090 GN=Carmil1 PE=1 SV=2,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007163; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:1900026; GO:1902745; GO:2000813,actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886],protein-containing complex binding [GO:0044877],GO:0005634; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0007163; GO:0016192; GO:0031410; GO:0043226; GO:0048870,nucleus; endosome; cytosol; cytoskeleton; plasma membrane; establishment or maintenance of cell polarity; vesicle-mediated transport; cytoplasmic vesicle; organelle; cell motility
OG_09034,0.9032424619539444,OG_09034,FUN_038634-T1,Peve_00013495,Pocillopora_meandrina_HIv1___RNAseq.g26493.t1,three_way,76.94633333333333,FUN_038634-T1,Q99PT9,KIF19_MOUSE,,Kinesin-like protein KIF19,Mus musculus (Mouse),46.3,864.0,9.200000000000002e-180,632.5,sp|Q99PT9|KIF19_MOUSE Kinesin-like protein KIF19 OS=Mus musculus OX=10090 GN=Kif19 PE=1 SV=2,GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0060404; GO:0070462,axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462],axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; plus-end-directed microtubule motor activity [GO:0008574],GO:0003774; GO:0003824; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_05944,0.903069815873954,OG_05944,FUN_026182-T1,Peve_00022314,Pocillopora_meandrina_HIv1___RNAseq.g3037.t1,three_way,64.16,,,,,,,,,,,,,,,,,
OG_03562,0.9028695090561538,OG_03562,FUN_014710-T1,Peve_00004185,Pocillopora_meandrina_HIv1___TS.g27294.t1,three_way,91.096,FUN_014710-T1,Q5SPC5,OTOF_DANRE,,Otoferlin (Fer-1-like protein 2),Danio rerio (Zebrafish) (Brachydanio rerio),49.8,2026.0,0.0,1855.5,sp|Q5SPC5|OTOF_DANRE Otoferlin OS=Danio rerio OX=7955 GN=otof PE=3 SV=1,GO:0000139; GO:0001964; GO:0005509; GO:0005789; GO:0007009; GO:0007605; GO:0010996; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0036465; GO:0042995; GO:0048787; GO:0050885,neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle recycling [GO:0036465],basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672],AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509],GO:0016192; GO:0050877; GO:0061024; GO:0065003,vesicle-mediated transport; nervous system process; membrane organization; protein-containing complex assembly
OG_05951,0.9028568694132928,OG_05951,FUN_026211-T1,Peve_00044665,Pocillopora_meandrina_HIv1___RNAseq.g3049.t1,three_way,49.01616666666666,FUN_026211-T1,A2AX52,CO6A4_MOUSE,,Collagen alpha-4(VI) chain,Mus musculus (Mouse),24.8,1256.0,9.1e-63,246.1,sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2,GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991],collagen binding [GO:0005518],GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_08501,0.9027765003011804,OG_08501,FUN_037385-T1,Peve_00014721,Pocillopora_meandrina_HIv1___RNAseq.g26899.t1,three_way,86.40616666666666,FUN_037385-T1,Q8K4Z5,,,,,62.7,762.0,3.3e-170,600.1,sp|Q8K4Z5|SF3A1_MOUSE Splicing factor 3A subunit 1 OS=Mus musculus OX=10090 GN=Sf3a1 PE=1 SV=1,,,,,,
OG_04794,0.9024477839665916,OG_04794,FUN_022710-T1,Peve_00006885,Pocillopora_meandrina_HIv1___RNAseq.g4817.t1,three_way,81.13166666666666,FUN_022710-T1,Q3T904,ATG9A_BOVIN,,Autophagy-related protein 9A (APG9-like 1) (Autophagy protein 9),Bos taurus (Bovine),54.5,462.0,1.2e-152,541.6,sp|Q3T904|ATG9A_BOVIN Autophagy-related protein 9A OS=Bos taurus OX=9913 GN=ATG9A PE=2 SV=1,GO:0000045; GO:0000139; GO:0000407; GO:0000421; GO:0000423; GO:0005739; GO:0005776; GO:0005789; GO:0005794; GO:0005802; GO:0017128; GO:0031902; GO:0031966; GO:0034045; GO:0034497; GO:0034727; GO:0055038; GO:0060349; GO:0061709; GO:0097300,autophagosome assembly [GO:0000045]; bone morphogenesis [GO:0060349]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; programmed necrotic cell death [GO:0097300]; protein localization to phagophore assembly site [GO:0034497]; reticulophagy [GO:0061709],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802],phospholipid scramblase activity [GO:0017128],GO:0005215; GO:0005739; GO:0005773; GO:0005794; GO:0006914; GO:0012501; GO:0043226,transporter activity; mitochondrion; vacuole; Golgi apparatus; autophagy; programmed cell death; organelle
OG_04639,0.9023174199756602,OG_04639,FUN_022365-T1,Peve_00021988,Pocillopora_meandrina_HIv1___TS.g22011.t1,three_way,64.79716666666667,FUN_022365-T1,A2RRU4,SCAP_RAT,,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),Rattus norvegicus (Rat),35.1,1375.0,2.4999999999999998e-147,525.0,sp|A2RRU4|SCAP_RAT Sterol regulatory element-binding protein cleavage-activating protein OS=Rattus norvegicus OX=10116 GN=Scap PE=2 SV=1,GO:0000139; GO:0001666; GO:0005789; GO:0006629; GO:0006955; GO:0008203; GO:0012507; GO:0019217; GO:0032868; GO:0032933; GO:0032934; GO:0032936; GO:0032991; GO:0033552; GO:0042304; GO:0044877; GO:0045540; GO:0045542; GO:0090110,cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; lipid metabolic process [GO:0006629]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to vitamin B3 [GO:0033552]; SREBP signaling pathway [GO:0032933],endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; protein-containing complex [GO:0032991]; SREBP-SCAP complex [GO:0032936],protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934],GO:0002376; GO:0006629; GO:0008289,immune system process; lipid metabolic process; lipid binding
OG_01631,0.9023130298363728,OG_01631,FUN_006748-T1,Peve_00029637,Pocillopora_meandrina_HIv1___TS.g29913.t1,three_way,74.56133333333334,FUN_006748-T1,P19804,NDKB_RAT,,Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18),Rattus norvegicus (Rat),77.0,148.0,1.1e-61,238.0,sp|P19804|NDKB_RAT Nucleoside diphosphate kinase B OS=Rattus norvegicus OX=10116 GN=Nme2 PE=1 SV=1,GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005634; GO:0005737; GO:0005882; GO:0006183; GO:0006228; GO:0006241; GO:0007189; GO:0007229; GO:0009142; GO:0010976; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0034599; GO:0042802; GO:0042981; GO:0043066; GO:0045618; GO:0045682; GO:0045893; GO:0045944; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0060416; GO:0071333; GO:0071398; GO:0071944; GO:1901363,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228],cell periphery [GO:0071944]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726],ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; heterocyclic compound binding [GO:1901363]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0008289; GO:0016740; GO:0043226; GO:0055086; GO:0060090; GO:0140096; GO:0140110; GO:1901135,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; lipid binding; transferase activity; organelle; nucleobase-containing small molecule metabolic process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity; carbohydrate derivative metabolic process"
OG_02024,0.9022845961461212,OG_02024,FUN_008214-T1,Peve_00005268,Pocillopora_meandrina_HIv1___RNAseq.g30183.t1,three_way,49.18816666666667,FUN_008214-T1,A0A8J1LLF7,DICRS_XENLA,,Endoribonuclease Dicer-S (EC 3.1.26.3),Xenopus laevis (African clawed frog),28.8,2019.0,7.3e-172,607.1,sp|A0A8J1LLF7|DICRS_XENLA Endoribonuclease Dicer-S OS=Xenopus laevis OX=8355 GN=dicer1.S PE=3 SV=1,GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0030422; GO:0031054; GO:0070578,apoptotic DNA fragmentation [GO:0006309]; pre-miRNA processing [GO:0031054]; siRNA processing [GO:0030422],cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578],ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05647,0.9022590740872312,OG_05647,FUN_025365-T1,Peve_00040518,Pocillopora_meandrina_HIv1___RNAseq.g13333.t1,three_way,68.1275,FUN_025365-T1,Q62504,MINT_MOUSE,,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),Mus musculus (Mouse),40.8,610.0,6.4e-84,314.3,sp|Q62504|MINT_MOUSE Msx2-interacting protein OS=Mus musculus OX=10090 GN=Spen PE=1 SV=2,GO:0003697; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0007219; GO:0045892; GO:0045893; GO:0060816,negative regulation of DNA-templated transcription [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; random inactivation of X chromosome [GO:0060816],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; RNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_05647,0.9022590740872312,OG_05647,FUN_025365-T1,Peve_00040518,Pocillopora_meandrina_HIv1___RNAseq.g13333.t1,three_way,68.1275,FUN_025365-T1,Q62504,MINT_MOUSE,,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),Mus musculus (Mouse),61.2,188.0,5.7e-56,221.5,sp|Q62504|MINT_MOUSE Msx2-interacting protein OS=Mus musculus OX=10090 GN=Spen PE=1 SV=2,GO:0003697; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0007219; GO:0045892; GO:0045893; GO:0060816,negative regulation of DNA-templated transcription [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; random inactivation of X chromosome [GO:0060816],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; RNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_00078,0.9020983304371668,OG_00078,FUN_000403-T1,Peve_00033519,Pocillopora_meandrina_HIv1___RNAseq.g2544.t1,three_way,79.21583333333334,FUN_000403-T1,A0A0G2K2P5,ZO1_RAT,,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),Rattus norvegicus (Rat),28.2,1783.0,6.4e-140,500.7,sp|A0A0G2K2P5|ZO1_RAT Tight junction protein ZO-1 OS=Rattus norvegicus OX=10116 GN=Tjp1 PE=1 SV=1,GO:0001825; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005921; GO:0005923; GO:0007605; GO:0008013; GO:0008284; GO:0009410; GO:0009986; GO:0014704; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0016327; GO:0019904; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0031410; GO:0032496; GO:0032991; GO:0034334; GO:0036305; GO:0043066; GO:0043116; GO:0043296; GO:0044325; GO:0045177; GO:0045216; GO:0045471; GO:0046581; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0070830; GO:0071000; GO:0071253; GO:0071277; GO:0071333; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; bicellular tight junction assembly [GO:0070830]; blastocyst formation [GO:0001825]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; intercalated disc [GO:0014704]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; connexin binding [GO:0071253]; kinase activity [GO:0016301]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0003824; GO:0005634; GO:0005886; GO:0007010; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,circulatory system process; catalytic activity; nucleus; plasma membrane; cytoskeleton organization; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_04503,0.9020652923416724,OG_04503,FUN_022013-T1,Peve_00042673,Pocillopora_meandrina_HIv1___RNAseq.g3139.t1,three_way,74.30833333333334,FUN_022013-T1,Q05360,,,,,43.6,676.0,1.9e-149,531.2,sp|Q05360|WHITE_LUCCU Protein white OS=Lucilia cuprina OX=7375 GN=W PE=2 SV=2,,,,,,
OG_10122,0.902044282620511,OG_10122,FUN_043500-T1,Peve_00024905,Pocillopora_meandrina_HIv1___RNAseq.g7966.t1,three_way,90.83083333333332,FUN_043500-T1,Q9DCD2,,,,,62.9,852.0,2e-304,1046.2,sp|Q9DCD2|SYF1_MOUSE Pre-mRNA-splicing factor SYF1 OS=Mus musculus OX=10090 GN=Xab2 PE=1 SV=1,,,,,,
OG_10059,0.9019958561391864,OG_10059,FUN_043355-T1,Peve_00016650,Pocillopora_meandrina_HIv1___TS.g20685.t1a,three_way,62.21816666666667,FUN_043355-T1,A1L1H3,,,,,26.3,758.0,1.4e-48,196.4,sp|A1L1H3|TDRD5_XENLA Tudor domain-containing protein 5 OS=Xenopus laevis OX=8355 GN=tdrd5 PE=2 SV=1,,,,,,
OG_05879,0.9013497960343796,OG_05879,FUN_026032-T1,Peve_00003809,Pocillopora_meandrina_HIv1___RNAseq.g10470.t1,three_way,63.20466666666667,FUN_026032-T1,P05205,HP1_DROME,,Heterochromatin protein 1 (HP1) (Non-histone chromosomal protein C1A9 antigen),Drosophila melanogaster (Fruit fly),49.7,191.0,4.3e-25,116.3,sp|P05205|HP1_DROME Heterochromatin protein 1 OS=Drosophila melanogaster OX=7227 GN=Su(var)205 PE=1 SV=2,GO:0000182; GO:0000278; GO:0000723; GO:0000775; GO:0000779; GO:0000781; GO:0000791; GO:0000792; GO:0000793; GO:0003682; GO:0003696; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005694; GO:0005700; GO:0005701; GO:0005703; GO:0005721; GO:0006355; GO:0010369; GO:0030544; GO:0030674; GO:0031507; GO:0031508; GO:0035064; GO:0042393; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0051276; GO:0070063; GO:0099122; GO:0141006; GO:0141194; GO:1905632; GO:1905634; GO:1905646,chromosome organization [GO:0051276]; heterochromatin formation [GO:0031507]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-templated transcription [GO:0045892]; pericentric heterochromatin formation [GO:0031508]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to euchromatin [GO:1905632]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization to chromatin [GO:1905634]; siRNA-mediated heterochromatin formation [GO:0141194]; telomere maintenance [GO:0000723]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],"chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696],GO:0000278; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0031047; GO:0032200; GO:0042393; GO:0043226; GO:0060090,mitotic cell cycle; DNA binding; RNA binding; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; regulatory ncRNA-mediated gene silencing; telomere organization; histone binding; organelle; molecular adaptor activity
OG_07862,0.901038714114702,OG_07862,FUN_035217-T1,Peve_00035882,Pocillopora_meandrina_HIv1___TS.g14965.t1,three_way,86.42566666666667,FUN_035217-T1,O43747,,,,,62.9,851.0,9.3e-281,967.6,sp|O43747|AP1G1_HUMAN AP-1 complex subunit gamma-1 OS=Homo sapiens OX=9606 GN=AP1G1 PE=1 SV=5,,,,,,
OG_08012,0.9009696861190218,OG_08012,FUN_035665-T1,Peve_00002788,Pocillopora_meandrina_HIv1___RNAseq.g28121.t1,three_way,70.55033333333334,FUN_035665-T1,Q9NRH2,,,,,66.7,330.0,4.4e-126,453.8,sp|Q9NRH2|SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=SNRK PE=1 SV=2,,,,,,
OG_09158,0.9008971659724744,OG_09158,FUN_039817-T1,Peve_00039024,Pocillopora_meandrina_HIv1___RNAseq.g7505.t1,three_way,89.61566666666667,FUN_039817-T1,Q9Z1Q9,,,,,66.3,991.0,0.0,1398.6,sp|Q9Z1Q9|SYVC_MOUSE Valine--tRNA ligase OS=Mus musculus OX=10090 GN=Vars1 PE=1 SV=1,,,,,,
OG_06864,0.900885199229176,OG_06864,FUN_031860-T1,Peve_00011073,Pocillopora_meandrina_HIv1___RNAseq.g5631.t4,three_way,80.47416666666668,FUN_031860-T1,Q86UA1,,,,,44.6,579.0,9.1e-144,512.3,sp|Q86UA1|PRP39_HUMAN Pre-mRNA-processing factor 39 OS=Homo sapiens OX=9606 GN=PRPF39 PE=1 SV=3,,,,,,
OG_00992,0.9007750291998224,OG_00992,FUN_004379-T1,Peve_00008069,Pocillopora_meandrina_HIv1___TS.g17623.t1,three_way,59.47683333333333,FUN_004379-T1,A2AJ76,HMCN2_MOUSE,,Hemicentin-2,Mus musculus (Mouse),31.6,190.0,1.7e-16,89.7,sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0030054; GO:0032154; GO:0062023,,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],calcium ion binding [GO:0005509],GO:0005576; GO:0030312; GO:0031012,extracellular region; external encapsulating structure; extracellular matrix
OG_03639,0.9006957216515004,OG_03639,FUN_014861-T1,Peve_00016000,Pocillopora_meandrina_HIv1___RNAseq.g22368.t1,three_way,62.06,FUN_014861-T1,Q69ZM6,STK36_MOUSE,,Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog),Mus musculus (Mouse),25.5,1026.0,5.9e-57,224.6,sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus OX=10090 GN=Stk36 PE=1 SV=3,GO:0001222; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007224; GO:0007420; GO:0009791; GO:0035082; GO:0042995; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310,axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222],GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005856; GO:0006355; GO:0007010; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0140096,"catalytic activity; extracellular region; nucleus; cytosol; cytoskeleton; regulation of DNA-templated transcription; cytoskeleton organization; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; catalytic activity, acting on a protein"
OG_01134,0.9006594776684087,OG_01134,FUN_004711-T1,Peve_00005084,Pocillopora_meandrina_HIv1___RNAseq.g8798.t1,three_way,84.41083333333333,FUN_004711-T1,Q8CFW7,C2D2A_MOUSE,,Coiled-coil and C2 domain-containing protein 2A,Mus musculus (Mouse),42.9,1526.0,8.4e-310,1065.1,sp|Q8CFW7|C2D2A_MOUSE Coiled-coil and C2 domain-containing protein 2A OS=Mus musculus OX=10090 GN=Cc2d2a PE=1 SV=1,GO:0001822; GO:0001843; GO:0005737; GO:0005856; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:1904491; GO:1905515; GO:1990403,axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224],ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; MKS complex [GO:0036038],,GO:0005856; GO:0007010; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeleton organization; organelle; cilium organization; anatomical structure development
OG_00835,0.9006181521991271,OG_00835,FUN_004084-T1,Peve_00006656,Pocillopora_meandrina_HIv1___RNAseq.g17235.t1,three_way,83.86,FUN_004084-T1,Q8IWG1,DNAI3_HUMAN,,Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63),Homo sapiens (Human),48.8,801.0,4.1e-223,776.2,sp|Q8IWG1|DNAI3_HUMAN Dynein axonemal intermediate chain 3 OS=Homo sapiens OX=9606 GN=DNAI3 PE=1 SV=1,GO:0005737; GO:0005858; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933,cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669],axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156],Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503],GO:0007018; GO:0065003,microtubule-based movement; protein-containing complex assembly
OG_01282,0.9003355790700031,OG_01282,FUN_005063-T1,Peve_00030190,Pocillopora_meandrina_HIv1___RNAseq.g8293.t1,three_way,74.4175,FUN_005063-T1,B2RR83,YTDC2_MOUSE,,3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2),Mus musculus (Mouse),47.1,1526.0,0.0,1282.7,sp|B2RR83|YTDC2_MOUSE 3'-5' RNA helicase YTHDC2 OS=Mus musculus OX=10090 GN=Ythdc2 PE=1 SV=1,GO:0003723; GO:0005524; GO:0005737; GO:0005783; GO:0007286; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247,"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063],GO:0003723; GO:0003824; GO:0005783; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0140098; GO:0140657,"RNA binding; catalytic activity; endoplasmic reticulum; hydrolase activity; isomerase activity; reproductive process; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08871,0.8997922008290793,OG_08871,FUN_038268-T1,Peve_00008000,Pocillopora_meandrina_HIv1___TS.g5412.t1,three_way,67.79916666666666,FUN_038268-T1,Q8N5R6,,,,,28.3,782.0,1.1e-70,270.0,sp|Q8N5R6|CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens OX=9606 GN=CCDC33 PE=1 SV=3,,,,,,
OG_04215,0.8996908834113493,OG_04215,FUN_016868-T1,Peve_00020503,Pocillopora_meandrina_HIv1___RNAseq.g9928.t1,three_way,70.04816666666666,FUN_016868-T1,Q9P2K8,E2AK4_HUMAN,,eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein),Homo sapiens (Human),38.7,1721.0,1.3999999999999998e-256,888.3,sp|Q9P2K8|E2AK4_HUMAN eIF-2-alpha kinase GCN2 OS=Homo sapiens OX=9606 GN=EIF2AK4 PE=1 SV=3,GO:0000049; GO:0000077; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004674; GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006446; GO:0006468; GO:0007612; GO:0007616; GO:0010998; GO:0019081; GO:0022626; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0070417; GO:0071264; GO:0106310; GO:0140469; GO:1900273; GO:1990138,adaptive immune response [GO:0002250]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634],ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0005840; GO:0006355; GO:0016740; GO:0043226; GO:0050877; GO:0140096,"immune system process; RNA binding; catalytic activity; nucleus; cytosol; ribosome; regulation of DNA-templated transcription; transferase activity; organelle; nervous system process; catalytic activity, acting on a protein"
OG_07955,0.8992059962637441,OG_07955,FUN_035498-T1,Peve_00033959,Pocillopora_meandrina_HIv1___RNAseq.g26992.t1,three_way,53.365833333333335,,,,,,,,,,,,,,,,,
OG_09116,0.898530169511698,OG_09116,FUN_039091-T1,Peve_00028752,Pocillopora_meandrina_HIv1___RNAseq.g28707.t1,three_way,75.19333333333334,FUN_039091-T1,A0A571BF63,ANKF1_MOUSE,,Ankyrin-repeat and fibronectin type III domain-containing 1,Mus musculus (Mouse),35.6,824.0,9.6e-135,483.0,sp|A0A571BF63|ANKF1_MOUSE Ankyrin-repeat and fibronectin type III domain-containing 1 OS=Mus musculus OX=10090 GN=Ankfn1 PE=1 SV=1,GO:0001662; GO:0045475; GO:0050957,behavioral fear response [GO:0001662]; equilibrioception [GO:0050957]; locomotor rhythm [GO:0045475],,,GO:0050877,nervous system process
OG_10196,0.8984821527834416,OG_10196,FUN_043620-T1,Peve_00008227,Pocillopora_meandrina_HIv1___RNAseq.g6930.t1,three_way,51.489333333333335,,,,,,,,,,,,,,,,,
OG_04584,0.8979309238900972,OG_04584,FUN_022249-T1,Peve_00021283,Pocillopora_meandrina_HIv1___RNAseq.g4723.t1,three_way,79.9,FUN_022249-T1,Q1ECX4,TLK2_DANRE,,Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (PKU-alpha) (Tousled-like kinase 2),Danio rerio (Zebrafish) (Brachydanio rerio),51.9,697.0,1.7e-174,614.4,sp|Q1ECX4|TLK2_DANRE Serine/threonine-protein kinase tousled-like 2 OS=Danio rerio OX=7955 GN=tlk2 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0035556; GO:0048471; GO:0106310,chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556],cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytoskeleton; chromosome segregation; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05290,0.8978171457003918,OG_05290,FUN_023956-T1,Peve_00017997,Pocillopora_meandrina_HIv1___RNAseq.g18522.t1,three_way,84.48,FUN_023956-T1,O60271,,,,,49.1,642.0,1.4e-149,531.2,sp|O60271|JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4,,,,,,
OG_05229,0.897711299393912,OG_05229,FUN_023642-T1,Peve_00027826,Pocillopora_meandrina_HIv1___RNAseq.g17815.t1,three_way,79.919,FUN_023642-T1,P06798,,,,,55.1,107.0,5.1e-20,99.8,sp|P06798|HXA4_MOUSE Homeobox protein Hox-A4 OS=Mus musculus OX=10090 GN=Hoxa4 PE=2 SV=4,,,,,,
OG_08280,0.8976223918326333,OG_08280,FUN_036204-T1,Peve_00038740,Pocillopora_meandrina_HIv1___RNAseq.g27360.t1,three_way,76.42366666666666,FUN_036204-T1,Q08DZ2,PRP4K_BOVIN,,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog),Bos taurus (Bovine),64.4,469.0,1.3e-160,568.5,sp|Q08DZ2|PRP4K_BOVIN Serine/threonine-protein kinase PRP4 homolog OS=Bos taurus OX=9913 GN=PRP4K PE=2 SV=1,GO:0000244; GO:0000387; GO:0000776; GO:0004674; GO:0005524; GO:0005681; GO:0016607; GO:0045292; GO:0090266; GO:0106310,"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244]",kinetochore [GO:0000776]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016071; GO:0016740; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; mRNA metabolic process; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_01034,0.8973914004887839,OG_01034,FUN_004469-T1,Peve_00007167,Pocillopora_meandrina_HIv1___RNAseq.g4952.t1,three_way,86.357,FUN_004469-T1,P14211,CALR_MOUSE,,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP),Mus musculus (Mouse),77.3,198.0,5.6e-85,315.5,sp|P14211|CALR_MOUSE Calreticulin OS=Mus musculus OX=10090 GN=Calr PE=1 SV=1,GO:0000122; GO:0001669; GO:0001849; GO:0002502; GO:0003729; GO:0005049; GO:0005178; GO:0005506; GO:0005509; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0005840; GO:0006611; GO:0007283; GO:0008284; GO:0009410; GO:0009897; GO:0010595; GO:0010628; GO:0016020; GO:0017148; GO:0030246; GO:0030866; GO:0031625; GO:0032355; GO:0033018; GO:0033144; GO:0033574; GO:0034504; GO:0040020; GO:0042277; GO:0042562; GO:0042824; GO:0044183; GO:0044194; GO:0044322; GO:0045335; GO:0045665; GO:0045787; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0055007; GO:0060473; GO:0071257; GO:0071285; GO:0090398; GO:0098586; GO:0098794; GO:0098978; GO:0140313; GO:1900026; GO:1901164; GO:1901224; GO:1901652; GO:1903416; GO:1904614; GO:2000510,cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to biphenyl [GO:1904614]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to peptide [GO:1901652]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynapse [GO:0098794]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003723; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0005840; GO:0006355; GO:0006886; GO:0006913; GO:0007010; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044183; GO:0065003; GO:0140104; GO:0140313,RNA binding; extracellular region; extracellular space; nuclear envelope; mitochondrion; lysosome; vacuole; endoplasmic reticulum; cytosol; ribosome; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; protein folding chaperone; protein-containing complex assembly; molecular carrier activity; molecular sequestering activity
OG_00119,0.8972923268271059,OG_00119,FUN_000537-T1,Peve_00039797,Pocillopora_meandrina_HIv1___RNAseq.g2375.t1,three_way,66.51866666666668,FUN_000537-T1,Q56A06,,,,,51.3,710.0,5.7e-140,500.0,sp|Q56A06|TMTC2_MOUSE Protein O-mannosyl-transferase TMTC2 OS=Mus musculus OX=10090 GN=Tmtc2 PE=2 SV=1,,,,,,
OG_00286,0.8972735702743537,OG_00286,FUN_001076-T1,Peve_00037405,Pocillopora_meandrina_HIv1___RNAseq.g2716.t1,three_way,76.12899999999999,FUN_001076-T1,Q75V66,ANO5_HUMAN,,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),Homo sapiens (Human),42.4,850.0,1.3999999999999999e-187,658.3,sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; plasma membrane; organelle; transmembrane transport; membrane organization
OG_04367,0.897079956038521,OG_04367,FUN_018023-T1,Peve_00005730,Pocillopora_meandrina_HIv1___RNAseq.g25298.t1,three_way,70.57966666666667,FUN_018023-T1,Q9WU06,AVIL_RAT,,Advillin (Peripheral nervous system villin-like protein) (Pervin),Rattus norvegicus (Rat),40.0,834.0,9e-156,552.4,sp|Q9WU06|AVIL_RAT Advillin OS=Rattus norvegicus OX=10116 GN=Avil PE=2 SV=2,GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480,actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005856; GO:0008092; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeletal protein binding; lipid binding; organelle; cilium organization; anatomical structure development
OG_00512,0.8968740242125184,OG_00512,FUN_001504-T1,Peve_00012115,Pocillopora_meandrina_HIv1___RNAseq.g1890.t1,three_way,97.17433333333334,FUN_001504-T1,A5PJW8,RPB2_BOVIN,,DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (RNA-directed RNA polymerase II subunit RPB2) (EC 2.7.7.48),Bos taurus (Bovine),87.3,1174.0,0.0,2134.4,sp|A5PJW8|RPB2_BOVIN DNA-directed RNA polymerase II subunit RPB2 OS=Bos taurus OX=9913 GN=POLR2B PE=1 SV=1,GO:0000781; GO:0003677; GO:0003682; GO:0003899; GO:0003968; GO:0005665; GO:0005739; GO:0006366; GO:0008270; GO:0016787; GO:0032549; GO:0071667,transcription by RNA polymerase II [GO:0006366],"chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; RNA polymerase II, core complex [GO:0005665]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; hydrolase activity [GO:0016787]; ribonucleoside binding [GO:0032549]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005739; GO:0006351; GO:0016740; GO:0016787; GO:0043226; GO:0140098,"DNA binding; catalytic activity; mitochondrion; DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03687,0.896686049211203,OG_03687,FUN_014949-T1,Peve_00006235,Pocillopora_meandrina_HIv1___RNAseq.g21116.t1,three_way,79.29216666666667,FUN_014949-T1,Q9Y6J0,,,,,36.0,1819.0,9e-282,972.2,sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1,,,,,,
OG_08884,0.8965798895088198,OG_08884,FUN_038286-T1,Peve_00041723,Pocillopora_meandrina_HIv1___RNAseq.g28308.t1,three_way,69.07466666666667,FUN_038286-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),52.2,69.0,7.9e-14,81.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_07457,0.8961819155142751,OG_07457,FUN_033958-T1,Peve_00022633,Pocillopora_meandrina_HIv1___RNAseq.g26600.t1,three_way,70.71616666666667,FUN_033958-T1,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),32.6,972.0,1.4e-144,516.2,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_02995,0.8958531009116742,OG_02995,FUN_012171-T1,Peve_00008639,Pocillopora_meandrina_HIv1___RNAseq.g23454.t1,three_way,61.8345,FUN_012171-T1,Q9R0Q1,SYTL4_MOUSE,,Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin),Mus musculus (Mouse),27.0,880.0,4.1e-66,254.6,sp|Q9R0Q1|SYTL4_MOUSE Synaptotagmin-like protein 4 OS=Mus musculus OX=10090 GN=Sytl4 PE=1 SV=1,GO:0001778; GO:0005543; GO:0005768; GO:0005886; GO:0006886; GO:0006887; GO:0008270; GO:0030073; GO:0030141; GO:0030658; GO:0031267; GO:0032418; GO:0042043; GO:0045921; GO:0046676; GO:0050714; GO:0071985; GO:1905684,exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684],endosome [GO:0005768]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658],neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0005768; GO:0005886; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; plasma membrane; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_04385,0.895236097834205,OG_04385,FUN_018091-T1,Peve_00001666,Pocillopora_meandrina_HIv1___TS.g25577.t1,three_way,73.79583333333333,FUN_018091-T1,Q6ZS30,,,,,36.6,2500.0,0.0,1536.9,sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3,,,,,,
OG_05035,0.8952294076032843,OG_05035,FUN_023216-T1,Peve_00029820,Pocillopora_meandrina_HIv1___RNAseq.g691.t1,three_way,77.107,FUN_023216-T1,Q90XN9,,,,,68.3,126.0,2e-36,154.1,sp|Q90XN9|HMX3B_ORYLA Homeobox protein HMX3-B OS=Oryzias latipes OX=8090 GN=hmx3b PE=2 SV=1,,,,,,
OG_06314,0.8952271727061756,OG_06314,FUN_028554-T1,Peve_00002501,Pocillopora_meandrina_HIv1___RNAseq.g20706.t2,three_way,70.67833333333333,FUN_028554-T1,A8MWY0,ELAP2_HUMAN,,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L),Homo sapiens (Human),35.5,1029.0,1.2e-176,622.1,sp|A8MWY0|ELAP2_HUMAN Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Homo sapiens OX=9606 GN=ELAPOR2 PE=1 SV=2,GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700,negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684],membrane [GO:0016020]; plasma membrane [GO:0005886],BMP receptor binding [GO:0070700],GO:0005886,plasma membrane
OG_00500,0.8951635163963682,OG_00500,FUN_001473-T1,Peve_00029354,Pocillopora_meandrina_HIv1___TS.g4480.t1,three_way,91.325,FUN_001473-T1,Q5ZLT0,,,,,70.9,1080.0,0.0,1511.1,sp|Q5ZLT0|XPO7_CHICK Exportin-7 OS=Gallus gallus OX=9031 GN=XPO7 PE=2 SV=1,,,,,,
OG_02786,0.8951570499056648,OG_02786,FUN_011741-T1,Peve_00015648,Pocillopora_meandrina_HIv1___RNAseq.g23891.t1,three_way,43.050666666666665,,,,,,,,,,,,,,,,,
OG_09736,0.8951550592157486,OG_09736,FUN_041995-T1,Peve_00023725,Pocillopora_meandrina_HIv1___RNAseq.g15224.t1,three_way,92.50633333333332,FUN_041995-T1,Q7ZXB1,MCM7B_XENLA,,DNA replication licensing factor mcm7-B (EC 3.6.4.12) (CDC47 homolog B) (CDC47-2p) (Minichromosome maintenance protein 7-B) (xMCM7-B),Xenopus laevis (African clawed frog),74.5,718.0,1.4e-309,1063.1,sp|Q7ZXB1|MCM7B_XENLA DNA replication licensing factor mcm7-B OS=Xenopus laevis OX=8355 GN=mcm7-b PE=1 SV=1,GO:0000727; GO:0000785; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006270; GO:0006271; GO:0008270; GO:0016887; GO:0017116; GO:0030174; GO:0042555; GO:0071162,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_01248,0.8950072557454345,OG_01248,FUN_004947-T1,Peve_00043267,Pocillopora_meandrina_HIv1___RNAseq.g8394.t1,three_way,76.3205,FUN_004947-T1,Q9BY12,SCAPE_HUMAN,,S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291),Homo sapiens (Human),41.5,1440.0,9.2e-140,500.0,sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2,GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917,antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827],nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0005654; GO:0005783; GO:0005829; GO:0022414; GO:0043226; GO:0048856,nucleoplasm; endoplasmic reticulum; cytosol; reproductive process; organelle; anatomical structure development
OG_07351,0.8948442741481972,OG_07351,FUN_033759-T1,Peve_00009253,Pocillopora_meandrina_HIv1___RNAseq.g28744.t1,three_way,61.443,FUN_033759-T1,Q28005,LSHR_BOVIN,,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Bos taurus (Bovine),36.1,498.0,3.2000000000000003e-80,301.6,sp|Q28005|LSHR_BOVIN Lutropin-choriogonadotropic hormone receptor OS=Bos taurus OX=9913 GN=LHCGR PE=2 SV=1,GO:0001541; GO:0004964; GO:0005886; GO:0007189; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_06110,0.8947417918921807,OG_06110,FUN_027815-T1,Peve_00036487,Pocillopora_meandrina_HIv1___RNAseq.g13889.t2,three_way,90.976,FUN_027815-T1,Q23356,MIG15_CAEEL,,Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15),Caenorhabditis elegans,44.9,1094.0,1.7e-240,833.9,sp|Q23356|MIG15_CAEEL Serine/threonine-protein kinase mig-15 OS=Caenorhabditis elegans OX=6239 GN=mig-15 PE=2 SV=3,GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0022414; GO:0030334; GO:0032228; GO:0033563; GO:0043408; GO:0048812; GO:0106310,"body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of MAPK cascade [GO:0043408]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproductive process [GO:0022414]",cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_00519,0.8947402823827232,OG_00519,FUN_001517-T1,Peve_00012127,Pocillopora_meandrina_HIv1___TS.g4391.t1,three_way,84.86149999999999,FUN_001517-T1,Q3SZ40,,,,,56.4,535.0,3.6000000000000003e-158,559.7,sp|Q3SZ40|DDX56_BOVIN Probable ATP-dependent RNA helicase DDX56 OS=Bos taurus OX=9913 GN=DDX56 PE=2 SV=1,,,,,,
OG_08046,0.8947186281526566,OG_08046,FUN_035734-T1,Peve_00044083,Pocillopora_meandrina_HIv1___RNAseq.g11861.t1,three_way,58.831,FUN_035734-T1,Q8C080,,,,,51.9,162.0,2.9e-41,171.0,sp|Q8C080|SNX16_MOUSE Sorting nexin-16 OS=Mus musculus OX=10090 GN=Snx16 PE=1 SV=2,,,,,,
OG_01736,0.8946216095214847,OG_01736,FUN_007055-T1,Peve_00003798,Pocillopora_meandrina_HIv1___RNAseq.g20072.t1,three_way,88.616,FUN_007055-T1,Q5SQX6,CYFP2_MOUSE,,Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121),Mus musculus (Mouse),61.2,1252.0,0.0,1540.4,sp|Q5SQX6|CYFP2_MOUSE Cytoplasmic FMR1-interacting protein 2 OS=Mus musculus OX=10090 GN=Cyfip2 PE=1 SV=2,GO:0005634; GO:0005737; GO:0006915; GO:0030833; GO:0031175; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0097484; GO:0098609; GO:0150052,apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; regulation of postsynapse assembly [GO:0150052],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202],small GTPase binding [GO:0031267],GO:0005634; GO:0007155; GO:0012501; GO:0043226,nucleus; cell adhesion; programmed cell death; organelle
OG_05601,0.8943644100073481,OG_05601,FUN_025233-T1,Peve_00034838,Pocillopora_meandrina_HIv1___RNAseq.g13605.t1,three_way,74.29116666666667,FUN_025233-T1,P49916,DNLI3_HUMAN,,DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3),Homo sapiens (Human),56.4,922.0,2.1e-265,916.8,sp|P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2,GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006273; GO:0006284; GO:0006287; GO:0006302; GO:0007005; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681,"base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]",DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006310; GO:0007005; GO:0016874; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; DNA recombination; mitochondrion organization; ligase activity; organelle; catalytic activity, acting on DNA"
OG_06433,0.8942760948755513,OG_06433,FUN_029127-T1,Peve_00004665,Pocillopora_meandrina_HIv1___RNAseq.g25779.t1,three_way,50.135333333333335,,,,,,,,,,,,,,,,,
OG_09021,0.8940901436438828,OG_09021,FUN_038610-T1,Peve_00002803,Pocillopora_meandrina_HIv1___RNAseq.g988.t1,three_way,58.11266666666667,FUN_038610-T1,Q60437,BAIP2_CRIGR,,BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53),Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),31.7,221.0,2.2e-23,111.7,sp|Q60437|BAIP2_CRIGR BAR/IMD domain-containing adapter protein 2 OS=Cricetulus griseus OX=10029 GN=BAIAP2 PE=1 SV=1,GO:0001726; GO:0005654; GO:0005829; GO:0005856; GO:0007009; GO:0008093; GO:0008360; GO:0016020; GO:0030175; GO:0030838; GO:0032956; GO:0051017; GO:0051764; GO:0070064,actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin filament polymerization [GO:0030838]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ruffle [GO:0001726],cytoskeletal anchor activity [GO:0008093]; proline-rich region binding [GO:0070064],GO:0005654; GO:0005829; GO:0005856; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; cytosol; cytoskeleton; organelle; molecular adaptor activity; membrane organization
OG_03849,0.8939974144344036,OG_03849,FUN_015340-T1,Peve_00011273,Pocillopora_meandrina_HIv1___RNAseq.g21716.t1,three_way,56.37466666666666,FUN_015340-T1,Q6NTW1,,,,,36.2,343.0,6.6e-45,183.3,sp|Q6NTW1|BSC1B_XENLA BSD domain-containing protein 1-B OS=Xenopus laevis OX=8355 GN=bsdc1-b PE=2 SV=1,,,,,,
OG_04103,0.8939832070205654,OG_04103,FUN_016454-T1,Peve_00040139,Pocillopora_meandrina_HIv1___RNAseq.g98.t1,three_way,77.08683333333333,FUN_016454-T1,Q6DJM7,CDK14_XENLA,,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14),Xenopus laevis (African clawed frog),56.3,421.0,1.8e-121,437.6,sp|Q6DJM7|CDK14_XENLA Cyclin-dependent kinase 14 OS=Xenopus laevis OX=8355 GN=cdk14 PE=2 SV=1,GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016055; GO:0030332; GO:0051301; GO:0060828; GO:0106310; GO:1901987,cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle phase transition [GO:1901987]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06197,0.8937672391885899,OG_06197,FUN_028122-T1,Peve_00004261,Pocillopora_meandrina_HIv1___RNAseq.g15557.t2,three_way,43.58133333333333,FUN_028122-T1,P36335,,,,,26.3,598.0,1.3e-35,152.9,sp|P36335|NCA12_XENLA Neural cell adhesion molecule 1-B OS=Xenopus laevis OX=8355 GN=ncam1-b PE=2 SV=1,,,,,,
OG_02562,0.8935466151384736,OG_02562,FUN_010661-T1,Peve_00031438,Pocillopora_meandrina_HIv1___RNAseq.g21311.t1,three_way,73.56683333333334,FUN_010661-T1,O43491,E41L2_HUMAN,,Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G),Homo sapiens (Human),49.4,336.0,2.6e-87,325.1,sp|O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1,GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778,actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778],cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091],actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198],GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,structural molecule activity; nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_05059,0.8932838413186994,OG_05059,FUN_023256-T1,Peve_00019260,Pocillopora_meandrina_HIv1___TS.g25273.t1,three_way,37.922666666666665,,,,,,,,,,,,,,,,,
OG_05336,0.8932596488673703,OG_05336,FUN_024051-T1,Peve_00020343,Pocillopora_meandrina_HIv1___RNAseq.g19268.t1a,three_way,33.204166666666666,,,,,,,,,,,,,,,,,
OG_03575,0.8931687681978971,OG_03575,FUN_014729-T1,Peve_00009500,Pocillopora_meandrina_HIv1___RNAseq.g22490.t1,three_way,91.43733333333331,,,,,,,,,,,,,,,,,
OG_05633,0.8929965460421616,OG_05633,FUN_025331-T1,Peve_00027057,Pocillopora_meandrina_HIv1___RNAseq.g13404.t2,three_way,84.81166666666667,FUN_025331-T1,Q5F499,OPA1_CHICK,,"Dynamin-like GTPase OPA1, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like GTPase OPA1, long form (L-OPA1); Dynamin-like GTPase OPA1, short form (S-OPA1)]",Gallus gallus (Chicken),53.5,939.0,5.199999999999999e-264,912.1,"sp|Q5F499|OPA1_CHICK Dynamin-like GTPase OPA1, mitochondrial OS=Gallus gallus OX=9031 GN=OPA1 PE=2 SV=1",GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005743; GO:0005758; GO:0005874; GO:0006897; GO:0006915; GO:0008017; GO:0008053; GO:0016559; GO:0031966; GO:0032740; GO:0046039; GO:0046872; GO:0048312; GO:0070300; GO:0097749; GO:0140523; GO:0180020; GO:1901612; GO:1990627; GO:2000330,apoptotic process [GO:0006915]; endocytosis [GO:0006897]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrial inner membrane fusion [GO:1990627]; peroxisome fission [GO:0016559]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330],cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966],cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; membrane bending activity [GO:0180020]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300],GO:0003824; GO:0003924; GO:0007005; GO:0008092; GO:0008289; GO:0012501; GO:0016192; GO:0016787; GO:0055086; GO:0061024; GO:1901135,catalytic activity; GTPase activity; mitochondrion organization; cytoskeletal protein binding; lipid binding; programmed cell death; vesicle-mediated transport; hydrolase activity; nucleobase-containing small molecule metabolic process; membrane organization; carbohydrate derivative metabolic process
OG_06978,0.8929577286586443,OG_06978,FUN_032113-T1,Peve_00030230,Pocillopora_meandrina_HIv1___RNAseq.g5388.t1,three_way,75.95,,,,,,,,,,,,,,,,,
OG_09412,0.8929547627508057,OG_09412,FUN_040923-T1,Peve_00012313,Pocillopora_meandrina_HIv1___RNAseq.g27560.t1,three_way,85.5445,FUN_040923-T1,Q4G0P3,HYDIN_HUMAN,,Hydrocephalus-inducing protein homolog,Homo sapiens (Human),43.3,3001.0,0.0,2169.8,sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3,GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718,axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0043226; GO:0048856,cilium; microtubule-based movement; organelle; anatomical structure development
OG_04775,0.8929457825484806,OG_04775,FUN_022679-T1,Peve_00018004,Pocillopora_meandrina_HIv1___RNAseq.g4840.t1,three_way,62.58166666666666,FUN_022679-T1,Q9UKJ3,,,,,46.6,223.0,1.2e-49,199.5,sp|Q9UKJ3|GPTC8_HUMAN G patch domain-containing protein 8 OS=Homo sapiens OX=9606 GN=GPATCH8 PE=1 SV=2,,,,,,
OG_03205,0.8929166919152701,OG_03205,FUN_012696-T1,Peve_00016827,Pocillopora_meandrina_HIv1___RNAseq.g22856.t1,three_way,62.6505,FUN_012696-T1,Q5F3A1,,,,,56.6,290.0,9.4e-52,205.7,sp|Q5F3A1|SEC62_CHICK Translocation protein SEC62 OS=Gallus gallus OX=9031 GN=SEC62 PE=2 SV=1,,,,,,
OG_02668,0.8927088047805973,OG_02668,FUN_010887-T1,Peve_00035839,Pocillopora_meandrina_HIv1___RNAseq.g21002.t1,three_way,87.91066666666666,FUN_010887-T1,Q32LP2,RADI_BOVIN,,Radixin,Bos taurus (Bovine),67.4,307.0,5e-129,463.0,sp|Q32LP2|RADI_BOVIN Radixin OS=Bos taurus OX=9913 GN=RDX PE=2 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0008360; GO:0030175; GO:0032154; GO:0045177; GO:0050839; GO:0051693; GO:0120044; GO:1902115; GO:1902966; GO:2000643,actin filament capping [GO:0051693]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839],GO:0005856; GO:0005886; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_06753,0.8923608823714917,OG_06753,FUN_031564-T1,Peve_00021506,Pocillopora_meandrina_HIv1___RNAseq.g5073.t1,three_way,72.53333333333333,FUN_031564-T1,Q8TBA6,GOGA5_HUMAN,,Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein),Homo sapiens (Human),36.0,745.0,2.7e-63,245.0,sp|Q8TBA6|GOGA5_HUMAN Golgin subfamily A member 5 OS=Homo sapiens OX=9606 GN=GOLGA5 PE=1 SV=3,GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0030133; GO:0031267; GO:0031985; GO:0042803; GO:0048193,"Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133],protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],GO:0005794; GO:0016192; GO:0031410; GO:0043226,Golgi apparatus; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09338,0.8921261980299645,OG_09338,FUN_040301-T1,Peve_00038647,Pocillopora_meandrina_HIv1___RNAseq.g9075.t1,three_way,65.522,FUN_040301-T1,Q80T21,ATL4_MOUSE,,ADAMTS-like protein 4 (ADAMTSL-4) (Thrombospondin repeat-containing protein 1),Mus musculus (Mouse),33.5,731.0,7.7e-109,396.4,sp|Q80T21|ATL4_MOUSE ADAMTS-like protein 4 OS=Mus musculus OX=10090 GN=Adamtsl4 PE=2 SV=1,GO:0002020; GO:0002064; GO:0005576; GO:0005614; GO:0006915; GO:0030198; GO:0031012; GO:0043065; GO:0070285,apoptotic process [GO:0006915]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; pigment cell development [GO:0070285]; positive regulation of apoptotic process [GO:0043065],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614],protease binding [GO:0002020],GO:0005576; GO:0012501; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; programmed cell death; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_00969,0.8920034727129232,OG_00969,FUN_004342-T1,Peve_00016486,Pocillopora_meandrina_HIv1___RNAseq.g12543.t1,three_way,62.193333333333335,FUN_004342-T1,Q9Y5Q9,,,,,36.5,824.0,3.8999999999999996e-142,507.3,sp|Q9Y5Q9|TF3C3_HUMAN General transcription factor 3C polypeptide 3 OS=Homo sapiens OX=9606 GN=GTF3C3 PE=1 SV=1,,,,,,
OG_01565,0.8919755863829211,OG_01565,FUN_006447-T1,Peve_00038421,Pocillopora_meandrina_HIv1___RNAseq.3855_t,three_way,43.964333333333336,,,,,,,,,,,,,,,,,
OG_03878,0.8919393179663725,OG_03878,FUN_015411-T1,Peve_00026943,Pocillopora_meandrina_HIv1___RNAseq.g21674.t1,three_way,92.28733333333334,FUN_015411-T1,Q7ZVM1,WASC5_DANRE,,WASH complex subunit 5 (WASH complex subunit strumpellin),Danio rerio (Zebrafish) (Brachydanio rerio),67.2,1161.0,0.0,1580.8,sp|Q7ZVM1|WASC5_DANRE WASH complex subunit 5 OS=Danio rerio OX=7955 GN=washc5 PE=2 SV=1,GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0048738; GO:0051125; GO:0060047; GO:0071203; GO:0140285; GO:1905304,actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; cardiac muscle tissue development [GO:0048738]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of cardiac myofibril assembly [GO:1905304],early endosome [GO:0005769]; endosome [GO:0005768]; WASH complex [GO:0071203],,GO:0003013; GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0065003,circulatory system process; endosome; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly
OG_07897,0.891646769343775,OG_07897,FUN_035276-T1,Peve_00044995,Pocillopora_meandrina_HIv1___RNAseq.g27859.t1,three_way,66.694,,,,,,,,,,,,,,,,,
OG_02147,0.8913741942460633,OG_02147,FUN_008455-T1,Peve_00011009,Pocillopora_meandrina_HIv1___RNAseq.g18074.t1,three_way,89.681,FUN_008455-T1,Q6ZMW3,,,,,62.3,1980.0,0.0,2556.9,sp|Q6ZMW3|EMAL6_HUMAN Echinoderm microtubule-associated protein-like 6 OS=Homo sapiens OX=9606 GN=EML6 PE=1 SV=2,,,,,,
OG_01148,0.8912618412622924,OG_01148,FUN_004747-T1,Peve_00007770,Pocillopora_meandrina_HIv1___RNAseq.g8813.t1,three_way,66.33366666666667,,,,,,,,,,,,,,,,,
OG_08928,0.8912488577796404,OG_08928,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_09295,0.8911617476897805,OG_09295,FUN_040146-T1,Peve_00038108,Pocillopora_meandrina_HIv1___RNAseq.g8511.t1,three_way,40.80866666666667,,,,,,,,,,,,,,,,,
OG_04468,0.8911613453512717,OG_04468,FUN_019560-T1,Peve_00032909,Pocillopora_meandrina_HIv1___RNAseq.g20816.t1,three_way,74.66783333333333,FUN_019560-T1,Q90941,,,,,38.3,1523.0,1.2e-280,968.4,sp|Q90941|PB1_CHICK Protein polybromo-1 OS=Gallus gallus OX=9031 GN=PBRM1 PE=1 SV=1,,,,,,
OG_09944,0.8911067962249278,OG_09944,FUN_043111-T1,Peve_00014954,Pocillopora_meandrina_HIv1___RNAseq.g7894.t1,three_way,96.616,FUN_043111-T1,Q8JGS9,,,,,89.1,101.0,5.5e-47,188.0,sp|Q8JGS9|RS18_DANRE Small ribosomal subunit protein uS13 OS=Danio rerio OX=7955 GN=rps18 PE=1 SV=1,,,,,,
OG_07889,0.8909000299767199,OG_07889,FUN_035267-T1,Peve_00032639,Pocillopora_meandrina_HIv1___RNAseq.g27876.t1,three_way,69.10499999999999,FUN_035267-T1,Q4R7K1,MCES_MACFA,,mRNA cap guanine-N(7) methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),55.7,334.0,8e-103,375.9,sp|Q4R7K1|MCES_MACFA mRNA cap guanine-N(7) methyltransferase OS=Macaca fascicularis OX=9541 GN=RNMT PE=2 SV=1,GO:0003723; GO:0004482; GO:0005634; GO:0006370; GO:0160130,7-methylguanosine mRNA capping [GO:0006370],mRNA cap methyltransferase RNMT:RAMAC complex [GO:0160130]; nucleus [GO:0005634],mRNA 5'-cap (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_04043,0.8908434702116961,OG_04043,FUN_016352-T1,Peve_00004333,Pocillopora_meandrina_HIv1___RNAseq.g9675.t1,three_way,65.38916666666667,FUN_016352-T1,Q8CI75,DI3L2_MOUSE,,DIS3-like exonuclease 2 (EC 3.1.13.-),Mus musculus (Mouse),48.3,818.0,3.1e-212,740.7,sp|Q8CI75|DI3L2_MOUSE DIS3-like exonuclease 2 OS=Mus musculus OX=10090 GN=Dis3l2 PE=1 SV=1,GO:0000175; GO:0000278; GO:0000287; GO:0000932; GO:0000956; GO:0004540; GO:0005737; GO:0005829; GO:0008266; GO:0008285; GO:0010587; GO:0019827; GO:0051301; GO:0051306; GO:1990074,cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process [GO:0000956]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827],cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932],3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; RNA nuclease activity [GO:0004540],GO:0000278; GO:0003723; GO:0003824; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"mitotic cell cycle; RNA binding; catalytic activity; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_05736,0.8907648948539723,OG_05736,FUN_025662-T1,Peve_00042169,Pocillopora_meandrina_HIv1___RNAseq.g23063.t1,three_way,85.11566666666667,FUN_025662-T1,P39656,OST48_HUMAN,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit),Homo sapiens (Human),69.1,414.0,8.6e-169,594.7,sp|P39656|OST48_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens OX=9606 GN=DDOST PE=1 SV=4,GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0006487; GO:0008047; GO:0008250; GO:0016020; GO:0018279; GO:0031647; GO:0034097; GO:0035577; GO:0042110; GO:0043231; GO:0160226; GO:0160227,protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110],azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226]; oligosaccharyltransferase complex B [GO:0160227]; plasma membrane [GO:0005886],enzyme activator activity [GO:0008047],GO:0002376; GO:0005783; GO:0005886; GO:0006486; GO:0009101; GO:0043226; GO:0098772; GO:1901135,immune system process; endoplasmic reticulum; plasma membrane; protein glycosylation; glycoprotein biosynthetic process; organelle; molecular function regulator activity; carbohydrate derivative metabolic process
OG_07596,0.8906876009175134,OG_07596,FUN_034303-T1,Peve_00019148,Pocillopora_meandrina_HIv1___RNAseq.g28500.t1,three_way,76.81366666666666,FUN_034303-T1,Q15256,,,,,35.3,544.0,8.4e-69,263.1,sp|Q15256|PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens OX=9606 GN=PTPRR PE=1 SV=2,,,,,,
OG_08440,0.8900274935910137,OG_08440,FUN_037199-T1,Peve_00004724,Pocillopora_meandrina_HIv1___RNAseq.g11071.t1,three_way,64.9865,FUN_037199-T1,F1M3L7,EPS8_RAT,,Epidermal growth factor receptor kinase substrate 8,Rattus norvegicus (Rat),31.0,826.0,2.5e-71,272.3,sp|F1M3L7|EPS8_RAT Epidermal growth factor receptor kinase substrate 8 OS=Rattus norvegicus OX=10116 GN=Eps8 PE=1 SV=2,GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030036; GO:0030426; GO:0030832; GO:0031267; GO:0032420; GO:0032421; GO:0032426; GO:0032587; GO:0035023; GO:0036336; GO:0045202; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830,actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],brush border [GO:0005903]; cell cortex [GO:0005938]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202],actin binding [GO:0003779]; small GTPase binding [GO:0031267],GO:0002376; GO:0005886; GO:0007010; GO:0008092; GO:0043226; GO:0048870,immune system process; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle; cell motility
OG_02045,0.8896434947444118,OG_02045,FUN_008250-T1,Peve_00025019,Pocillopora_meandrina_HIv1___RNAseq.21440_t,three_way,71.38866666666667,FUN_008250-T1,Q9DCU6,,,,,44.4,216.0,2.7999999999999997e-41,170.6,sp|Q9DCU6|RM04_MOUSE Large ribosomal subunit protein uL4m OS=Mus musculus OX=10090 GN=Mrpl4 PE=1 SV=1,,,,,,
OG_02627,0.8895743006429762,OG_02627,FUN_010779-T1,Peve_00004487,Pocillopora_meandrina_HIv1___TS.g25955.t1,three_way,91.82266666666666,FUN_010779-T1,Q9D1P2,KAT8_MOUSE,,"Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (Males-absent on the first protein homolog) (mMof) (Protein acetyltransferase KAT8) (EC 2.3.1.-) (Protein propionyltransferase KAT8) (EC 2.3.1.-)",Mus musculus (Mouse),76.1,397.0,6.4e-180,631.7,sp|Q9D1P2|KAT8_MOUSE Histone acetyltransferase KAT8 OS=Mus musculus OX=10090 GN=Kat8 PE=1 SV=1,GO:0000123; GO:0000776; GO:0003713; GO:0005634; GO:0005694; GO:0005739; GO:0008270; GO:0009048; GO:0010506; GO:0010719; GO:0016363; GO:0016407; GO:0019899; GO:0022008; GO:0030099; GO:0032480; GO:0035166; GO:0043995; GO:0043996; GO:0044545; GO:0045815; GO:0045892; GO:0045893; GO:0046972; GO:0048477; GO:0050684; GO:0060261; GO:0061629; GO:0061733; GO:0061920; GO:0071339; GO:0072487; GO:1902726; GO:1903108; GO:1990841,dosage compensation by inactivation of X chromosome [GO:0009048]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; promoter-specific chromatin binding [GO:1990841]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005694; GO:0005739; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; mitochondrion; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_07674,0.8894648196169671,OG_07674,FUN_034781-T1,Peve_00029730,Pocillopora_meandrina_HIv1___RNAseq.g12276.t1,three_way,58.02466666666667,FUN_034781-T1,Q6DIJ4,UBP10_XENTR,,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),43.1,485.0,6.800000000000001e-100,366.7,sp|Q6DIJ4|UBP10_XENTR Ubiquitin carboxyl-terminal hydrolase 10 OS=Xenopus tropicalis OX=8364 GN=usp10 PE=2 SV=1,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344,"autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; rescue of stalled ribosome [GO:0072344]",cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005634; GO:0005768; GO:0006281; GO:0006914; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; DNA repair; autophagy; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_10133,0.889400295185914,OG_10133,FUN_043517-T1,Peve_00017256,Pocillopora_meandrina_HIv1___RNAseq.g8028.t1,three_way,92.006,FUN_043517-T1,O61491,,,,,66.1,419.0,1.6e-84,314.7,sp|O61491|FLOT1_DROME Flotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1,,,,,,
OG_09757,0.8893292714585262,OG_09757,FUN_042029-T1,Peve_00025063,Pocillopora_meandrina_HIv1___RNAseq.g15174.t1,three_way,47.64533333333333,FUN_042029-T1,Q9QYM2,,,,,31.9,354.0,1.1e-38,163.7,sp|Q9QYM2|PARG_RAT Poly(ADP-ribose) glycohydrolase OS=Rattus norvegicus OX=10116 GN=Parg PE=1 SV=1,,,,,,
OG_04326,0.889046603327594,OG_04326,FUN_017929-T1,Peve_00001599,Pocillopora_meandrina_HIv1___RNAseq.g283.t1,three_way,89.11483333333334,FUN_017929-T1,O75165,DJC13_HUMAN,,DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8),Homo sapiens (Human),66.3,1643.0,0.0,2240.3,sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5,GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0070062; GO:1902954; GO:2000641,endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667],,GO:0005829; GO:0005886; GO:0016192; GO:0030154; GO:0043226,cytosol; plasma membrane; vesicle-mediated transport; cell differentiation; organelle
OG_03846,0.8889663417172036,OG_03846,FUN_015325-T1,Peve_00023983,Pocillopora_meandrina_HIv1___RNAseq.g21727.t1,three_way,67.91250000000001,FUN_015325-T1,Q9VKJ9,C2D1_DROME,,Coiled-coil and C2 domain-containing protein 1-like (Lethal (2) giant discs 1 protein),Drosophila melanogaster (Fruit fly),40.0,758.0,1e-103,379.8,sp|Q9VKJ9|C2D1_DROME Coiled-coil and C2 domain-containing protein 1-like OS=Drosophila melanogaster OX=7227 GN=l(2)gd1 PE=1 SV=1,GO:0000281; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006357; GO:0006886; GO:0007219; GO:0007423; GO:0007472; GO:0008586; GO:0010008; GO:0016197; GO:0016327; GO:0032509; GO:0045035; GO:0045746; GO:0048132; GO:0048749; GO:0098592; GO:1901981; GO:1905367,compound eye development [GO:0048749]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of intralumenal vesicle formation [GO:1905367]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472],apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidylinositol phosphate binding [GO:1901981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0000910; GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0006886; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0140110,cytokinesis; DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; transcription regulator activity
OG_00127,0.8889584731616044,OG_00127,FUN_000554-T1,Peve_00039816,Pocillopora_meandrina_HIv1___RNAseq.g2466.t1,three_way,58.334,,,,,,,,,,,,,,,,,
OG_03486,0.8889455626298111,OG_03486,FUN_014589-T1,Peve_00011858,Pocillopora_meandrina_HIv1___TS.g27493.t1,three_way,81.65599999999999,FUN_014589-T1,O43147,,,,,45.5,1038.0,4.3e-227,789.6,sp|O43147|SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens OX=9606 GN=SGSM2 PE=1 SV=4,,,,,,
OG_06961,0.8889124065009708,OG_06961,FUN_032091-T1,Peve_00012819,Pocillopora_meandrina_HIv1___RNAseq.g5277.t1,three_way,71.29066666666667,FUN_032091-T1,Q00IB7,,,,,40.9,952.0,1.5e-190,668.7,sp|Q00IB7|PKHH1_DANRE Pleckstrin homology domain-containing family H member 1 OS=Danio rerio OX=7955 GN=plekhh1 PE=2 SV=1,,,,,,
OG_07090,0.8888414407510449,OG_07090,FUN_032347-T1,Peve_00032203,Pocillopora_meandrina_HIv1___RNAseq.g29799.t1,three_way,82.527,,,,,,,,,,,,,,,,,
OG_03609,0.8888116261013008,OG_03609,FUN_014787-T1,Peve_00001877,Pocillopora_meandrina_HIv1___RNAseq.g22513.t1,three_way,64.53133333333334,,,,,,,,,,,,,,,,,
OG_01124,0.888735732705906,OG_01124,FUN_004693-T1,Peve_00003276,Pocillopora_meandrina_HIv1___RNAseq.g8747.t1,three_way,73.396,,,,,,,,,,,,,,,,,
OG_10053,0.888656555529432,OG_10053,FUN_043327-T1,Peve_00043037,Pocillopora_meandrina_HIv1___RNAseq.g8955.t1,three_way,55.082,FUN_043327-T1,D6WMX4,PINK1_TRICA,,"Serine/threonine-protein kinase Pink1, mitochondrial (EC 2.7.11.1) (PTEN-induced putative kinase 1)",Tribolium castaneum (Red flour beetle),36.7,450.0,9.499999999999999e-69,262.7,"sp|D6WMX4|PINK1_TRICA Serine/threonine-protein kinase Pink1, mitochondrial OS=Tribolium castaneum OX=7070 GN=Pink1 PE=1 SV=1",GO:0000422; GO:0004674; GO:0005524; GO:0005739; GO:0005741; GO:0005743; GO:0005829; GO:0031398; GO:0031625; GO:0042981; GO:0046777; GO:0046872; GO:0090141; GO:1904544,autophagy of mitochondrion [GO:0000422]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein ubiquitination [GO:0031398]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005739; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; cytosol; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06953,0.8884207580042416,OG_06953,FUN_032067-T1,Peve_00024741,Pocillopora_meandrina_HIv1___RNAseq.g6039.t1,three_way,74.31583333333334,FUN_032067-T1,Q8N128,,,,,48.1,52.0,4e-10,67.0,sp|Q8N128|F177A_HUMAN Protein FAM177A1 OS=Homo sapiens OX=9606 GN=FAM177A1 PE=1 SV=1,,,,,,
OG_05645,0.8884009721485804,OG_05645,FUN_025363-T1,Peve_00040516,Pocillopora_meandrina_HIv1___RNAseq.g13346.t1,three_way,65.52933333333334,FUN_025363-T1,Q9ER65,CSTN2_MOUSE,,Calsyntenin-2,Mus musculus (Mouse),27.8,856.0,4.6e-77,291.2,sp|Q9ER65|CSTN2_MOUSE Calsyntenin-2 OS=Mus musculus OX=10090 GN=Clstn2 PE=1 SV=2,GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0008306; GO:0009986; GO:0014069; GO:0030425; GO:0045211; GO:0050806; GO:0051965; GO:0098839; GO:0098978; GO:1904862,associative learning [GO:0008306]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inhibitory synapse assembly [GO:1904862]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806],cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211],calcium ion binding [GO:0005509],GO:0007155; GO:0034330; GO:0043226; GO:0050877,cell adhesion; cell junction organization; organelle; nervous system process
OG_05797,0.888012019520373,OG_05797,FUN_025780-T1,Peve_00009651,Pocillopora_meandrina_HIv1___RNAseq.g10358.t1,three_way,87.72200000000001,FUN_025780-T1,P18687,,,,,71.6,556.0,2.2e-220,766.5,"sp|P18687|CH60_CRIGR 60 kDa heat shock protein, mitochondrial OS=Cricetulus griseus OX=10029 GN=HSPD1 PE=2 SV=1",,,,,,
OG_06147,0.8877716779354391,OG_06147,FUN_027977-T1,Peve_00031366,Pocillopora_meandrina_HIv1___RNAseq.g14058.t1,three_way,74.97666666666666,FUN_027977-T1,Q9Z2F6,,,,,44.0,175.0,4.2000000000000005e-33,143.7,sp|Q9Z2F6|BCL3_MOUSE B-cell lymphoma 3 protein homolog OS=Mus musculus OX=10090 GN=Bcl3 PE=1 SV=2,,,,,,
OG_10079,0.8876974997344522,OG_10079,FUN_043389-T1,Peve_00024250,Pocillopora_meandrina_HIv1___RNAseq.g9000.t1,three_way,64.57716666666667,FUN_043389-T1,Q64322,,,,,41.2,131.0,5.3e-15,83.6,sp|Q64322|NPDC1_MOUSE Neural proliferation differentiation and control protein 1 OS=Mus musculus OX=10090 GN=Npdc1 PE=2 SV=2,,,,,,
OG_05514,0.8875209125810434,OG_05514,FUN_024614-T1,Peve_00041134,Pocillopora_meandrina_HIv1___RNAseq.g19147.t1,three_way,72.74433333333333,FUN_024614-T1,B3EWZ9,HEPHL_ACRMI,,Hephaestin-like protein (EC 1.-.-.-),Acropora millepora (Staghorn coral) (Heteropora millepora),96.7,1114.0,0.0,2249.2,sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491,copper ion transport [GO:0006825]; iron ion transport [GO:0006826],plasma membrane [GO:0005886],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005886; GO:0016491,catalytic activity; plasma membrane; oxidoreductase activity
OG_04731,0.8874658329945219,OG_04731,FUN_022599-T1,Peve_00012273,Pocillopora_meandrina_HIv1___RNAseq.g4424.t2,three_way,83.4855,FUN_022599-T1,F1LZW6,S2513_RAT,,"Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (Solute carrier family 25 member 13)",Rattus norvegicus (Rat),51.9,671.0,7.100000000000001e-186,652.1,"sp|F1LZW6|S2513_RAT Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial OS=Rattus norvegicus OX=10116 GN=Slc25a13 PE=3 SV=4",GO:0000514; GO:0000515; GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006094; GO:0006754; GO:0015172; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490; GO:0045333; GO:0051592,aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; response to calcium ion [GO:0051592],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],"3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]",GO:0005215; GO:0005739; GO:0005975; GO:0006091; GO:0043226; GO:0055085; GO:0055086; GO:1901135,transporter activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04370,0.8873231444190425,OG_04370,FUN_018029-T1,Peve_00017615,Pocillopora_meandrina_HIv1___RNAseq.g25340.t1,three_way,59.88433333333333,FUN_018029-T1,Q9ULJ8,,,,,25.1,1213.0,1.4999999999999999e-40,170.2,sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2,,,,,,
OG_04758,0.887247205676191,OG_04758,FUN_022647-T1,Peve_00036577,Pocillopora_meandrina_HIv1___RNAseq.g4454.t1,three_way,72.587,FUN_022647-T1,Q15434,,,,,61.2,232.0,9.8e-69,262.7,"sp|Q15434|RBMS2_HUMAN RNA-binding motif, single-stranded-interacting protein 2 OS=Homo sapiens OX=9606 GN=RBMS2 PE=1 SV=1",,,,,,
OG_00322,0.8871199714538295,OG_00322,FUN_001141-T1,Peve_00029338,Pocillopora_meandrina_HIv1___RNAseq.g29333.t1,three_way,78.69883333333334,FUN_001141-T1,Q8WML3,,,,,47.3,752.0,2.700000000000001e-186,654.1,sp|Q8WML3|KAT6B_MACFA Histone acetyltransferase KAT6B OS=Macaca fascicularis OX=9541 GN=KAT6B PE=2 SV=1,,,,,,
OG_01670,0.8870059767483516,OG_01670,FUN_006857-T1,Peve_00016203,Pocillopora_meandrina_HIv1___RNAseq.g19910.t1b,three_way,63.460166666666666,FUN_006857-T1,B9EJ80,PDZD8_MOUSE,,PDZ domain-containing protein 8,Mus musculus (Mouse),28.5,1009.0,2.5000000000000004e-80,302.0,sp|B9EJ80|PDZD8_MOUSE PDZ domain-containing protein 8 OS=Mus musculus OX=10090 GN=Pdzd8 PE=1 SV=1,GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008270; GO:0008289; GO:0022604; GO:0044233; GO:0051560; GO:1990456,cytoskeleton organization [GO:0007010]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604],endoplasmic reticulum membrane [GO:0005789]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; zinc ion binding [GO:0008270],GO:0005739; GO:0007010; GO:0008289; GO:0043226,mitochondrion; cytoskeleton organization; lipid binding; organelle
OG_04280,0.8869895319370265,OG_04280,FUN_017841-T1,Peve_00016638,Pocillopora_meandrina_HIv1___RNAseq.g9589.t1,three_way,64.23916666666666,,,,,,,,,,,,,,,,,
OG_09609,0.8869714035104701,OG_09609,FUN_041767-T1,Peve_00041572,Pocillopora_meandrina_HIv1___RNAseq.g15244.t1,three_way,57.924,FUN_041767-T1,Q6WRH9,,,,,29.6,406.0,5.6000000000000005e-28,128.6,sp|Q6WRH9|IGS10_RAT Immunoglobulin superfamily member 10 OS=Rattus norvegicus OX=10116 GN=Igsf10 PE=1 SV=1,,,,,,
OG_04037,0.8866772913583022,OG_04037,FUN_016345-T1,Peve_00004334,Pocillopora_meandrina_HIv1___TS.g23380.t1,three_way,66.87283333333333,FUN_016345-T1,P63252,KCNJ2_HUMAN,,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",Homo sapiens (Human),42.7,328.0,8.2e-70,265.8,sp|P63252|KCNJ2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens OX=9606 GN=KCNJ2 PE=1 SV=1,GO:0005242; GO:0005546; GO:0005886; GO:0006813; GO:0008076; GO:0014704; GO:0014861; GO:0015693; GO:0016020; GO:0030007; GO:0030315; GO:0034765; GO:0042802; GO:0043025; GO:0043197; GO:0045211; GO:0051289; GO:0055119; GO:0060075; GO:0060306; GO:0071260; GO:0071805; GO:0086002; GO:0086004; GO:0086008; GO:0086011; GO:0086012; GO:0086013; GO:0086091; GO:0090076; GO:0098978; GO:1901381; GO:1990573,cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to mechanical stimulus [GO:0071260]; intracellular potassium ion homeostasis [GO:0030007]; magnesium ion transport [GO:0015693]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076],dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076],"identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]",GO:0003012; GO:0005215; GO:0005886; GO:0008289; GO:0055085; GO:0065003,muscle system process; transporter activity; plasma membrane; lipid binding; transmembrane transport; protein-containing complex assembly
OG_08813,0.886595090991939,OG_08813,FUN_038139-T1,Peve_00043370,Pocillopora_meandrina_HIv1___RNAseq.g761.t1,three_way,73.74383333333333,FUN_038139-T1,Q12767,,,,,33.1,1424.0,3.2e-177,624.4,sp|Q12767|TMM94_HUMAN Transmembrane protein 94 OS=Homo sapiens OX=9606 GN=TMEM94 PE=1 SV=1,,,,,,
OG_01356,0.8862034841519564,OG_01356,FUN_005270-T1,Peve_00003341,Pocillopora_meandrina_HIv1___RNAseq.g8160.t1,three_way,74.97566666666667,FUN_005270-T1,O95163,ELP1_HUMAN,,Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) (p150),Homo sapiens (Human),45.8,1348.0,0.0,1135.9,sp|O95163|ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens OX=9606 GN=ELP1 PE=1 SV=3,GO:0000049; GO:0002098; GO:0002926; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0033588,regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634],tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005829; GO:0006399; GO:0043226,RNA binding; nucleus; cytosol; tRNA metabolic process; organelle
OG_03042,0.8861442151727451,OG_03042,FUN_012281-T1,Peve_00024232,Pocillopora_meandrina_HIv1___RNAseq.g23579.t1,three_way,65.3465,FUN_012281-T1,Q5TB80,CE162_HUMAN,,Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog),Homo sapiens (Human),31.5,791.0,2.9e-91,339.0,sp|Q5TB80|CE162_HUMAN Centrosomal protein of 162 kDa OS=Homo sapiens OX=9606 GN=CEP162 PE=1 SV=2,GO:0005654; GO:0005794; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005879; GO:0034451; GO:0036064; GO:0043231; GO:0060271,cilium assembly [GO:0060271],axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; spindle [GO:0005819],,GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0043226; GO:0044782,nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; organelle; cilium organization
OG_10020,0.8858281233833625,OG_10020,FUN_043261-T1,Peve_00032607,Pocillopora_meandrina_HIv1___RNAseq.g8893.t1,three_way,65.95816666666667,FUN_043261-T1,Q7Z7G8,VP13B_HUMAN,,Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B),Homo sapiens (Human),28.7,4270.0,0.0,1449.5,sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2,GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168,acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0008289; GO:0016192; GO:0022414; GO:0048856; GO:0050877,lipid binding; vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process
OG_08382,0.8856221690303389,OG_08382,FUN_036967-T1,Peve_00040021,Pocillopora_meandrina_HIv1___RNAseq.g10880.t1,three_way,57.36033333333334,FUN_036967-T1,Q8NBR6,MINY2_HUMAN,,Ubiquitin carboxyl-terminal hydrolase MINDY-2 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-2) (Protein FAM63B),Homo sapiens (Human),57.9,328.0,8.6e-100,365.9,sp|Q8NBR6|MINY2_HUMAN Ubiquitin carboxyl-terminal hydrolase MINDY-2 OS=Homo sapiens OX=9606 GN=MINDY2 PE=1 SV=2,GO:0004843; GO:0005654; GO:0006508; GO:0016807; GO:0036435; GO:0070530; GO:0071795; GO:0071796; GO:1990380,proteolysis [GO:0006508],nucleoplasm [GO:0005654],cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type deubiquitinase activity [GO:0004843]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked deubiquitinase activity [GO:1990380]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530],GO:0003824; GO:0005654; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; catalytic activity, acting on a protein"
OG_06090,0.8855782947320803,OG_06090,FUN_027128-T1,Peve_00039620,Pocillopora_meandrina_HIv1___TS.g10360.t2,three_way,69.8775,FUN_027128-T1,O60244,MED14_HUMAN,,Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150),Homo sapiens (Human),36.0,1532.0,7.500000000000001e-225,782.7,sp|O60244|MED14_HUMAN Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens OX=9606 GN=MED14 PE=1 SV=2,GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0032968; GO:0035019; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847,positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019],core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_07519,0.8854660561936945,OG_07519,FUN_034088-T1,Peve_00037071,Pocillopora_meandrina_HIv1___RNAseq.g26059.t1,three_way,77.17566666666667,FUN_034088-T1,Q4V920,PACN1_DANRE,,Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1),Danio rerio (Zebrafish) (Brachydanio rerio),36.1,449.0,4.1e-70,266.9,sp|Q4V920|PACN1_DANRE Protein kinase C and casein kinase substrate in neurons protein 1 OS=Danio rerio OX=7955 GN=pacsin1b PE=1 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0006897; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0060271; GO:0097320; GO:1900006,actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; regulation of endocytosis [GO:0030100],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; neuron projection [GO:0043005]; ruffle membrane [GO:0032587]; synapse [GO:0045202],phospholipid binding [GO:0005543],GO:0005768; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0044782; GO:0061024,endosome; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; cilium organization; membrane organization
OG_00947,0.885360373816129,OG_00947,FUN_004306-T1,Peve_00033931,Pocillopora_meandrina_HIv1___RNAseq.g11777.t1,three_way,85.68866666666666,FUN_004306-T1,Q86VS8,HOOK3_HUMAN,,Protein Hook homolog 3 (h-hook3) (hHK3),Homo sapiens (Human),49.9,711.0,5.7e-82,307.0,sp|Q86VS8|HOOK3_HUMAN Protein Hook homolog 3 OS=Homo sapiens OX=9606 GN=HOOK3 PE=1 SV=2,GO:0000242; GO:0005737; GO:0005801; GO:0005813; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150; GO:1905719,cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242],dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0007040; GO:0008092; GO:0016192; GO:0043226,microtubule organizing center; cytoskeleton organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; organelle
OG_03650,0.8852483265520381,OG_03650,FUN_014882-T1,Peve_00013645,Pocillopora_meandrina_HIv1___RNAseq.g21054.t1,three_way,56.43533333333333,FUN_014882-T1,Q5SSG4,GA2L2_MOUSE,,GAS2-like protein 2 (Growth arrest-specific protein 2-like 2),Mus musculus (Mouse),35.9,473.0,1.6999999999999998e-53,213.0,sp|Q5SSG4|GA2L2_MOUSE GAS2-like protein 2 OS=Mus musculus OX=10090 GN=Gas2l2 PE=1 SV=1,GO:0001578; GO:0001725; GO:0001965; GO:0005737; GO:0005884; GO:0005886; GO:0007026; GO:0008017; GO:0008093; GO:0035371; GO:0036064; GO:0045745; GO:0051015; GO:0060296; GO:1904825,microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein localization to microtubule plus-end [GO:1904825]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; plasma membrane [GO:0005886]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; G-protein alpha-subunit binding [GO:0001965]; microtubule binding [GO:0008017],GO:0005815; GO:0005886; GO:0007010; GO:0008092; GO:0060090,microtubule organizing center; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; molecular adaptor activity
OG_04931,0.8848425610172778,OG_04931,FUN_022998-T1,Peve_00006898,Pocillopora_meandrina_HIv1___RNAseq.g3792.t1,three_way,50.482,,,,,,,,,,,,,,,,,
OG_07117,0.8845210166679618,OG_07117,FUN_032394-T1,Peve_00018856,Pocillopora_meandrina_HIv1___RNAseq.g29832.t1,three_way,75.89816666666667,FUN_032394-T1,P40123,CAP2_HUMAN,,Adenylyl cyclase-associated protein 2 (CAP 2),Homo sapiens (Human),40.3,467.0,2.3e-79,297.7,sp|P40123|CAP2_HUMAN Adenylyl cyclase-associated protein 2 OS=Homo sapiens OX=9606 GN=CAP2 PE=1 SV=1,GO:0000902; GO:0003779; GO:0005737; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0014069; GO:0019933; GO:0042802; GO:0099140,actin filament organization [GO:0007015]; activation of adenylate cyclase activity [GO:0007190]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; presynaptic actin cytoskeleton organization [GO:0099140]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802],GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0043226,plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; organelle
OG_00530,0.8844695790768955,OG_00530,FUN_001535-T1,Peve_00014195,Pocillopora_meandrina_HIv1___RNAseq.g2057.t1,three_way,71.78833333333333,FUN_001535-T1,Q9Y4D2,,,,,34.3,829.0,1.0999999999999999e-127,459.5,sp|Q9Y4D2|DGLA_HUMAN Diacylglycerol lipase-alpha OS=Homo sapiens OX=9606 GN=DAGLA PE=1 SV=3,,,,,,
OG_04699,0.884465133371698,OG_04699,FUN_022499-T1,Peve_00033031,Pocillopora_meandrina_HIv1___RNAseq.g4275.t1,three_way,69.74766666666667,FUN_022499-T1,A4IH82,,,,,29.7,290.0,3.3e-22,107.8,sp|A4IH82|3BP5L_XENTR SH3 domain-binding protein 5-like OS=Xenopus tropicalis OX=8364 GN=sh3bp5l PE=2 SV=1,,,,,,
OG_09136,0.8842821468210956,OG_09136,FUN_039774-T1,Peve_00030564,Pocillopora_meandrina_HIv1___RNAseq.g7453.t1,three_way,59.15083333333333,FUN_039774-T1,Q810V0,,,,,40.6,702.0,1.4999999999999998e-68,262.3,sp|Q810V0|MPP10_MOUSE U3 small nucleolar ribonucleoprotein protein MPP10 OS=Mus musculus OX=10090 GN=Mphosph10 PE=1 SV=2,,,,,,
OG_09513,0.8839102619296922,OG_09513,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,27.8,752.0,2.7e-39,166.4,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_09513,0.8839102619296922,OG_09513,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,36.9,187.0,1.8e-19,100.5,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_03300,0.8831761914901733,OG_03300,FUN_013368-T1,Peve_00001209,Pocillopora_meandrina_HIv1___RNAseq.g13344.t1,three_way,89.73183333333333,FUN_013368-T1,Q96C19,,,,,64.6,161.0,5.9e-50,198.7,sp|Q96C19|EFHD2_HUMAN EF-hand domain-containing protein D2 OS=Homo sapiens OX=9606 GN=EFHD2 PE=1 SV=1,,,,,,
OG_01632,0.8830153637730119,OG_01632,FUN_006750-T1,Peve_00029281,Pocillopora_meandrina_HIv1___RNAseq.g20533.t1,three_way,80.3975,FUN_006750-T1,Q9H3E2,,,,,37.7,871.0,3.8e-161,570.5,sp|Q9H3E2|SNX25_HUMAN Sorting nexin-25 OS=Homo sapiens OX=9606 GN=SNX25 PE=1 SV=2,,,,,,
OG_00065,0.8827117992630878,OG_00065,FUN_000378-T1,Peve_00033520,Pocillopora_meandrina_HIv1___RNAseq.g29123.t1,three_way,81.29066666666667,FUN_000378-T1,O42479,,,,,70.2,372.0,8.7e-155,548.1,"sp|O42479|HEMH_CHICK Ferrochelatase, mitochondrial OS=Gallus gallus OX=9031 GN=FECH PE=1 SV=1",,,,,,
OG_08345,0.8826982539695998,OG_08345,FUN_036872-T1,Peve_00039758,Pocillopora_meandrina_HIv1___TS.g13142.t1,three_way,53.678333333333335,FUN_036872-T1,O08710,THYG_MOUSE,,Thyroglobulin (Tg),Mus musculus (Mouse),21.6,1359.0,7.8e-40,168.7,sp|O08710|THYG_MOUSE Thyroglobulin OS=Mus musculus OX=10090 GN=Tg PE=1 SV=3,GO:0005179; GO:0005615; GO:0006590; GO:0015705; GO:0030878; GO:0031641; GO:0042403; GO:0042446; GO:0042802,hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403],extracellular space [GO:0005615],hormone activity [GO:0005179]; identical protein binding [GO:0042802],GO:0005615; GO:0006575; GO:0048018; GO:0048856; GO:0098772,extracellular space; modified amino acid metabolic process; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_08601,0.8825407191517443,OG_08601,FUN_037744-T1,Peve_00037368,Pocillopora_meandrina_HIv1___RNAseq.g1332.t1,three_way,88.86283333333334,FUN_037744-T1,Q5ZI08,SPT5H_CHICK,,Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit),Gallus gallus (Chicken),57.9,1017.0,1.5e-258,894.0,sp|Q5ZI08|SPT5H_CHICK Transcription elongation factor SPT5 OS=Gallus gallus OX=9031 GN=SUPT5H PE=2 SV=1,GO:0003729; GO:0006357; GO:0006368; GO:0032044; GO:0032784; GO:0140673,regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673],DSIF complex [GO:0032044],mRNA binding [GO:0003729],GO:0003723; GO:0006325; GO:0006355,RNA binding; chromatin organization; regulation of DNA-templated transcription
OG_02661,0.8824169446788211,OG_02661,FUN_010875-T1,Peve_00009757,Pocillopora_meandrina_HIv1___RNAseq.g7085.t1,three_way,62.856,FUN_010875-T1,Q99LH1,,,,,67.8,466.0,6.2e-182,639.4,sp|Q99LH1|NOG2_MOUSE Nucleolar GTP-binding protein 2 OS=Mus musculus OX=10090 GN=Gnl2 PE=1 SV=2,,,,,,
OG_00554,0.882342385635311,OG_00554,FUN_001599-T1,Peve_00004146,Pocillopora_meandrina_HIv1___RNAseq.g1982.t1,three_way,81.72066666666667,FUN_001599-T1,Q9Y2D4,EXC6B_HUMAN,,Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2),Homo sapiens (Human),50.0,800.0,4.7e-223,775.8,sp|Q9Y2D4|EXC6B_HUMAN Exocyst complex component 6B OS=Homo sapiens OX=9606 GN=EXOC6B PE=1 SV=3,GO:0000145; GO:0000281; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522],exocyst [GO:0000145],,GO:0000910; GO:0006886; GO:0016192; GO:0061024,cytokinesis; intracellular protein transport; vesicle-mediated transport; membrane organization
OG_06479,0.882238355095458,OG_06479,FUN_029247-T1,Peve_00013745,Pocillopora_meandrina_HIv1___TS.g9395.t1,three_way,61.76716666666667,FUN_029247-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),37.3,496.0,4.5e-84,314.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_05348,0.8821066803227168,OG_05348,FUN_024111-T1,Peve_00000186,Pocillopora_meandrina_HIv1___RNAseq.g19189.t1,three_way,75.39166666666667,FUN_024111-T1,O00408,PDE2A_HUMAN,,"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)",Homo sapiens (Human),45.4,868.0,9.700000000000001e-196,685.3,"sp|O00408|PDE2A_HUMAN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Homo sapiens OX=9606 GN=PDE2A PE=1 SV=1",GO:0000122; GO:0000287; GO:0003170; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0008270; GO:0010628; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030224; GO:0030552; GO:0030553; GO:0030911; GO:0035904; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071320; GO:0071321; GO:0071466; GO:0071560; GO:0097011; GO:0097060; GO:0106072; GO:1904613,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; ventricular septum development [GO:0003281]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]",GO:0003013; GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:1901135,circulatory system process; catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01405,0.8817159850182599,OG_01405,FUN_005473-T1,Peve_00002044,Pocillopora_meandrina_HIv1___RNAseq.g6627.t2,three_way,52.35033333333333,FUN_005473-T1,Q5N8Z0,,,,,28.4,278.0,5.1e-06,55.1,sp|Q5N8Z0|DRB1_ORYSJ Double-stranded RNA-binding protein 1 OS=Oryza sativa subsp. japonica OX=39947 GN=DRB1 PE=2 SV=1,,,,,,
OG_03261,0.8815872361787354,OG_03261,FUN_013085-T1,Peve_00027392,Pocillopora_meandrina_HIv1___RNAseq.g13092.t2,three_way,58.874,FUN_013085-T1,Q8IZH2,XRN1_HUMAN,,5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog),Homo sapiens (Human),45.9,1541.0,0.0,1238.8,sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:1905795,cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; rRNA catabolic process [GO:0016075],cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886],5'-3' RNA exonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; plasma membrane; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_02647,0.8813587117626022,OG_02647,FUN_010829-T1,Peve_00017534,Pocillopora_meandrina_HIv1___RNAseq.g20912.t1,three_way,43.3975,,,,,,,,,,,,,,,,,
OG_08798,0.8811813271420744,OG_08798,FUN_038100-T1,Peve_00025352,Pocillopora_meandrina_HIv1___TS.g5371.t2,three_way,85.98966666666666,FUN_038100-T1,P05696,KPCA_RAT,,Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13),Rattus norvegicus (Rat),67.3,652.0,6.6e-269,927.9,sp|P05696|KPCA_RAT Protein kinase C alpha type OS=Rattus norvegicus OX=10116 GN=Prkca PE=1 SV=3,GO:0000302; GO:0001525; GO:0001938; GO:0002026; GO:0002062; GO:0002159; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006874; GO:0006937; GO:0007155; GO:0007611; GO:0008270; GO:0008283; GO:0008285; GO:0008289; GO:0009612; GO:0009636; GO:0010595; GO:0010613; GO:0014704; GO:0016020; GO:0017148; GO:0018107; GO:0019899; GO:0021955; GO:0030335; GO:0030424; GO:0030425; GO:0030593; GO:0031666; GO:0031966; GO:0032355; GO:0032991; GO:0034351; GO:0035403; GO:0035556; GO:0035866; GO:0036064; GO:0043025; GO:0043409; GO:0043434; GO:0043536; GO:0044305; GO:0045177; GO:0045184; GO:0045471; GO:0045651; GO:0045766; GO:0045780; GO:0045785; GO:0045921; GO:0045931; GO:0046325; GO:0046627; GO:0046716; GO:0048471; GO:0048661; GO:0048863; GO:0050729; GO:0050930; GO:0051412; GO:0051965; GO:0070374; GO:0070528; GO:0070555; GO:0071322; GO:0090330; GO:0097193; GO:0099171; GO:0099523; GO:0106310; GO:0110063; GO:0120199; GO:1904627; GO:1990917; GO:2000300; GO:2000707,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular response to carbohydrate stimulus [GO:0071322]; central nervous system neuron axonogenesis [GO:0021955]; chondrocyte differentiation [GO:0002062]; desmosome assembly [GO:0002159]; establishment of protein localization [GO:0045184]; induction of positive chemotaxis [GO:0050930]; intracellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; learning or memory [GO:0007611]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of D-glucose import [GO:0046325]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of translation [GO:0017148]; neutrophil chemotaxis [GO:0030593]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of angiotensin-activated signaling pathway [GO:0110063]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synapse assembly [GO:0051965]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C signaling [GO:0070528]; regulation of muscle contraction [GO:0006937]; regulation of platelet aggregation [GO:0090330]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of the force of heart contraction [GO:0002026]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; stem cell differentiation [GO:0048863],alphav-beta3 integrin-PKCalpha complex [GO:0035866]; apical part of cell [GO:0045177]; axon [GO:0030424]; calyx of Held [GO:0044305]; ciliary basal body [GO:0036064]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; intercalated disc [GO:0014704]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991],"ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; enzyme binding [GO:0019899]; histone H3T6 kinase activity [GO:0035403]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005783; GO:0005815; GO:0005829; GO:0005886; GO:0007155; GO:0008289; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0048870; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; endoplasmic reticulum; microtubule organizing center; cytosol; plasma membrane; cell adhesion; lipid binding; transferase activity; cell differentiation; cell junction organization; organelle; cell motility; nervous system process; catalytic activity, acting on a protein"
OG_03889,0.8810693507798152,OG_03889,FUN_015442-T1,Peve_00024428,Pocillopora_meandrina_HIv1___RNAseq.g22272.t2,three_way,80.65666666666667,FUN_015442-T1,Q7KZ85,SPT6H_HUMAN,,Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),Homo sapiens (Human),55.5,1411.0,0.0,1521.5,sp|Q7KZ85|SPT6H_HUMAN Transcription elongation factor SPT6 OS=Homo sapiens OX=9606 GN=SUPT6H PE=1 SV=2,GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0031491; GO:0034728; GO:0042393; GO:0045191; GO:0051028; GO:0051147; GO:0140673,blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; regulation of isotype switching [GO:0045191]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673],nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023],DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005654; GO:0006325; GO:0016071; GO:0042393,DNA binding; RNA binding; nucleoplasm; chromatin organization; mRNA metabolic process; histone binding
OG_08459,0.8808403175357673,OG_08459,FUN_037228-T1,Peve_00044304,Pocillopora_meandrina_HIv1___TS.g13535.t1,three_way,54.508833333333335,,,,,,,,,,,,,,,,,
OG_07605,0.8807961459284966,OG_07605,FUN_034322-T1,Peve_00015003,Pocillopora_meandrina_HIv1___RNAseq.g28482.t1,three_way,81.48233333333333,FUN_034322-T1,Q14008,,,,,45.2,2083.0,0.0,1544.3,sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3,,,,,,
OG_02372,0.8801997841039569,OG_02372,FUN_008981-T1,Peve_00017856,Pocillopora_meandrina_HIv1___RNAseq.g3907.t1,three_way,83.092,FUN_008981-T1,Q9UK96,,,,,33.1,505.0,5.8e-66,254.2,sp|Q9UK96|FBX10_HUMAN F-box only protein 10 OS=Homo sapiens OX=9606 GN=FBXO10 PE=1 SV=3,,,,,,
OG_00234,0.8800317552547795,OG_00234,FUN_000988-T1,Peve_00022149,Pocillopora_meandrina_HIv1___RNAseq.g29209.t1,three_way,82.41166666666666,FUN_000988-T1,Q92828,,,,,47.6,401.0,3.4e-101,370.5,sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2,,,,,,
OG_02122,0.8798706018746435,OG_02122,FUN_008415-T1,Peve_00015094,Pocillopora_meandrina_HIv1___RNAseq.g18042.t1,three_way,72.59683333333334,FUN_008415-T1,Q9H2M9,RBGPR_HUMAN,,Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit),Homo sapiens (Human),37.2,1459.0,3.6999999999999996e-242,840.1,sp|Q9H2M9|RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP2 PE=1 SV=1,GO:0005096; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006886; GO:0008047; GO:0016236; GO:0030234; GO:0031267; GO:0032991; GO:0042734; GO:0043087; GO:0097051; GO:0099536; GO:1903061; GO:1903373; GO:2000786,establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]; synaptic signaling [GO:0099536],autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991],enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0023052; GO:0043226; GO:0098772,vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; signaling; organelle; molecular function regulator activity
OG_02328,0.879820099388376,OG_02328,FUN_008921-T1,Peve_00006943,Pocillopora_meandrina_HIv1___TS.g30078.t1,three_way,78.52199999999999,FUN_008921-T1,F1PCT7,,,,,39.1,591.0,6.2e-114,412.9,sp|F1PCT7|RPN2_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 OS=Canis lupus familiaris OX=9615 GN=RPN2 PE=1 SV=3,,,,,,
OG_06689,0.879818178339719,OG_06689,FUN_031221-T1,Peve_00043066,Pocillopora_meandrina_HIv1___RNAseq.g5197.t1,three_way,64.83466666666666,FUN_031221-T1,P51901,,,,,29.0,635.0,6.1e-63,245.0,sp|P51901|ANXA6_CHICK Annexin A6 OS=Gallus gallus OX=9031 GN=ANXA6 PE=2 SV=1,,,,,,
OG_04026,0.879653655153698,OG_04026,FUN_016333-T1,Peve_00044546,Pocillopora_meandrina_HIv1___TS.g23374.t1,three_way,71.42983333333333,FUN_016333-T1,P35869,AHR_HUMAN,,Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76),Homo sapiens (Human),40.4,381.0,7.4e-62,240.4,sp|P35869|AHR_HUMAN Aryl hydrocarbon receptor OS=Homo sapiens OX=9606 GN=AHR PE=1 SV=2,GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001094; GO:0001223; GO:0001568; GO:0002819; GO:0002841; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006805; GO:0006915; GO:0009410; GO:0009636; GO:0010468; GO:0017025; GO:0030888; GO:0032922; GO:0032991; GO:0034751; GO:0034752; GO:0034753; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837,"apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]",aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic aryl hydrocarbon receptor complex [GO:0034752]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_03077,0.8796419668047532,OG_03077,FUN_012349-T1,Peve_00021548,Pocillopora_meandrina_HIv1___RNAseq.9691_t,three_way,89.12533333333333,FUN_012349-T1,B3EX35,KATL1_SORAR,,Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 5.6.1.1) (p60 katanin-like 1),Sorex araneus (Eurasian common shrew) (European shrew),62.4,519.0,1.3e-168,594.3,sp|B3EX35|KATL1_SORAR Katanin p60 ATPase-containing subunit A-like 1 OS=Sorex araneus OX=42254 GN=KATNAL1 PE=3 SV=1,GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0016887; GO:0051013,microtubule severing [GO:0051013]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568],GO:0003824; GO:0005815; GO:0007010; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140096; GO:0140657,"catalytic activity; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on a protein; ATP-dependent activity"
OG_04778,0.8795137714713656,OG_04778,FUN_022684-T1,Peve_00019690,Pocillopora_meandrina_HIv1___TS.g22251.t2,three_way,75.05633333333333,FUN_022684-T1,O94880,PHF14_HUMAN,,PHD finger protein 14,Homo sapiens (Human),48.8,291.0,4.8e-73,276.6,sp|O94880|PHF14_HUMAN PHD finger protein 14 OS=Homo sapiens OX=9606 GN=PHF14 PE=1 SV=3,GO:0000122; GO:0000785; GO:0002314; GO:0005634; GO:0005694; GO:0005737; GO:0008270; GO:0008285; GO:0010463; GO:0042393; GO:0048286; GO:0060916; GO:0072201; GO:0140566; GO:2000584; GO:2000791,germinal center B cell differentiation [GO:0002314]; lung alveolus development [GO:0048286]; mesenchymal cell proliferation [GO:0010463]; mesenchymal cell proliferation involved in lung development [GO:0060916]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122],chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634],histone binding [GO:0042393]; histone reader activity [GO:0140566]; zinc ion binding [GO:0008270],GO:0002376; GO:0005634; GO:0005694; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0048856; GO:0060090,immune system process; nucleus; chromosome; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; anatomical structure development; molecular adaptor activity
OG_03594,0.8793255564478752,OG_03594,FUN_014752-T1,Peve_00039159,Pocillopora_meandrina_HIv1___TS.g27211.t1c,three_way,80.13483333333333,FUN_014752-T1,Q04678,,,,,57.2,617.0,2e-173,610.9,sp|Q04678|SSRP1_CHICK FACT complex subunit SSRP1 OS=Gallus gallus OX=9031 GN=SSRP1 PE=2 SV=2,,,,,,
OG_04036,0.8793232167297114,OG_04036,FUN_016344-T1,Peve_00004330,Pocillopora_meandrina_HIv1___RNAseq.g9849.t1,three_way,55.79433333333333,FUN_016344-T1,Q28GL6,,,,,30.6,281.0,2.7e-14,80.9,sp|Q28GL6|S7A6O_XENTR Probable RNA polymerase II nuclear localization protein SLC7A6OS OS=Xenopus tropicalis OX=8364 GN=slc7a6os PE=2 SV=1,,,,,,
OG_05000,0.8790396855706407,OG_05000,FUN_023136-T1,Peve_00008523,Pocillopora_meandrina_HIv1___RNAseq.g1752.t1,three_way,64.003,,,,,,,,,,,,,,,,,
OG_04440,0.8790018777383626,OG_04440,FUN_018842-T1,Peve_00035790,Pocillopora_meandrina_HIv1___RNAseq.g9855.t1,three_way,61.89533333333333,FUN_018842-T1,Q5U4Q0,,,,,31.7,221.0,1.2e-12,76.6,sp|Q5U4Q0|WAC_XENTR WW domain-containing adapter protein with coiled-coil OS=Xenopus tropicalis OX=8364 GN=wac PE=2 SV=1,,,,,,
OG_03032,0.878803935423041,OG_03032,FUN_012266-T1,Peve_00036382,Pocillopora_meandrina_HIv1___RNAseq.g23541.t2,three_way,83.19966666666666,FUN_012266-T1,Q921C3,BRWD1_MOUSE,,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),Mus musculus (Mouse),45.5,1509.0,1.3e-305,1051.2,sp|Q921C3|BRWD1_MOUSE Bromodomain and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Brwd1 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005930; GO:0006357; GO:0007010; GO:0008360; GO:0031514,cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357],axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005929; GO:0006355; GO:0007010; GO:0043226,nucleus; nucleoplasm; nucleolus; cytosol; cilium; regulation of DNA-templated transcription; cytoskeleton organization; organelle
OG_00710,0.8783826901188394,OG_00710,FUN_002577-T1,Peve_00025545,Pocillopora_meandrina_HIv1___RNAseq.g25716.t1,three_way,77.45466666666667,FUN_002577-T1,Q6NU27,,,,,52.6,196.0,2.5000000000000002e-58,226.9,sp|Q6NU27|I4E3B_XENLA Eukaryotic translation initiation factor 4E type 3-B OS=Xenopus laevis OX=8355 GN=eif4e3-b PE=2 SV=1,,,,,,
OG_03842,0.8782706055715123,OG_03842,FUN_015304-T1,Peve_00004797,Pocillopora_meandrina_HIv1___RNAseq.g22098.t1,three_way,76.9795,FUN_015304-T1,Q174D3,,,,,51.8,114.0,2.2e-23,110.9,sp|Q174D3|MED19_AEDAE Mediator of RNA polymerase II transcription subunit 19 OS=Aedes aegypti OX=7159 GN=MED19 PE=3 SV=1,,,,,,
OG_04504,0.8781022376082047,OG_04504,FUN_022016-T1,Peve_00042666,Pocillopora_meandrina_HIv1___RNAseq.g3182.t2,three_way,75.399,FUN_022016-T1,P07228,,,,,38.2,808.0,2.6e-144,514.2,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_06611,0.8780695435455365,OG_06611,FUN_029761-T1,Peve_00019503,Pocillopora_meandrina_HIv1___RNAseq.g17322.t1,three_way,61.18983333333333,FUN_029761-T1,Q8NC51,SERB1_HUMAN,,SERPINE1 mRNA-binding protein 1 (PAI1 RNA-binding protein 1) (PAI-RBP1) (Plasminogen activator inhibitor 1 RNA-binding protein),Homo sapiens (Human),31.6,152.0,5e-06,53.9,sp|Q8NC51|SERB1_HUMAN SERPINE1 mRNA-binding protein 1 OS=Homo sapiens OX=9606 GN=SERBP1 PE=1 SV=2,GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0017148; GO:0030371; GO:0030578; GO:0032183; GO:0043022; GO:0043488; GO:0045296; GO:0048471; GO:0061770; GO:0070062; GO:0141014,negative regulation of translation [GO:0017148]; PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488]; ribosome hibernation [GO:0141014],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; translation elongation factor binding [GO:0061770]; translation repressor activity [GO:0030371],GO:0003723; GO:0005634; GO:0005829; GO:0043226; GO:0045182,RNA binding; nucleus; cytosol; organelle; translation regulator activity
OG_05693,0.8779800698148353,OG_05693,FUN_025544-T1,Peve_00032952,Pocillopora_meandrina_HIv1___TS.g2798.t1,three_way,69.56033333333333,FUN_025544-T1,O60308,CE104_HUMAN,,Centrosomal protein of 104 kDa (Cep104),Homo sapiens (Human),38.5,925.0,9.3e-159,562.4,sp|O60308|CE104_HUMAN Centrosomal protein of 104 kDa OS=Homo sapiens OX=9606 GN=CEP104 PE=1 SV=1,GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0005929,,centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_03425,0.8778531673173188,OG_03425,FUN_014480-T1,Peve_00037298,Pocillopora_meandrina_HIv1___RNAseq.g22815.t1,three_way,78.496,FUN_014480-T1,Q6AZJ9,,,,,63.9,83.0,3e-28,125.9,sp|Q6AZJ9|RS21_XENLA Small ribosomal subunit protein eS21 OS=Xenopus laevis OX=8355 GN=rps21 PE=1 SV=1,,,,,,
OG_07046,0.8775782467891263,OG_07046,FUN_032249-T1,Peve_00042108,Pocillopora_meandrina_HIv1___TS.g12806.t2,three_way,79.56116666666667,FUN_032249-T1,Q4H4B6,SCRIB_DANRE,,Protein scribble homolog (Scribble1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,938.0,2.3e-130,468.8,sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1,GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887,"activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944]",adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793],protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0005886; GO:0006886; GO:0007010; GO:0007155; GO:0007163; GO:0012501; GO:0016192; GO:0043226; GO:0048856; GO:0048870; GO:0072659,plasma membrane; intracellular protein transport; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; programmed cell death; vesicle-mediated transport; organelle; anatomical structure development; cell motility; protein localization to plasma membrane
OG_08417,0.8775769899184871,OG_08417,FUN_037075-T1,Peve_00004732,Pocillopora_meandrina_HIv1___RNAseq.g26676.t1,three_way,77.25566666666667,FUN_037075-T1,Q6ZT07,,,,,45.3,1328.0,2.4e-304,1046.6,sp|Q6ZT07|TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens OX=9606 GN=TBC1D9 PE=1 SV=2,,,,,,
OG_08070,0.8774411424023911,OG_08070,FUN_035775-T1,Peve_00017724,Pocillopora_meandrina_HIv1___RNAseq.g11904.t1,three_way,71.4095,FUN_035775-T1,Q1LUT1,,,,,33.8,1359.0,3e-127,458.4,sp|Q1LUT1|EDC4_DANRE Enhancer of mRNA-decapping protein 4 OS=Danio rerio OX=7955 GN=edc4 PE=3 SV=1,,,,,,
OG_05055,0.8773863853786855,OG_05055,FUN_023251-T1,Peve_00019255,Pocillopora_meandrina_HIv1___RNAseq.g1743.t1,three_way,82.61816666666667,FUN_023251-T1,Q6PCJ1,DCTN1_XENLA,,Dynactin subunit 1,Xenopus laevis (African clawed frog),41.7,763.0,1.9e-112,409.1,sp|Q6PCJ1|DCTN1_XENLA Dynactin subunit 1 OS=Xenopus laevis OX=8355 GN=dctn1 PE=2 SV=1,GO:0000132; GO:0000776; GO:0000922; GO:0005813; GO:0005814; GO:0005874; GO:0005875; GO:0005938; GO:0007097; GO:0008017; GO:0030286; GO:0030424; GO:0031122; GO:0035371; GO:0051301; GO:0060236; GO:0090316; GO:0099738,cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; nuclear migration [GO:0007097]; positive regulation of intracellular protein transport [GO:0090316]; regulation of mitotic spindle organization [GO:0060236],axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_06763,0.8773843045585361,OG_06763,FUN_031595-T1,Peve_00012520,Pocillopora_meandrina_HIv1___RNAseq.g5058.t1,three_way,67.68833333333333,FUN_031595-T1,A2CG63,ARI4B_MOUSE,,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180),Mus musculus (Mouse),27.0,562.0,3e-13,79.0,sp|A2CG63|ARI4B_MOUSE AT-rich interactive domain-containing protein 4B OS=Mus musculus OX=10090 GN=Arid4b PE=1 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006366; GO:0007283; GO:0030336; GO:0030512; GO:0045944; GO:0070822; GO:0071514; GO:0097368; GO:1902455; GO:1902459,chromatin organization [GO:0006325]; establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleus; mitochondrion; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development
OG_02507,0.8773531880860524,OG_02507,FUN_010019-T1,Peve_00036456,Pocillopora_meandrina_HIv1___TS.g12195.t1a,three_way,70.6275,FUN_010019-T1,Q7Z5K2,WAPL_HUMAN,,Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor),Homo sapiens (Human),38.7,545.0,3.8e-92,340.9,sp|Q7Z5K2|WAPL_HUMAN Wings apart-like protein homolog OS=Homo sapiens OX=9606 GN=WAPL PE=1 SV=1,GO:0000070; GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0035562; GO:0043231; GO:0045171; GO:0045875; GO:0051301; GO:0071168; GO:0072686; GO:0140083,cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; protein localization to chromatin [GO:0071168],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP-dependent protein-DNA unloader activity [GO:0140083],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007059; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; chromosome segregation; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03482,0.8772777210324898,OG_03482,FUN_014584-T1,Peve_00001487,Pocillopora_meandrina_HIv1___RNAseq.g22720.t1,three_way,49.659333333333336,FUN_014584-T1,Q1L5Z9,LONF2_HUMAN,,LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192),Homo sapiens (Human),31.0,625.0,2.6999999999999993e-68,261.5,sp|Q1L5Z9|LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 OS=Homo sapiens OX=9606 GN=LONRF2 PE=1 SV=3,GO:0005737; GO:0006515; GO:0008270; GO:0021522; GO:0031175; GO:0043021; GO:0043524; GO:0050905; GO:0051402; GO:0051787; GO:0061630; GO:0061744,motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737],misfolded protein binding [GO:0051787]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0012501; GO:0016740; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; programmed cell death; transferase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_03051,0.8772342433746781,OG_03051,FUN_012298-T1,Peve_00038614,Pocillopora_meandrina_HIv1___RNAseq.g23768.t1,three_way,61.748,,,,,,,,,,,,,,,,,
OG_04547,0.8771418404619691,OG_04547,FUN_022170-T1,Peve_00036602,Pocillopora_meandrina_HIv1___RNAseq.g4779.t1,three_way,50.17433333333334,FUN_022170-T1,B8UU78,,,,,90.7,1117.0,0.0,1992.2,sp|B8UU78|ELP_ACRMI EGF and laminin G domain-containing protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02974,0.8768458264879432,OG_02974,FUN_012139-T1,Peve_00001103,Pocillopora_meandrina_HIv1___RNAseq.g23864.t3,three_way,77.9845,FUN_012139-T1,Q8N7X0,ADGB_HUMAN,,Androglobin,Homo sapiens (Human),29.8,1939.0,1.4e-185,652.5,sp|Q8N7X0|ADGB_HUMAN Androglobin OS=Homo sapiens OX=9606 GN=ADGB PE=1 SV=3,GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227,proteolysis [GO:0006508]; spermatid development [GO:0007286],sperm annulus [GO:0097227]; sperm midpiece [GO:0097225],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825],GO:0003824; GO:0016787; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; hydrolase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_02940,0.876780941980351,OG_02940,FUN_012049-T1,Peve_00004088,Pocillopora_meandrina_HIv1___RNAseq.g23650.t3,three_way,68.88266666666667,FUN_012049-T1,E7EZG2,MY9AA_DANRE,,Unconventional myosin-IXAa (Myosin IXAa),Danio rerio (Zebrafish) (Brachydanio rerio),33.3,2215.0,4.1e-257,890.2,sp|E7EZG2|MY9AA_DANRE Unconventional myosin-IXAa OS=Danio rerio OX=7955 GN=myo9aa PE=3 SV=1,GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0007626; GO:0008270; GO:0016020; GO:0016459; GO:0035556; GO:0036269; GO:0044295; GO:0045198; GO:0045202; GO:0048675; GO:0051015; GO:0061564; GO:0098529,"axon development [GO:0061564]; axon extension [GO:0048675]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; swimming behavior [GO:0036269]",actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; membrane [GO:0016020]; myosin complex [GO:0016459]; synapse [GO:0045202],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270],GO:0003774; GO:0003824; GO:0007163; GO:0008092; GO:0016853; GO:0030154; GO:0034330; GO:0098772; GO:0140657,cytoskeletal motor activity; catalytic activity; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; cell differentiation; cell junction organization; molecular function regulator activity; ATP-dependent activity
OG_09210,0.8766991428487779,OG_09210,FUN_039923-T1,Peve_00010141,Pocillopora_meandrina_HIv1___RNAseq.g7340.t1,three_way,61.899,,,,,,,,,,,,,,,,,
OG_02932,0.8765345077167788,OG_02932,FUN_012033-T1,Peve_00037665,Pocillopora_meandrina_HIv1___RNAseq.g24057.t1,three_way,77.83616666666667,FUN_012033-T1,Q5ZIN1,NUDC_CHICK,,Nuclear migration protein nudC (Nuclear distribution protein C homolog),Gallus gallus (Chicken),62.9,329.0,2.6e-77,290.4,sp|Q5ZIN1|NUDC_CHICK Nuclear migration protein nudC OS=Gallus gallus OX=9031 GN=NUDC PE=2 SV=1,GO:0005737; GO:0005874; GO:0006457; GO:0007052; GO:0007080; GO:0030496; GO:0051082; GO:0051301; GO:0072686,cell division [GO:0051301]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; protein folding [GO:0006457],cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686],unfolded protein binding [GO:0051082],GO:0006457; GO:0007010; GO:0043226,protein folding; cytoskeleton organization; organelle
OG_00438,0.8763307809439087,OG_00438,FUN_001349-T1,Peve_00023406,Pocillopora_meandrina_HIv1___RNAseq.g1876.t1,three_way,83.4015,FUN_001349-T1,Q8IYW2,,,,,31.7,2766.0,0.0,1193.3,sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3,,,,,,
OG_06198,0.8763267660969201,OG_06198,FUN_028130-T1,Peve_00004260,Pocillopora_meandrina_HIv1___RNAseq.g15556.t1,three_way,59.60266666666666,FUN_028130-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),26.8,276.0,4.9e-14,81.6,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_00153,0.8761705894084327,OG_00153,FUN_000607-T1,Peve_00041268,Pocillopora_meandrina_HIv1___RNAseq.g2497.t1,three_way,77.315,FUN_000607-T1,Q16543,,,,,63.4,372.0,2.3e-90,334.0,sp|Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo sapiens OX=9606 GN=CDC37 PE=1 SV=1,,,,,,
OG_09180,0.876150921179082,OG_09180,FUN_039860-T1,Peve_00014924,Pocillopora_meandrina_HIv1___TS.g1030.t3,three_way,76.61816666666667,,,,,,,,,,,,,,,,,
OG_04829,0.8760274345716869,OG_04829,FUN_022823-T1,Peve_00027665,Pocillopora_meandrina_HIv1___RNAseq.g3439.t1,three_way,69.43183333333333,FUN_022823-T1,A8MU46,SMTL1_HUMAN,,Smoothelin-like protein 1,Homo sapiens (Human),49.5,101.0,9.6e-22,106.7,sp|A8MU46|SMTL1_HUMAN Smoothelin-like protein 1 OS=Homo sapiens OX=9606 GN=SMTNL1 PE=1 SV=2,GO:0005516; GO:0005523; GO:0005634; GO:0005737; GO:0008157; GO:0009410; GO:0014823; GO:0031430; GO:0031674; GO:0042310; GO:0043292; GO:0045892; GO:0045907; GO:0048644; GO:0051401; GO:0097718,muscle organ morphogenesis [GO:0048644]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310],contractile muscle fiber [GO:0043292]; cytoplasm [GO:0005737]; I band [GO:0031674]; M band [GO:0031430]; nucleus [GO:0005634],calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523],GO:0003013; GO:0005634; GO:0006355; GO:0008092; GO:0043226,circulatory system process; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; organelle
OG_02707,0.8757686656367428,OG_02707,FUN_010984-T1,Peve_00013386,Pocillopora_meandrina_HIv1___RNAseq.g22009.t1,three_way,79.6975,FUN_010984-T1,Q7Z3V4,UBE3B_HUMAN,,Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B),Homo sapiens (Human),50.4,1075.0,3.1e-310,1065.8,sp|Q7Z3V4|UBE3B_HUMAN Ubiquitin-protein ligase E3B OS=Homo sapiens OX=9606 GN=UBE3B PE=1 SV=3,GO:0000209; GO:0005739; GO:0006511; GO:0014069; GO:0061630; GO:0098978; GO:0150052,protein polyubiquitination [GO:0000209]; regulation of postsynapse assembly [GO:0150052]; ubiquitin-dependent protein catabolic process [GO:0006511],glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; postsynaptic density [GO:0014069],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09705,0.8757571354526409,OG_09705,FUN_041939-T1,Peve_00023589,Pocillopora_meandrina_HIv1___RNAseq.g15705.t1,three_way,68.18516666666667,FUN_041939-T1,Q15696,U2AFM_HUMAN,,"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)",Homo sapiens (Human),56.4,172.0,6.7e-51,202.6,sp|Q15696|U2AFM_HUMAN U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 OS=Homo sapiens OX=9606 GN=ZRSR2 PE=1 SV=2,GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008270; GO:0008380; GO:0030628; GO:0042802; GO:0089701,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701],identical protein binding [GO:0042802]; pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270],GO:0003723; GO:0005654; GO:0016071; GO:0065003,RNA binding; nucleoplasm; mRNA metabolic process; protein-containing complex assembly
OG_10087,0.875568117636659,OG_10087,FUN_043414-T1,Peve_00045005,Pocillopora_meandrina_HIv1___RNAseq.g7825.t1,three_way,56.5365,FUN_043414-T1,Q69Z28,ATS16_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Mus musculus (Mouse),30.5,1138.0,9.8e-129,463.0,sp|Q69Z28|ATS16_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Mus musculus OX=10090 GN=Adamts16 PE=2 SV=2,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; catalytic activity, acting on a protein"
OG_04123,0.87551736557874,OG_04123,FUN_016504-T1,Peve_00016812,Pocillopora_meandrina_HIv1___RNAseq.g9720.t1,three_way,88.1275,FUN_016504-T1,Q9Y2X3,NOP58_HUMAN,,Nucleolar protein 58 (Nucleolar protein 5),Homo sapiens (Human),71.5,445.0,1.6e-174,614.0,sp|Q9Y2X3|NOP58_HUMAN Nucleolar protein 58 OS=Homo sapiens OX=9606 GN=NOP58 PE=1 SV=1,GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0048254; GO:0051117; GO:0070761,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254],box C/D methylation guide snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732],ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0043226,RNA binding; nucleoplasm; nucleolus; cytosol; organelle
OG_04768,0.8754567356289576,OG_04768,FUN_022670-T1,Peve_00003746,Pocillopora_meandrina_HIv1___RNAseq.g4535.t1,three_way,78.69650000000001,FUN_022670-T1,Q05096,MYO1B_RAT,,Unconventional myosin-Ib (Myosin I alpha) (MMI-alpha) (MMIa) (Myosin heavy chain myr 1),Rattus norvegicus (Rat),57.9,1094.0,2.4e-300,1033.1,sp|Q05096|MYO1B_RAT Unconventional myosin-Ib OS=Rattus norvegicus OX=10116 GN=Myo1b PE=1 SV=1,GO:0000146; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005769; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0006892; GO:0006897; GO:0007015; GO:0007399; GO:0010008; GO:0015629; GO:0016459; GO:0030048; GO:0030175; GO:0032588; GO:0033572; GO:0045177; GO:0048471; GO:0051015; GO:0051017; GO:0071944,actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; microvillus [GO:0005902]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0003774; GO:0003824; GO:0005768; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0016192; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_05409,0.8754431360631998,OG_05409,FUN_024343-T1,Peve_00016806,Pocillopora_meandrina_HIv1___RNAseq.g18931.t1,three_way,80.135,FUN_024343-T1,Q6BRB4,,,,,37.3,83.0,3.1e-06,53.9,sp|Q6BRB4|NHP6_DEBHA Non-histone chromosomal protein 6 OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) OX=284592 GN=NHP6 PE=3 SV=1,,,,,,
OG_08131,0.8753058469375424,OG_08131,FUN_035891-T1,Peve_00029395,Pocillopora_meandrina_HIv1___RNAseq.g12008.t1,three_way,81.82483333333333,FUN_035891-T1,Q9WUU6,,,,,68.0,325.0,9.9e-122,438.3,sp|Q9WUU6|HNF4G_MOUSE Hepatocyte nuclear factor 4-gamma OS=Mus musculus OX=10090 GN=Hnf4g PE=2 SV=2,,,,,,
OG_02035,0.8752253822752701,OG_02035,FUN_008237-T1,Peve_00003879,Pocillopora_meandrina_HIv1___RNAseq.g17928.t1,three_way,82.36666666666666,FUN_008237-T1,Q29RK2,PYC_BOVIN,,"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)",Bos taurus (Bovine),65.5,1165.0,0.0,1567.0,"sp|Q29RK2|PYC_BOVIN Pyruvate carboxylase, mitochondrial OS=Bos taurus OX=9913 GN=PC PE=2 SV=2",GO:0004736; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0046872,gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; pyruvate metabolic process [GO:0006090],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736],GO:0003824; GO:0005739; GO:0005975; GO:0006629; GO:0016874; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lipid metabolic process; ligase activity; organelle
OG_03800,0.8752210593013575,OG_03800,FUN_015183-T1,Peve_00023878,Pocillopora_meandrina_HIv1___RNAseq.g22309.t1,three_way,61.66833333333334,FUN_015183-T1,Q86US8,EST1A_HUMAN,,Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a),Homo sapiens (Human),34.5,918.0,1.2999999999999999e-129,466.1,sp|Q86US8|EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens OX=9606 GN=SMG6 PE=1 SV=2,GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006406; GO:0032204; GO:0032210; GO:0035303; GO:0036064; GO:0042162; GO:0043021; GO:0046872; GO:0070034; GO:0070182; GO:1904354,"mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]","chromosome, telomeric region [GO:0000781]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; telomerase holoenzyme complex [GO:0005697]",DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0005815; GO:0005829; GO:0005886; GO:0006913; GO:0016071; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; nucleolus; microtubule organizing center; cytosol; plasma membrane; nucleocytoplasmic transport; mRNA metabolic process; organelle; catalytic activity, acting on RNA"
OG_04542,0.8751880496410005,OG_04542,FUN_022103-T1,Peve_00009716,Pocillopora_meandrina_HIv1___RNAseq.g4105.t1,three_way,85.40766666666667,FUN_022103-T1,A6H779,FBXL2_BOVIN,,F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2),Bos taurus (Bovine),69.6,102.0,2.1e-37,158.3,sp|A6H779|FBXL2_BOVIN F-box/LRR-repeat protein 2 OS=Bos taurus OX=9913 GN=FBXL2 PE=2 SV=1,GO:0005516; GO:0006513; GO:0010506; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830; GO:0050727; GO:0051896; GO:1900226; GO:1990756,modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005],calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_06658,0.8748744947885899,OG_06658,FUN_030874-T1,Peve_00043625,Pocillopora_meandrina_HIv1___RNAseq.g30289.t1,three_way,83.54933333333334,FUN_030874-T1,Q9P2D3,HTR5B_HUMAN,,HEAT repeat-containing protein 5B,Homo sapiens (Human),50.9,2060.0,0.0,1933.7,sp|Q9P2D3|HTR5B_HUMAN HEAT repeat-containing protein 5B OS=Homo sapiens OX=9606 GN=HEATR5B PE=1 SV=2,GO:0005654; GO:0005794; GO:0005829; GO:0006897; GO:0008104; GO:0015031; GO:0016020; GO:0030136; GO:0030139; GO:0042147; GO:0043231; GO:0048471,"endocytosis [GO:0006897]; protein localization [GO:0008104]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],,GO:0005654; GO:0005794; GO:0005829; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; Golgi apparatus; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_00273,0.8748011569187529,OG_00273,FUN_001053-T1,Peve_00023870,Pocillopora_meandrina_HIv1___RNAseq.g29644.t1,three_way,85.719,FUN_001053-T1,Q5REU4,,,,,58.1,904.0,2.8e-296,1019.2,sp|Q5REU4|SND1_PONAB Staphylococcal nuclease domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SND1 PE=2 SV=1,,,,,,
OG_03904,0.8745150860085623,OG_03904,FUN_015978-T1,Peve_00024021,Pocillopora_meandrina_HIv1___RNAseq.g21408.t2,three_way,79.68833333333333,FUN_015978-T1,P40939,ECHA_HUMAN,,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (MLCL AT) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]",Homo sapiens (Human),57.7,766.0,5.7e-253,875.2,"sp|P40939|ECHA_HUMAN Trifunctional enzyme subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=HADHA PE=1 SV=2",GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0052816; GO:0070403,cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868],mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; NAD+ binding [GO:0070403],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0016740; GO:0016787; GO:0016829; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; transferase activity; hydrolase activity; lyase activity; organelle
OG_00130,0.8743886661536999,OG_00130,FUN_000559-T1,Peve_00010241,Pocillopora_meandrina_HIv1___RNAseq.g2460.t1,three_way,74.06333333333333,FUN_000559-T1,Q14247,SRC8_HUMAN,,Src substrate cortactin (Amplaxin) (Oncogene EMS1),Homo sapiens (Human),65.2,66.0,8.9e-19,96.7,sp|Q14247|SRC8_HUMAN Src substrate cortactin OS=Homo sapiens OX=9606 GN=CTTN PE=1 SV=2,GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0007165; GO:0008076; GO:0030027; GO:0030036; GO:0030139; GO:0030426; GO:0030516; GO:0030838; GO:0030863; GO:0043197; GO:0043231; GO:0045296; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098871; GO:0098885; GO:0098978; GO:1901524; GO:1990023; GO:2001237,"actin cytoskeleton organization [GO:0030036]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; regulation of mitophagy [GO:1901524]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]",actin filament [GO:0005884]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; voltage-gated potassium channel complex [GO:0008076],Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064],GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007010; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0048870,endoplasmic reticulum; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; intracellular protein transport; cytoskeleton organization; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; cell motility
OG_01082,0.8743132568646702,OG_01082,FUN_004570-T1,Peve_00041478,Pocillopora_meandrina_HIv1___RNAseq.g6646.t1a,three_way,78.209,FUN_004570-T1,Q6NRZ4,,,,,43.9,640.0,5.6e-150,532.7,sp|Q6NRZ4|CERT_XENLA Ceramide transfer protein OS=Xenopus laevis OX=8355 GN=cert1 PE=2 SV=1,,,,,,
OG_09512,0.8742550493941971,OG_09512,FUN_041566-T1,Peve_00033115,Pocillopora_meandrina_HIv1___TS.g10998.t1,three_way,76.251,FUN_041566-T1,P57080,UBP25_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25) (mUSP25),Mus musculus (Mouse),40.6,1023.0,9.3e-192,672.2,sp|P57080|UBP25_MOUSE Ubiquitin carboxyl-terminal hydrolase 25 OS=Mus musculus OX=10090 GN=Usp25 PE=1 SV=2,GO:0000502; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0006955; GO:0006979; GO:0016071; GO:0016579; GO:0031098; GO:0097400; GO:0101005,immune response [GO:0006955]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA metabolic process [GO:0016071]; protein deubiquitination [GO:0016579]; response to oxidative stress [GO:0006979]; stress-activated protein kinase signaling cascade [GO:0031098]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502],cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005],GO:0002376; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01290,0.8741812598421583,OG_01290,FUN_005113-T1,Peve_00007463,Pocillopora_meandrina_HIv1___RNAseq.g8268.t1,three_way,72.56616666666666,FUN_005113-T1,O15945,ARNT_DROME,,Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango),Drosophila melanogaster (Fruit fly),57.4,378.0,5.4e-115,416.8,sp|O15945|ARNT_DROME Aryl hydrocarbon receptor nuclear translocator homolog OS=Drosophila melanogaster OX=7227 GN=tgo PE=1 SV=3,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0034751; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575,appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04178,0.8741193938003308,OG_04178,FUN_016668-T1,Peve_00002514,Pocillopora_meandrina_HIv1___RNAseq.g9697.t1,three_way,79.70833333333333,FUN_016668-T1,A0JNI5,CLASR_BOVIN,,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16)",Bos taurus (Bovine),51.1,309.0,1.2e-50,202.6,sp|A0JNI5|CLASR_BOVIN CLK4-associating serine/arginine rich protein OS=Bos taurus OX=9913 GN=CLASRP PE=2 SV=1,GO:0005634; GO:0006397; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nucleus [GO:0005634],,GO:0005634; GO:0016071; GO:0043226,nucleus; mRNA metabolic process; organelle
OG_08111,0.8738547018270363,OG_08111,FUN_035864-T1,Peve_00042154,Pocillopora_meandrina_HIv1___RNAseq.g11966.t1,three_way,90.75366666666666,FUN_035864-T1,O60231,DHX16_HUMAN,,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),Homo sapiens (Human),62.5,1039.0,0.0,1148.7,sp|O60231|DHX16_HUMAN Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 OS=Homo sapiens OX=9606 GN=DHX16 PE=1 SV=2,GO:0000398; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0008380; GO:0016887; GO:0038187; GO:0043130; GO:0060090; GO:0071005; GO:0140374,"antiviral innate immune response [GO:0140374]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; molecular adaptor activity [GO:0060090]; pattern recognition receptor activity [GO:0038187]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ubiquitin binding [GO:0043130],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0060090; GO:0098542; GO:0140098; GO:0140657,"immune system process; RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; molecular transducer activity; molecular adaptor activity; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_00787,0.8737130426977766,OG_00787,FUN_003900-T1,Peve_00025157,Pocillopora_meandrina_HIv1___RNAseq.g17184.t1,three_way,80.535,FUN_003900-T1,Q69ZJ7,RIC1_MOUSE,,Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1),Mus musculus (Mouse),40.0,1396.0,3.9000000000000003e-284,979.5,sp|Q69ZJ7|RIC1_MOUSE Guanine nucleotide exchange factor subunit RIC1 OS=Mus musculus OX=10090 GN=Ric1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547,"intracellular protein transport [GO:0006886]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005829; GO:0006886; GO:0016192; GO:0098772,cytosol; intracellular protein transport; vesicle-mediated transport; molecular function regulator activity
OG_08386,0.8736745242494027,OG_08386,FUN_036993-T1,Peve_00002136,Pocillopora_meandrina_HIv1___RNAseq.g26710.t1,three_way,55.684333333333335,FUN_036993-T1,Q6L8S8,,,,,31.9,990.0,7.700000000000001e-126,453.4,"sp|Q6L8S8|B4GN3_MOUSE Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Mus musculus OX=10090 GN=B4galnt3 PE=2 SV=1",,,,,,
OG_04142,0.8735266200781177,OG_04142,FUN_016599-T1,Peve_00003402,Pocillopora_meandrina_HIv1___RNAseq.g414.t2,three_way,67.56366666666666,,,,,,,,,,,,,,,,,
OG_07211,0.873523121677485,OG_07211,FUN_032755-T1,Peve_00023820,Pocillopora_meandrina_HIv1___RNAseq.g29864.t1,three_way,82.49766666666667,FUN_032755-T1,Q62825,,,,,43.2,750.0,3.3e-160,567.0,sp|Q62825|EXOC3_RAT Exocyst complex component 3 OS=Rattus norvegicus OX=10116 GN=Exoc3 PE=1 SV=1,,,,,,
OG_05397,0.8733082835668206,OG_05397,FUN_024224-T1,Peve_00031887,Pocillopora_meandrina_HIv1___TS.g28304.t1,three_way,65.771,FUN_024224-T1,O60343,TBCD4_HUMAN,,TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160),Homo sapiens (Human),33.6,1274.0,8.199999999999999e-148,526.6,sp|O60343|TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens OX=9606 GN=TBC1D4 PE=1 SV=2,GO:0005096; GO:0005794; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869,cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],GTPase activator activity [GO:0005096],GO:0005794; GO:0005829; GO:0016192; GO:0043226; GO:0098772,Golgi apparatus; cytosol; vesicle-mediated transport; organelle; molecular function regulator activity
OG_09983,0.8733007861768953,OG_09983,FUN_043175-T1,Peve_00025846,Pocillopora_meandrina_HIv1___RNAseq.g6800.t1,three_way,71.23483333333334,FUN_043175-T1,Q28036,SL9A1_BOVIN,,Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1),Bos taurus (Bovine),47.8,557.0,4.8999999999999995e-141,503.4,sp|Q28036|SL9A1_BOVIN Sodium/hydrogen exchanger 1 OS=Bos taurus OX=9913 GN=SLC9A1 PE=2 SV=2,GO:0005516; GO:0005543; GO:0005654; GO:0005737; GO:0005886; GO:0006883; GO:0006885; GO:0010447; GO:0010613; GO:0010882; GO:0015385; GO:0015386; GO:0016323; GO:0016324; GO:0030346; GO:0035994; GO:0036376; GO:0042802; GO:0045121; GO:0045944; GO:0048306; GO:0048863; GO:0051259; GO:0051453; GO:0055007; GO:0070886; GO:0071468; GO:0071805; GO:0071872; GO:0086092; GO:0090533; GO:0098719; GO:0098735,cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to epinephrine stimulus [GO:0071872]; intracellular sodium ion homeostasis [GO:0006883]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; stem cell differentiation [GO:0048863],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005654; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0055085; GO:0065003,transporter activity; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; transmembrane transport; protein-containing complex assembly
OG_03566,0.8732528580639317,OG_03566,FUN_014715-T1,Peve_00023482,Pocillopora_meandrina_HIv1___RNAseq.g22525.t1,three_way,70.94933333333333,FUN_014715-T1,Q5RA75,,,,,35.2,1159.0,4.4e-158,560.5,sp|Q5RA75|F135A_PONAB Protein FAM135A OS=Pongo abelii OX=9601 GN=FAM135A PE=2 SV=1,,,,,,
OG_04966,0.8730512945289288,OG_04966,FUN_023066-T1,Peve_00024667,Pocillopora_meandrina_HIv1___RNAseq.g3884.t2,three_way,87.49933333333333,FUN_023066-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),46.5,2103.0,0.0,1895.2,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_09347,0.8729828949558871,OG_09347,FUN_040402-T1,Peve_00014984,Pocillopora_meandrina_HIv1___RNAseq.g6531.t1,three_way,64.912,FUN_040402-T1,P19137,LAMA1_MOUSE,,Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha),Mus musculus (Mouse),22.5,3355.0,9.5e-78,295.0,sp|P19137|LAMA1_MOUSE Laminin subunit alpha-1 OS=Mus musculus OX=10090 GN=Lama1 PE=1 SV=2,GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046,branching involved in salivary gland morphogenesis [GO:0060445]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888],basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637],extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; signaling receptor binding [GO:0005102],GO:0005198; GO:0005576; GO:0005615; GO:0007155; GO:0007163; GO:0008289; GO:0030154; GO:0030312; GO:0031012; GO:0048856,structural molecule activity; extracellular region; extracellular space; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_05904,0.87279906978941,OG_05904,FUN_026090-T1,Peve_00004127,Pocillopora_meandrina_HIv1___TS.g13992.t1,three_way,76.80466666666666,FUN_026090-T1,Q08D64,ABCB6_XENTR,,ATP-binding cassette sub-family B member 6 (ABC-type heme transporter ABCB6) (EC 7.6.2.5),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),55.9,755.0,4.0999999999999995e-234,812.8,sp|Q08D64|ABCB6_XENTR ATP-binding cassette sub-family B member 6 OS=Xenopus tropicalis OX=8364 GN=abcb6 PE=2 SV=1,GO:0000139; GO:0005524; GO:0005739; GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005886; GO:0006778; GO:0006878; GO:0015439; GO:0016887; GO:0031901; GO:0031902; GO:0032585; GO:0033013; GO:0033162; GO:0035351; GO:0036020; GO:0042168; GO:0046906; GO:0070062; GO:0098849; GO:0140359; GO:1903232,cellular detoxification of cadmium ion [GO:0098849]; heme metabolic process [GO:0042168]; heme transmembrane transport [GO:0035351]; intracellular copper ion homeostasis [GO:0006878]; melanosome assembly [GO:1903232]; porphyrin-containing compound metabolic process [GO:0006778]; tetrapyrrole metabolic process [GO:0033013],early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type heme transporter activity [GO:0015439]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; tetrapyrrole binding [GO:0046906],GO:0003824; GO:0005215; GO:0005739; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0098754; GO:0140657,catalytic activity; transporter activity; mitochondrion; Golgi apparatus; plasma membrane; hydrolase activity; organelle; transmembrane transport; detoxification; ATP-dependent activity
OG_07086,0.8727985152936389,OG_07086,FUN_032343-T1,Peve_00043851,Pocillopora_meandrina_HIv1___RNAseq.g29795.t1,three_way,70.73383333333334,FUN_032343-T1,Q9VCA2,,,,,31.8,528.0,2.3999999999999997e-61,238.0,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_09107,0.8724828578518348,OG_09107,FUN_038934-T1,Peve_00043964,Pocillopora_meandrina_HIv1___RNAseq.g1039.t1,three_way,93.333,FUN_038934-T1,Q5ZLL1,KC1E_CHICK,,Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1),Gallus gallus (Chicken),76.2,420.0,1.2e-178,627.5,sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus OX=9031 GN=CSNK1E PE=2 SV=2,GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006897; GO:0007165; GO:0032436; GO:0048511; GO:0090263; GO:0106310,endocytosis [GO:0006897]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; rhythmic process [GO:0048511]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016192; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vesicle-mediated transport; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06138,0.8723954183674789,OG_06138,FUN_027960-T1,Peve_00017205,Pocillopora_meandrina_HIv1___RNAseq.g14049.t1,three_way,88.88733333333333,,,,,,,,,,,,,,,,,
OG_07007,0.8723952034645389,OG_07007,FUN_032160-T1,Peve_00005389,Pocillopora_meandrina_HIv1___RNAseq.g5308.t1,three_way,84.28083333333333,FUN_032160-T1,Q9BX10,GTPB2_HUMAN,,GTP-binding protein 2,Homo sapiens (Human),61.1,535.0,2.7e-191,669.8,sp|Q9BX10|GTPB2_HUMAN GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=GTPBP2 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802; GO:0070966; GO:0072344; GO:1904678,"nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]",extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093],alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802],GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0016071; GO:0016787,RNA binding; catalytic activity; GTPase activity; extracellular region; mRNA metabolic process; hydrolase activity
OG_02407,0.8722719560393636,OG_02407,FUN_009056-T1,Peve_00032033,Pocillopora_meandrina_HIv1___RNAseq.g14479.t1,three_way,51.15833333333333,,,,,,,,,,,,,,,,,
OG_02463,0.8721109816478555,OG_02463,FUN_009654-T1,Peve_00003555,Pocillopora_meandrina_HIv1___RNAseq.g24583.t1,three_way,69.71183333333333,FUN_009654-T1,A6H8T7,CBPC2_DANRE,,Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) (Testis-expressed protein 25),Danio rerio (Zebrafish) (Brachydanio rerio),48.3,484.0,1.8e-128,462.2,sp|A6H8T7|CBPC2_DANRE Cytosolic carboxypeptidase 2 OS=Danio rerio OX=7955 GN=zte25 PE=2 SV=1,GO:0004181; GO:0005737; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0035610; GO:0036064,protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508],centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09854,0.8719496025642431,OG_09854,FUN_042847-T1,Peve_00023278,Pocillopora_meandrina_HIv1___RNAseq.g7253.t2,three_way,70.20666666666666,FUN_042847-T1,Q924L9,,,,,46.9,557.0,1.5e-131,471.5,"sp|Q924L9|FOLC_CRIGR Folylpolyglutamate synthase, mitochondrial OS=Cricetulus griseus OX=10029 GN=FPGS PE=2 SV=1",,,,,,
OG_05065,0.8717577501754533,OG_05065,FUN_023268-T1,Peve_00018794,Pocillopora_meandrina_HIv1___TS.g17377.t1b,three_way,60.35533333333333,FUN_023268-T1,Q96N46,,,,,35.8,433.0,8.1e-59,230.3,sp|Q96N46|TTC14_HUMAN Tetratricopeptide repeat protein 14 OS=Homo sapiens OX=9606 GN=TTC14 PE=1 SV=1,,,,,,
OG_02741,0.8716324665819457,OG_02741,FUN_011284-T1,Peve_00033625,Pocillopora_meandrina_HIv1___RNAseq.g22145.t2,three_way,53.47266666666667,FUN_011284-T1,Q5M775,CYTSB_HUMAN,,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),Homo sapiens (Human),46.2,106.0,1.9e-21,106.3,sp|Q5M775|CYTSB_HUMAN Cytospin-B OS=Homo sapiens OX=9606 GN=SPECC1 PE=1 SV=1,GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177,actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824],apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0048856; GO:0050877,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; organelle; anatomical structure development; nervous system process
OG_09650,0.8709949551595333,OG_09650,FUN_041848-T1,Peve_00010478,Pocillopora_meandrina_HIv1___RNAseq.g15073.t1,three_way,64.9195,FUN_041848-T1,P78543,BTG2_HUMAN,,Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3),Homo sapiens (Human),41.4,116.0,4e-19,96.3,sp|P78543|BTG2_HUMAN Protein BTG2 OS=Homo sapiens OX=9606 GN=BTG2 PE=1 SV=1,GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007405; GO:0007406; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0051602; GO:0060213; GO:0070062; GO:1904628,anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuroblast proliferation [GO:0007405]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0005829; GO:0006281; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140110,nucleus; cytosol; DNA repair; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; transcription regulator activity
OG_08057,0.8707459234538051,OG_08057,FUN_035752-T1,Peve_00044203,Pocillopora_meandrina_HIv1___RNAseq.g11880.t1,three_way,86.57133333333333,FUN_035752-T1,Q64701,RBL1_MOUSE,,Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1),Mus musculus (Mouse),50.0,1056.0,2.6e-275,949.9,sp|Q64701|RBL1_MOUSE Retinoblastoma-like protein 1 OS=Mus musculus OX=10090 GN=Rbl1 PE=1 SV=3,GO:0000122; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0010629; GO:0051726; GO:1990841; GO:2000773,chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],promoter-specific chromatin binding [GO:1990841],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_09692,0.8705803173497977,OG_09692,FUN_041921-T1,Peve_00007872,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1a,three_way,76.00366666666666,FUN_041921-T1,Q68F70,,,,,40.3,1001.0,6.6e-185,649.4,sp|Q68F70|INT4_XENLA Integrator complex subunit 4 OS=Xenopus laevis OX=8355 GN=ints4 PE=2 SV=1,,,,,,
OG_08835,0.8705483269185723,OG_08835,FUN_038179-T1,Peve_00009439,Pocillopora_meandrina_HIv1___RNAseq.g965.t1,three_way,67.80166666666668,FUN_038179-T1,Q9Y4F3,,,,,28.7,1454.0,1.1e-132,476.9,sp|Q9Y4F3|MARF1_HUMAN Meiosis regulator and mRNA stability factor 1 OS=Homo sapiens OX=9606 GN=MARF1 PE=1 SV=6,,,,,,
OG_07173,0.8705389631476638,OG_07173,FUN_032611-T1,Peve_00026810,Pocillopora_meandrina_HIv1___RNAseq.g29794.t1,three_way,66.65333333333334,FUN_032611-T1,P23359,BMP7_MOUSE,,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1),Mus musculus (Mouse),42.2,393.0,4.2e-78,293.5,sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2,GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0036305; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312,allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; vesicle [GO:0031982],BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005615; GO:0006355; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell adhesion; programmed cell death; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_02316,0.870478737367378,OG_02316,FUN_008907-T1,Peve_00027548,Pocillopora_meandrina_HIv1___RNAseq.g3972.t1,three_way,56.05233333333333,FUN_008907-T1,Q8CH34,ZP4_RAT,,Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4) (Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4],Rattus norvegicus (Rat),27.7,332.0,4.3e-14,80.5,sp|Q8CH34|ZP4_RAT Zona pellucida sperm-binding protein 4 OS=Rattus norvegicus OX=10116 GN=Zp4 PE=2 SV=1,GO:0002922; GO:0005576; GO:0005886; GO:0007339; GO:0032190; GO:0035804; GO:0035805; GO:0042102; GO:0042802; GO:0060468; GO:0060478; GO:0062023; GO:2000344; GO:2000360,acrosomal vesicle exocytosis [GO:0060478]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of humoral immune response [GO:0002922]; positive regulation of T cell proliferation [GO:0042102]; prevention of polyspermy [GO:0060468],collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],acrosin binding [GO:0032190]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804],GO:0005198; GO:0005576; GO:0005886; GO:0016192; GO:0030312; GO:0031012,structural molecule activity; extracellular region; plasma membrane; vesicle-mediated transport; external encapsulating structure; extracellular matrix
OG_02720,0.870410300106214,OG_02720,FUN_011048-T1,Peve_00013435,Pocillopora_meandrina_HIv1___RNAseq.g21483.t1,three_way,68.41766666666666,FUN_011048-T1,Q5PQT2,MTMR3_RAT,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase)",Rattus norvegicus (Rat),37.4,1193.0,2.4e-206,720.7,"sp|Q5PQT2|MTMR3_RAT Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Rattus norvegicus OX=10116 GN=Mtmr3 PE=1 SV=1",GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0008138; GO:0008270; GO:0016020; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785,cellular response to glucose starvation [GO:0042149]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],"molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0060090; GO:0061024; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; hydrolase activity; molecular adaptor activity; membrane organization; catalytic activity, acting on a protein"
OG_06230,0.8701199917427513,OG_06230,FUN_028180-T1,Peve_00001282,Pocillopora_meandrina_HIv1___RNAseq.g16511.t1,three_way,66.941,FUN_028180-T1,Q8BLN6,UNC80_MOUSE,,Protein unc-80 homolog (mUNC-80),Mus musculus (Mouse),29.5,3133.0,7.3e-307,1056.2,sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3,GO:0005886; GO:0030425; GO:0034706,,dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706],,GO:0005886,plasma membrane
OG_00048,0.8700284954599535,OG_00048,FUN_000285-T1,Peve_00033562,Pocillopora_meandrina_HIv1___RNAseq.g29071.t1,three_way,75.66833333333334,FUN_000285-T1,Q8BYH7,,,,,30.3,307.0,1.2e-37,159.1,sp|Q8BYH7|TBC17_MOUSE TBC1 domain family member 17 OS=Mus musculus OX=10090 GN=Tbc1d17 PE=1 SV=2,,,,,,
OG_04532,0.8699616766351166,OG_04532,FUN_022076-T1,Peve_00038277,Pocillopora_meandrina_HIv1___RNAseq.g9325.t1,three_way,82.528,FUN_022076-T1,B2GUE2,,,,,35.5,338.0,2.8e-25,117.9,sp|B2GUE2|LRRF2_XENTR Leucine-rich repeat flightless-interacting protein 2 OS=Xenopus tropicalis OX=8364 GN=lrrfip2 PE=2 SV=1,,,,,,
OG_01954,0.8699097551348165,OG_01954,FUN_008020-T1,Peve_00031302,Pocillopora_meandrina_HIv1___RNAseq.g30341.t1,three_way,85.20216666666667,FUN_008020-T1,P27448,MARK3_HUMAN,,MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78),Homo sapiens (Human),52.2,826.0,3.2000000000000005e-201,703.4,sp|P27448|MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens OX=9606 GN=MARK3 PE=1 SV=5,GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0048156; GO:0050321; GO:0070062; GO:0106310; GO:1900181,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005829; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06431,0.8698390832797246,OG_06431,FUN_029125-T1,Peve_00024870,Pocillopora_meandrina_HIv1___RNAseq.g25775.t1,three_way,64.52616666666667,FUN_029125-T1,A4IHD2,,,,,50.8,846.0,7.7e-237,822.4,sp|A4IHD2|ARIP4_XENTR Helicase ARIP4 OS=Xenopus tropicalis OX=8364 GN=rad54l2 PE=2 SV=1,,,,,,
OG_10009,0.8697001777624913,OG_10009,FUN_043244-T1,Peve_00001455,Pocillopora_meandrina_HIv1___RNAseq.g8844.t1,three_way,80.65866666666668,FUN_043244-T1,Q5ZJF4,PRDX6_CHICK,,Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx),Gallus gallus (Chicken),69.4,219.0,2.4e-87,323.2,sp|Q5ZJF4|PRDX6_CHICK Peroxiredoxin-6 OS=Gallus gallus OX=9031 GN=PRDX6 PE=2 SV=3,GO:0004601; GO:0004623; GO:0005615; GO:0005764; GO:0005829; GO:0016042; GO:0045454; GO:0047184; GO:0051920,cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042],cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005829; GO:0006629; GO:0016209; GO:0016491; GO:0016740; GO:0016787; GO:0043226,catalytic activity; extracellular space; lysosome; vacuole; cytosol; lipid metabolic process; antioxidant activity; oxidoreductase activity; transferase activity; hydrolase activity; organelle
OG_05325,0.8695136623666345,OG_05325,FUN_024017-T1,Peve_00023794,Pocillopora_meandrina_HIv1___RNAseq.g19284.t1,three_way,80.70366666666666,FUN_024017-T1,F6UA42,,,,,57.2,797.0,4.3e-248,859.0,sp|F6UA42|UHRF1_XENTR E3 ubiquitin-protein ligase UHRF1 OS=Xenopus tropicalis OX=8364 GN=uhrf1 PE=3 SV=2,,,,,,
OG_08475,0.8695011149606969,OG_08475,FUN_037298-T1,Peve_00004415,Pocillopora_meandrina_HIv1___RNAseq.g10685.t1,three_way,84.8545,FUN_037298-T1,Q8IVV2,,,,,40.2,2254.0,0.0,1702.6,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_09297,0.8694587145409366,OG_09297,FUN_040150-T1,Peve_00038146,Pocillopora_meandrina_HIv1___TS.g20237.t1,three_way,63.22716666666667,FUN_040150-T1,Q7Z591,AKNA_HUMAN,,Microtubule organization protein AKNA (AT-hook-containing transcription factor),Homo sapiens (Human),27.6,254.0,1.3e-09,67.4,sp|Q7Z591|AKNA_HUMAN Microtubule organization protein AKNA OS=Homo sapiens OX=9606 GN=AKNA PE=1 SV=2,GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234,delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654],DNA binding [GO:0003677],GO:0003677; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0030154; GO:0043226,DNA binding; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle
OG_09640,0.869443669257559,OG_09640,FUN_041835-T1,Peve_00009638,Pocillopora_meandrina_HIv1___RNAseq.g15085.t1,three_way,89.23433333333334,FUN_041835-T1,Q2HJ40,BACE1_BOVIN,,Beta-secretase 1 (EC 3.4.23.46) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2),Bos taurus (Bovine),47.6,429.0,8.5e-117,422.2,sp|Q2HJ40|BACE1_BOVIN Beta-secretase 1 OS=Bos taurus OX=9913 GN=BACE1 PE=2 SV=1,GO:0004175; GO:0004190; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006508; GO:0006509; GO:0009986; GO:0030424; GO:0030425; GO:0030659; GO:0045121; GO:0050435; GO:0055037,amyloid-beta metabolic process [GO:0050435]; membrane protein ectodomain proteolysis [GO:0006509]; proteolysis [GO:0006508],axon [GO:0030424]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_06104,0.8692105240567143,OG_06104,FUN_027805-T1,Peve_00036485,Pocillopora_meandrina_HIv1___RNAseq.g13898.t1,three_way,81.17733333333334,FUN_027805-T1,Q8BHJ5,TBL1R_MOUSE,,F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1),Mus musculus (Mouse),58.4,514.0,4.8e-120,433.0,sp|Q8BHJ5|TBL1R_MOUSE F-box-like/WD repeat-containing protein TBL1XR1 OS=Mus musculus OX=10090 GN=Tbl1xr1 PE=1 SV=1,GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0008013; GO:0010468; GO:0016042; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0045892; GO:0045944; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263,adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; fat pad development [GO:0060613]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872],histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0006629; GO:0030154; GO:0030163; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; cell differentiation; protein catabolic process; histone binding; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_00307,0.8690676662764159,OG_00307,FUN_001109-T1,Peve_00029332,Pocillopora_meandrina_HIv1___RNAseq.g29364.t1,three_way,74.86366666666667,FUN_001109-T1,Q571G4,LIN54_MOUSE,,Protein lin-54 homolog,Mus musculus (Mouse),44.9,499.0,9.2e-94,345.9,sp|Q571G4|LIN54_MOUSE Protein lin-54 homolog OS=Mus musculus OX=10090 GN=Lin54 PE=2 SV=2,GO:0001067; GO:0003680; GO:0034728; GO:0046872; GO:0090571,nucleosome organization [GO:0034728],RNA polymerase II transcription repressor complex [GO:0090571],metal ion binding [GO:0046872]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; transcription regulatory region nucleic acid binding [GO:0001067],GO:0003677; GO:0006325,DNA binding; chromatin organization
OG_06620,0.8689594590972232,OG_06620,FUN_029881-T1,Peve_00008451,Pocillopora_meandrina_HIv1___TS.g3099.t1,three_way,53.879333333333335,,,,,,,,,,,,,,,,,
OG_03792,0.8689353262844188,OG_03792,FUN_015158-T1,Peve_00001862,Pocillopora_meandrina_HIv1___RNAseq.g21765.t1,three_way,81.74516666666666,FUN_015158-T1,Q96DH6,,,,,47.2,335.0,2.3e-67,257.7,sp|Q96DH6|MSI2H_HUMAN RNA-binding protein Musashi homolog 2 OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=1,,,,,,
OG_09153,0.8688126640581402,OG_09153,FUN_039808-T1,Peve_00020313,Pocillopora_meandrina_HIv1___RNAseq.g7486.t1,three_way,89.93166666666667,FUN_039808-T1,P42026,NDUS7_BOVIN,,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)",Bos taurus (Bovine),82.2,169.0,2.1000000000000002e-81,303.1,"sp|P42026|NDUS7_BOVIN NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS7 PE=1 SV=1",GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0015990; GO:0032981; GO:0045271; GO:0046872; GO:0048038; GO:0051539,"aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]",mitochondrial inner membrane [GO:0005743]; respiratory chain complex I [GO:0045271],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]",GO:0005215; GO:0006091; GO:0055085; GO:0065003,transporter activity; generation of precursor metabolites and energy; transmembrane transport; protein-containing complex assembly
OG_02443,0.8687985938232428,OG_02443,FUN_009512-T1,Peve_00040630,Pocillopora_meandrina_HIv1___TS.g24209.t1,three_way,57.00666666666667,FUN_009512-T1,A6LX31,,,,,46.4,252.0,2.1e-56,221.5,sp|A6LX31|Y2760_CLOB8 Putative hydro-lyase Cbei_2760 OS=Clostridium beijerinckii (strain ATCC 51743 / NCIMB 8052) OX=290402 GN=Cbei_2760 PE=3 SV=1,,,,,,
OG_00348,0.8686307553585983,OG_00348,FUN_001175-T1,Peve_00015994,Pocillopora_meandrina_HIv1___RNAseq.g29156.t1,three_way,64.6045,FUN_001175-T1,Q1LUQ4,,,,,24.8,568.0,1.6e-35,152.5,sp|Q1LUQ4|MFD6A_DANRE Major facilitator superfamily domain-containing protein 6-A OS=Danio rerio OX=7955 GN=mfsd6a PE=3 SV=1,,,,,,
OG_05684,0.8686259077909426,OG_05684,FUN_025527-T1,Peve_00009002,Pocillopora_meandrina_HIv1___RNAseq.g23047.t1,three_way,85.454,FUN_025527-T1,Q9D2N4,DTNA_MOUSE,,Dystrobrevin alpha (DTN-A) (Alpha-dystrobrevin),Mus musculus (Mouse),46.0,554.0,2.5e-117,424.1,sp|Q9D2N4|DTNA_MOUSE Dystrobrevin alpha OS=Mus musculus OX=10090 GN=Dtna PE=1 SV=2,GO:0005737; GO:0008270; GO:0016014; GO:0032991; GO:0042383; GO:0045202,,cytoplasm [GO:0005737]; dystrobrevin complex [GO:0016014]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005886,plasma membrane
OG_09379,0.8686071617877124,OG_09379,FUN_040615-T1,Peve_00015411,Pocillopora_meandrina_HIv1___RNAseq.g6470.t1,three_way,87.62333333333333,FUN_040615-T1,E9PV86,,,,,44.3,711.0,1.7e-153,544.7,sp|E9PV86|MCTP1_MOUSE Multiple C2 and transmembrane domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mctp1 PE=1 SV=1,,,,,,
OG_01447,0.8683834153044595,OG_01447,FUN_005896-T1,Peve_00035817,Pocillopora_meandrina_HIv1___RNAseq.3177_t,three_way,67.3925,FUN_005896-T1,Q8K2Y0,,,,,39.0,141.0,1.2e-15,86.3,sp|Q8K2Y0|OBI1_MOUSE ORC ubiquitin ligase 1 OS=Mus musculus OX=10090 GN=Obi1 PE=1 SV=2,,,,,,
OG_02339,0.868283064527769,OG_02339,FUN_008935-T1,Peve_00036395,Pocillopora_meandrina_HIv1___TS.g5740.t1,three_way,79.28566666666667,FUN_008935-T1,A0JM56,,,,,51.8,1431.0,1.4000000000000001e-186,655.6,sp|A0JM56|LRRC9_XENTR Leucine-rich repeat-containing protein 9 OS=Xenopus tropicalis OX=8364 GN=lrrc9 PE=2 SV=2,,,,,,
OG_00383,0.8675931732902357,OG_00383,FUN_001235-T1,Peve_00002839,Pocillopora_meandrina_HIv1___TS.g5021.t3,three_way,88.22116666666666,FUN_001235-T1,Q60520,SIN3A_MOUSE,,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),Mus musculus (Mouse),56.3,1191.0,0.0,1134.4,sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3,GO:0000122; GO:0000776; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351,activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337],kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416],GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006325; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; RNA binding; nucleus; nucleoplasm; nucleolus; DNA replication; chromatin organization; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_05078,0.8675101873976002,OG_05078,FUN_023307-T1,Peve_00041315,Pocillopora_meandrina_HIv1___RNAseq.g17774.t1,three_way,62.178,FUN_023307-T1,Q9QXT1,,,,,36.0,86.0,3.4e-10,67.4,sp|Q9QXT1|DAPP1_MOUSE Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide OS=Mus musculus OX=10090 GN=Dapp1 PE=1 SV=1,,,,,,
OG_06541,0.8673729045400327,OG_06541,FUN_029405-T1,Peve_00035059,Pocillopora_meandrina_HIv1___RNAseq.g17144.t1,three_way,85.84700000000001,FUN_029405-T1,Q3MHG1,SPTC1_BOVIN,,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),Bos taurus (Bovine),57.5,463.0,4.2e-156,552.7,sp|Q3MHG1|SPTC1_BOVIN Serine palmitoyltransferase 1 OS=Bos taurus OX=9913 GN=SPTLC1 PE=2 SV=1,GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0017059; GO:0030170; GO:0046512; GO:0046513; GO:1904649,ceramide biosynthetic process [GO:0046513]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059],pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_09280,0.8673679884501274,OG_09280,FUN_040095-T1,Peve_00037198,Pocillopora_meandrina_HIv1___RNAseq.g7609.t1,three_way,67.75166666666667,,,,,,,,,,,,,,,,,
OG_05403,0.867306753063685,OG_05403,FUN_024334-T1,Peve_00016307,Pocillopora_meandrina_HIv1___RNAseq.g18941.t1,three_way,70.359,FUN_024334-T1,Q99MK9,,,,,38.3,313.0,2e-57,224.9,sp|Q99MK9|RASF1_MOUSE Ras association domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rassf1 PE=1 SV=1,,,,,,
OG_02640,0.8671967788592989,OG_02640,FUN_010808-T1,Peve_00006509,Pocillopora_meandrina_HIv1___RNAseq.g20903.t1,three_way,79.348,FUN_010808-T1,Q3TYL0,,,,,49.1,489.0,1.2e-64,249.2,sp|Q3TYL0|IQAK1_MOUSE IQ motif and ankyrin repeat domain-containing protein 1 OS=Mus musculus OX=10090 GN=Iqank1 PE=1 SV=3,,,,,,
OG_02111,0.8671700040869909,OG_02111,FUN_008396-T1,Peve_00043608,Pocillopora_meandrina_HIv1___RNAseq.g6175.t1,three_way,71.88550000000001,FUN_008396-T1,Q9EQC5,SCYL1_MOUSE,,N-terminal kinase-like protein (105 kDa kinase-like protein) (Mitosis-associated kinase-like protein NTKL) (SCY1-like protein 1),Mus musculus (Mouse),51.4,675.0,2.1e-182,641.0,sp|Q9EQC5|SCYL1_MOUSE N-terminal kinase-like protein OS=Mus musculus OX=10090 GN=Scyl1 PE=1 SV=1,GO:0004672; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005813; GO:0005829; GO:0006890; GO:0006954; GO:0008104; GO:0021522; GO:0030126; GO:0048666,"inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]",centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; protein kinase activity [GO:0004672],GO:0003824; GO:0005794; GO:0005815; GO:0005829; GO:0006954; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; microtubule organizing center; cytosol; inflammatory response; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08301,0.8670362112844111,OG_08301,FUN_036251-T1,Peve_00045290,Pocillopora_meandrina_HIv1___RNAseq.g27588.t1,three_way,74.035,FUN_036251-T1,P20042,IF2B_HUMAN,,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta),Homo sapiens (Human),85.7,168.0,3.3000000000000003e-80,300.1,sp|P20042|IF2B_HUMAN Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens OX=9606 GN=EIF2S2 PE=1 SV=2,GO:0001701; GO:0001731; GO:0002176; GO:0002183; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0008270; GO:0008584; GO:0031369; GO:0045202,cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202],"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]",GO:0003723; GO:0005829; GO:0022414; GO:0048856; GO:0065003,RNA binding; cytosol; reproductive process; anatomical structure development; protein-containing complex assembly
OG_10105,0.8666932142233652,OG_10105,FUN_043447-T1,Peve_00015294,Pocillopora_meandrina_HIv1___RNAseq.g7900.t1,three_way,62.12,FUN_043447-T1,Q9Z148,EHMT2_MOUSE,,Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a),Mus musculus (Mouse),35.3,538.0,2.6e-88,328.6,sp|Q9Z148|EHMT2_MOUSE Histone-lysine N-methyltransferase EHMT2 OS=Mus musculus OX=10090 GN=Ehmt2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006346; GO:0006357; GO:0007130; GO:0007286; GO:0008270; GO:0009267; GO:0009566; GO:0016279; GO:0016607; GO:0018027; GO:0035265; GO:0036166; GO:0044027; GO:0046974; GO:0046976; GO:0048148; GO:0048599; GO:0048665; GO:0070742; GO:0071314; GO:0140759; GO:0140947; GO:1902902; GO:1990841,behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130],chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],C2H2 zinc finger domain binding [GO:0070742]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K56 methyltransferase activity [GO:0140759]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9me2 methyltransferase activity [GO:0140947]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09545,0.8666837292388065,OG_09545,FUN_041642-T1,Peve_00007386,Pocillopora_meandrina_HIv1___RNAseq.g14207.t1,three_way,91.14133333333334,FUN_041642-T1,Q13620,,,,,73.3,580.0,1.9e-245,849.7,sp|Q13620|CUL4B_HUMAN Cullin-4B OS=Homo sapiens OX=9606 GN=CUL4B PE=1 SV=4,,,,,,
OG_08516,0.8666000565653631,OG_08516,FUN_037445-T1,Peve_00027035,Pocillopora_meandrina_HIv1___RNAseq.g10976.t1,three_way,56.40266666666667,FUN_037445-T1,Q56UN5,M3K19_HUMAN,,"Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)",Homo sapiens (Human),61.7,274.0,1.7999999999999997e-95,353.2,sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens OX=9606 GN=MAP3K19 PE=2 SV=1,GO:0000165; GO:0004709; GO:0005524; GO:0106310,MAPK cascade [GO:0000165],,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04281,0.8664512614730986,OG_04281,FUN_017843-T1,Peve_00018632,Pocillopora_meandrina_HIv1___RNAseq.g9587.t3,three_way,50.5255,,,,,,,,,,,,,,,,,
OG_00107,0.8664259403498055,OG_00107,FUN_000499-T1,Peve_00024155,Pocillopora_meandrina_HIv1___RNAseq.g2414.t1,three_way,82.06683333333332,FUN_000499-T1,Q14432,PDE3A_HUMAN,,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)",Homo sapiens (Human),37.6,1034.0,2.2e-143,511.5,"sp|Q14432|PDE3A_HUMAN cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A OS=Homo sapiens OX=9606 GN=PDE3A PE=1 SV=3",GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0019933; GO:0019934; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072; GO:0141162,apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; membrane [GO:0016020],"3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284]",GO:0003013; GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0022414; GO:0060089; GO:0140110,circulatory system process; catalytic activity; cytosol; lipid metabolic process; hydrolase activity; reproductive process; molecular transducer activity; transcription regulator activity
OG_07259,0.8664095603117711,OG_07259,FUN_033036-T1,Peve_00017502,Pocillopora_meandrina_HIv1___RNAseq.g24450.t1,three_way,76.906,FUN_033036-T1,Q96QG7,,,,,53.2,329.0,2.6e-101,370.2,sp|Q96QG7|MTMR9_HUMAN Myotubularin-related protein 9 OS=Homo sapiens OX=9606 GN=MTMR9 PE=1 SV=1,,,,,,
OG_09672,0.8663005049689125,OG_09672,FUN_041890-T1,Peve_00033394,Pocillopora_meandrina_HIv1___RNAseq.g15420.t1,three_way,92.026,FUN_041890-T1,P38117,ETFB_HUMAN,,Electron transfer flavoprotein subunit beta (Beta-ETF),Homo sapiens (Human),68.8,253.0,1.4e-94,347.4,sp|P38117|ETFB_HUMAN Electron transfer flavoprotein subunit beta OS=Homo sapiens OX=9606 GN=ETFB PE=1 SV=3,GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251,amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904],electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],electron transfer activity [GO:0009055],GO:0005739; GO:0006091; GO:0006520; GO:0006629; GO:0043226,mitochondrion; generation of precursor metabolites and energy; amino acid metabolic process; lipid metabolic process; organelle
OG_07938,0.8661000429135851,OG_07938,FUN_035444-T1,Peve_00002174,Pocillopora_meandrina_HIv1___RNAseq.g27111.t1,three_way,85.51933333333334,FUN_035444-T1,Q8BZZ3,WWP1_MOUSE,,NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase WWP1) (WW domain-containing protein 1),Mus musculus (Mouse),57.0,910.0,8.499999999999999e-234,811.6,sp|Q8BZZ3|WWP1_MOUSE NEDD4-like E3 ubiquitin-protein ligase WWP1 OS=Mus musculus OX=10090 GN=Wwp1 PE=1 SV=2,GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0016567; GO:0030217; GO:0030324; GO:0043161; GO:0045892; GO:0061630; GO:0070161,lung development [GO:0030324]; negative regulation of DNA-templated transcription [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217],anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03660,0.8659887268869527,OG_03660,FUN_014897-T1,Peve_00003545,Pocillopora_meandrina_HIv1___RNAseq.g21065.t1,three_way,70.15983333333334,FUN_014897-T1,Q9Y4D8,,,,,34.5,4127.0,0.0,2025.4,sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5,,,,,,
OG_09101,0.865966928639115,OG_09101,FUN_038918-T1,Peve_00004516,Pocillopora_meandrina_HIv1___RNAseq.g1083.t1,three_way,89.98166666666667,FUN_038918-T1,Q5ZL26,,,,,61.2,366.0,3.8e-122,439.5,sp|Q5ZL26|KPRB_CHICK Phosphoribosyl pyrophosphate synthase-associated protein 2 OS=Gallus gallus OX=9031 GN=PRPSAP2 PE=2 SV=1,,,,,,
OG_05779,0.8657317566147386,OG_05779,FUN_025750-T1,Peve_00007726,Pocillopora_meandrina_HIv1___RNAseq.g10411.t1,three_way,86.325,FUN_025750-T1,O57656,,,,,52.3,392.0,2.1999999999999998e-107,390.6,"sp|O57656|GPDA_TAKRU Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic OS=Takifugu rubripes OX=31033 GN=gpd1 PE=3 SV=1",,,,,,
OG_02697,0.8656405995056432,OG_02697,FUN_010962-T1,Peve_00007923,Pocillopora_meandrina_HIv1___TS.g26730.t1,three_way,80.4425,FUN_010962-T1,Q3U319,BRE1B_MOUSE,,E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B),Mus musculus (Mouse),32.2,997.0,1.5e-111,405.6,sp|Q3U319|BRE1B_MOUSE E3 ubiquitin-protein ligase BRE1B OS=Mus musculus OX=10090 GN=Rnf40 PE=1 SV=2,GO:0003730; GO:0004842; GO:0005654; GO:0006325; GO:0008270; GO:0016567; GO:0031625; GO:0033503; GO:0042803; GO:0045944,chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567],HULC complex [GO:0033503]; nucleoplasm [GO:0005654],mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0140096,"RNA binding; catalytic activity; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; catalytic activity, acting on a protein"
OG_00746,0.8654776197814702,OG_00746,FUN_002736-T1,Peve_00041437,Pocillopora_meandrina_HIv1___RNAseq.g14951.t1,three_way,65.202,FUN_002736-T1,Q9BXT6,M10L1_HUMAN,,RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1),Homo sapiens (Human),39.3,1153.0,1.3999999999999999e-221,771.5,sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196,germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; cytosol; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04851,0.8652897078363747,OG_04851,FUN_022863-T1,Peve_00025604,Pocillopora_meandrina_HIv1___RNAseq.g3607.t1,three_way,83.18433333333333,FUN_022863-T1,Q5F450,PAN2_CHICK,,PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2),Gallus gallus (Chicken),51.1,1129.0,0.0,1086.6,sp|Q5F450|PAN2_CHICK PAN2-PAN3 deadenylation complex catalytic subunit PAN2 OS=Gallus gallus OX=9031 GN=PAN2 PE=2 SV=1,GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872,mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535],GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03658,0.865287081293972,OG_03658,FUN_014895-T1,Peve_00003547,Pocillopora_meandrina_HIv1___RNAseq.g21105.t1,three_way,67.7525,FUN_014895-T1,Q0VH32,,,,,50.8,122.0,6.3999999999999975e-25,116.3,sp|Q0VH32|MNT_XENLA Max-binding protein MNT OS=Xenopus laevis OX=8355 GN=mnt PE=2 SV=1,,,,,,
OG_01905,0.8652407073907746,OG_01905,FUN_007919-T1,Peve_00040675,Pocillopora_meandrina_HIv1___RNAseq.g30121.t1,three_way,90.73183333333331,FUN_007919-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),63.3,608.0,1.6e-207,724.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_00548,0.865164506335865,OG_00548,FUN_001587-T1,Peve_00005425,Pocillopora_meandrina_HIv1___RNAseq.g2036.t2,three_way,66.00816666666667,FUN_001587-T1,Q8R3B7,BRD8_MOUSE,,Bromodomain-containing protein 8,Mus musculus (Mouse),26.4,981.0,8.299999999999999e-46,187.2,sp|Q8R3B7|BRD8_MOUSE Bromodomain-containing protein 8 OS=Mus musculus OX=10090 GN=Brd8 PE=1 SV=2,GO:0000786; GO:0000812; GO:0003713; GO:0005739; GO:0006325; GO:0035267; GO:0042981; GO:0045893; GO:0045944; GO:0046966; GO:0051726; GO:0097067; GO:1905168; GO:2000779,cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779],mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812],nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713],GO:0005739; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,mitochondrion; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_04914,0.865158135133265,OG_04914,FUN_022968-T1,Peve_00011901,Pocillopora_meandrina_HIv1___RNAseq.g3762.t1,three_way,74.65283333333333,FUN_022968-T1,Q14185,,,,,47.2,1635.0,0.0,1488.4,sp|Q14185|DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=2,,,,,,
OG_02710,0.8650794388543059,OG_02710,FUN_010988-T1,Peve_00013393,Pocillopora_meandrina_HIv1___TS.g26769.t2,three_way,57.87616666666666,FUN_010988-T1,Q6NWI1,,,,,32.3,189.0,1.5e-11,72.0,sp|Q6NWI1|RSRC2_DANRE Arginine/serine-rich coiled-coil protein 2 OS=Danio rerio OX=7955 GN=rsrc2 PE=2 SV=1,,,,,,
OG_02482,0.8650117672579611,OG_02482,FUN_009776-T1,Peve_00002105,Pocillopora_meandrina_HIv1___TS.g12502.t1,three_way,70.31866666666666,FUN_009776-T1,Q9JID6,,,,,50.2,665.0,5.3e-189,662.5,sp|Q9JID6|ACSL1_CAVPO Long-chain-fatty-acid--CoA ligase 1 OS=Cavia porcellus OX=10141 GN=ACSL1 PE=2 SV=1,,,,,,
OG_07272,0.8649259944033468,OG_07272,FUN_033210-T1,Peve_00043517,Pocillopora_meandrina_HIv1___RNAseq.g29763.t1,three_way,93.34833333333331,FUN_033210-T1,P63328,PP2BA_MOUSE,,Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform),Mus musculus (Mouse),80.6,407.0,2.1e-201,703.0,sp|P63328|PP2BA_MOUSE Protein phosphatase 3 catalytic subunit alpha OS=Mus musculus OX=10090 GN=Ppp3ca PE=1 SV=1,GO:0000082; GO:0004721; GO:0004723; GO:0005516; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008287; GO:0008544; GO:0009898; GO:0010613; GO:0010628; GO:0010629; GO:0014883; GO:0014898; GO:0019722; GO:0023057; GO:0030018; GO:0030216; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0042104; GO:0042383; GO:0043197; GO:0045669; GO:0045672; GO:0045807; GO:0045944; GO:0046872; GO:0046878; GO:0046983; GO:0048741; GO:0048813; GO:0050774; GO:0050804; GO:0051117; GO:0051592; GO:0060079; GO:0061006; GO:0070886; GO:0090193; GO:0097205; GO:0098685; GO:0098978; GO:0099170; GO:0110062; GO:1903244; GO:1905205; GO:1905665; GO:1905949,calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy in response to stress [GO:0014898]; dendrite morphogenesis [GO:0048813]; epidermis development [GO:0008544]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiotensin-activated signaling pathway [GO:0110062]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of signaling [GO:0023057]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of saliva secretion [GO:0046878]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; regulation of cell proliferation involved in kidney morphogenesis [GO:0061006]; renal filtration [GO:0097205]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883],calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein serine/threonine phosphatase complex [GO:0008287]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018],ATPase binding [GO:0051117]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein dimerization activity [GO:0046983],GO:0003012; GO:0003014; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"muscle system process; renal system process; catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01393,0.864729575941274,OG_01393,FUN_005369-T1,Peve_00041469,Pocillopora_meandrina_HIv1___RNAseq.g6632.t2,three_way,79.86133333333333,FUN_005369-T1,Q9UPW5,CBPC1_HUMAN,,Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1 homolog) (Protein deglutamylase CCP1),Homo sapiens (Human),42.5,1201.0,9.6e-233,808.5,sp|Q9UPW5|CBPC1_HUMAN Cytosolic carboxypeptidase 1 OS=Homo sapiens OX=9606 GN=AGTPBP1 PE=1 SV=3,GO:0001754; GO:0004181; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006508; GO:0007005; GO:0007628; GO:0008270; GO:0008285; GO:0015630; GO:0015631; GO:0021702; GO:0021772; GO:0021954; GO:0034451; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0050905; GO:0060041; GO:0098957; GO:0098958; GO:1904115; GO:2000060,adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958],axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007005; GO:0007018; GO:0008092; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; mitochondrion organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_03895,0.8647118618824567,OG_03895,FUN_015470-T1,Peve_00009523,Pocillopora_meandrina_HIv1___RNAseq.g20981.t1,three_way,61.727,FUN_015470-T1,Q12872,SFSWA_HUMAN,,"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)",Homo sapiens (Human),40.4,451.0,5e-19,97.8,"sp|Q12872|SFSWA_HUMAN Splicing factor, suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3",GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025,"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]",nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_07091,0.8646952527287216,OG_07091,FUN_032348-T1,Peve_00012753,Pocillopora_meandrina_HIv1___TS.g25052.t1,three_way,72.73100000000001,FUN_032348-T1,Q9PT60,,,,,44.5,263.0,4.7e-52,207.2,sp|Q9PT60|RBP1A_XENLA RalA-binding protein 1-A OS=Xenopus laevis OX=8355 GN=ralbp1-a PE=1 SV=3,,,,,,
OG_07764,0.8646884147069747,OG_07764,FUN_034958-T1,Peve_00036684,Pocillopora_meandrina_HIv1___RNAseq.g27833.t1,three_way,75.85683333333333,FUN_034958-T1,Q8IXH6,T53I2_HUMAN,,Tumor protein p53-inducible nuclear protein 2 (Diabetes and obesity-regulated gene) (p53-inducible protein U) (PIG-U),Homo sapiens (Human),47.5,80.0,5.2e-12,72.8,sp|Q8IXH6|T53I2_HUMAN Tumor protein p53-inducible nuclear protein 2 OS=Homo sapiens OX=9606 GN=TP53INP2 PE=1 SV=2,GO:0000045; GO:0001649; GO:0001894; GO:0005634; GO:0005776; GO:0005829; GO:0006511; GO:0008104; GO:0016605; GO:0031410; GO:0043130; GO:0045893; GO:1903828,autophagosome assembly [GO:0000045]; negative regulation of protein localization [GO:1903828]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization [GO:0008104]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511],autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605],ubiquitin binding [GO:0043130],GO:0005634; GO:0005773; GO:0005829; GO:0006355; GO:0030154; GO:0031410; GO:0043226,nucleus; vacuole; cytosol; regulation of DNA-templated transcription; cell differentiation; cytoplasmic vesicle; organelle
OG_07222,0.8646079358113238,OG_07222,FUN_032815-T1,Peve_00014570,Pocillopora_meandrina_HIv1___RNAseq.g29707.t1,three_way,69.17233333333334,FUN_032815-T1,Q5HYM0,ZC12B_HUMAN,,Probable ribonuclease ZC3H12B (EC 3.1.-.-) (MCP-induced protein 2) (Zinc finger CCCH domain-containing protein 12B),Homo sapiens (Human),59.1,220.0,8.099999999999997e-69,263.1,sp|Q5HYM0|ZC12B_HUMAN Probable ribonuclease ZC3H12B OS=Homo sapiens OX=9606 GN=ZC3H12B PE=1 SV=3,GO:0003729; GO:0004521; GO:0005634; GO:0008270; GO:0036464,,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; organelle; catalytic activity, acting on RNA"
OG_05816,0.8644343473983581,OG_05816,FUN_025823-T1,Peve_00036294,Pocillopora_meandrina_HIv1___RNAseq.g9342.t1,three_way,86.49533333333333,FUN_025823-T1,Q2TCH3,ACLY_SHEEP,,ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme),Ovis aries (Sheep),69.7,1104.0,0.0,1583.2,sp|Q2TCH3|ACLY_SHEEP ATP-citrate synthase OS=Ovis aries OX=9940 GN=ACLY PE=2 SV=1,GO:0003878; GO:0005524; GO:0005829; GO:0006085; GO:0006101; GO:0006633; GO:0008610; GO:0046872,acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610],cytosol [GO:0005829],ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872],GO:0003824; GO:0005829; GO:0006629; GO:0006790; GO:0016740; GO:0055086,catalytic activity; cytosol; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process
OG_04293,0.864368467422406,OG_04293,FUN_017859-T1,Peve_00014752,Pocillopora_meandrina_HIv1___RNAseq.g9574.t2,three_way,59.749500000000005,FUN_017859-T1,Q04205,,,,,47.0,285.0,3.1e-68,261.9,sp|Q04205|TENS1_CHICK Tensin-1 OS=Gallus gallus OX=9031 GN=TNS1 PE=1 SV=3,,,,,,
OG_00478,0.8641532592882034,OG_00478,FUN_001417-T1,Peve_00008743,Pocillopora_meandrina_HIv1___RNAseq.g2096.t1,three_way,84.827,FUN_001417-T1,Q8C5L3,CNOT2_MOUSE,,CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2),Mus musculus (Mouse),43.2,562.0,2.8e-94,347.8,sp|Q8C5L3|CNOT2_MOUSE CCR4-NOT transcription complex subunit 2 OS=Mus musculus OX=10090 GN=Cnot2 PE=1 SV=2,GO:0000122; GO:0001222; GO:0001829; GO:0004535; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006417; GO:0010606; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:2000036,negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829],CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],poly(A)-specific ribonuclease activity [GO:0004535]; transcription corepressor binding [GO:0001222],GO:0003824; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0031047; GO:0140098,"catalytic activity; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; regulatory ncRNA-mediated gene silencing; catalytic activity, acting on RNA"
OG_06443,0.8640740436333874,OG_06443,FUN_029154-T1,Peve_00041026,Pocillopora_meandrina_HIv1___RNAseq.g25735.t1,three_way,90.00566666666667,FUN_029154-T1,Q86XH1,,,,,57.3,820.0,1.7000000000000002e-218,760.8,sp|Q86XH1|DRC11_HUMAN Dynein regulatory complex protein 11 OS=Homo sapiens OX=9606 GN=IQCA1 PE=1 SV=1,,,,,,
OG_04524,0.8640127025876613,OG_04524,FUN_022059-T1,Peve_00014932,Pocillopora_meandrina_HIv1___RNAseq.g4610.t1,three_way,48.778,FUN_022059-T1,Q9NVV4,PAPD1_HUMAN,,"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)",Homo sapiens (Human),35.3,292.0,4.3e-40,167.9,"sp|Q9NVV4|PAPD1_HUMAN Poly(A) RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=MTPAP PE=1 SV=1",GO:0000287; GO:0000965; GO:0002134; GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0006397; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0043231; GO:0071044; GO:1990817,histone mRNA catabolic process [GO:0071044]; mitochondrial RNA 3'-end processing [GO:0000965]; mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123],intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; poly(A) RNA polymerase activity [GO:1990817]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0016071; GO:0016740; GO:0043226; GO:0140053,RNA binding; catalytic activity; nucleoplasm; mitochondrion; mRNA metabolic process; transferase activity; organelle; mitochondrial gene expression
OG_02517,0.863995787506158,OG_02517,FUN_010576-T1,Peve_00032735,Pocillopora_meandrina_HIv1___RNAseq.g21522.t1,three_way,61.242666666666665,,,,,,,,,,,,,,,,,
OG_03406,0.8639914061778846,OG_03406,FUN_014449-T1,Peve_00009606,Pocillopora_meandrina_HIv1___RNAseq.1985_t,three_way,77.316,FUN_014449-T1,Q54BU4,ABCB1_DICDI,,ABC transporter B family member 1 (ABC transporter ABCB.1),Dictyostelium discoideum (Social amoeba),51.9,620.0,1.3e-162,575.1,sp|Q54BU4|ABCB1_DICDI ABC transporter B family member 1 OS=Dictyostelium discoideum OX=44689 GN=abcB1 PE=3 SV=1,GO:0005524; GO:0006935; GO:0006972; GO:0016020; GO:0016887; GO:0031154; GO:0042626; GO:0055085; GO:0140359,chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085],membrane [GO:0016020],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626],GO:0003824; GO:0005215; GO:0016787; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_04488,0.8638810541907476,OG_04488,FUN_021610-T1,Peve_00002673,Pocillopora_meandrina_HIv1___RNAseq.g2919.t1,three_way,82.09833333333333,FUN_021610-T1,Q07537,GALT1_BOVIN,,Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form],Bos taurus (Bovine),47.5,556.0,7.3e-141,502.3,sp|Q07537|GALT1_BOVIN Polypeptide N-acetylgalactosaminyltransferase 1 OS=Bos taurus OX=9913 GN=GALNT1 PE=1 SV=1,GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471,protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005576; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; extracellular region; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04906,0.8637113652939776,OG_04906,FUN_022955-T1,Peve_00001405,Pocillopora_meandrina_HIv1___RNAseq.17404_t,three_way,60.97516666666667,FUN_022955-T1,Q8CGI1,,,,,56.6,76.0,3.5e-19,99.0,sp|Q8CGI1|F193A_MOUSE Protein FAM193A OS=Mus musculus OX=10090 GN=Fam193a PE=1 SV=2,,,,,,
OG_10132,0.8635694380750302,OG_10132,FUN_043515-T1,Peve_00040847,Pocillopora_meandrina_HIv1___RNAseq.g15975.t1,three_way,75.199,,,,,,,,,,,,,,,,,
OG_02017,0.8635317422447352,OG_02017,FUN_008194-T1,Peve_00022158,Pocillopora_meandrina_HIv1___RNAseq.g30170.t1,three_way,74.29066666666667,FUN_008194-T1,Q99538,LGMN_HUMAN,,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (AEP) (Protease, cysteine 1)",Homo sapiens (Human),62.9,280.0,2.7e-100,366.7,sp|Q99538|LGMN_HUMAN Legumain OS=Homo sapiens OX=9606 GN=LGMN PE=1 SV=1,GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0019886; GO:0032801; GO:0035729; GO:0036021; GO:0040015; GO:0042359; GO:0043202; GO:0043524; GO:0045177; GO:0045931; GO:0048156; GO:0048471; GO:0051603; GO:0051604; GO:0061133; GO:0070062; GO:0071277; GO:0090026; GO:0097061; GO:1900273; GO:1901185; GO:1904646; GO:2001028,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; vacuolar protein processing [GO:0006624]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; peptidase activity [GO:0008233]; tau protein binding [GO:0048156],GO:0002376; GO:0003014; GO:0003824; GO:0005576; GO:0005764; GO:0005768; GO:0005773; GO:0006629; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0050877; GO:0051604; GO:0098772; GO:0140096,"immune system process; renal system process; catalytic activity; extracellular region; lysosome; endosome; vacuole; lipid metabolic process; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; nervous system process; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06792,0.8635288181231706,OG_06792,FUN_031678-T1,Peve_00012833,Pocillopora_meandrina_HIv1___RNAseq.g5745.t1,three_way,69.84783333333333,FUN_031678-T1,Q5R4I2,RNF8_PONAB,,E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),29.4,446.0,2.1e-21,105.5,sp|Q5R4I2|RNF8_PONAB E3 ubiquitin-protein ligase RNF8 OS=Pongo abelii OX=9601 GN=RNF8 PE=2 SV=1,GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168,cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_06087,0.8635151652911907,OG_06087,FUN_027086-T1,Peve_00012245,Pocillopora_meandrina_HIv1___TS.g17920.t1,three_way,91.32083333333333,FUN_027086-T1,Q14562,DHX8_HUMAN,,ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1),Homo sapiens (Human),75.5,1179.0,0.0,1576.2,sp|Q14562|DHX8_HUMAN ATP-dependent RNA helicase DHX8 OS=Homo sapiens OX=9606 GN=DHX8 PE=1 SV=1,GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008186; GO:0008380; GO:0016604; GO:0016887; GO:0042802; GO:0071007; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]",GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_03990,0.863351158287095,OG_03990,FUN_016158-T1,Peve_00022563,Pocillopora_meandrina_HIv1___RNAseq.g21233.t1,three_way,67.15366666666667,FUN_016158-T1,G3UYX5,,,,,31.1,775.0,2.5e-103,379.4,sp|G3UYX5|RGS22_MOUSE Regulator of G-protein signaling 22 OS=Mus musculus OX=10090 GN=Rgs22 PE=1 SV=1,,,,,,
OG_02968,0.863209413265937,OG_02968,FUN_012130-T1,Peve_00035469,Pocillopora_meandrina_HIv1___RNAseq.g23786.t1,three_way,43.8205,FUN_012130-T1,Q5R7K9,,,,,32.1,156.0,7.5e-10,66.6,sp|Q5R7K9|EDIL3_PONAB EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Pongo abelii OX=9601 GN=EDIL3 PE=2 SV=1,,,,,,
OG_04195,0.8631222435397987,OG_04195,FUN_016720-T1,Peve_00014673,Pocillopora_meandrina_HIv1___RNAseq.g230.t1,three_way,61.32066666666666,FUN_016720-T1,Q64729,TGFR1_MOUSE,,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),Mus musculus (Mouse),38.4,487.0,5.7e-74,280.0,sp|Q64729|TGFR1_MOUSE TGF-beta receptor type-1 OS=Mus musculus OX=10090 GN=Tgfbr1 PE=1 SV=1,GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001935; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0005929; GO:0006915; GO:0007179; GO:0007507; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0016020; GO:0030199; GO:0030307; GO:0030335; GO:0030336; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0035556; GO:0036446; GO:0042118; GO:0043065; GO:0043066; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046847; GO:0046872; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0050431; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060391; GO:0060395; GO:0060412; GO:0060978; GO:0060982; GO:0061450; GO:0070021; GO:0070411; GO:0070723; GO:0071560; GO:1901203; GO:1902462; GO:1904018; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237,activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; cilium [GO:0005929]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021],"ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005929; GO:0006355; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; nucleoplasm; endosome; plasma membrane; cilium; regulation of DNA-templated transcription; programmed cell death; transferase activity; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_01709,0.8631122547229201,OG_01709,FUN_006982-T1,Peve_00045260,Pocillopora_meandrina_HIv1___TS.g29608.t2b,three_way,78.57366666666667,FUN_006982-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),44.9,187.0,1.9e-40,167.5,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_00599,0.8630866350046255,OG_00599,FUN_001747-T1,Peve_00023224,Pocillopora_meandrina_HIv1___RNAseq.13551_t,three_way,50.601,,,,,,,,,,,,,,,,,
OG_00380,0.8629878957818861,OG_00380,FUN_001228-T1,Peve_00027708,Pocillopora_meandrina_HIv1___RNAseq.g29245.t1,three_way,84.69233333333334,FUN_001228-T1,Q569D5,,,,,71.9,469.0,1.8e-212,740.0,sp|Q569D5|SBP1_XENTR Methanethiol oxidase OS=Xenopus tropicalis OX=8364 GN=selenbp1 PE=2 SV=1,,,,,,
OG_04373,0.8629617096549989,OG_04373,FUN_018033-T1,Peve_00020008,Pocillopora_meandrina_HIv1___TS.g25636.t1,three_way,60.77283333333334,,,,,,,,,,,,,,,,,
OG_03081,0.862872767685583,OG_03081,FUN_012353-T1,Peve_00042562,Pocillopora_meandrina_HIv1___RNAseq.g23278.t2,three_way,88.492,FUN_012353-T1,Q6ZQ88,KDM1A_MOUSE,,Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2),Mus musculus (Mouse),68.2,692.0,4.4000000000000004e-274,945.3,sp|Q6ZQ88|KDM1A_MOUSE Lysine-specific histone demethylase 1A OS=Mus musculus OX=10090 GN=Kdm1a PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0006366; GO:0010569; GO:0010718; GO:0010725; GO:0016491; GO:0019899; GO:0021983; GO:0030154; GO:0030851; GO:0031398; GO:0032452; GO:0032453; GO:0032454; GO:0032880; GO:0032991; GO:0034644; GO:0043426; GO:0045648; GO:0045654; GO:0045944; GO:0050660; GO:0050681; GO:0050767; GO:0050768; GO:0055001; GO:0061629; GO:0071480; GO:0106222; GO:0120162; GO:0140297; GO:0140682; GO:0140684; GO:0140861; GO:0160217; GO:1990138; GO:1990391; GO:1990841; GO:2000179; GO:2000648,cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA repair-dependent chromatin remodeling [GO:0140861]; granulocyte differentiation [GO:0030851]; muscle cell development [GO:0055001]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription initiation-coupled chromatin remodeling [GO:0160217]; neuron projection extension [GO:1990138]; pituitary gland development [GO:0021983]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neurogenesis [GO:0050767]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; DNA repair complex [GO:1990391]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; FAD-dependent H3K4me/H3K4me3 demethylase activity [GO:0140682]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone H3K4 demethylase activity [GO:0032453]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me2/H3K9me3 demethylase activity [GO:0140684]; lncRNA binding [GO:0106222]; MRF binding [GO:0043426]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity [GO:0016491]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0006325; GO:0006351; GO:0006355; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"DNA binding; RNA binding; catalytic activity; nucleus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02796,0.8628665638127915,OG_02796,FUN_011761-T1,Peve_00005550,Pocillopora_meandrina_HIv1___TS.g16681.t2,three_way,83.095,FUN_011761-T1,Q8TBF4,,,,,75.6,131.0,1.9e-54,213.4,sp|Q8TBF4|ZCRB1_HUMAN Zinc finger CCHC-type and RNA-binding motif-containing protein 1 OS=Homo sapiens OX=9606 GN=ZCRB1 PE=1 SV=2,,,,,,
OG_03451,0.8628134899467526,OG_03451,FUN_014525-T1,Peve_00044380,Pocillopora_meandrina_HIv1___RNAseq.g22618.t1,three_way,89.524,FUN_014525-T1,Q7PPA5,,,,,70.7,996.0,0.0,1408.7,sp|Q7PPA5|ATC1_ANOGA Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type OS=Anopheles gambiae OX=7165 GN=SERCA PE=3 SV=5,,,,,,
OG_01742,0.8626876015287939,OG_01742,FUN_007064-T1,Peve_00008212,Pocillopora_meandrina_HIv1___RNAseq.g20107.t1,three_way,83.80433333333333,FUN_007064-T1,Q66HG8,RED_RAT,,Protein Red (Cytokine IK) (IK factor),Rattus norvegicus (Rat),54.1,603.0,1e-108,395.6,sp|Q66HG8|RED_RAT Protein Red OS=Rattus norvegicus OX=10116 GN=Ik PE=1 SV=1,GO:0000228; GO:0000278; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0007094; GO:0034501; GO:0042802; GO:0071005; GO:0097431,"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]",cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005],identical protein binding [GO:0042802],GO:0000228; GO:0000278; GO:0005634; GO:0005654; GO:0005694; GO:0016071; GO:0043226,nuclear chromosome; mitotic cell cycle; nucleus; nucleoplasm; chromosome; mRNA metabolic process; organelle
OG_01671,0.8623929868733353,OG_01671,FUN_006858-T1,Peve_00006602,Pocillopora_meandrina_HIv1___RNAseq.g19910.t1a,three_way,92.78333333333332,FUN_006858-T1,Q27802,,,,,65.6,4362.0,0.0,5570.0,sp|Q27802|DYHC2_TRIGR Cytoplasmic dynein 2 heavy chain 1 OS=Tripneustes gratilla OX=7673 GN=DYH1B PE=2 SV=2,,,,,,
OG_09024,0.8622603937274722,OG_09024,FUN_038614-T1,Peve_00002807,Pocillopora_meandrina_HIv1___RNAseq.g972.t1,three_way,69.6525,FUN_038614-T1,Q9Z0Y8,CAC1I_RAT,,Voltage-dependent T-type calcium channel subunit alpha-1I (CaVT.3) (Voltage-gated calcium channel subunit alpha Cav3.3),Rattus norvegicus (Rat),43.5,1698.0,3.2999999999999997e-299,1030.0,sp|Q9Z0Y8|CAC1I_RAT Voltage-dependent T-type calcium channel subunit alpha-1I OS=Rattus norvegicus OX=10116 GN=Cacna1i PE=1 SV=3,GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0006816; GO:0008332; GO:0019228; GO:0030431; GO:0042391; GO:0043005; GO:0045956; GO:0060402; GO:0070509; GO:0086010,calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of membrane potential [GO:0042391]; sleep [GO:0030431],neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518],low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_10148,0.8622123795704227,OG_10148,FUN_043539-T1,Peve_00012551,Pocillopora_meandrina_HIv1___TS.g1775.t1,three_way,61.17516666666667,FUN_043539-T1,Q9DBQ9,,,,,27.4,592.0,6.5e-46,187.6,sp|Q9DBQ9|SWT1_MOUSE Transcriptional protein SWT1 OS=Mus musculus OX=10090 GN=Swt1 PE=2 SV=3,,,,,,
OG_02967,0.861898008034164,OG_02967,FUN_012126-T1,Peve_00035474,Pocillopora_meandrina_HIv1___RNAseq.g23920.t1,three_way,60.626333333333335,FUN_012126-T1,B3EWY9,,,,,38.6,166.0,3.999999999999999e-28,128.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05316,0.8616774146722098,OG_05316,FUN_024001-T1,Peve_00034187,Pocillopora_meandrina_HIv1___RNAseq.g19350.t1,three_way,77.74116666666666,FUN_024001-T1,P15056,BRAF_HUMAN,,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),Homo sapiens (Human),47.0,743.0,1.8999999999999998e-173,610.9,sp|P15056|BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens OX=9606 GN=BRAF PE=1 SV=4,GO:0000165; GO:0002318; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006468; GO:0007173; GO:0008270; GO:0008542; GO:0009887; GO:0010628; GO:0010764; GO:0010828; GO:0016079; GO:0030878; GO:0033077; GO:0033138; GO:0034446; GO:0034451; GO:0035019; GO:0036064; GO:0042127; GO:0042802; GO:0043005; GO:0043066; GO:0043149; GO:0043231; GO:0043367; GO:0043369; GO:0043524; GO:0044297; GO:0045580; GO:0048538; GO:0048680; GO:0050772; GO:0050852; GO:0051496; GO:0060291; GO:0060323; GO:0060324; GO:0070371; GO:0070374; GO:0071277; GO:0071466; GO:0072577; GO:0090150; GO:0097110; GO:0098793; GO:0098794; GO:0098978; GO:0099170; GO:0106310; GO:1900026; GO:2000301; GO:2000352,"animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; visual learning [GO:0008542]",cell body [GO:0044297]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0007155; GO:0012501; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; cell adhesion; programmed cell death; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_09600,0.8616493886863611,OG_09600,FUN_041750-T1,Peve_00042716,Pocillopora_meandrina_HIv1___RNAseq.g15091.t1,three_way,84.30533333333332,FUN_041750-T1,Q5ZJH9,DKC1_CHICK,,H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (Dyskerin),Gallus gallus (Chicken),71.6,437.0,1.2e-177,624.4,sp|Q5ZJH9|DKC1_CHICK H/ACA ribonucleoprotein complex subunit DKC1 OS=Gallus gallus OX=9031 GN=DKC1 PE=2 SV=1,GO:0000455; GO:0000495; GO:0003723; GO:0005654; GO:0005697; GO:0007004; GO:0009982; GO:0015030; GO:0031118; GO:0031120; GO:0031429; GO:1990481,box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004],box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697],pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005654; GO:0016071; GO:0016073; GO:0016853; GO:0032200; GO:0043226,RNA binding; catalytic activity; nucleoplasm; mRNA metabolic process; snRNA metabolic process; isomerase activity; telomere organization; organelle
OG_01041,0.8615279837976373,OG_01041,FUN_004481-T1,Peve_00008403,Pocillopora_meandrina_HIv1___RNAseq.g11617.t2,three_way,80.77366666666667,FUN_004481-T1,Q96LB3,,,,,39.8,553.0,9.4e-89,329.3,sp|Q96LB3|IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens OX=9606 GN=IFT74 PE=1 SV=1,,,,,,
OG_06857,0.8613717536407687,OG_06857,FUN_031838-T1,Peve_00030279,Pocillopora_meandrina_HIv1___RNAseq.g5598.t1,three_way,67.74966666666667,FUN_031838-T1,Q3UJB0,,,,,70.4,540.0,9.5e-162,572.4,sp|Q3UJB0|SF3B2_MOUSE Splicing factor 3B subunit 2 OS=Mus musculus OX=10090 GN=Sf3b2 PE=2 SV=1,,,,,,
OG_06720,0.8612628325660765,OG_06720,FUN_031471-T1,Peve_00026551,Pocillopora_meandrina_HIv1___RNAseq.g5081.t1,three_way,81.32666666666667,FUN_031471-T1,P97376,,,,,43.9,214.0,1.7e-44,181.0,sp|P97376|FRG1_MOUSE Protein FRG1 OS=Mus musculus OX=10090 GN=Frg1 PE=1 SV=2,,,,,,
OG_03659,0.8612415051527209,OG_03659,FUN_014896-T1,Peve_00003546,Pocillopora_meandrina_HIv1___RNAseq.g21104.t1,three_way,65.60683333333333,FUN_014896-T1,Q69ZX6,MOR2A_MOUSE,,ATPase MORC2A (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2A) (Zinc finger CW-type coiled-coil domain protein 1),Mus musculus (Mouse),41.3,920.0,5.7999999999999996e-151,536.6,sp|Q69ZX6|MOR2A_MOUSE ATPase MORC2A OS=Mus musculus OX=10090 GN=Morc2a PE=1 SV=2,GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042393; GO:0042803; GO:0140719; GO:0141005,chromatin remodeling [GO:0006338]; constitutive heterochromatin formation [GO:0140719]; DNA damage response [GO:0006974]; transposable element silencing by heterochromatin formation [GO:0141005],cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0016787; GO:0042393; GO:0043226,catalytic activity; nucleus; cytosol; chromatin organization; hydrolase activity; histone binding; organelle
OG_05518,0.8610651935957823,OG_05518,FUN_024618-T1,Peve_00027329,Pocillopora_meandrina_HIv1___RNAseq.g19153.t1,three_way,82.87033333333333,FUN_024618-T1,Q9VJ79,PDE11_DROME,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11) (PDE11)",Drosophila melanogaster (Fruit fly),51.3,915.0,3.4e-254,879.4,"sp|Q9VJ79|PDE11_DROME Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 OS=Drosophila melanogaster OX=7227 GN=Pde11 PE=1 SV=4",GO:0004115; GO:0005829; GO:0019933; GO:0046058; GO:0046068; GO:0046872; GO:0047555,cAMP metabolic process [GO:0046058]; cAMP-mediated signaling [GO:0019933]; cGMP metabolic process [GO:0046068],cytosol [GO:0005829],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_10145,0.861010667322562,OG_10145,FUN_043535-T1,Peve_00016667,Pocillopora_meandrina_HIv1___RNAseq.g8056.t1,three_way,80.87466666666667,FUN_043535-T1,O14733,,,,,44.9,256.0,1.8e-48,194.5,sp|O14733|MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP2K7 PE=1 SV=2,,,,,,
OG_07474,0.8609244621157737,OG_07474,FUN_033989-T1,Peve_00004922,Pocillopora_meandrina_HIv1___RNAseq.g26102.t1,three_way,69.42083333333333,FUN_033989-T1,E9Q2Z1,CECR2_MOUSE,,Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2 homolog),Mus musculus (Mouse),46.8,571.0,1.8e-84,316.2,sp|E9Q2Z1|CECR2_MOUSE Chromatin remodeling regulator CECR2 OS=Mus musculus OX=10090 GN=Cecr2 PE=1 SV=1,GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006338; GO:0007338; GO:0021915; GO:0031010; GO:0060122; GO:0090102; GO:0090537; GO:0097194; GO:0140658,chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338],CERF complex [GO:0090537]; euchromatin [GO:0000791]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634],ATP-dependent chromatin remodeler activity [GO:0140658],GO:0003824; GO:0005634; GO:0006325; GO:0022414; GO:0043226; GO:0048856; GO:0140097; GO:0140657,"catalytic activity; nucleus; chromatin organization; reproductive process; organelle; anatomical structure development; catalytic activity, acting on DNA; ATP-dependent activity"
OG_04003,0.8608594755012317,OG_04003,FUN_016299-T1,Peve_00025246,Pocillopora_meandrina_HIv1___RNAseq.g9888.t1,three_way,47.610166666666665,FUN_016299-T1,Q64337,SQSTM_MOUSE,,Sequestosome-1 (STONE14) (Ubiquitin-binding protein p62),Mus musculus (Mouse),47.7,44.0,4.8e-06,55.5,sp|Q64337|SQSTM_MOUSE Sequestosome-1 OS=Mus musculus OX=10090 GN=Sqstm1 PE=1 SV=1,GO:0000122; GO:0000407; GO:0000423; GO:0000425; GO:0000932; GO:0001659; GO:0002376; GO:0002931; GO:0003712; GO:0005080; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0010508; GO:0016235; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0030163; GO:0030674; GO:0031397; GO:0031625; GO:0034144; GO:0035255; GO:0035591; GO:0035973; GO:0038023; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0043232; GO:0044753; GO:0044754; GO:0044877; GO:0061635; GO:0070342; GO:0070530; GO:0071211; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:0098978; GO:0110076; GO:0140036; GO:0140311; GO:0140693; GO:0140694; GO:1900273; GO:1903078; GO:1905719,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; membraneless organelle assembly [GO:0140694]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pexophagy [GO:0000425]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; intracellular membraneless organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225],identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; transcription coregulator activity [GO:0003712]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0002376; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006914; GO:0012501; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0060089; GO:0060090; GO:0140110; GO:0140313,immune system process; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; autophagy; programmed cell death; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity; molecular adaptor activity; transcription regulator activity; molecular sequestering activity
OG_09923,0.8608369311368133,OG_09923,FUN_043035-T1,Peve_00026975,Pocillopora_meandrina_HIv1___RNAseq.g7043.t1,three_way,57.261,FUN_043035-T1,Q9UBN4,,,,,29.3,744.0,3.7999999999999996e-68,261.2,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_02432,0.8607979648670695,OG_02432,FUN_009438-T1,Peve_00031029,Pocillopora_meandrina_HIv1___RNAseq.g25068.t1,three_way,73.89733333333334,,,,,,,,,,,,,,,,,
OG_00164,0.8607468868214896,OG_00164,FUN_000639-T1,Peve_00011494,Pocillopora_meandrina_HIv1___RNAseq.g1868.t2,three_way,79.212,FUN_000639-T1,Q9EQQ9,,,,,39.0,918.0,1.2000000000000001e-180,635.2,sp|Q9EQQ9|OGA_MOUSE Protein O-GlcNAcase OS=Mus musculus OX=10090 GN=Oga PE=1 SV=2,,,,,,
OG_07520,0.8607002436606725,OG_07520,FUN_034090-T1,Peve_00037070,Pocillopora_meandrina_HIv1___RNAseq.g26061.t1,three_way,75.31133333333334,FUN_034090-T1,Q9I9H8,,,,,36.6,1258.0,6.2000000000000005e-146,520.4,sp|Q9I9H8|APAF_DANRE Apoptotic protease-activating factor 1 OS=Danio rerio OX=7955 GN=apaf1 PE=2 SV=1,,,,,,
OG_09981,0.8606696769814441,OG_09981,FUN_043171-T1,Peve_00025849,Pocillopora_meandrina_HIv1___RNAseq.g6793.t1,three_way,67.71433333333333,,,,,,,,,,,,,,,,,
OG_08305,0.8604324309757869,OG_08305,FUN_036260-T1,Peve_00012320,Pocillopora_meandrina_HIv1___RNAseq.g27582.t1,three_way,82.303,FUN_036260-T1,Q8WXH2,JPH3_HUMAN,,Junctophilin-3 (JP-3) (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein),Homo sapiens (Human),66.7,57.0,9.9e-20,99.4,sp|Q8WXH2|JPH3_HUMAN Junctophilin-3 OS=Homo sapiens OX=9606 GN=JPH3 PE=1 SV=2,GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0010880; GO:0010882; GO:0014701; GO:0016020; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060402,calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic plasticity [GO:0048167],endoplasmic reticulum membrane [GO:0005789]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886],,GO:0005886; GO:0050877; GO:0055085,plasma membrane; nervous system process; transmembrane transport
OG_09907,0.8604191231617984,OG_09907,FUN_043004-T1,Peve_00017776,Pocillopora_meandrina_HIv1___RNAseq.g7028.t1,three_way,85.60833333333333,FUN_043004-T1,Q64380,SARDH_RAT,,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)",Rattus norvegicus (Rat),66.3,750.0,0.0,1121.7,"sp|Q64380|SARDH_RAT Sarcosine dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Sardh PE=1 SV=2",GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006545; GO:0008480; GO:0016491; GO:0035999; GO:0042426; GO:0050660; GO:1901053,choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480],GO:0003824; GO:0005739; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_06005,0.8602961474116781,OG_06005,FUN_026501-T1,Peve_00004184,Pocillopora_meandrina_HIv1___TS.g21607.t1,three_way,44.153333333333336,FUN_026501-T1,Q9VTT0,SEM5C_DROME,,Semaphorin 5c,Drosophila melanogaster (Fruit fly),27.1,630.0,1.7e-51,206.1,sp|Q9VTT0|SEM5C_DROME Semaphorin 5c OS=Drosophila melanogaster OX=7227 GN=Sema5c PE=1 SV=3,GO:0001700; GO:0005768; GO:0005886; GO:0007411; GO:0016324; GO:0016328; GO:0030215; GO:0030335; GO:0042048; GO:0045499; GO:0048036; GO:0071526,axon guidance [GO:0007411]; central complex development [GO:0048036]; embryonic development via the syncytial blastoderm [GO:0001700]; olfactory behavior [GO:0042048]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526],apical plasma membrane [GO:0016324]; endosome [GO:0005768]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215],GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0048018; GO:0048856; GO:0098772,endosome; plasma membrane; cytoplasmic vesicle; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06971,0.8598832920925802,OG_06971,FUN_032104-T1,Peve_00011277,Pocillopora_meandrina_HIv1___RNAseq.g6000.t1,three_way,72.7205,FUN_032104-T1,Q8IWV8,UBR2_HUMAN,,E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II),Homo sapiens (Human),42.3,1795.0,0.0,1350.1,sp|Q8IWV8|UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens OX=9606 GN=UBR2 PE=1 SV=1,GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010526; GO:0016567; GO:0031507; GO:0032007; GO:0043161; GO:0050862; GO:0061630; GO:0070534; GO:0070728; GO:0071233; GO:0071596; GO:0141053,cellular response to L-leucine [GO:0071233]; heterochromatin formation [GO:0031507]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],histone H2A ubiquitin ligase activity [GO:0141053]; L-leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006310; GO:0006325; GO:0016740; GO:0022414; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"catalytic activity; nucleus; cytosol; DNA recombination; chromatin organization; transferase activity; reproductive process; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_04646,0.8598400314606862,OG_04646,FUN_022378-T1,Peve_00013226,Pocillopora_meandrina_HIv1___RNAseq.g9303.t1,three_way,49.90833333333334,,,,,,,,,,,,,,,,,
OG_07859,0.8598165236853258,OG_07859,FUN_035214-T1,Peve_00027702,Pocillopora_meandrina_HIv1___RNAseq.g27840.t2,three_way,74.03666666666668,FUN_035214-T1,Q8RDT4,,,,,46.5,372.0,1.0000000000000001e-88,328.6,sp|Q8RDT4|MEGL_FUSNN L-methionine gamma-lyase OS=Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355) OX=190304 GN=FN1419 PE=1 SV=1,,,,,,
OG_02565,0.8597782302456176,OG_02565,FUN_010664-T1,Peve_00031444,Pocillopora_meandrina_HIv1___RNAseq.g21358.t1,three_way,89.18366666666667,FUN_010664-T1,O46629,ECHB_BOVIN,,"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]",Bos taurus (Bovine),74.7,442.0,6.5e-191,668.3,"sp|O46629|ECHB_BOVIN Trifunctional enzyme subunit beta, mitochondrial OS=Bos taurus OX=9913 GN=HADHB PE=2 SV=1",GO:0003985; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0016507; GO:0050633,fatty acid beta-oxidation [GO:0006635],endoplasmic reticulum [GO:0005783]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741],acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-myristoyltransferase activity [GO:0050633],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_09140,0.8597343661346664,OG_09140,FUN_039779-T1,Peve_00017588,Pocillopora_meandrina_HIv1___RNAseq.g7461.t1,three_way,84.48583333333333,FUN_039779-T1,O95263,,,,,46.7,904.0,5.4e-218,759.2,"sp|O95263|PDE8B_HUMAN High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B OS=Homo sapiens OX=9606 GN=PDE8B PE=1 SV=2",,,,,,
OG_00420,0.8596020370438304,OG_00420,FUN_001325-T1,Peve_00036958,Pocillopora_meandrina_HIv1___RNAseq.g2268.t1,three_way,83.70033333333333,FUN_001325-T1,P81004,,,,,62.9,280.0,5.2e-103,375.6,sp|P81004|VDAC2_XENLA Non-selective voltage-gated ion channel VDAC2 OS=Xenopus laevis OX=8355 GN=vdac2 PE=1 SV=1,,,,,,
OG_08369,0.8594928331833689,OG_08369,FUN_036922-T1,Peve_00018419,Pocillopora_meandrina_HIv1___RNAseq.g10827.t3,three_way,57.46,,,,,,,,,,,,,,,,,
OG_03048,0.8594778331543869,OG_03048,FUN_012295-T1,Peve_00036365,Pocillopora_meandrina_HIv1___RNAseq.g23560.t1b,three_way,72.36266666666667,FUN_012295-T1,D3ZGS3,OCRL_RAT,,"Inositol polyphosphate 5-phosphatase OCRL (EC 3.1.3.36) (EC 3.1.3.56) (Inositol polyphosphate 5-phosphatase OCRL-1) (OCRL-1) (Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase) (EC 3.1.3.86)",Rattus norvegicus (Rat),48.5,616.0,3.2e-174,613.6,sp|D3ZGS3|OCRL_RAT Inositol polyphosphate 5-phosphatase OCRL OS=Rattus norvegicus OX=10116 GN=Ocrl PE=1 SV=1,GO:0001701; GO:0001750; GO:0004439; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005802; GO:0005886; GO:0005905; GO:0007165; GO:0016020; GO:0030136; GO:0030670; GO:0031267; GO:0031901; GO:0034485; GO:0043005; GO:0046856; GO:0052658; GO:0052659; GO:0052745; GO:0060271,cilium assembly [GO:0060271]; in utero embryonic development [GO:0001701]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],"GTPase activator activity [GO:0005096]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; small GTPase binding [GO:0031267]",GO:0003824; GO:0005634; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0098772,catalytic activity; nucleus; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_05882,0.8593455118977772,OG_05882,FUN_026035-T1,Peve_00022186,Pocillopora_meandrina_HIv1___TS.g13968.t3,three_way,87.66533333333334,FUN_026035-T1,Q5ZKI4,,,,,58.3,604.0,6.5000000000000004e-186,652.1,sp|Q5ZKI4|CCD93_CHICK Coiled-coil domain-containing protein 93 OS=Gallus gallus OX=9031 GN=CCDC93 PE=2 SV=1,,,,,,
OG_08336,0.8593400483098423,OG_08336,FUN_036841-T1,Peve_00006959,Pocillopora_meandrina_HIv1___TS.g13168.t1,three_way,71.919,FUN_036841-T1,P80457,XDH_BOVIN,,Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)],Bos taurus (Bovine),33.5,1310.0,3.4e-197,690.6,sp|P80457|XDH_BOVIN Xanthine dehydrogenase/oxidase OS=Bos taurus OX=9913 GN=XDH PE=1 SV=4,GO:0002197; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0009115; GO:0030151; GO:0042803; GO:0043546; GO:0050660; GO:0051537; GO:0071949,xanthine catabolic process [GO:0009115],extracellular space [GO:0005615]; peroxisome [GO:0005777]; xanthine dehydrogenase complex [GO:0002197],"2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]",GO:0003824; GO:0005615; GO:0005777; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; peroxisome; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_06844,0.8591478971010594,OG_06844,FUN_031784-T1,Peve_00010429,Pocillopora_meandrina_HIv1___TS.g24287.t1,three_way,83.68866666666666,FUN_031784-T1,Q9ULT8,HECD1_HUMAN,,E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1),Homo sapiens (Human),52.0,2736.0,0.0,2536.5,sp|Q9ULT8|HECD1_HUMAN E3 ubiquitin-protein ligase HECTD1 OS=Homo sapiens OX=9606 GN=HECTD1 PE=1 SV=4,GO:0003170; GO:0003281; GO:0006511; GO:0016567; GO:0032436; GO:0035904; GO:0046872; GO:0061630,aorta development [GO:0035904]; heart valve development [GO:0003170]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281],,metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_06513,0.8591050230383985,OG_06513,FUN_029310-T1,Peve_00038264,Pocillopora_meandrina_HIv1___RNAseq.g12579.t1,three_way,89.39833333333333,FUN_029310-T1,O00139,KIF2A_HUMAN,,Kinesin-like protein KIF2A (Kinesin-2) (hK2),Homo sapiens (Human),53.7,709.0,1.3e-187,657.9,sp|O00139|KIF2A_HUMAN Kinesin-like protein KIF2A OS=Homo sapiens OX=9606 GN=KIF2A PE=1 SV=3,GO:0000226; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0007052; GO:0007399; GO:0008017; GO:0016020; GO:0016604; GO:0016887; GO:0030154; GO:0030334; GO:0036064; GO:0051301; GO:0072686; GO:0090307; GO:0120103,cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334],centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005654; GO:0005730; GO:0005815; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleoplasm; nucleolus; microtubule organizing center; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; cell differentiation; organelle; anatomical structure development; ATP-dependent activity
OG_02643,0.8590564143345911,OG_02643,FUN_010811-T1,Peve_00006518,Pocillopora_meandrina_HIv1___RNAseq.g20907.t1,three_way,57.91116666666667,FUN_010811-T1,Q0P4V4,,,,,29.0,715.0,7.6e-73,276.9,sp|Q0P4V4|KTU_XENTR Protein kintoun OS=Xenopus tropicalis OX=8364 GN=dnaaf2 PE=2 SV=1,,,,,,
OG_05222,0.8590296545049055,OG_05222,FUN_023634-T1,Peve_00027833,Pocillopora_meandrina_HIv1___RNAseq.g17811.t1,three_way,78.49183333333333,FUN_023634-T1,Q98TX3,,,,,45.7,438.0,1.4e-94,348.2,sp|Q98TX3|PDCD4_CHICK Programmed cell death protein 4 OS=Gallus gallus OX=9031 GN=PDCD4 PE=2 SV=1,,,,,,
OG_06024,0.8586882617783431,OG_06024,FUN_026582-T1,Peve_00006460,Pocillopora_meandrina_HIv1___RNAseq.g4513.t1,three_way,81.87833333333333,FUN_026582-T1,Q8TAQ2,SMRC2_HUMAN,,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),Homo sapiens (Human),51.1,991.0,1.4e-241,837.8,sp|Q8TAQ2|SMRC2_HUMAN SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2 PE=1 SV=1,GO:0000776; GO:0000785; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514],histone binding [GO:0042393]; transcription coactivator activity [GO:0003713],GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06558,0.8586588826230699,OG_06558,FUN_029440-T1,Peve_00028190,Pocillopora_meandrina_HIv1___RNAseq.g17154.t1,three_way,63.96833333333333,FUN_029440-T1,Q8TDY2,,,,,32.0,596.0,2.7e-76,288.9,sp|Q8TDY2|RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3,,,,,,
OG_06385,0.8586009980738365,OG_06385,FUN_029018-T1,Peve_00028035,Pocillopora_meandrina_HIv1___TS.g9259.t2,three_way,56.882666666666665,FUN_029018-T1,Q6IC98,GRAM4_HUMAN,,GRAM domain-containing protein 4 (Death-inducing protein),Homo sapiens (Human),33.6,429.0,2.2e-54,215.3,sp|Q6IC98|GRAM4_HUMAN GRAM domain-containing protein 4 OS=Homo sapiens OX=9606 GN=GRAMD4 PE=1 SV=1,GO:0005739; GO:0005789; GO:0006915; GO:0031966; GO:0034164; GO:0043065,apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of apoptotic process [GO:0043065],endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],,GO:0005739; GO:0012501; GO:0043226,mitochondrion; programmed cell death; organelle
OG_07101,0.8583648651395789,OG_07101,FUN_032361-T1,Peve_00045028,Pocillopora_meandrina_HIv1___RNAseq.g29818.t1,three_way,57.91883333333333,FUN_032361-T1,Q8C3S2,,,,,33.1,1162.0,1.7e-147,525.4,sp|Q8C3S2|TNG6_MOUSE Transport and Golgi organization protein 6 homolog OS=Mus musculus OX=10090 GN=Tango6 PE=1 SV=1,,,,,,
OG_08300,0.8583301568153348,OG_08300,FUN_036249-T1,Peve_00045287,Pocillopora_meandrina_HIv1___RNAseq.g27590.t1,three_way,48.918,,,,,,,,,,,,,,,,,
OG_08703,0.8581982664949712,OG_08703,FUN_037952-T1,Peve_00040734,Pocillopora_meandrina_HIv1___RNAseq.g26514.t2,three_way,73.35300000000001,FUN_037952-T1,Q6PIF6,MYO7B_HUMAN,,Unconventional myosin-VIIb,Homo sapiens (Human),26.7,797.0,3.1000000000000003e-66,255.4,sp|Q6PIF6|MYO7B_HUMAN Unconventional myosin-VIIb OS=Homo sapiens OX=9606 GN=MYO7B PE=1 SV=2,GO:0000146; GO:0005524; GO:0005737; GO:0005902; GO:0005903; GO:0007015; GO:0007605; GO:0015629; GO:0016020; GO:0016459; GO:0030048; GO:0030154; GO:0051015; GO:0090651; GO:1904970,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory perception of sound [GO:0007605],actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146],GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0016853; GO:0030154; GO:0043226; GO:0050877; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; isomerase activity; cell differentiation; organelle; nervous system process; ATP-dependent activity
OG_05140,0.8580675311058538,OG_05140,FUN_023416-T1,Peve_00017406,Pocillopora_meandrina_HIv1___RNAseq.g17587.t2,three_way,86.484,FUN_023416-T1,Q9UHX1,,,,,45.5,569.0,4.5e-115,416.8,sp|Q9UHX1|PUF60_HUMAN Poly(U)-binding-splicing factor PUF60 OS=Homo sapiens OX=9606 GN=PUF60 PE=1 SV=1,,,,,,
OG_00833,0.8580463293235239,OG_00833,FUN_004078-T1,Peve_00006662,Pocillopora_meandrina_HIv1___RNAseq.g17237.t1,three_way,69.94466666666666,FUN_004078-T1,B1AS42,NB5R5_MOUSE,,NADH-cytochrome b5 reductase-like (EC 1.6.2.2),Mus musculus (Mouse),39.5,311.0,9.999999999999999e-64,245.4,sp|B1AS42|NB5R5_MOUSE NADH-cytochrome b5 reductase-like OS=Mus musculus OX=10090 GN=Cyb5rl PE=2 SV=1,GO:0004128; GO:0005654; GO:0005789,,endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]",GO:0003824; GO:0005654; GO:0016491,catalytic activity; nucleoplasm; oxidoreductase activity
OG_07018,0.8579187877660458,OG_07018,FUN_032194-T1,Peve_00017482,Pocillopora_meandrina_HIv1___RNAseq.g24398.t1,three_way,85.27199999999999,FUN_032194-T1,P48506,GSH1_HUMAN,,Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase),Homo sapiens (Human),62.3,628.0,4.5e-227,788.9,sp|P48506|GSH1_HUMAN Glutamate--cysteine ligase catalytic subunit OS=Homo sapiens OX=9606 GN=GCLC PE=1 SV=2,GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237,blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877],GO:0003013; GO:0003824; GO:0005739; GO:0005829; GO:0005975; GO:0006355; GO:0006520; GO:0006575; GO:0006790; GO:0007005; GO:0016874; GO:0043226; GO:0061024,circulatory system process; catalytic activity; mitochondrion; cytosol; carbohydrate metabolic process; regulation of DNA-templated transcription; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; mitochondrion organization; ligase activity; organelle; membrane organization
OG_09949,0.8576828430441699,OG_09949,FUN_043116-T1,Peve_00026297,Pocillopora_meandrina_HIv1___RNAseq.g7889.t1,three_way,69.772,FUN_043116-T1,O77633,,,,,35.3,744.0,1.4000000000000001e-117,425.2,sp|O77633|ADA10_PIG Disintegrin and metalloproteinase domain-containing protein 10 OS=Sus scrofa OX=9823 GN=ADAM10 PE=2 SV=2,,,,,,
OG_10204,0.8576034071252456,OG_10204,FUN_043636-T1,Peve_00008249,Pocillopora_meandrina_HIv1___RNAseq.g6909.t1,three_way,53.50783333333334,FUN_043636-T1,Q8NDA2,,,,,26.3,753.0,7.9000000000000025e-59,231.5,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_05063,0.8575175705351873,OG_05063,FUN_023260-T1,Peve_00019268,Pocillopora_meandrina_HIv1___RNAseq.g578.t1,three_way,89.18833333333333,FUN_023260-T1,Q9W676,,,,,61.8,382.0,2.4e-114,413.7,sp|Q9W676|LDB2_CHICK LIM domain-binding protein 2 OS=Gallus gallus OX=9031 GN=LDB2 PE=2 SV=1,,,,,,
OG_08628,0.8574349914803088,OG_08628,FUN_037796-T1,Peve_00026135,Pocillopora_meandrina_HIv1___RNAseq.g1556.t1,three_way,91.083,FUN_037796-T1,Q9CWF6,BBS2_MOUSE,,BBSome complex member BBS2 (Bardet-Biedl syndrome 2 protein homolog),Mus musculus (Mouse),66.9,718.0,8.9e-285,980.7,sp|Q9CWF6|BBS2_MOUSE BBSome complex member BBS2 OS=Mus musculus OX=10090 GN=Bbs2 PE=1 SV=1,GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010467; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033210; GO:0033365; GO:0034451; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0044321; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515,adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0003012; GO:0003013; GO:0005815; GO:0005929; GO:0007010; GO:0016192; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0072659,muscle system process; circulatory system process; microtubule organizing center; cilium; cytoskeleton organization; vesicle-mediated transport; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein localization to plasma membrane
OG_01208,0.8574263077314396,OG_01208,FUN_004881-T1,Peve_00043727,Pocillopora_meandrina_HIv1___RNAseq.g8658.t1,three_way,72.80466666666666,FUN_004881-T1,Q8IWZ8,SUGP1_HUMAN,,SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4),Homo sapiens (Human),55.6,169.0,3.899999999999999e-46,187.2,sp|Q8IWZ8|SUGP1_HUMAN SURP and G-patch domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SUGP1 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005654; GO:0005681; GO:0006397; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0016071,RNA binding; nucleoplasm; mRNA metabolic process
OG_07167,0.8572889970082034,OG_07167,FUN_032602-T1,Peve_00001527,Pocillopora_meandrina_HIv1___RNAseq.g24628.t1,three_way,85.47983333333333,FUN_032602-T1,Q9Y2J2,E41L3_HUMAN,,"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]",Homo sapiens (Human),51.7,348.0,4e-95,349.7,sp|Q9Y2J2|E41L3_HUMAN Band 4.1-like protein 3 OS=Homo sapiens OX=9606 GN=EPB41L3 PE=1 SV=2,GO:0002175; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005929; GO:0006915; GO:0008360; GO:0030054; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0036064; GO:0043217; GO:0044224; GO:0048812; GO:0071205; GO:0072659; GO:0098696; GO:0098794; GO:0098978; GO:0106006,actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696],cell junction [GO:0030054]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],actin binding [GO:0003779]; cytoskeletal protein-membrane anchor activity [GO:0106006]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007010; GO:0008092; GO:0012501; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659,structural molecule activity; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeleton organization; cytoskeletal protein binding; programmed cell death; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane
OG_03862,0.8572250472800358,OG_03862,FUN_015365-T1,Peve_00000208,Pocillopora_meandrina_HIv1___RNAseq.g21709.t1,three_way,84.68366666666667,FUN_015365-T1,P91119,PDE5_CAEEL,,"Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17)",Caenorhabditis elegans,44.3,774.0,3.4e-175,617.1,"sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3",GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0019933; GO:0032528; GO:0042542; GO:0046872; GO:0047555,cAMP-mediated signaling [GO:0019933]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542],,"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]",GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_06427,0.8569666725657334,OG_06427,FUN_029117-T1,Peve_00013133,Pocillopora_meandrina_HIv1___RNAseq.g25773.t1,three_way,89.271,FUN_029117-T1,Q6NYH1,IF122_DANRE,,Intraflagellar transport protein 122 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),70.9,1191.0,0.0,1824.3,sp|Q6NYH1|IF122_DANRE Intraflagellar transport protein 122 homolog OS=Danio rerio OX=7955 GN=ift122 PE=2 SV=1,GO:0001823; GO:0005737; GO:0005929; GO:0007507; GO:0008589; GO:0008594; GO:0030991; GO:0032402; GO:0035721; GO:0036064; GO:0036372; GO:0042073; GO:0045494; GO:0045879; GO:0048593; GO:0060271; GO:0061512; GO:0097730; GO:1905515,camera-type eye morphogenesis [GO:0048593]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; melanosome transport [GO:0032402]; mesonephros development [GO:0001823]; negative regulation of smoothened signaling pathway [GO:0045879]; non-motile cilium assembly [GO:1905515]; opsin transport [GO:0036372]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; regulation of smoothened signaling pathway [GO:0008589],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730],,GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_02934,0.8569367686075379,OG_02934,FUN_012035-T1,Peve_00037664,Pocillopora_meandrina_HIv1___RNAseq.g24058.t1,three_way,60.38016666666667,FUN_012035-T1,Q29RT6,KI20A_BOVIN,,Kinesin-like protein KIF20A,Bos taurus (Bovine),35.5,843.0,4.8e-114,414.8,sp|Q29RT6|KI20A_BOVIN Kinesin-like protein KIF20A OS=Bos taurus OX=9913 GN=KIF20A PE=2 SV=1,GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0030496; GO:0032465; GO:0061952,microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465],cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0000910; GO:0003774; GO:0003824; GO:0005634; GO:0005794; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0061024; GO:0140657,cytokinesis; cytoskeletal motor activity; catalytic activity; nucleus; Golgi apparatus; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; membrane organization; ATP-dependent activity
OG_04186,0.8567653714692174,OG_04186,FUN_016706-T1,Peve_00034244,Pocillopora_meandrina_HIv1___RNAseq.g282.t2,three_way,70.44399999999999,FUN_016706-T1,Q8VDM6,HNRL1_MOUSE,,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Mus musculus (Mouse),50.9,399.0,8.3e-112,406.4,sp|Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Mus musculus OX=10090 GN=Hnrnpul1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0005654; GO:0019899; GO:0045202; GO:1990904,,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],enzyme binding [GO:0019899]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0043226,RNA binding; nucleus; nucleoplasm; organelle
OG_04594,0.85673199160665,OG_04594,FUN_022278-T1,Peve_00022094,Pocillopora_meandrina_HIv1___RNAseq.g4704.t1,three_way,78.5305,FUN_022278-T1,Q08CH6,CATIP_DANRE,,Ciliogenesis-associated TTC17-interacting protein,Danio rerio (Zebrafish) (Brachydanio rerio),43.1,341.0,9.5e-73,275.4,sp|Q08CH6|CATIP_DANRE Ciliogenesis-associated TTC17-interacting protein OS=Danio rerio OX=7955 GN=catip PE=1 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0060271; GO:0061371,actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005856; GO:0005886; GO:0043226; GO:0044782; GO:0065003,nucleus; cytoskeleton; plasma membrane; organelle; cilium organization; protein-containing complex assembly
OG_08482,0.8567293189930515,OG_08482,FUN_037313-T1,Peve_00006178,Pocillopora_meandrina_HIv1___RNAseq.g10707.t1,three_way,74.689,FUN_037313-T1,Q32PP9,,,,,66.0,94.0,6.7e-27,122.5,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_04982,0.8565884960053737,OG_04982,FUN_023109-T1,Peve_00001973,Pocillopora_meandrina_HIv1___RNAseq.g1688.t1,three_way,60.158,FUN_023109-T1,Q5VV63,ATRN1_HUMAN,,Attractin-like protein 1,Homo sapiens (Human),32.3,1320.0,4.1e-183,643.7,sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2,GO:0005112; GO:0007186; GO:0016020; GO:0030246,G protein-coupled receptor signaling pathway [GO:0007186],membrane [GO:0016020],carbohydrate binding [GO:0030246]; Notch binding [GO:0005112],,
OG_02908,0.856383891744083,OG_02908,FUN_011985-T1,Peve_00000524,Pocillopora_meandrina_HIv1___RNAseq.g23714.t1,three_way,77.837,FUN_011985-T1,P21872,,,,,57.5,1039.0,0.0,1168.3,sp|P21872|PUR2_CHICK Trifunctional purine biosynthetic protein adenosine-3 OS=Gallus gallus OX=9031 GN=GART PE=1 SV=1,,,,,,
OG_02531,0.856141294165434,OG_02531,FUN_010606-T1,Peve_00032719,Pocillopora_meandrina_HIv1___RNAseq.g21491.t1,three_way,76.36316666666666,FUN_010606-T1,Q5SSZ7,ZNRF3_MOUSE,,E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3),Mus musculus (Mouse),50.3,302.0,2.7e-80,300.8,sp|Q5SSZ7|ZNRF3_MOUSE E3 ubiquitin-protein ligase ZNRF3 OS=Mus musculus OX=10090 GN=Znrf3 PE=1 SV=1,GO:0004842; GO:0005109; GO:0005886; GO:0006511; GO:0008270; GO:0016055; GO:0016567; GO:0030178; GO:0038018; GO:0060173; GO:0060828; GO:0072089; GO:0090090; GO:2000051; GO:2000095,"limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]",plasma membrane [GO:0005886],frizzled binding [GO:0005109]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_02644,0.8560569128812437,OG_02644,FUN_010814-T1,Peve_00006521,Pocillopora_meandrina_HIv1___RNAseq.g20908.t1,three_way,94.45533333333331,FUN_010814-T1,Q96BR1,SGK3_HUMAN,,Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like),Homo sapiens (Human),64.1,485.0,1e-175,617.8,sp|Q96BR1|SGK3_HUMAN Serine/threonine-protein kinase Sgk3 OS=Homo sapiens OX=9606 GN=SGK3 PE=1 SV=1,GO:0001558; GO:0004672; GO:0004674; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0006468; GO:0015459; GO:0017080; GO:0017081; GO:0030334; GO:0035091; GO:0035556; GO:0042127; GO:0051090; GO:0055037; GO:0106310; GO:2001240,intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090],cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037],ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080],GO:0003824; GO:0005768; GO:0005829; GO:0006355; GO:0008289; GO:0016740; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endosome; cytosol; regulation of DNA-templated transcription; lipid binding; transferase activity; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09086,0.8559401176704581,OG_09086,FUN_038833-T1,Peve_00028686,Pocillopora_meandrina_HIv1___RNAseq.21094_t,three_way,62.954166666666666,FUN_038833-T1,O15169,AXIN1_HUMAN,,Axin-1 (Axis inhibition protein 1) (hAxin),Homo sapiens (Human),27.2,904.0,3.3e-52,208.4,sp|O15169|AXIN1_HUMAN Axin-1 OS=Homo sapiens OX=9606 GN=AXIN1 PE=1 SV=2,GO:0000209; GO:0001701; GO:0002039; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0010629; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043539; GO:0044725; GO:0045599; GO:0045732; GO:0046330; GO:0046332; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1990756; GO:1990909; GO:2000060,apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605],beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0006325; GO:0006355; GO:0006913; GO:0007010; GO:0012501; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0065003; GO:0098772,nucleus; nucleolus; cytosol; cytoskeleton; plasma membrane; chromatin organization; regulation of DNA-templated transcription; nucleocytoplasmic transport; cytoskeleton organization; programmed cell death; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity
OG_08095,0.8559372591038198,OG_08095,FUN_035833-T1,Peve_00002593,Pocillopora_meandrina_HIv1___RNAseq.g11963.t1,three_way,82.79166666666667,FUN_035833-T1,O74212,,,,,49.9,443.0,1.9999999999999999e-128,460.7,sp|O74212|D5FAD_MORAP Acyl-lipid (8-3)-desaturase OS=Mortierella alpina OX=64518 GN=DES1 PE=1 SV=1,,,,,,
OG_03644,0.8559091335480726,OG_03644,FUN_014875-T1,Peve_00012982,Pocillopora_meandrina_HIv1___RNAseq.g21044.t1,three_way,69.73266666666667,,,,,,,,,,,,,,,,,
OG_08267,0.8558839932220816,OG_08267,FUN_036179-T1,Peve_00027218,Pocillopora_meandrina_HIv1___RNAseq.g27513.t1,three_way,49.457,FUN_036179-T1,O94763,,,,,33.3,249.0,4.4e-29,130.6,sp|O94763|RMP_HUMAN Unconventional prefoldin RPB5 interactor 1 OS=Homo sapiens OX=9606 GN=URI1 PE=1 SV=3,,,,,,
OG_01021,0.8558037913004173,OG_01021,FUN_004453-T1,Peve_00024317,Pocillopora_meandrina_HIv1___RNAseq.g5040.t1,three_way,69.144,FUN_004453-T1,Q5GN48,DMD_PIG,,Dystrophin,Sus scrofa (Pig),36.3,557.0,9.2e-96,352.4,sp|Q5GN48|DMD_PIG Dystrophin OS=Sus scrofa OX=9823 GN=DMD PE=1 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0007519; GO:0008270; GO:0016010; GO:0042383; GO:0045211; GO:0048666; GO:0055001; GO:0090257; GO:0099536; GO:0120025,muscle cell development [GO:0055001]; neuron development [GO:0048666]; regulation of muscle system process [GO:0090257]; skeletal muscle tissue development [GO:0007519]; synaptic signaling [GO:0099536],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; plasma membrane bounded cell projection [GO:0120025]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383],actin binding [GO:0003779]; zinc ion binding [GO:0008270],GO:0005856; GO:0005886; GO:0008092; GO:0023052; GO:0043226; GO:0048856,cytoskeleton; plasma membrane; cytoskeletal protein binding; signaling; organelle; anatomical structure development
OG_05479,0.855466226079323,OG_05479,FUN_024473-T1,Peve_00002830,Pocillopora_meandrina_HIv1___RNAseq.g18567.t1,three_way,52.34666666666666,FUN_024473-T1,P97460,NPAS2_MOUSE,,Neuronal PAS domain-containing protein 2 (Neuronal PAS2),Mus musculus (Mouse),34.6,413.0,1.1999999999999999e-46,190.7,sp|P97460|NPAS2_MOUSE Neuronal PAS domain-containing protein 2 OS=Mus musculus OX=10090 GN=Npas2 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006974; GO:0007623; GO:0009410; GO:0032922; GO:0042745; GO:0042752; GO:0045475; GO:0045739; GO:0045893; GO:0045944; GO:0046872; GO:0046983; GO:0051775; GO:2000987,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; DNA damage response [GO:0006974]; locomotor rhythm [GO:0045475]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; response to redox state [GO:0051775]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_03142,0.8554651557208465,OG_03142,FUN_012527-T1,Peve_00013904,Pocillopora_meandrina_HIv1___RNAseq.g23975.t1,three_way,73.94666666666667,FUN_012527-T1,Q6REY9,,,,,36.4,571.0,4.2e-87,325.1,sp|Q6REY9|RHG20_RAT Rho GTPase-activating protein 20 OS=Rattus norvegicus OX=10116 GN=Arhgap20 PE=1 SV=2,,,,,,
OG_08983,0.8553438585556373,OG_08983,FUN_038502-T1,Peve_00013538,Pocillopora_meandrina_HIv1___RNAseq.g28192.t1,three_way,75.99333333333333,FUN_038502-T1,Q7RTV0,PHF5A_HUMAN,,PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b),Homo sapiens (Human),97.1,104.0,8.6e-59,229.9,sp|Q7RTV0|PHF5A_HUMAN PHD finger-like domain-containing protein 5A OS=Homo sapiens OX=9606 GN=PHF5A PE=1 SV=1,GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011; GO:1903241,"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of DNA-templated transcription [GO:0045893]; stem cell differentiation [GO:0048863]; U2-type prespliceosome assembly [GO:1903241]",nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0030154; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_03570,0.8552876857800011,OG_03570,FUN_014724-T1,Peve_00006846,Pocillopora_meandrina_HIv1___RNAseq.g22497.t1,three_way,52.973,,,,,,,,,,,,,,,,,
OG_03161,0.8552861602227626,OG_03161,FUN_012557-T1,Peve_00030425,Pocillopora_meandrina_HIv1___TS.g16464.t1,three_way,86.991,FUN_012557-T1,Q8IZN3,ZDH14_HUMAN,,Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14),Homo sapiens (Human),65.3,303.0,6.5e-121,435.6,sp|Q8IZN3|ZDH14_HUMAN Palmitoyltransferase ZDHHC14 OS=Homo sapiens OX=9606 GN=ZDHHC14 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580,peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0003824; GO:0005783; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08427,0.8551490478854911,OG_08427,FUN_037089-T1,Peve_00004758,Pocillopora_meandrina_HIv1___RNAseq.g11095.t1,three_way,84.80416666666667,FUN_037089-T1,Q9NQ94,,,,,49.9,583.0,6.8e-140,499.2,sp|Q9NQ94|A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens OX=9606 GN=A1CF PE=1 SV=1,,,,,,
OG_06420,0.8548439569780597,OG_06420,FUN_029108-T1,Peve_00017655,Pocillopora_meandrina_HIv1___RNAseq.g25465.t1,three_way,91.391,FUN_029108-T1,Q3SZ71,MPPB_BOVIN,,Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP),Bos taurus (Bovine),69.1,469.0,1.3000000000000006e-186,654.1,sp|Q3SZ71|MPPB_BOVIN Mitochondrial-processing peptidase subunit beta OS=Bos taurus OX=9913 GN=PMPCB PE=2 SV=1,GO:0004222; GO:0005739; GO:0005759; GO:0006627; GO:0046872,protein processing involved in protein targeting to mitochondrion [GO:0006627],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_00816,0.8548359319822116,OG_00816,FUN_004029-T1,Peve_00003922,Pocillopora_meandrina_HIv1___TS.g18515.t2,three_way,93.10066666666664,FUN_004029-T1,Q9R050,,,,,40.6,414.0,1.6999999999999998e-53,211.5,sp|Q9R050|SSBP3_RAT Single-stranded DNA-binding protein 3 OS=Rattus norvegicus OX=10116 GN=Ssbp3 PE=1 SV=1,,,,,,
OG_10017,0.8547949578234058,OG_10017,FUN_043254-T1,Peve_00030637,Pocillopora_meandrina_HIv1___RNAseq.g8858.t1,three_way,79.7325,,,,,,,,,,,,,,,,,
OG_08321,0.8547873208923087,OG_08321,FUN_036748-T1,Peve_00029513,Pocillopora_meandrina_HIv1___RNAseq.g12118.t1,three_way,83.22666666666667,FUN_036748-T1,Q5ZJ85,PRPF3_CHICK,,U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3),Gallus gallus (Chicken),52.0,696.0,1.8000000000000006e-165,584.3,sp|Q5ZJ85|PRPF3_CHICK U4/U6 small nuclear ribonucleoprotein Prp3 OS=Gallus gallus OX=9031 GN=PRPF3 PE=2 SV=1,GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0016607; GO:0046540,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]",nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540],,GO:0005634; GO:0016071; GO:0043226; GO:0065003,nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_02267,0.8546959618550487,OG_02267,FUN_008716-T1,Peve_00034975,Pocillopora_meandrina_HIv1___RNAseq.g74.t1,three_way,91.29516666666667,FUN_008716-T1,P16036,,,,,73.7,354.0,1.1e-145,517.7,sp|P16036|S25A3_RAT Solute carrier family 25 member 3 OS=Rattus norvegicus OX=10116 GN=Slc25a3 PE=1 SV=1,,,,,,
OG_06818,0.8546648613356258,OG_06818,FUN_031724-T1,Peve_00000894,Pocillopora_meandrina_HIv1___TS.g24210.t1,three_way,56.0895,FUN_031724-T1,Q9P219,DAPLE_HUMAN,,Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues) (hDaple) (Hook-related protein 2) (HkRP2),Homo sapiens (Human),35.4,432.0,7.8e-60,235.3,sp|Q9P219|DAPLE_HUMAN Protein Daple OS=Homo sapiens OX=9606 GN=CCDC88C PE=1 SV=3,GO:0001578; GO:0001965; GO:0003383; GO:0005085; GO:0005109; GO:0005576; GO:0005737; GO:0005813; GO:0007026; GO:0007264; GO:0008017; GO:0030054; GO:0030165; GO:0030705; GO:0031122; GO:0031648; GO:0035567; GO:0042802; GO:0043296; GO:0044782; GO:0046330; GO:0046983; GO:0051959; GO:0060071; GO:0090090; GO:0120197; GO:1902691,"apical constriction [GO:0003383]; cilium organization [GO:0044782]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule bundle formation [GO:0001578]; mucociliary clearance [GO:0120197]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of JNK cascade [GO:0046330]; protein destabilization [GO:0031648]; respiratory basal cell differentiation [GO:1902691]; small GTPase-mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",apical junction complex [GO:0043296]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular region [GO:0005576],dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983],GO:0003016; GO:0005576; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0030154; GO:0044782; GO:0098772,respiratory system process; extracellular region; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; cell differentiation; cilium organization; molecular function regulator activity
OG_02853,0.8546517497539764,OG_02853,FUN_011890-T1,Peve_00042786,Pocillopora_meandrina_HIv1___RNAseq.g13675.t1,three_way,73.18133333333333,FUN_011890-T1,Q9ULI1,,,,,28.0,898.0,2.4e-78,296.2,sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3,,,,,,
OG_05460,0.8546243488811095,OG_05460,FUN_024439-T1,Peve_00004162,Pocillopora_meandrina_HIv1___RNAseq.g18714.t1,three_way,80.35366666666667,FUN_024439-T1,Q9Z206,ARHG8_MOUSE,,Neuroepithelial cell-transforming gene 1 protein (Rho guanine nucleotide exchange factor 8),Mus musculus (Mouse),45.5,444.0,1.8000000000000002e-104,381.3,sp|Q9Z206|ARHG8_MOUSE Neuroepithelial cell-transforming gene 1 protein OS=Mus musculus OX=10090 GN=Net1 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005737; GO:0005886; GO:0031267; GO:0035556; GO:0043065; GO:0043547; GO:0051451; GO:0070301; GO:0071479; GO:1900026,cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005634; GO:0005886; GO:0043226; GO:0048870; GO:0098772,nucleus; plasma membrane; organelle; cell motility; molecular function regulator activity
OG_09613,0.8545411297941194,OG_09613,FUN_041771-T1,Peve_00021185,Pocillopora_meandrina_HIv1___RNAseq.g15894.t1,three_way,85.66066666666667,FUN_041771-T1,P17870,ARRB1_BOVIN,,Beta-arrestin-1 (Arrestin beta-1) (Arrestin-2),Bos taurus (Bovine),64.8,341.0,1.1000000000000001e-118,427.9,sp|P17870|ARRB1_BOVIN Beta-arrestin-1 OS=Bos taurus OX=9913 GN=ARRB1 PE=1 SV=1,GO:0000822; GO:0001664; GO:0001934; GO:0002029; GO:0002031; GO:0002092; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0007165; GO:0015031; GO:0030132; GO:0030276; GO:0031143; GO:0031410; GO:0031623; GO:0032050; GO:0033130; GO:0035612; GO:0036094; GO:0045746; GO:0060090; GO:0070374; GO:0072583,clathrin-dependent endocytosis [GO:0072583]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],"acetylcholine receptor binding [GO:0033130]; AP-2 adaptor complex binding [GO:0035612]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; G protein-coupled receptor binding [GO:0001664]; inositol hexakisphosphate binding [GO:0000822]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small molecule binding [GO:0036094]",GO:0005634; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0060090,nucleus; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_01567,0.8545277314230226,OG_01567,FUN_006449-T1,Peve_00038439,Pocillopora_meandrina_HIv1___RNAseq.g20307.t1b,three_way,72.05333333333333,FUN_006449-T1,Q6ZWJ1,STXB4_HUMAN,,Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip),Homo sapiens (Human),28.6,768.0,1.2e-64,250.0,sp|Q6ZWJ1|STXB4_HUMAN Syntaxin-binding protein 4 OS=Homo sapiens OX=9606 GN=STXBP4 PE=1 SV=2,GO:0006605; GO:0006974; GO:0008286; GO:0010827; GO:0010838; GO:0019905; GO:0031410; GO:0045335; GO:0050821; GO:0061178; GO:0070062; GO:0071346; GO:1902808,cellular response to type II interferon [GO:0071346]; DNA damage response [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178],cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335],syntaxin binding [GO:0019905],GO:0031410; GO:0043226,cytoplasmic vesicle; organelle
OG_00352,0.8544775158977659,OG_00352,FUN_001180-T1,Peve_00018946,Pocillopora_meandrina_HIv1___RNAseq.g29544.t1,three_way,57.39666666666667,FUN_001180-T1,E9Q7E2,ARID2_MOUSE,,AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200),Mus musculus (Mouse),33.1,834.0,1.3e-106,390.2,sp|E9Q7E2|ARID2_MOUSE AT-rich interactive domain-containing protein 2 OS=Mus musculus OX=10090 GN=Arid2 PE=1 SV=1,GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005654; GO:0005667; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008270; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0045944; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:0072359; GO:1905168; GO:2000045; GO:2000781; GO:2000819,cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0005886; GO:0006325; GO:0006355; GO:0043226; GO:0048856,DNA binding; nucleoplasm; plasma membrane; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development
OG_04661,0.8543857581531258,OG_04661,FUN_022406-T1,Peve_00037585,Pocillopora_meandrina_HIv1___TS.g21958.t2,three_way,79.75416666666666,FUN_022406-T1,Q8BXK8,AGAP1_MOUSE,,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 (AGAP-1) (Centaurin-gamma-2) (Cnt-g2)",Mus musculus (Mouse),46.3,525.0,1e-111,405.6,"sp|Q8BXK8|AGAP1_MOUSE Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 OS=Mus musculus OX=10090 GN=Agap1 PE=1 SV=1",GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0008270; GO:0015031,protein transport [GO:0015031],cytosol [GO:0005829],GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270],GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0098772,catalytic activity; GTPase activity; cytosol; hydrolase activity; molecular function regulator activity
OG_04336,0.8542479327483974,OG_04336,FUN_017948-T1,Peve_00000381,Pocillopora_meandrina_HIv1___RNAseq.g25232.t1,three_way,82.87233333333333,,,,,,,,,,,,,,,,,
OG_02997,0.8542413170056771,OG_02997,FUN_012176-T1,Peve_00040994,Pocillopora_meandrina_HIv1___RNAseq.g23858.t1,three_way,63.23466666666666,FUN_012176-T1,Q709C8,VP13C_HUMAN,,Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C),Homo sapiens (Human),24.7,4222.0,0.0,1083.2,sp|Q709C8|VP13C_HUMAN Intermembrane lipid transfer protein VPS13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090,Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of type 2 mitophagy [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741],,GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0006886; GO:0007005; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; lipid droplet; cytosol; intracellular protein transport; mitochondrion organization; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09942,0.8541816930026093,OG_09942,FUN_043106-T1,Peve_00014958,Pocillopora_meandrina_HIv1___RNAseq.g7005.t1,three_way,83.65,FUN_043106-T1,Q17GZ9,,,,,39.5,731.0,1.6e-124,448.4,sp|Q17GZ9|ARP5_AEDAE Actin-related protein 5 OS=Aedes aegypti OX=7159 GN=Arp5 PE=3 SV=1,,,,,,
OG_08254,0.853397405428,OG_08254,FUN_036164-T1,Peve_00027211,Pocillopora_meandrina_HIv1___RNAseq.g27499.t1,three_way,89.75383333333333,FUN_036164-T1,Q5RC80,RBM39_PONAB,,RNA-binding protein 39 (RNA-binding motif protein 39),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),58.2,385.0,3.1e-117,423.7,sp|Q5RC80|RBM39_PONAB RNA-binding protein 39 OS=Pongo abelii OX=9601 GN=RBM39 PE=2 SV=1,GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733,"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]",centriolar satellite [GO:0034451]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; RS domain binding [GO:0050733],GO:0003723; GO:0016071; GO:0043226,RNA binding; mRNA metabolic process; organelle
OG_07280,0.8533842459818564,OG_07280,FUN_033223-T1,Peve_00021001,Pocillopora_meandrina_HIv1___RNAseq.g29776.t1,three_way,67.0795,,,,,,,,,,,,,,,,,
OG_03251,0.853322234640401,OG_03251,FUN_012973-T1,Peve_00026801,Pocillopora_meandrina_HIv1___RNAseq.g12974.t1,three_way,78.81466666666667,FUN_012973-T1,B1AJZ9,FHAD1_HUMAN,,Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1),Homo sapiens (Human),25.4,1528.0,7.0000000000000006e-34,148.3,sp|B1AJZ9|FHAD1_HUMAN Forkhead-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHAD1 PE=1 SV=2,GO:0036126,,sperm flagellum [GO:0036126],,GO:0005929; GO:0043226,cilium; organelle
OG_01660,0.853307169854557,OG_01660,FUN_006843-T1,Peve_00023777,Pocillopora_meandrina_HIv1___RNAseq.g20469.t1,three_way,55.36333333333334,,,,,,,,,,,,,,,,,
OG_04950,0.8532480086672022,OG_04950,FUN_023040-T1,Peve_00008504,Pocillopora_meandrina_HIv1___RNAseq.g3859.t1,three_way,86.40083333333334,FUN_023040-T1,Q28479,IDH3B_MACFA,,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),57.6,337.0,1.3e-112,407.9,"sp|Q28479|IDH3B_MACFA Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial OS=Macaca fascicularis OX=9541 GN=IDH3B PE=2 SV=2",GO:0000287; GO:0005739; GO:0006099; GO:0006102; GO:0016616; GO:0051287,isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],mitochondrion [GO:0005739],"magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_00572,0.8532119675945075,OG_00572,FUN_001631-T1,Peve_00029327,Pocillopora_meandrina_HIv1___RNAseq.g2162.t1,three_way,60.284333333333336,FUN_001631-T1,Q5FWK3,RHG01_MOUSE,,Rho GTPase-activating protein 1 (Rho-type GTPase-activating protein 1),Mus musculus (Mouse),47.0,372.0,3.2e-91,337.4,sp|Q5FWK3|RHG01_MOUSE Rho GTPase-activating protein 1 OS=Mus musculus OX=10090 GN=Arhgap1 PE=1 SV=1,GO:0001726; GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0007264; GO:0010008; GO:0016197; GO:0017124; GO:0031252; GO:0031267; GO:0033572; GO:0048471; GO:0097443; GO:2001136,endosomal transport [GO:0016197]; negative regulation of endocytic recycling [GO:2001136]; small GTPase-mediated signal transduction [GO:0007264]; transferrin transport [GO:0033572],cell leading edge [GO:0031252]; cilium [GO:0005929]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; sorting endosome [GO:0097443],GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267],GO:0005768; GO:0005829; GO:0005886; GO:0005929; GO:0016192; GO:0031410; GO:0043226; GO:0098772,endosome; cytosol; plasma membrane; cilium; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_05444,0.8530486042175298,OG_05444,FUN_024399-T1,Peve_00021813,Pocillopora_meandrina_HIv1___RNAseq.g18632.t1,three_way,82.354,FUN_024399-T1,Q9QZN3,,,,,52.8,267.0,1.5e-81,304.3,sp|Q9QZN3|FBX8_MOUSE F-box only protein 8 OS=Mus musculus OX=10090 GN=Fbxo8 PE=2 SV=2,,,,,,
OG_00493,0.8530427567103182,OG_00493,FUN_001463-T1,Peve_00027128,Pocillopora_meandrina_HIv1___RNAseq.g1963.t1,three_way,62.418,FUN_001463-T1,Q5S007,LRRK2_HUMAN,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin),Homo sapiens (Human),28.8,2337.0,8.6e-257,889.4,sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2,GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005615; GO:0005654; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0007040; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0061024; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; extracellular space; nucleoplasm; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
